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Our understanding of the folding of membrane proteins lags behind that of soluble proteins 
due to the challenges posed by the exposure of hydrophobic regions during in vitro chemical 
denaturation and refolding experiments. While different folding models are accepted for 
soluble proteins, only the two-stage model and the long-range interactions model have been 
proposed so far for helical membrane proteins. 
 
To address our knowledge gap on how different membrane proteins traverse their folding 
landscapes, Chapter 2 investigates the structural features of SDS-denatured states and the 
kinetics for reversible unfolding of sensory rhodopsin II (pSRII), a retinal-binding 
photophobic receptor from Natronomonas pharaonis. pSRII is difficult to denature, and only 
SDS can dislodge the retinal chromophore without rapid aggregation. Even in 30% SDS 
(0.998 ΧSDS), pSRII retains the equivalent of six out of seven transmembrane helices, while 
the retinal binding pocket is disrupted, with transmembrane residues becoming more 
solvent-exposed. Folding of pSRII from an SDS-denatured state harbouring a 
covalently-bound retinal chromophore shows deviations from an apparent two-state 
behaviour. SDS denaturation to form the sensory opsin apo-protein is reversible. This chapter 
establishes pSRII as a new model protein which is suitable for membrane protein folding 
studies and has a unique folding mechanism that differs from those of bacteriorhodopsin and 
bovine rhodopsin. 
 
In Chapter 3, SDS-denatured pSRII, acid-denatured pSRII and sensory opsin obtained by 
hydroxylamine-mediated bleaching of pSRII were characterised by solution-state NMR. 1D 
1H and 19F NMR were first used to characterise global changes in backbone amide protons 
and tryptophan side-chains. Residue-specific changes in backbone amide chemical shifts and 
peak intensities in 2D [1H,15N]-correlation spectra were analysed. While only small changes 
in the chemical environment of backbone amides were detected, changes in backbone amide 
dynamics were identified as an important feature of SDS- and acid-denatured pSRII and 
sensory opsin. 15N relaxation experiments were performed to study the backbone amide 
dynamics of SDS-denatured pSRII, reflecting motions on different timescales, including fast 




contributions on the µs timescale. These studies shed insight on differences in the unfolding 
pathways under different denaturing conditions and the crucial role of the retinal 
chromophore in governing the structural integrity and dynamics of the pSRII helical bundle. 
 
Hydrogen bonds play fundamental roles in stabilising protein secondary and tertiary structure, 
and regulating protein function. Successful detection of hydrogen bonds in denatured states 
and during protein folding would contribute towards our understanding on the unfolding and 
folding pathways of the protein. Previous studies have demonstrated residue-specific 
detection of stable and transient hydrogen bonds in small globular proteins by measuring 1JNH 
scalar coupling constants using NMR. In Chapter 4, different methods for measuring 1JNH 
scalar coupling were explored using RalA, a small GTPase with a mixed alpha/beta fold, as 
proof-of-concept. Detection of hydrogen bonds was then attempted with OmpX, a beta-barrel 
membrane protein, both in its folded state in DPC micelles and in the urea-denatured state. 
While 1JNH measurement holds promise for studying hydrogen bond formation, further 
optimisation of NMR experiments and utilisation of perdeuterated samples are required to 
improve the precision of such measurements in large detergent-membrane protein complexes. 
 
Naturally-occurring split inteins can mediate spontaneous trans-splicing both in vivo and 
in vitro. Previous studies have demonstrated successful assembly of proteorhodopsin from 
two separate fragments consisting of helices A–B and helices C–G via a splicing site in the 
BC loop. To complement the in vitro unfolding/folding studies, pSRII assembly in vivo was 
attempted by introducing a splicing site in the loop region of the beta-hairpin constituting the 
BC loop of pSRII. The expression conditions for the N- and C-terminal pSRII-intein 
segments were optimised, and the two segments co-expressed. However, the native 
chromophore was not observed. Further optimisation is required for successful in vivo 
trans-splicing of pSRII and application of this approach towards understanding the roles of 
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1.1 Protein folding: lessons from soluble proteins 
Protein folding is a process of molecular self-assembly during which a polypeptide chain 
undergoes numerous conformational changes to form its functional structure. Understanding 
the mechanisms of protein folding has profound implications on biological research and 
medical applications. Misfolding, or failure of a protein to fold into its functional 
conformation, can lead to disruption of regulated cell functions and diseases through various 
mechanisms, including loss of function of the misfolded protein, cellular stress responses and 
cell death triggered by toxic accumulation of misfolded protein [1,2]. 
 
Studying how a protein folds to its native structure is far more complex than solving classical 
chemical mechanisms. While changes in only a small number of covalent bonds are involved 
in a chemical reaction, thousands of weak non-covalent interactions are being made or 
broken simultaneously during protein folding. Moreover, protein folding intermediates are 
very difficult to trap because of their unstable nature. Research into the protein folding 
problem has been ongoing for more than 50 years, during which different folding 
mechanisms of small, water-soluble proteins have been proposed and become 
well-characterised. By contrast, progress in understanding membrane protein folding were 
slower due to various experimental challenges [3], including the necessity of a membrane 
mimetic environment for in vitro studies and difficulties in finding suitable conditions for 
reversible unfolding. 
 
It has been known since 1961 that proteins fold spontaneously, and that the amino acid 
sequence encodes the final folded structures and information on how the protein folds [4]. 
Anfinsen formed the thermodynamic hypothesis of protein folding. It was postulated that the 
native conformations of proteins are at global free energy minima relative to all other states. 
Under thermodynamic control, folding is independent of the starting conformation and the 
pathway. Experimental evidence cited in support of the thermodynamic hypothesis is that the 
folding/unfolding reactions of many small proteins are reversible [5,6].  
 






The proposal of the “Levinthal’s paradox” in the late 1960s [7] led to the conclusion that 
proteins must fold via defined pathways (i.e. kinetic control), as an unbiased search through 
an astronomical number of conformations, which are theoretically available to the unfolded 
state of a protein, would take too long. Under kinetic control, the protein traverses a 
convoluted energy surface with multiple energy minima. Whether the protein reaches a 
global or local energetic minimum depends on the height of the energy barriers, the folding 
pathway and the starting conformation. 
 
The debate between these two viewpoints has continued, with numerous experimentalists and 
theoreticians investigating whether proteins reach their global energy minimum in a 
pathway-independent manner under thermodynamic control, or follow a specific pathway to 
either a local or the global minimum under kinetic control. Levinthal’s work initiated the 
search for folding pathways and characterisation of intermediate states in order to understand 
how an unfolded protein finds its native structure amongst the large number of possible 
conformations. 
 
1.1.1 Thermodynamics of protein folding 
The overall protein folding process must assume a negative change in Gibbs free energy in 
order to be spontaneous. The change in Gibbs free energy is a function of change in enthalpy 
(Δ%) and change in entropy (Δ&) at a given temperature (T): 
 Δ' = Δ% − *Δ& (1.1) 
 
The denatured state has considerable conformational freedom, and thus high entropy (S) 
based on the Boltzmann equation: 
 & = + ln. (1.2) 
where W is the number of accessible states and k is the Boltzmann constant. 
 
The denatured states of a protein constitute a collection of conformations with very similar 
energies and are in rapid equilibrium with one another. Many hydrophobic side chains are 
exposed to solvent, and hydrogen bond donors and acceptors are hydrogen-bonded to 
surrounding water molecules. The entropy and enthalpy of water molecules are lowered as 






individual molecules have less freedom and hydrogen bonds are made with the denatured 
protein. 
 
Under denaturing conditions, the denatured states are more thermodynamically favoured than 
other states. Molecular dynamics simulations suggest that aqueous denaturants, such as 
guanidinium hydrochloride (GdmCl) and urea, stabilise the denatured states by facilitating 
the solvation of their nonpolar surfaces [8]. Single-molecule fluorescence study shows that 
the GdmCl-denatured states of IgG-binding domain of protein L expand with increasing 
GdmCl concentrations [9]. Calculation of folding free energies from single-molecule data 
shows linear change in free energy across all denaturant concentrations, suggesting a gradual 
thermodynamic stabilisation of the denatured states in the presence of higher denaturant 
concentrations. Conformational entropy has a large contribution to the free energy of folding, 
as expansion of the denatured states necessitates a large change in entropy [8,9]. Various 
models have been proposed for the denaturing mechanism of surfactants, as 
protein-surfactant interactions are too diverse to be accommodated in one model [10]: 
(1) a “rod-like” prolate ellipsoidal protein-surfactant aggregate, in which the length depends 
on the protein molecular weight and the width of ~18 Å corresponds to the alkyl chain 
length of SDS [11]; 
(2) the decorated micelle model: the extended denatured protein wraps around a flexible 
capped cylindrical micelle, and the complex is stabilised by hydrogen bonds between the 
protein and detergent headgroups [12]; 
(3) the necklace-and-beads model: the polypeptide chain is considered to be mostly flexible, 
and micelles could form on different parts of the extended protein. Electrostatic repulsion 
between individual micelles is a driving force for protein denaturation [13,14]. 
The same protein may engage in different types of protein-micelle interactions during 
different stages of protein denaturation (Figure 1.1). Factors which determine the stability 
and properties of protein-micelle complexes include the protein structure, the type of 
surfactant, the protein-to-surfactant ratio, and solvent conditions [10]. 
 







Figure 1.1: Schematic representations of different stages in the denaturation of bovine 
acyl-coenzyme-A-binding protein (ACBP) 
In stage (a), ACBP binds SDS monomers without losing the native structure. Stage (b) involves the 
formation of a decorated micelle with 37 SDS molecules binding 2 ACBP molecules. In stage (c), 
further binding of SDS leads to a total of 40 SDS molecules forming a shell-like structure and binding 
to monomeric ACBP. Stage (d) shows a speculative structure representing the “necklace-and-beads” 
model which has been proposed for protein interactions with SDS micelles above the CMC. The 
hydrocarbon tails of SDS are represented with red dots, the headgroup and counterions of SDS are 
represented with green dots, and protein distribution is represented with blue dots. Figure retrieved 
from [15]. 
 
Protein folding is guided by different driving forces, mainly the formation of hydrophobic 
interactions and intramolecular hydrogen bonds, and is opposed by the loss of conformational 
entropy. The folding process also depends on the surrounding environment, including the 
type of solvent (aqueous environment vs. lipid bilayer), salt concentration, pH, temperature, 
and the presence of cofactors and molecular chaperones. Hydrophobicity is the dominant 
driving force in protein folding, leading to compact conformations with nonpolar cores [5] 
and contributing 1.1 ± 0.5 kcal/mol for every CH2 group that is buried upon folding [16]. 
A hydrogen bond contributes 1.1 ± 0.8 kcal/mol to protein stability [16]. Other forces are 
weaker but can also affect stability. These include disulphide bonds, electrostatic interactions, 
hydrogen bonds to buried charged side-chains, salt bridges, nàπ* interactions (electron 
delocalisation) between carbonyl groups, and gain in conformational entropy of water 
molecules [16]. 
 
The protein loses entropy as it folds, while the enthalpy of the packing of side-chains is 
favourable and compensates for the low entropy in the native state. The loss of 
conformational entropy of the protein is a major barrier to protein folding, and is estimated to 






be ~2.4 kcal/mol per residue [16]. The marginal stabilities of proteins arise from the small 
difference between the large driving and opposing forces of protein folding [16]. Water 
molecules are also released during protein folding. The gain in entropy of water molecules 
further compensates for the loss of conformational entropy in the protein. 
 
The thermodynamic description of chemical denaturation has traditionally been based on 
Tanford’s transfer model [6,17], which relates the free energy of folding to changes in 
solvation of amino acid residues when transferred from denaturant to water: 
 Δ'D0N = Δ'D0N234 − 5D0N[denaturant] (1.3) 
where Δ'D0N234 is the free energy of denaturation in water, and N and D refer to the native 
states and denatured states, respectively. 
 
The transfer model assumes that the folding process is represented by only the folded and the 
denatured conformations (i.e. two-state kinetics). 
 
The slope, 5D0N, can be expressed in terms of the free energy of transfer of group i from 
water to a denaturant solution with concentration of 1 M (>?@), and the fractional change in 
the solvent-accessible surface area (SASA) of group i between the folded and the unfolded 
states (>A@): 
 5D0N = ∑ >A@>?@@  (1.4) 
 
It is important to note that the free energy of a particular molecule at equilibrium depends 
only on the state of the molecule and is independent of the pathway by which it is formed. 
Measurements of the equilibrium distribution of different folding species (native, 
intermediates, denatured) yield only the relative thermodynamic properties of these species 
and not the pathway between them [6]. 
 
1.1.2 Kinetics of protein folding 
The classical models for protein folding are based on simple kinetic models proposed from 
raw data of single- or multi-exponential time decays of optical properties of the protein after 
a jump to folding or unfolding conditions [6]. While high-resolution structural information of 






the folded state can be obtained by X-ray crystallography or NMR, kinetic folding 
intermediates have short lifetimes and cannot be isolated for structural studies. Spectroscopic 
methods are typically used for studying kinetic folding intermediates. These techniques yield 
valuable kinetics information, but provide little structural information and only probe the 
average behaviour of the entire protein population. 
 
Two principal factors are required for kinetics studies [18]: 
(1) simultaneous population of the native (folded) and denatured states under conditions that 
can be related to conditions of the native state, for which the free energy of folding is 
desired; and 
(2) conditions in which the reaction is fast enough to reach equilibrium. 
 
Chemical denaturation in vitro offers an avenue for accessing selected conformations within 
the ensemble of structural states adopted by a protein whilst it is folding [19].  
 
Although protein folding is very complex and involves the formation and breaking of many 
weak non-covalent bonds, this process follows simple rate laws that are governed by a few 
basic principles. 
 
“Two-state” kinetics refers to a single exponential decay being observed in both the folding 
and unfolding directions, meaning the data can be fitted by assuming only the presence of a 
native state (N) and a denatured state (D). The transition state is the ensemble of states which 
differ slightly from one another in energy around the saddle point of the energy surface. On 
average, the transition states ensemble is intermediate in structure between the denatured and 
native states. Denaturants lower the activation energy for unfolding and raise the activation 
energy for folding. The transition state is stabilised by denaturant with respect to the native 
structure, but is destabilised relative to the denatured state. The stabilisation energy terms are 
linear with denaturant concentration ([denaturant]) (Figure 1.2a): 
 Δ'‡0N = Δ'‡0N234 − 5‡0N[denaturant] (1.5) 
 Δ'‡0D = Δ'‡0D234 +5‡0D[denaturant] (1.6) 
 






Many small proteins demonstrate two-state behaviour. A plot of the natural logarithm of the 
rate constant for unfolding (ku) against [denaturant] is linear (Figure 1.2b): 
 ln +E = ln+E234 + 5E[denaturant] (1.7) 
where +E234 is the rate constant for unfolding in the absence of denaturant obtained by 
extrapolation and 5E is the constant of proportionality.  
 
The natural logarithm of the rate constant for folding (kf) is also linear against [denaturant]: 
 ln +F = ln +F234 +5F[denaturant] (1.8) 
 
The two curves combine to form a V-shaped kinetics curve, also known as the chevron plot 
(Figure 1.2b): 
 ln +GHI = ln J+F234exp(−5F[denaturant]) + +E234exp(5E[denaturant])O (1.9) 
 
The total free energy of unfolding and the corresponding m value can be derived from 
kinetics data: 
 Δ'D0N234 = −P* lnQ+E234 +F234R S (1.10) 
 5D0N234 = −P*(5E + 5F) (1.11) 
 







Figure 1.2: Energy diagram and chevron plot for two-state kinetics and three-state kinetics 
(a–b) Two state kinetics. (a) Energy diagram, showing that the denatured state (D) and the native 
state (N) have a free energy difference of ΔGD–N and are separated by one transition state (‡) which 
determines the folding (kf) and unfolding (ku) rate constants. (b) Two-state kinetics yield linear 
folding and unfolding arms on the chevron plot. The inset shows the corresponding energy diagrams 
at three denaturant concentrations (yellow, green and purple dots), illustrating that denaturant 
stabilises ‡ and D relative to N. (c–d) Three-state kinetics with an on-pathway intermediate (I). (c) 
The major transition state is between I and N, and hence ΔGI–N is observed. (d) Non-linearity 
(“roll-over”) is observed in the chevron plot because apparent kf = kI–N < kD–N. See main text for 
information on ln +F234, ln +E234 and m values. Figure adapted from [6]. 
 






It is essential to measure the refolding arm of the chevron plot down to zero denaturant in 
order to conclusively demonstrate that there is no deviation from the kinetics in the presence 
of low concentrations of denaturant during refolding. Exposure of hydrophobic surfaces in 
denatured states could lead to aggregation, leading to artifacts in the kinetics that could be 
mistaken for the presence of folding intermediates. The dependence of refolding kinetics on 
protein concentration must therefore be assessed carefully. 
 
The energy landscape around transition states can be probed by structure-reactivity 
relationships. Protein folding studies of mutants effectively move the protein along the 
reaction coordinate. The Tanford TU value provides an index for the position of the transition 
state along the reaction coordinate and its compactness; it is a measure of the average degree 
of exposure in the transition state relative to that of the denatured state from the native state: 




where A@‡ and A@ are the fractional degrees of exposure in the transition state and denatured 
state, respectively, and >?@ is the free energy of transfer from water to a denaturant solution 
with concentration of 1 M. 
 
Protein engineering approaches have been employed to study the structures of transition 
states and intermediates. ϕ-value analysis involves making mutations to introduce small 
changes and remove a specific interaction which stabilises the native structure, and 
measuring the kinetics of folding/unfolding and changes in equilibrium stability (ΔΔ'N0D) in 
different mutants. Structures of transition states and intermediates may be inferred from 
changes in kinetics and equilibria upon mutation. 
 ϕ = ^^_‡`D^^_N`D (1.13) 
 
The observation of simple two-state kinetics does not necessarily prove that there are no 
intermediates on the folding pathway. Multistate denaturation equilibria might exhibit 
apparent two-state behaviour if the intermediates are present at low concentrations or have 
high energies and are kinetically undetectable. 
 






More complex models are required if multiple exponentials are observed, indicating the 
presence of more than two states. Three procedures have been described that are effective for 
detecting intermediates for both apparent two-state kinetics and multi-state kinetics: 
1) The ratio of ku and kf for a two-state transition must give the same equilibrium constant 
(Keq) as that measured directly by solvent denaturation determined using the ratio of 
denatured state concentration ([D]) and native state concentration ([N]): 
 abc = dedf =
[g]
[h] (1.14) 
For a three-state reaction in which there is one intermediate state (I), and the rate-limiting 
step and the major transition state are between I and N, the ratio of the rate constants for 
the apparent folding step (kf) and for unfolding in water (+E234) gives the equilibrium 
constant between I and N, and not between D and N (Figure 1.2c): 
 +F = +i→h < +g→h (1.15) 
2) The sum of the forward and reverse m values must be equal to the m value for 
equilibrium unfolding for a two-state transition (Figure 1.2a): 
 5‡0N +5‡0D = 5D0N (1.16) 
where all terms are algebraically positive 
3) Deviation from linearity (“roll-over”) is observed in either/both arms of the chevron plot, 
where the calculated rate constant(s) derived from a linear extrapolation is much higher 
than the observed rate constant(s) (Figure 1.2d). 
 
Intermediate states can be on pathway: 
 D
dlm⇌dml I
dmo⇌dom N (1.17) 
or off pathway: 
 I
dml⇌dlm D
dlo⇌dol N (1.18) 
where kXY denotes the rate constant for the forward or the reverse reaction in the equilibrium 
between states X and Y. 
 
Hence, the formation of N speeds up with the accumulation of I in the on-pathway model, but 
slows down in the off-pathway model. 
 






According to the on-pathway model, the folding rate is: 
 +F = pi+ih (1.19) 
where pi is the fraction of the total protein molecules in the I state. 
 
According to the off-pathway model, 
 +F = (1 − pi)+gh (1.20) 
 
Hence, in the on pathway model, roll-over in the chevron plot occurs because [20]: 
+F ∝ +gi+ih/+ig when pi ≪ 1 (i.e. low [denaturant] and +gi < +ig); 
+F ∝ +uv when pi~1. 
 
On the other hand, roll-over in the chevron plot occurs in the off-pathway model because: 
+F ∝ +gh when pi ≪ 1; 
+F ∝ (1 − pi)+gh when pi~1. 
 
Since protein folding kinetics studies often focus on monitoring the disappearance of D or the 
formation of N, it is very difficult to determine whether the observed “intermediate” is on or 
off the pathway. In principle, on pathway intermediates cause a lag in the rate of formation of 
N, whereas off pathway intermediates lead to a burst of formation of N followed by slower 
folding, as there is initially rapid partitioning of D to I and N followed by slower folding 
from I to N via D. However, given that the rate constant for the formation of I is much greater 
than that for N, detection of the lag or burst phase is difficult and requires exquisite data 
sensitivity. The best method would be to measure the accumulation of a detectable 
intermediate. However, direct observation of the intermediate state is very challenging in 
protein folding studies since folding intermediates usually have short lifetimes relative to 
experimentally-accessible timescales, and the sum of all spectroscopic signals from D, I and 
N is usually being collected [6]. 
 
Multistate kinetics which do not constitute as the typical three-state system have also been 
observed for a handful of soluble proteins. For example, 86% of hen egg white lysozyme 
molecules fold via an intermediate due to a kinetic trap at low GdmCl concentrations. This 
leads to an accumulation of the intermediate and slowing down of the folding rate. The 






remaining 14% of the molecules escape this kinetic trap and fold directly from the denatured 
state to the native state [21]. Complex kinetics are also observed for dihydrofolate reductase 
(DHFR). Native DHFR is composed of the NADPH-binding conformation and the 
non-NADPH-binding conformation, and there are separate folding and unfolding pathways 
for both conformations [22]. 
 
Proline cis–trans isomerisation also plays an important role in the kinetics and the 
rate-determining steps of protein folding [23]. The equilibrium constant for the normal 
peptide bond in proteins favours the trans conformation by a factor of 103–104 due to 
interactions of the Cαi and Hαi with Cαi+1 and Hαi+1 in the cis conformation, along with the 
more favourable electrostatic interactions between Oi and C’i+1. Proline groups exist 
essentially in either the cis or the trans form in native proteins because they are almost 
isoenergetic. At ambient temperatures, proline isomerisation occurs with half-life of 10–100 s, 
which is generally much slower than conformational folding [6]. An equilibrium mixture of 
the cis and trans forms is also present in unfolded proteins. Several slow refolding phases are 
observed as the different isomers fold in parallel. Classic hallmarks of proline isomerisation 
include slow reaction with an activation energy of 20 kcal/mol, possibly due to the partial 
double-bond character of the peptide bond, and catalysis by peptidylprolyl isomerases [23]. 
 
The kinetic and structural simplicity of proline isomerisation (which is essentially 
conformational change in the peptide bond dihedral angle ω) provides an assay for 
conformational changes and folding pathways [23]. Ribonuclease (RNase A) has four 
prolines, of which Pro-93 and Pro-114 are cis in the native state, and Pro-42 and Pro-117 are 
trans [24]. GdmCl-unfolded RNase A contains a heterogeneous mixture of cis/trans proline 
isomers. Double-jump refolding experiments on the wild-type and proline-to-alanine mutants 
of RNase A involving a first jump to high GdmCl concentrations followed by a second jump 
to dilute the GdmCl enabled the contributions of the three essential prolines to the five 
observed refolding phases to be elucidated [25,26]. It is postulated that non-native proline 
isomers induce localised disruptions by altering local peptide-peptide hydrogen bonds (local 
secondary structure) which are essential for subsequent steps of protein folding [23]. For 
example, the native cis isomer of Pro-93 naturally forms a β-turn, which may then act as the 
folding nucleus, catalysing the formation of the two-stranded β-hairpin [23,27]. Conversely, 






the non-native trans isomer of Pro-93 disrupts the native β-turn, thus inhibiting the formation 
of the adjacent β-hairpin motif [23,28]. In this case, formation of the native hairpin would 
require nucleation by longer range interactions, and might also compete against the formation 
of non-native local structure, both of which would lead to slow conformational folding [23]. 
 
1.1.3 Classical view: Folding pathways 
Three classical models have emerged from protein folding research on soluble proteins [6,29] 
(Figure 1.3): 
(1) framework model [30,31], 
(2) hydrophobic collapse [32–34], and 
(3) nucleation condensation [35,36]. 
 
At one extreme, the framework (or hierarchic) model postulates stepwise formation of 
structure beginning with rapid formation of local secondary structures, which function as a 
scaffold for subsequent interactions between different secondary structure elements to form 
more advanced folding intermediate(s) and the tertiary structure. Diffusion-collision involves 
the formation of “microdomains” of secondary structures, which diffuse, collide and coalesce 
to form the native tertiary structure [37]. The framework model implies the existence of 
folding intermediates. Early intermediates have secondary structures fluctuating around their 
native positions; late intermediates are compact, have native-like architecture, but lack the 
unique native tertiary structure. Each step forward in the folding process provides 
stabilisation of the major structural elements formed at the previous stage. 
 
 







Figure 1.3: The three classical mechanisms for protein folding 
In the framework model, early intermediates feature secondary structures fluctuating around their 
native positions. These elements diffuse and collide to form late intermediates with compact, 
native-like architecture and well-formed secondary structure elements. The hallmarks of the 
nucleation condensation model are the lack of folding intermediates and no fully-formed secondary or 
tertiary structures in the transition state. Hydrophobic collapse involves the formation of a compact 
molten globule state followed by its rearrangement to form the native structure. Figure adapted from 
[6]. 
 
The framework model is exemplified by Bacillus amyloliquefaciens ribonuclease (barnase). 
Barnase has an α + β structure with a major helix, two smaller helices, and an antiparallel 
β-sheet with five strands. There is a well-packed hydrophobic core formed by the major helix 
packing against one face of the sheet. All the peptidyl-proline bonds are in the trans 
conformation [38]. Detection of amide-to-amide NOEs by NMR shows that the denatured 
ensemble contains helical structure in the C-terminal portion of helix 1 and non-native 
hydrophobic clustering between β-strands 3 and 4 [39]. Molecular dynamics simulations 
further suggest the presence of tertiary contacts between residues in helix 1 and the 






C-terminal portion of the β-sheet, suggesting important roles of long-range interactions in 
stabilising the helix [40]. The folding of barnase proceeds via an intermediate and the major 
transition state is between the intermediate and the native state. ϕ-value analysis shows that 
many mutants of barnase have ϕ-values of close to 0 or 1 for the intermediate and the 
transition states, indicating that the interactions which are probed by the mutation are either 
completely absent or fully formed, respectively. The center portions of the β-sheet and the 
major α helix are nearly completely folded, but the hydrophobic core formed by docking of 
the major helix onto the sheet is weak. The rate-determining step involves the consolidation 
and rearrangement of the hydrophobic core [41].  
 
Interestingly, the folding nucleus need not be an essential initiation site. The major helix of 
barnase is subjected to comparative studies on the effects of Ala vs. Gly mutations 
(AlaàGly scanning) of the residues at solvent-exposed positions. As the helix is destabilised, 
it becomes less structured in the major transition state and is consolidated only late in folding. 
Conversely, the structure of the rest of the protein becomes formed more completely. This 
suggests that the structure of the transition state moves gradually around the potential energy 
surface, and the energy levels are very close together in order to manifest a coordinated effect 
on the structure upon mutation [42]. The fragment 23–110, consisting of the β-sheet and the 
remaining α-helices, is capable of partial folding to achieve a catalytically competent state. 
The full native-like structure is attained upon addition of fragment 1–22 containing the major 
helix [43]. This behaviour shows that barnase can fold in separate modules, and is consistent 
with the postulation that the major helix is not an essential initiation site. 
 
At the other extreme, the hydrophobic collapse mechanism proposes that the initial steps in 
folding involve sequestration of hydrophobic side-chains from surrounding water molecules. 
This collapsed intermediate is also referred to as “molten globule”. Molten globules are 
compact, partially folded states, and are characterised by having few tertiary interactions, 
some secondary structure and a fluctuating hydrophobic core. The acid-induced molten 
globule of bovine α-lactalbumin has native-like compactness and secondary structure, but has 
symmetrical environment of aromatic side-chains and faster hydrogen exchange than in the 
native state [32]. Studies on apomyoglobin [44,45] and cytochrome c [46] show that some 
clusters of helices and other parts of the protein are substantially protected from hydrogen 






exchange in the molten globule state. The most stable helices in the molten globule state are 
largely the same ones which appear at the early stages of protein folding, for example, helices 
A, G and H in apomyoglobin. Disruptive mutations in helix A/H and G/H packing sites in 
apomyoglobin lead to substantial destabilisation of both the native structure and the 
urea-induced molten globule. In comparison, mutations outside helices A, G and H 
destabilise the native state but have little influence on the stability of the molten globule. 
These results suggest the importance of tight packing interactions amongst side-chains in 
stabilising molten globules [47]. After formation of the molten globule state, the protein 
rearranges within the restricted conformational space. Studies on cytochrome c provide 
evidence for the importance of tight side-chain interactions during the early stages of protein 
folding. Leu-94 is located at an interface between N- and C-terminal helices. The effects of 
different mutations of Leu-94 on folding intermediates were compared. Replacement of 
Leu-94 by similar residues, such as Ile or Val, has little influence on the population of the 
compact but relatively unstructured intermediate IC, but leads to a strong decrease in the 
population of the subsequent partially folded intermediate INC. On the other hand, mutation to 
Ala decreases the stability of both intermediates. These results suggest that the early IC 
intermediate is stabilised mainly by hydrophobic interactions, while the later INC intermediate 
is stabilised by specific interactions mediated by proper packing of the two helices [48]. 
 
The nucleation condensation model postulates that neighbouring residues in some parts of the 
protein sequence would form native secondary structure which acts as a nucleus for stepwise 
propagation of the native structure. The nucleation site need not be extensively pre-formed in 
the denatured state and may be in the process of being formed in the transition state. This 
weak local nucleus is stabilised by long-range interactions to give a large extended nucleus. 
In the transition state, there must be a critical number of interactions, such that the lowering 
of enthalpy is more rapid than the loss of entropy for subsequent interactions which are made 
during folding. This is because the stabilising interactions cluster together and form 
cooperatively. The choice of residues which constitute the nucleus is somewhat arbitrary, and 
is conventionally chosen as the residues with the highest ϕ-values. 
 
The nucleation condensation model arose from kinetics studies of chymotrypsin inhibitor 2 
(CI2). The native state of CI2 consists of a binding loop, a single α-helix and a mixed parallel 






and antiparallel β-sheet. Its four peptidyl-proline bonds are all in the trans conformation. The 
denatured state is relatively expanded and has little residual native structure. CI2 folds and 
unfolds via simple two-state kinetics, with no intermediates accumulating at equilibrium or in 
the folding pathway. ϕ-value analysis shows fractional ϕ-values for the majority of sites 
probed [49]. The interpretation of fractional ϕ-values is given by the Brønsted plot of Δln kf 
against Δln KD–N, where a linear trend is consistent with a narrow ensemble of structures 
whose average resembles an expanded transition state. This suggests that no region of CI2 is 
fully formed in the transition state, and interactions in the transition state are weakened 
compared to those of the native state. The transition state is constructed around an extended, 
delocalised nucleus consisting of the N-terminal region of the helix and ancillary interactions 
with residues in the hydrophobic core. Secondary and tertiary structure are formed in parallel 
as CI2 folds [50]. 
 
While there is unlikely to be a single mechanism for protein folding, the three classical 
folding models point toward a unified scheme, variations of which could be used to describe 
a large number of pathways [6]. The basic hypothesis is that the folding of small proteins 
(e.g. CI2) emulates the folding of foldons – basic units which fold quasi-independently in a 
single cooperative step. Larger proteins can be thought of as comprising multiple foldons so 
that parallelisation of the search process enables the folding time of the entire molecule to be 
comparable to that of the smaller individual molecule. The duration of the folding process 
varies depending on the protein of interest. Under in vitro conditions, very small 
single-domain proteins could be capable of folding in a single step within timescales of 
milliseconds, or even microseconds, whereas the slowest folding proteins require minutes to 
hours to fold primarily due to proline isomerisation and formation of obligatory intermediate 
states. Whether folding proceeds in a concerted (nucleation condensation model) or stepwise 
(framework model) fashion could depend on the stability of individual foldons within the 
protein and their ability to fold independently to adopt native-like conformations. It has also 
been suggested that different folding models might dominate at different stages in folding 
[51]. Microscopic-level conformational search at the earliest stages of folding enables 
preliminary folding of individual foldons. Foldon-foldon interactions then collectively 
provide structural guidance and free energy bias for efficient formation of the native 
conformation.  







1.1.4 Energy landscapes and folding funnels 
Energy landscapes, a seminal concept proposed by Frauenfelder, Sligar and Wolynes in 1991 
[52], are multidimensional representations of the free energy of different conformations as a 
function of the degrees of freedom. Each conformation is represented by a point on the 
landscape. This “New View” for protein folding kinetics emerged as a result of advances in 
experimental methods and statistical mechanics models (lattice-based representations of 
chain geometries and interactions, analysed by analytical methods and computer simulations). 
These experimental and modelling methods recognise that the denatured, transition, 
intermediate and native states are effectively ensembles of individual chain conformations, 
and elements of molecular configurations can overlap substantially between different states 
[53]. Effectively, energy landscapes place more emphasis on conformational ensembles and 
parallel folding routes and less emphasis on specific structures and pathways. The kinetic 
process of folding or unfolding a protein is likened to rolling a ball on the energy landscape. 
Folding is described as a diffusion-like process. The motions of individual chains are 
asynchronous in the denatured state. Individual chains fold by Brownian type motion – the 
chains collapse and reconfigure between multiple geometrically similar conformations and 
follow a general drift from higher to lower energy conformations, ultimately resulting in the 
same native structure [53].  
 
Different representations of the energy landscape have been used to draw parallels to 
Levinthal’s paradox and the concept of folding pathways. The Levinthal's paradox, which 
involves exhaustive sampling of all chain conformations, is analogous to an absolutely flat 
“golf course” model of the protein potential energy surface (Figure 1.4a). This model is 
unrealistic, as the protein must lose all of its entropy before any loss in enthalpy. Figure 1.4b 
shows the “pathway” solution to the random search problem, in which a defined pathway 
leads from the denatured state to the native conformation. While the concept of a pathway is 
useful for explaining folding “milestones” such as accumulated intermediates and rate 
determining steps, it does not enable explanation of minor populations with alternative 
folding mechanisms or species which are unobservable on experimental timescales. 
 






The “New View” recognises that part of the solution to Levinthal’s paradox is the concept of 
“folding funnels”, which replaces the pathway concept of sequential events by showing how 
different folding events can occur in parallel [54]. The funnel is a progressive collection of 
geometrically similar collapsed structures, of which the native state is more 
thermodynamically favourable than all other states. The width of the funnel represents the 
entropy of the system, and the depth represents the enthalpy. Figure 1.4c shows an idealised 
smooth protein folding funnel. However, the smooth funnel model assumes that kinetic 
pathways always follow downhill thermodynamic trajectories and does not explain the 
observation of folding “milestones” such as accumulated intermediates and transition states. 
This means although the smooth funnel is justified when barriers between states are very low 
and all conformations are effectively in rapid thermal equilibrium, this model is not justified 
in scenarios where there are high energy barriers. 
 
Bryngelson et al. first explored bumpiness or “frustration” in protein folding landscapes. 
Rugged folding landscapes are a consequence of the impossibility to simultaneously 
minimise the energies of all the interactions being formed during the protein folding process 
[55]. A rough landscape leads to slower folding by limiting the rate at which the protein can 
find the native state. Depending on the height of the energy barrier, local energetic minima 
can also act to separate the conformational search into multiple, smaller problems, thereby 
accelerating the conformational search process. 
 
A detailed representation of the folding funnel was derived from a simulation study of a 
60-residue fast-folding helical protein by Onuchic et al [56]. The funnel is described by its 
ruggedness, gradient toward the folded state and configurational entropy. At the folding 
transition, the energy (enthalpy) loss must equal the temperature multiplied by the entropy 
loss. Using thermodynamics, the estimated entropy yields the slope of the folding funnel. 
Measurement of the reconfiguration time of the molten globule enables estimation of the 
ruggedness of the energy landscape. Folding is driven by an increase in Q, the fraction of 
correct contacts made in a state i, as the collection of states rapidly interconverts: 
 x@ = (number	of	native	pairwise	contacts)in	state	Z(total	number	of	pairwise	contacts	in	native	state) (1.21) 
 






A cross section of the funnel (Figure 1.4e) illustrates that a fast-folding helical protein has an 
ensemble of collapsed molten globule states at Q ~ 0.27. Nucleation occurs if certain regions 
experience an increase in Q more rapidly than others. At Q ~ 0.6, the incomplete 
compensation of entropy decrease by enthalpy decrease leads to a sizeable energy barrier 
(~3kBT). The sizes of energy barriers are described in terms of the product of the Boltzmann 
constant (kB) and the absolute temperature (T). According to the Arrhenius equation, the rate 
constant for a reaction is given as: 
 + = ÇÉ0
ÑÖ
Üáà (1.22) 
where the activation energy per molecule (Ea) is in the same units as kBT, and A is a constant 
of proportionality. 
 
The transition state consists of an ensemble of structures, reflecting multiple pathways of 
protein folding. The entropy continues to decrease until discrete kinetic intermediates appear 
at Q ~ 0.7. The search through these native-like but misfolded structures can be rate-limiting 
if the thermodynamic bottleneck remains fairly wide and the landscape is still rough at this 
stage. Hence, folding intermediates are relics of the landscape ruggedness. The native state 
must be thermodynamically more favourable than the kinetic intermediates in order for the 
protein to escape these “traps” [54]. 
 
The funnel-like shape of the energy diagram, which originates from illustrating the decrease 
in conformational entropy, often creates a misconception that the funnel “guides” folding to 
the native state [57]. It must be emphasised again that the decrease in conformational entropy 
is a major barrier for protein folding and does not aid the polypeptide chain in finding its 
native state. The major determinant of the folding rate is the free energy landscape. The free 
energy is the sum of enthalpy and entropy. The free energy barrier to folding manifests as a 
result of the delicate balance between the favourable decrease in enthalpy and the 
unfavourable decrease in entropy. 
 
 







Figure 1.4: Energy landscapes 
(a) The Levinthal “golf course” landscape. The polypeptide chain searches for the native 
conformation (N) randomly, i.e. on a flat energy landscape. (b) A specific folding pathway leads from 
a denatured conformation A to the native conformation N, hence enabling faster folding than random 
searching. (c) An idealised smooth funnel landscape. The width of the funnel represents entropy and 
the depth represents enthalpy. At the top of the funnel, the protein exists in many conformations with 
high enthalpy and high entropy. During folding, the loss of enthalpy with the formation of native-like 
structures compensates for the unfavourable loss of conformational entropy. (d) A rugged energy 
landscape with kinetic traps, energy barriers, and narrowing selection of paths to the native state. 
Panels a–d are retrieved from [53]. (e) Cross-section of a folding funnel from a simulation of a 
fast-folding helical protein. Q represents the fraction of correct contacts made. Retrieved from [58]. 
 






Developments in experimental and computational methods have enabled more detailed 
descriptions of energy landscapes. Emphasis on structural and thermodynamic parameters 
can be found in computational methods, including lattice models, course-grained models and 
atomistic simulations with implicit or explicit representations of the solvent [6,57]. 
 
In recent years, folding trajectories are studied experimentally by single-molecule 
fluorescence techniques. Single-molecule FRET (smFRET) data can be summarised as 
histograms of the native and denatured ensembles as a function of denaturant concentrations. 
Important thermodynamic and kinetic parameters, such as the free energy of unfolding and 
the interconversion rates between different states, can be derived from these histograms. 
smFRET studies have been performed on adenylate kinase (AK) encapsulated in lipid 
vesicles immobilised on a glass surface [59]. smFRET trajectories of AK show that 
transitions between different FRET efficiency levels are generally much smaller than the 
difference expected between the fully folded and the fully unfolded conformations, 
suggesting the presence of multiple states and that direct transitions between the folded and 
unfolded states are rare. Statistical analysis on the smFRET data using Hidden Markov 
modelling reveals six metastable states on the landscape, and enables detailed reconstruction 
of transition maps. The relative populations and transitions between these states vary with 
GdmCl concentrations, and multiple intersecting folding pathways co-exist at low GdmCl 
concentrations. This approach has therefore provided a comprehensive description of the 
folding landscape of a large multidomain protein. 
 
Single-molecule force spectroscopy (SMFS) has also emerged as a powerful tool for 
reconstructing one-dimensional representations of the folding landscape based on 
measurements of a single molecule placed under controlled tension. Different 
implementations of SMFS have enabled characterisation of folding barriers and landscape 
ruggedness, although interpretation of reconstructed folding landscapes could be convoluted 
by various factors, including properties of the measurement apparatus, the presence of 
multiple folding pathways, and the multidimensional nature of the landscape [60]. 
 
In summary, advanced single-molecule analysis has begun to facilitate detailed 
characterisation of several aspects of the complex folding landscape. It is expected that future 






studies will require the development of experimental methodologies with improved detection 
efficiencies, improved data analysis methods and the use of computer simulations in 
conjunction with experimental tools [61]. 
 
1.1.5 Open questions 
Despite considerable advances in the soluble protein folding field, many fundamental 
questions remain unanswered about this complex yet fundamental biological process. 
Existing in vitro studies have often focused on simple folding systems, and the folding of 
more complicated systems, such as multi-domain proteins, require more in-depth studies. 
Purified protein samples are typically studied under equilibrium, in highly diluted and 
optimised conditions in vitro, whereas folding in the cellular milieu is more complex. Protein 
folding in vivo often begins co-translationally [62,63]. The pace of translation can regulate 
the vectorial folding of nascent protein domains and the protein folding landscape, thereby 
altering how much correctly folded, soluble protein is present in the cell. Modulation of 
translation rates (or even translational stalling) could occur due to various reasons [64], 
including the presence of rare codons in mRNAs [65–67], inefficient peptidyl transfer [68], 
possible presence of secondary structures in mRNAs [69–71], and interactions between 
positively charged residues in the nascent chain with the negatively charged ribosome exit 
tunnel walls [72–74]. Translation is slow (5 amino acids/second in eukaryotes or 15 amino 
acids/second in E. coli) relative to local folding events (µs–ms timescale) [75]. Vectorial 
folding in the confined space of the exit tunnel and interactions between the nascent chain 
and the exit tunnel are likely to define the landscape of protein folding, and result in lower 
energies than would be the case for protein synthesis without co-translational folding [62]. 
Given the differences between in vivo and in vitro folding landscapes, co-translational folding 
intermediates may also be structurally dissimilar to in vitro refolding intermediates [76–78]. 
 
The ribosome also serves as a platform for protein biogenesis factors to interact with the 
emerging nascent chain and effect its maturation and proper cellular localisation. Emerging 
peptides can first interact with the ribosome surface [79–81], during which the ribosome may 
exert a chaperoning effect, protecting the nascent chain from misfolding and aggregation 
until the protein is fully synthesised and extruded from the peptide exit tunnel [64,77]. 
Beginning with N-terminal processing, the nascent polypeptide chain emerging from the 






ribosome has access to a huge ensemble of chaperones and quality control mechanisms to 
assist its folding, cellular localisation and proteastasis [82,83]. Thus, in contrast to the 
utilisation of purified protein samples in in vitro experiments, it is unclear how much time 
proteins spend unfolded and unprotected in vivo. 
 
Moreover, protein folding in vivo occurs in spatially organised (e.g. for membrane proteins 
and in eukaryotic cells), inhomogeneous and crowded environments with macromolecule 
concentrations ranging from 200 to 400 mg/ml. These properties are often very difficult to 











1.2 Folding of membrane proteins 
Folding of integral membrane proteins adhere to similar physical principles to those for 
soluble protein folding. Integral membrane proteins are constrained by the additional need to 
compensate for the energetic cost of ~1.2 kcal/mol per peptide bond for burying peptide 
bonds in the lipid bilayer. This high cost of interfacial partitioning of the peptide bond could 
explain the coupled insertion-folding mechanisms and the tendency of membrane spanning 
regions to form regular secondary structural elements in order to maximise the hydrogen 
bonding potential. Secondary structure formation reduces the energetic cost of incorporating 
peptide bonds into a bilayer by ~0.4 kcal/mol per peptide bond for α-helical structures and 
~0.5 kcal/mol per peptide bond for β-sheet structures [84]. Hence, although the lipid bilayer 
is a complex and inhomogeneous environment, it imposes thermodynamic and geometric 
constraints which limit the number of feasible structural motifs to α-helical bundles and 
β-barrels. 
 
Membrane protein misfolding is implicated in the progression of various diseases such as 
cystic fibrosis, Charcot-Marie-Tooth disease and retinitis pigmentosa [85]. Insights on the 
folding mechanisms of membrane proteins might pave the way towards discovering new 
therapeutic approaches for membrane misfolding diseases. 
 
Advances in studying membrane protein folding progress slower than that for globular 
protein folding due to various experimental challenges [3]. Characterisation of the denatured 
states, and the unfolding and folding pathways require maximal and reversible unfolding of 
the protein with minimal aggregation. In vitro studies require membrane proteins to be 
functionally reconstituted in a detergent or lipid environment, which often also renders them 
resistant toward denaturation. The inability of membrane proteins to unfold completely in a 
lipid or detergent environment is related to water being less available to hydrogen-bond with 
protein backbone and side-chain moieties in the membrane [86]. Another challenge is the 
formation of aggregates due to the exposure of large hydrophobic regions upon membrane 
protein denaturation. Moreover, identifying experimentally favourable folding conditions for 
any particular membrane protein is a difficult process of finding the suitable combination of 
detergent or lipid composition, buffer, pH and temperature [18]. Similar to the soluble protein 






folding field, chemical denaturants, pH and temperature have been used as denaturants in 
membrane protein unfolding/folding studies [18]. Several studies indicate the limited use of 
temperature in deriving thermodynamic parameters for both α-helical and β-barrel membrane 
proteins as thermal denaturation of membrane proteins is often irreversible. Like for soluble 
proteins, the choice of denaturant and the membrane protein of study both profoundly affect 
the conformations represented in the denatured states ensemble. 
 
Unfolding/folding studies on membrane proteins have historically focused on 
bacteriorhodopsin [87] and OmpA [88]. The studies to date tend to be dominated by proteins 
of bacterial or archaeal origin, with only a handful of eukaryotic proteins having been 
explored [18]. Several other membrane proteins have also emerged as model systems which 
are amenable to detailed kinetics and thermodynamics studies, leading to the proposal of 
different folding models for β-barrel and α-helical membrane proteins. 
 
1.2.1 β-barrel 
β-barrel membrane proteins are formed by membrane-spanning β-strands which are held 
together by a lateral hydrogen bond network, resulting in an overall cylindrical topology in 
order to satisfy all possible hydrogen bonds in the peptide backbone. In contrast to the 
ubiquitous distribution of α-helical transmembrane proteins, β-barrel membrane proteins are 
found exclusively in the outer membranes of Gram-negative bacteria, mitochondria and 
chloroplasts [89]. 
 
β-barrel transmembrane proteins offer distinct technical advantages over their α-helical 
counterparts, as β-barrel transmembrane proteins have much smaller average sequence 
hydrophobicities and can be completely unfolded in aqueous denaturants and refolding into 
membranes can be studied from such states [90]. While aqueous denaturants such as urea and 
GdmCl generally induce the canonical unfolded, random coil state, these denatured states can 
still contain measurable amounts of residual structure. For example, an NMR study of the 
denatured state ensemble of outer membrane protein X (OmpX) shows the presence of 
non-random structure in urea [91]. 
 






The general mechanism for β-barrel membrane protein membrane insertion and folding has 
been elucidated through time-resolved tryptophan fluorescence quenching (TDFQ) 
experiments on OmpA [89,92]. Tryptophan fluorescence quenchers are placed at different 
depths in the membrane, and the time courses for the passage of tryptophans past these zones 
of quenchers are followed. All tryptophan residues of OmpA cross the membrane with the 
same timecourse, suggesting that individual transmembrane β-strands are translocated in a 
concerted fashion. Different membrane insertion and folding intermediates of OmpA were 
also characterised by TDFQ. The five tryptophan residues which are distributed across four 
transmembrane segments of OmpA have specific distances from the center of the bilayer in 
each of the folding intermediates (Figure 1.5) [93]. The unfolded state first hydrophobically 
collapses into a water-soluble intermediate, which then binds to the membrane surface to 
form the first membrane-bound intermediate with disordered tryptophans located 14–16 Å 
from the center of the bilayer. This intermediate then forms a molten disk structure with some 
developed β structure and all tryptophans located at ~ 10 Å away from the bilayer center. 
Next, the four tryptophans on the four β-hairpin loops translocate through the bilayer while 
forming a molten globule intermediate. The molten globule intermediate then proceeds to the 
native state, in which all tryptophans are located at ~ 10 Å from the bilayer center. Identical 
kinetics were observed for secondary structure (CD spectroscopy) and tertiary structure (cold 
SDS-PAGE) formation, indicating that inter-strand hydrogen bonds and the barrel structure 
form while the protein translocates across the membrane [94]. The co-translocational folding 
mechanism is logical for β-barrel membrane proteins, because membrane insertion after 
barrel formation would have required the creation of a large defect in the membrane to insert 
the fully-formed barrel. Further studies have involved characterisation of the dependence of 
the free energy of unfolding and the m-value on the thickness of phosphatidylcholine bilayers, 
showing that folding into thick bilayers is a thermodynamic two-state process whereas 
folding into thin bilayers is a multi-state process [95]. These studies indicate that increasing 
the lateral bilayer pressure increases the thermodynamic stability of the protein, whereas 
hydrophobic mismatch leads to easier penetration of water molecules into the hydrophobic 
core of thin bilayers and stabilisation of folding intermediates. 
 
 







Figure 1.5: Schematic for the concerted folding and insertion mechanism of OmpA 
The collapsed OmpA first adsorbs to the membrane surface, with all Trps located on the cis 
monolayer, at 14–16 Å away from the center of the bilayer (not shown). An IM2 “molten disk” 
intermediate forms with all Trps at 10 Å away from the bilayer center. Trp-15, Trp-57, Trp-102 and 
Trp-143 then translocate through the bilayer while forming the IM3 “molten globule” intermediate. 
Finally, the native state (N) is formed, with all Trps located 10 Å away from the bilayer center, and 
only Trp-7 remaining on the cis monolayer. This model shows nearly synchronous insertion and 
translocation of Trp-15, Trp-57, Trp-102 and Trp-143 across the bilayer. Figure adapted from [93]. 
 
One of the major unresolved questions is how folding models derived from in vitro studies 
can be reconciled with the transport and insertion of β-barrel membrane proteins in vivo, 
especially considering the requirement for β-barrel membrane protein precursors to traverse 
multiple membranes with different lipid and protein compositions during cellular localisation 
followed by chaperone-assisted folding and insertion in different non-cytosolic milieus. In 
vivo, bacterial β-barrel membrane proteins are synthesised in the cytosol, secreted by the SEC 
translocase across the inner membrane into the bacterial periplasm and the unfolded proteins 
are subsequently inserted and folded into the Gram-negative outer membrane with the 
assistance of the bacterial β-barrel machinery (BAM) [96–98]. In the bacterial periplasm, Skp 
[99] and SurA (a peptidylprolyl isomerase) [100] assist the folding of several membrane 
proteins including OmpA, OmpF and LamB [90] and act as chaperones to prevent the 
aggregation of precursors. In eukaryotic mitochondria, β-barrel precursor proteins 
synthesised in the cytosol are translocated through the translocase of the outer membrane 
(TOM) into the intermembrane space [101]. Small TIM complexes act as chaperones in the 
intermembrane space [98]. X-ray crystallography and NMR studies suggest that oxidised 
small TIM monomers assemble into hexameric chaperone complexes [102,103] in the 
intermembrane space and hold client proteins in a nascent chain-like extended conformation 






to facilitate insertion into the mitochondrial inner or outer membrane [104]. β-barrel 
membrane proteins are inserted into the mitochondrial outer membrane by the sorting and 
assembly machinery at the outer membrane (SAM/TOB). α-helical metabolite carrier 
proteins are inserted into the mitochondrial inner membrane by the carrier translocase of the 
inner membrane (TIM22) in a membrane potential-dependent manner [96–98]. 
 
1.2.2 α-helical 
α-helical membrane proteins are found in most eukaryotic membranes and in the inner 
membranes of bacteria [18]. Studies on denaturation and refolding of α-helical membrane 
proteins began with research from the Khorana group, showing that bacteriorhodopsin can be 
renatured from a fully-denatured state in 88% formic acid or anhydrous trifluoroacetic acid 
via an SDS-solubilised state [87]. Kinetic folding studies on α-helical membrane proteins 
typically begin with a partially, reversibly denatured state. Most α-helical membrane proteins 
are resistant to aqueous denaturants, with a few exceptions including the denatured state 
ensembles of diacylglycerol kinase (DAGK) in GdmCl or urea in the presence of 1% formic 
acid [105], and tobacco light-harvesting chlorophyll a/b protein complex (LHCIIb) in neutral 
GdmCl [106]. Mixed micelles containing ionic detergents such as SDS have been shown to 
be efficient denaturants for some cases, though the proteins are likely to be recalcitrant to 
complete unfolding, possibly because SDS tends to favour the formation of non-native helical 
structures [18]. The SDS-denatured bacterio-opsin apo-protein shows partial loss of 
secondary structure and loss of retinal binding, and can be renatured upon the addition of 
renaturing phospholipid/cholate mixtures [107]. Folding studies are typically initiated by 
mixing denatured protein with renaturing detergents or lipids, and followed by changes in 
intrinsic fluorescence, secondary structure and recovery of protein function. Reversible 
chemical denaturation has only been demonstrated for a handful of α-helical membrane 
proteins [87,105,108–115]. Nevertheless, biophysical, thermodynamic and kinetic studies 
have enabled extensive characterisation of the molecular nature of denatured states [87,105–
107,109,111,114,115], protein stability [108,110,111,115,116], transition state [117,118], and 
folding intermediates [119,120], hence yielding valuable insights on the folding mechanisms 
of α-helical membrane proteins. 
 






Very different folding mechanisms have been proposed for α-helical vs. β-barrel 
transmembrane proteins. This is likely due to their distinct hydrogen bonding patterns. A 
widely held concept for explaining the folding of integral α-helical membrane proteins is the 
two-stage model originally proposed by Popot and Engelman [86] (Figure 1.6a). This model 
postulates that transmembrane helices are first formed independently after insertion into the 
membrane environment, followed by formation of tertiary packing during the second stage. 
Parallels can be drawn between the two-stage model for α-helical membrane protein folding 
and the framework model for soluble protein folding. The essence of the two-stage model is 
that much of α-helical membrane protein folding can be understood by focusing on helix 
association in the bilayer without substantial consideration of the insertion process. Though 
possibly oversimplified, the two-stage model nevertheless led to subsequent informative 
studies on helix-helix interactions, including identification of the GxxxG motif for helix 
dimerisation [121], the importance of stereochemical fit between side-chains of helices in 
interhelical interactions [122], and the role of hydrogen bonds between main chain Cα–H and 
backbone or side-chain oxygen atoms [123]. 
 
Bacteriorhodopsin is a light-driven proton pump in the purple membrane of Halobacterium 
salinarium. The SDS-denatured apo-protein can be spontaneously refolded to the native state 
[107], enabling in vitro thermodynamics and kinetics studies on folding and unfolding. The 
two-stage model originated from successful reconstitution of the native chromophore in 
bacteriorhodopsin by assembling complementary combinations of proteolytic fragments 
[124,125] and/or complementary synthetic peptides [126,127], or 
complementary/overlapping fragments which have been individually expressed in and 
purified from E. coli [128]. Absence of one or more of the transmembrane segments results in 
abolishment of pigment formation. These results indicate that the assembly of 
bacteriorhodopsin requires each of the seven helices, whereas the surface loops appear to be 
dispensable. The large retention of secondary structure in the SDS-denatured state of 
bacteriorhodopsin also appears to support the idea that individual secondary structure 
elements can be stabilised in a micellar environment and are formed before native tertiary 
packing is established. However, the notion of individual transmembrane helices folding 
independently in a membrane environment has been partly questioned by structural studies 
on isolated helical fragments of bacteriorhodopsin, which show that C-terminal helices are 






only partially helical and require the presence of N-terminal helices to fold [129], hence 
implying that tertiary contacts are necessary for some transmembrane helices to acquire 
stable folds. 
 
The toolkits for studying soluble protein folding have been successfully applied to in vitro 
kinetics studies of bacteriorhodopsin. SDS-denatured bacteriorhodopsin, with 
covalently-bound retinal and absorption peak at 440 nm (bO440), folds with two-state kinetics. 
The transition state is much closer to the denatured state than to the native state (βT ~ 0.14). 
ϕ-value analyses on helices B [117] and G [130] by the Booth group reveal high ϕ-values 
(ϕ > 0.8) in helix B, suggesting that this helix is structured in the transition state, thus 
forming a folding nucleus for the rest of the protein. Packing and consolidation of helix G 
occurs late in folding, with low (ϕ ≤ 0.2) or intermediate (0.3 < ϕ < 0.7) ϕ-values being 
observed. Similar studies pursued by Bowie et al. [118], however, show consistently low 
ϕ-values of less than 0.4 across the protein, suggesting that the transition state is a loosely 
organised ensemble of conformations. It was therefore proposed that the rate-limiting step of 
refolding is the topological rearrangement of largely preformed helices from an ensemble of 
rapidly interconverting conformations. Differences in the results between the studies by the 
Booth and Bowie groups might be attributable to the different detergent/lipid conditions used 
in the two studies. Nevertheless, interpretations of ϕ-values are rather reserved in both studies, 
given that the SDS-denatured bO440 retains substantial α-helical content and the main 
structural changes in refolding are the formation of native interhelical packing and tertiary 
structure. 
 
The two-stage model was subsequently further developed by adding an additional stage to 
account for ligand binding after helix association [131]. Retinal binding in SDS-denatured 
bacterioopsin has been characterised on a ms–min timescale using circular dichroism [132], 
stopped-flow fluorescence spectroscopy [120] and absorption spectroscopy [133], leading to 




SDS-denatured apo-bacterioopsin (bO) refolds spontaneously upon diluting SDS with 
renaturing micelles or vesicles. Two intermediates, I1 and I2, are formed prior to retinal 






binding. The formation of the transient I1 intermediate is accompanied by a change in light 
scattering of the micelles and could reflect a change in the micelle structure or protein folding. 
I2 is a key apoprotein intermediate with native helical content. Its formation is the 
rate-limiting step in apo-protein folding, and the rate can be controlled by altering lipid 
composition or mutations. Different I2 states can be observed depending on the folding 
conditions. In the absence of retinal, an equilibrium is established between bO and I2. Retinal 
(R) binding occurs in at least two steps, first non-covalently to yield IR followed by formation 
of a covalent Schiff base linkage to Lys-216 to yield the native chromophore. IR consists of at 
least two observable states which absorb at 380 and 440 nm, respectively, both of which form 
bacteriorhodopsin (bR) with absorption at 560 nm at the same rate. This folded state initially 
contains covalently-bound all-trans retinal, which then isomerises over the course of about 
1 h to yield a mixture of all-trans and 13-cis retinal, analogous to the representation of retinal 
isomers in the dark-adapted state [134]. The retinal cofactor is therefore a major contributor 
to the unfolding and folding kinetics of bacteriorhodopsin. 
 
The folding of rhodopsin deviates substantially from the two-stage model. Rhodopsin is a 
G protein-coupled receptor which functions as a dim light photoreceptor in the retina. 
Rhodopsin shares a similar transmembrane heptahelical fold but no sequence similarity to 
bacteriorhodopsin. SDS-denatured rhodopsin reveals extensive abolishment of helicity and 
native tertiary interactions, and the formation of largely unfolded structures with some 
residual structure elements causing the burial of specific cysteines and tryptophans [135]. 
Cell-based [136] and in vitro [135,137,138] folding studies on rhodopsin suggest that 
interactions between the extracellular and transmembrane domains constitute a “folding core” 
which is important in the early stages of folding. Single-molecule dynamic force 
spectroscopy reveals a core of rigid structural elements in bovine rhodopsin but not in 
bacteriorhodopsin [137]. NMR and EPR studies of SDS-denatured rhodopsin show flexible 
cytoplasmic and extracellular ends while some residual structure remains in the 
transmembrane and extracellular regions [138]. The distributions of rigid and flexible 
segments in rhodopsin identified in these experiments are consistent with the results from 
simulated thermal unfolding studies using the Floppy Inclusions and Rigid Substructure 
Topography (FIRST) method. In comparison, simulation with bacteriorhodopsin shows 
clusters that align with individual helices and break off early in the simulation. The unfolding 






mechanism of bacteriorhodopsin therefore illustrates better consistency with the two-stage 
model [139]. The more recent “long-range interactions model” [140] (Figure 1.6b) has been 
proposed in order to emphasise the importance of interactions between residues which are far 
apart in sequence but come close in space during early stages of protein folding. The 
long-range interactions model is similar to the nucleation condensation model for soluble 
proteins. To date, rhodopsin is the only α-helical membrane protein which is known to adhere 
the long-range interactions model. Detailed comparison of the modes of activation and signal 
transduction across different membrane receptors underline the importance of all three types 
of long-range interactions: (1) between transmembrane helices; (2) between helices and 
soluble loops; and (3) between loops [140]. Fundamental understanding on the roles of such 
interactions in the folding, stability and function of membrane proteins will have profound 
implications on addressing membrane protein misfolding diseases. 
 
Unfolding and refolding of disulphide bond reducing protein B (DsbB) in SDS and DDM 
have been fitted to a three-state folding scheme [141]. Three linear regimes are observed in 
the chevron plot of DsbB, at 0–0.2 ΧSDS, 0.3–0.5 ΧSDS and > 0.5 ΧSDS, respectively. The 
chevron plot is consistent with the presence of an intermediate state I which accumulates at 
high ΧSDS, and a rate-limiting transition state between I and denatured state D. ϕ-value 
analysis of alanine-scanning mutants of DsbB reveals a folding nucleus in the transition state 
consisting of 2–3 residues with ϕ > 0.5 clustered at one end of the transmembrane helical 
bundle. In the intermediate state, the nucleus expands to include residues closer to the middle 
of the protein. This suggests early formation of structure near the tips of the transmembrane 
helices which nucleate subsequent structure formation in other regions of the protein.  
 
To summarise, seminal denaturation, kinetics and thermodynamics studies on 
bacteriorhodopsin have by-and-large supported the two-stage model for α-helical membrane 
protein folding, although some alterations have been recommended in view of structural 
studies on isolated helices, suggesting some importance of tertiary interactions. Most 
α-helical membrane proteins which have been studied to date appear to adhere the two-stage 
model. While alternative models have been postulated, including the long-range interactions 
model for rhodopsin and the three-state model for DsbB, studies with new model proteins and 






across comparable experimental conditions are required to further explore these alternative 
models for α-helical membrane protein folding. 
 
 
Figure 1.6: Models for α-helical membrane protein folding 
(a) The two-stage model postulates that transmembrane helices are first formed independently after 
insertion into the membrane environment, followed by formation of tertiary packing. (b) The 
long-range interactions model emphasises the importance of long-range tertiary contacts in the 
formation of a “folding core” during early stages of protein folding. The “folding core” is identified as 
elements of residual structure in the denatured states, and provides a scaffold for the folding of the 
rest of the protein. Figure retrieved from [140]. 
 
Most prokaryotic and eukaryotic α-helical membrane proteins are co-translationally inserted 
into the membrane in vivo via the SecYEG/Sec61 translocon [142,143] or YidC-like 
insertases [144,145]. In the Sec pathway, the first hydrophobic element, either a cleavable 
N-terminal signal sequence or a transmembrane domain, emerges from a translating ribosome, 
and is recognised by the signal recognition particle (SRP) [146]. SRP and its receptor, SR (or 
FtsY), form a heterodimeric complex, which stimulates GTP hydrolysis on both proteins, 






thereby enabling transfer of the SRP/FtsY/nascent chain ternary complex to the translocon 
[147]. The ribosome exit tunnel is located in close proximity to the translocon pore, so that 
the nascent chain emerges from the ribosome directly into the translocon channel. The 
transmembrane helices partition into the membrane via a lateral gate in the translocon [143]. 
The association of SecY with the ribosome provides the energy for co-translational insertion. 
Integral membrane proteins with large hydrophilic periplasmic domains also require the 
presence of a cytoplasmic SecA ATPase to translocate such domains across the membrane 
[143,148]. An alternative model suggests that the transmembrane helices do not enter the Sec 
translocon. Instead, transmembrane helices first partition with the interfacial headgroup 
region of the lipid bilayer before inserting into the membrane by sliding down the lateral gate 
of the translocon. In this model, the helices are constantly in contact with the lipid bilayer, 
and membrane insertion is driven by the highly favourable association of the membrane 
protein with the surrounding lipids [149]. 
 
Proteins can also be inserted into membranes via YidC-like insertases, including YidC from 
E. coli, Oxa1 from mitochondria, and Alb3 and Alb4 from chloroplast thylakoids [145]. The 
mechanisms of YidC-like insertases are less well understood. Unlike the Sec translocon, 
YidC does not possess a membrane-spanning pore or channel. It has been proposed that the 
hydrophilic region of the membrane protein substrate is translocated across the periplasmic 
membrane by first binding to the hydrophilic groove of YidC, while the hydrophobic 
transmembrane segments of the membrane protein slide along the transmembrane region of 
YidC and into the lipid bilayer [144,150]. The currently identified range of substrates for the 
YidC-only pathway is limited, but are strikingly all part of large oligomeric assemblies, thus 
leading to speculations that YidC is involved in the assembly of multimeric membrane 
protein complexes [151]. YidC can also form a functional complex with the Sec translocon, 
and interact with transmembrane helices as they emerge from the lateral gate of SecYEG, 
although the functional importance of this interaction is not well understood [145]. 
 
Various factors affect the efficiency of transmembrane insertion and folding in vivo. Gating 
of the Sec translocon and membrane insertion are determined by the average hydrophobicity 
of transmembrane helices, the length of a given transmembrane helix, its amino acid 
composition, and the relative positions of amino acids within the transmembrane domain 






[143,152,153]. The Sec translocon and YidC insertase have been proposed to have important 
roles in membrane protein folding. In certain SecY mutants, lactose permease LacY can be 
inserted but is misfolded and susceptible to cellular proteolysis [154]. Susceptibility to 
misfolding and proteolysis of LacY are also observed when YidC is depleted [155]. These 
data suggest that SecY and YidC are important in the insertion and folding of membrane 
proteins. Interactions between the translocon and the substrate membrane protein could 
facilitate early folding events. A study on the insertion of aquaporin-4 (AQP4) water channel 
via the Sec61 translocon shows that each transmembrane helix of AQP4 moves through the 
translocon in a highly ordered and sequential fashion, but up to four transmembrane helices 
of AQP4 can simultaneously contact Sec61α after being displaced from their initial site of 
interaction. This suggests that the translocon uses a single primary site for transmembrane 
insertion while providing a scaffold or protected environment for facilitating early protein 
folding [156]. The lipid bilayer can also influence membrane protein insertion [157–161], 
folding [110,162–164], topology [165,166], oligomerisation [167,168] and function [169–
172], either directly through specific interactions with the headgroup region, or indirectly via 
the lateral pressure of the bilayer [173]. Moreover, protein-lipid interactions are crucial 
during various stages of membrane protein insertion and folding, including recognition of the 
inserting transmembrane segment by the translocon [174,175], the release of nascent chains 
from the SRP-FtsY complex [176–178], and stimulation of the GTPase activity of FtsY 
[179,180]. Given the large variations in the lipid compositions of native membranes between 
different organisms and organelles [181], such complex native membrane environments are 
difficult to replicate in in vitro experiments [173]. 
 
Summarising the above, membrane protein insertion and folding in vivo is complex and 
dynamic. While the majority of work on α-helical membrane protein folding has so far been 
done in vitro and has yielded valuable kinetic and thermodynamic information, reconciling in 
vitro reversible folding studies with co-translational folding in vivo remains as a very 
challenging goal in this field. 






1.3 Hydrogen bonding 
A hydrogen bond (H-bond), typically represented as X−H!Y−Z, is an attractive interaction 
between a hydrogen atom from a molecule X−H, in which X is more electronegative than H, 
and atom(s) in the same or different molecule in which there is evidence of bond formation 
(Y−Z) [182]. H-bonds have an intermediate energy range (0.5−40 kcal mol-1 per H-bond) that 
spans between the energy levels for van der Waals interactions and covalent interactions. 
This explains the functional versatility of H-bonds both in stabilising static structures and in 
mediating dynamical processes [183]. 
 
H-bonds underpin protein stability, structure and function. The hydrophobic environment of 
the lipid membrane necessitates membrane proteins to establish hydrogen bonds to avoid 
exposing their polar groups to the lipid environment, which would be energetically highly 
unfavourable. All H-bonds in these regions of the membrane protein must be self-satisfied 
[184]. In α-helical membrane proteins, backbone H-bonds are aligned parallel to helical axes 
and stabilise the individual helices. Backbone H-bonds in β-barrel proteins are formed 
between neighbouring β-strands and stabilise the tertiary structure. 
 
1.3.1 Methods for studying H-bonds 
Accurate description of H-bonds has been a long-standing goal for experimental and 
theoretical studies in structural biology. Knowledge about the geometric properties, including 
distance and torsion angles, dynamics and strength of H-bonds, is essential for further 
understanding of the highly context-dependent contribution of H-bonds to protein stability, 
structure and function. It is difficult to obtain precise information on H-bonds from X-ray 
crystallography due to the weak scattering density of the hydrogen atom. The presence of 
H-bonds is usually inferred from the spatial arrangement of the donor and acceptor groups in 
crystal structures. Generally, a H-bond is assumed to be present when the distance between 
the donor and acceptor atoms is less than or equal to the sum of the van der Waals radii of the 
two electronegative atoms [182]. High-resolution solution-state NMR has contributed 
significantly towards the understanding of H-bonds. A number of NMR observables provide 
indirect evidence for H-bonds, including kinetic hydrogen/deuterium exchange, the 
equilibrium hydrogen/deuterium isotope fractionation factor, changes in chemical shift, scalar 






coupling and deuterium quadrupole coupling [185]. Characterising structure-to-function 
relationships of H-bonds by solution-state NMR, nevertheless, remains challenging due to the 
weak strength, dynamic nature and abundance of H-bonds in bio-macromolecules.  
 
Many polar hydrogen atoms, such as those of amide, imino and hydroxyl groups, 
continuously exchange with solvent hydrogens. This exchange is significantly slowed down 
when the hydrogen participates in an H-bond, even when this bond is directly exposed to the 
solvent. The rate of hydrogen/deuterium exchange (kex) is described as a combination of the 
rates of the opening (kop) and closing (kcl) of the hydrogen bond in addition to the inherent 
rate of exchange of the hydrogen once it is in the open state (kint) [186]. For an amide group: 
 NHèê
dëí⇌dìî NHGï
dñóòô⎯õ ND (1.23) 
Once an amide hydrogen reaches the open state, the exchange kinetics is defined by the 
balance between reverting to the closed state and moving forward with exchange. 
 
H/D exchange kinetics detected using NMR spectroscopy and mass spectrometry have 
produced numerous interesting studies in the context of protein folding. For example, 
residue-specific kinetics of inter-strand H-bond formation has been studied in the β-barrel 
outer membrane protein X (OmpX) in detergent micelles, showing that the kinetics of 
H-bond formation are uniform across the entire β-barrel and synchronised with tertiary 
structure formation. This suggests that OmpX folding progresses via an ensemble of different 
short-lived, partially-folded and interconverting conformations in which all backbone amides 
are accessible to solvent exchange and engage in H-bonds transiently [187]. 
 
H-bond strength is traditionally examined by disrupting native H-bonds through chemical 
(amide-to-ester or amide-to-E-olefin) [188] or side-chain [189] mutagenesis, hence limiting 
such investigations to only a few bonds at a time and possibly also leading to disruption of 
the native protein structure. H/D fractionation factors (Ф) have been widely used to 
characterise H-bond strengths in small molecules and proteins. 
 NHïúGùbûü + DIGê†büù = NDïúGùbûü + HIGê†büù (1.24) 
 Φ = ([hg] [h2]⁄ )í£ëò§ñó([g] [2]⁄ )•ëî¶§óò  (1.25) 
 






Ф is determined by the difference in vibrational energy between N–H and N–D bonds at an 
exchangeable site [190]. Due to its larger mass, the vibrational energy minimum 
(or zero-point energy) for deuterium is lower than that for a proton. This principle applies to 
both solvent and protein. If the energy difference is larger in a protein amide site than in the 
solvent, the amide site will be enriched in deuterium (Ф > 1). Conversely, Ф < 1 indicates a 
preference for proton over deuterium. Studies on small soluble proteins [191–194] show that 
most Ф values are close to 1, and that Ф < 1 have been observed for “strong” H-bonds, 
whereas amide sites with H-bonds which are weak compared to solvent–solvent H-bonds 
have Ф > 1. 
 
H/D amide isotope substitution has provided an avenue for identifying the formation of 
H-bonds during protein folding. Equilibrium and kinetic isotope effects are quantified by 
measuring the change in stability due to replacement of deuterated amides with hydrogens 
from the solvent, ΔΔGD–H. Isotope substitution of backbone amide leads to changes in 
denaturant dependence of folding and unfolding rates. The perturbation of folding free energy 
QΔΔGF‡g02S can then be compared against the global stability change (ΔΔGD–H) using an 
isotopic ϕfD–H value: 
 ϕFg02 = ΔΔGF
‡g02
ΔΔGg02®  (1.26) 
 
This method has been applied to characterising the extent of H-bond formation in the 
transition state of soluble proteins which fold with two-state kinetics. Cross-linked and 
dimeric GCN4-D7A have ϕfD–H of ~0.59, indicating that about half of the helical H-bonds are 
formed in the transition states of the coiled-coil [195]. While ΔΔGD–H is found to correlate 
with the number of helical hydrogen bonds, β-sheet and long-range hydrogen bonds have 
little isotope effect [196]. Hence, there is limited general applicability of H/D amide isotope 
substitution to different structural motifs. 
 
The application of H/D exchange-based methods to studying H-bonds relies fundamentally 
on detailed quantification of the amount (at equilibrium) and the rate of solvent exchange 
within the suitable experimental timescales. Membrane proteins often have little access to 
water molecules when partitioned in the detergent or bilayer milieu for in vitro studies. 






Measurement and interpretation of kinetic and equilibrium thermodynamic parameters 
derived from H/D exchange could therefore be complicated by their limited accessibility to 
the bulk solvent. 
 
Chemical shift changes are usually observed for nuclei involved in H-bonds, as H-bond 
formation leads to redistribution of electron densities. Various trends have been noted, for 
example H-bonding to an electronegative acceptor atom leads to a downfield shift of the 
isotropic 1H chemical shift, while H-bonding to π-electrons in aromatic rings usually results 
in an upfield shift [185]. However, the correlation between changes in H-bonding and 
chemical shift changes could often be convoluted by other factors, such as structural changes 
in neighbouring or distal residues. 
 
Quadrupole coupling refers to the interaction of a quadrupolar nucleus with an electric field 
gradient. The electric field gradient arises from an asymmetric distribution of electron density 
around the nucleus. The quadrupole coupling constant (QCC) of a deuteron within an H-bond 
is very sensitive to the asymmetric charge distribution in the H-bond [185]. The T1 relaxation 
rate of a deuteron is dominated by its QCC. QCCs for backbone amide deuterons in human 
ubiquitin show good correlation with H-bond distances and angles in the crystal structure 
[197]. Precise measurement of QCC requires accurate structural knowledge for modelling the 
rotational diffusion of individual N–D bond vectors and accurate measurement of the 1JND 
scalar coupling constant. The main challenges with accurate measurement of QCC lies with 
the broad linewidths of quadrupolar nuclei due to fast relaxation. Hence, this methodology 
may be somewhat restricted to proteins with low molecular weight and dynamics which are 
favourable on the NMR timescale [197]. 
 
1.3.2 Scalar coupling 
Scalar coupling (or J-coupling) arises from the magnetic interaction between nuclei and is 
mediated by bonding electrons [185,198]. The nuclear spin polarisation of one atom affects 
the polarisation of the surrounding electrons (Figure 1.7a). The polarised electron cloud 
produces a change in the magnetic field surrounding the coupled spin. For example, in 
amides, the bonding electrons in the σ orbital become polarised by the proton magnetic 
dipole. Protons have two spin states. Depending on the orientation of the proton spin, the 






polarisation of electrons can either increase or decrease the magnetic field at the N nucleus, 
causing either an upfield or a downfield shift in the resonance line. The observed spectrum 
thus contains two peaks which are separated by the J-coupling constant (resonance splitting) 
(Figure 1.7b). J-couplings are denoted as nJAX, where A and X are the interacting nuclei, and 
n is the number of interceding covalent bonds. The size of the coupling constant depends on 
the number of bonds separating the coupled nuclei, and on the configuration and spatial 
arrangements of the bonding electrons. The value of the coupling constant can be either 
positive or negative. 
 
 
Figure 1.7: Scalar coupling 
(a) Schematic representation of the scalar coupling mechanism across H-bonds. (b) Schematic 
diagram showing the splitting of an amide 1H resonance by the 1JNH coupling constant. The direction 
of the applied magnetic field (B0) is shown by the yellow arrow. The orientations of the 1H spins for 
different resonances are shown using black arrows. Figure adapted from [185]. 
 
Since J-couplings are mediated by bonding electrons, they yield valuable information on the 
chemical connectivity of atoms and structures of bio-macromolecules, and provide angular 
restraints in NMR structure calculations [198]. J-coupling also underpins the transfer of 
magnetisation across bonded systems in multidimensional NMR [199]. The magnitude of 
J-couplings should always be compared against the linewidth of associated signals. Since 
linewidth increases with molecular weight, the detection of small, long-range n-bond 
couplings would be difficult for large proteins [198]. The typical values [198,200] and 
applications of several J-coupling constants in proteins are summarised in Table 1.1. 
 






Previous investigations have elucidated the 1JNH values in the random coil protein Tau, 
thereby providing an amino acid-specific reference for non-H-bonded residues. Xiang et al. 
have identified H-bonds by calculating Δ1JNH, the difference of 1JNH values measured in 
folded proteins (e.g. ubiquitin) and the amino acid-specific random coil values [201]. The 
authors have provided a modest error range of ± 0.35 Hz to account for perturbations in the 
random coil 1JNH measurements due to differences in pH and magnetic field strength between 
their different samples. In ubiquitin, residues with Δ1JNH smaller (i.e. more negative) than 
−0.35 Hz correlate well with H-bonding predictions by the WhatIf server [202]. 
 
nJAX J (Hz) Applications & Empirical relationships Ref. 
1JNH (–)89–95 
Presence of backbone H-bonding: H-bond is detected as Δ1JNH, the deviation of 1JNH 
values from random coil values, being smaller than −0.35 Hz 
[201] 
1JNC’ (–)13–15 Correlation with backbone amide H-bonds in different secondary structures [203] 
1JCαCβ (+)32–38 
Correlation with ϕ and ψ backbone dihedral angles: 
Δ1JCαCβ = 1.3 + 0.6 cos(ψ − 61°) + 2.2 cos[2(ψ − 61°)] − 0.9 cos[2(φ + 20°)] ± 0.5 Hz 
where Δ1JCαCβ is the deviation from 1JCαCβ in the corresponding free amino acid 
[204] 
1JCαHα (+)130–150 
Correlation with ϕ and ψ backbone dihedral angles: 
1JCαHα	= Ç + ™ cos´(¨ − 30°) + ∞ cos´(± − 30°)	
where A, B and C are empirically-derived coefficients 
[205] 
2JHαHβ (+)15–19 Torsional ψ angle in glycines [200] 
3JHN–Hα (+)0–11 Backbone ϕ angle 3J = Ç cos´ ≤ − ™ cos≤ + ∞ sin´ ≤ 
(The Karplus relationship) 
[200,206] 
3JHαHβ (+)1–12 Side-chain χ1 angle 
3hJNC’ (–)0.5 
Cross H-bond coupling: 
3hJNC’ = (−357 Hz) exp(−3.2rHO) cos2θ 
where rHO represents the H!O distance (Å) and θ the H!O=C angle 
[207] 
 
Table 1.1: Nuclear spin-spin couplings in proteins 
 
Δ1JNH measurement has also enabled the detection of a transient H-bond in the folding 
nucleus of the coiled-coil GCN4 leucine zipper [208]. GCN(16–31) comprises the trigger 
sequence, a short autonomous helical folding unit which is indispensable for coiled-coil 
formation. Arg-25 in native GCN(16–31) has the most negative Δ1JNH value of –0.46 ± 0.09 
Hz. Given the small experimental error of ~0.05 Hz estimated by recording the NMR 
experiment at least twice for each sample, and assuming a rigid helix has Δ1JNH of –1.0 Hz, 






Arg-25 is suggested to be involved in an intramolecular H-bond for ~46% of the time. This 
transient H-bond is validated by H/D exchange [208], and is consistent with the results from 
NMR and CD studies [209]. Δ1JNH values at other residues of GCN(16–31) correlate well 
with trifluoroethanol-induced helical structures, and show the lack of helical structures in the 
presence of GdmCl and in the R25A mutant, in which Arg-25-mediated electrostatic 
interactions that are essential for GCN stability are abolished [208]. Overall, 1JNH 
measurements have been demonstrated to be highly sensitive tools for the detection of stable 
and transient H-bonds in small soluble proteins. 
 







Rhodopsins are photochemically reactive membrane proteins that covalently bind to retinal 
chromophores. Type I rhodopsins are found in prokaryotes and eukaryotic microbes, and 
function as light-driven ion transporters (e.g. bacteriorhodopsin for pumping H+ and 
halorhodopsin for pumping Cl-), or phototaxis receptors (e.g. sensory rhodopsins I and II). 
Type II rhodopsins consist of photosensitive G protein-coupled receptors (GPCRs) in animal 
vision (e.g. bovine rhodopsin), and also in the pineal gland, hypothalamus and other tissues 
of lower vertebrates [210,211]. All proteins in the rhodopsin family harbour a seven 
transmembrane (7TM) α-helical fold and a Schiff base linkage between the e-amino group of 
a conserved lysine residue on helix G (or Helix 7) and the retinal chromophore. Despite 
structural similarities between bacteriorhodopsin and bovine rhodopsin, there are noted 
mechanistic differences between the two proteins. The retinal chromophore in archaeal 
rhodopsins photoisomerises and remains covalently attached to the protein throughout the 
photocycle before the chromophore re-isomerises and the protein returns to the ground state 
[212]. On the other hand, retinal in bovine rhodopsin photoisomerises from 11-cis to all-trans, 
dissociates from the protein, and is regenerated via a series of enzymatic steps to 11-cis 
retinal, which rebinds to opsin to regenerate rhodopsin [213]. 
 
The unfolding/folding pathways between bacteriorhodopsin and bovine rhodopsin are highly 
different, leading to different folding models being proposed. One of the major unanswered 
questions in the field is how the same heptahelical transmembrane architecture gives rise to 
different responses to denaturants and the proposal of different folding models. Most 
α-helical membrane proteins which have been studied to date appear to adhere the two-stage 
model. Studies with new model proteins and across comparable experimental conditions are 
required to further explore the long-range interactions model and the three-state model for 
α-helical membrane protein folding. 
 
The aims of this thesis broadly involve the investigation of the folding mechanism of a 7TM 
α-helical membrane protein, sensory rhodopsin II, and further development and application 
of methods for membrane protein folding studies. Specific aspects of these broad aims are 
addressed in separate chapters of this thesis: 






1. To screen for suitable in vitro conditions and to characterise the unfolding and refolding 
kinetics of pSRII using biophysical techniques (Chapter 2); 
2. To characterise the denatured states of pSRII using biophysical techniques and 
solution-state NMR (Chapters 2 & 3); 
3. To investigate the application of 1JNH scalar coupling measurements for detecting 
H-bonds in membrane proteins (Chapter 4); 
4. To further explore the possibility of assembling membrane proteins with split inteins 
using pSRII as proof-of-concept (Chapter 5). 
 
 
Figure 1.8: 3D structures of bacteriorhodopsin, bovine rhodopsin and sensory rhodopsin II 
1.55 Å crystal structure of H. salinarium bacteriorhodopsin (PDB 1C3W) [214]; 2.6 Å crystal 
structure of bovine rhodopsin (PDB 1L9H) [215]; and solution-state NMR structure of N. phararonis 
sensory rhodopsin II (PDB 2KSY) [216]. The retinal chromophore in each protein is shown as black 
sticks. 
 
Sensory rhodopsin II (pSRII) (Figure 1.8), from the archaeon Natronomonas pharaonis, 
functions as a repellent phototactic receptor to blue light. The photocycle of pSRII begins 
with photoisomerisation of the all-trans retinal chromophore to the 13-cis conformation, 
proceeding through a series of photointermediates (K, L, M, N and O) and initiating a series 
of conformational changes in the seven transmembrane helix core [217]. Proton transfer from 
the protonated Schiff base to its counterion, Asp-75, occurs upon the formation of the M-state, 
which is the signalling state [218,219]. The decay of the O-state coincides with proton 
transfer from the protonated Asp-75 to the proton releasing group, Asp-193, located at the 






extracellular surface through an extracellular proton conduction channel (consisting of Pro-
182, Pro-183 and Val-194 in pSRII) [220]. Proton uptake occurs subsequently, leading to 
reprotonation of the Schiff base and enabling pSRII to exhibit weak outward proton pumping 
activity in the absence of pHtrII (the cognate transducer of pSRII) [221,222]. The 
photocycles and photointermediates of different archaeal rhodopsins are tuned to the function 
of the protein: in the case of pumps such as bacteriorhodopsin, the photocycle time is fast 
(several milliseconds) [223], consistent with rapid proton pumping, whereas in sensory 
rhodopsins such as pSRII, the photocycle lasts longer (~ 1 s) [224], allowing signal transfer. 
 
The two transmembrane helices (TM1 and TM2) of pHtrII interact with helices F and G of 
pSRII to form a 2:2 complex with the two transducer molecules at the center of the complex. 
Light activation of pSRII triggers an outward movement of the cytoplasmic side of helix F, 
leading to a rotation of TM2 and the unwinding of helices in the cytoplasmic region of pHtrII 
[225]. This conformational change is recognised by the homodimeric histidine kinase CheA 
via a coupling protein CheW. CheA undergoes autophosphorylation and activation, and 
phosphorylates CheY, an aspartate kinase. Phosphorylated CheY interacts with the flagellar 
motor to induce clockwise rotation of the flagellum, enabling the archaeon to tumble away 
from light. Photoadaptation (sensitivity of the response to light activation) is regulated by 
CheB (a methylesterase) and CheR (a methyltransferase): autophosphorylated CheA also 
phosphorylates CheB, which competes against CheR to control the methylation state of 
specific glutamate residues in the cytoplasmic coiled-coil domain of pHtrII [226]. Ssignalling 
continues until the O-state photointermediate decays back to the ground-state conformation. 
 
Simulated thermal unfolding experiments suggest that pSRII is stabilised by a combination of 
mechanisms found for rhodopsin and bacteriorhodopsin [139], with a subset of helices 
breaking off early in the simulation and a core involving residues from other helices and 
loops remaining until late. More experimental studies are needed to understand the folding 
pathway of membrane proteins, particularly how and when secondary and tertiary structure 
elements are being formed. Retinal-binding 7TM helical proteins are excellent models for 
these studies, since the retinal chromophore acts as a natural reporter of the binding pocket 
and thus, the tertiary structure.  
 






To address our knowledge gap on how different membrane proteins traverse their folding 
landscapes, the SDS-denatured states and kinetics for the unfolding and refolding of pSRII in 
SDS/diheptanoylphosphatidylcholine (c7-DHPC) mixed detergent micelles were investigated 
in Chapter 2. Extensive screening of different denaturants and additives identified SDS as the 
most suitable denaturant for studying the unfolding of pSRII. Circular dichroism, UV/visible 
spectroscopy and tryptophan fluorescence showed that the SDS-denatured state is 
characterised by loss of tertiary structure (inter-helical contacts) and little loss in secondary 
structure, similar to bacteriorhodopsin and hence distinguishing pSRII from the long-range 
interactions model. The native chromophore can be reformed from a SDS-denatured state 
with retinal remaining covalently attached and from the apo-protein state, showing that both 
protein folding and retinal attachment are reversible. Notable differences were found in the 
kinetics of SDS denaturation and the refolding of pSRII compared to bacteriorhodopsin and 
other membrane proteins, which fold with two-state kinetics. These results suggest marked 
differences in the unfolding and folding pathways amongst pSRII, bacteriorhodopsin and 
bovine rhodopsin. Overall, this chapter has established pSRII as a new model protein for 
membrane protein folding studies. 
 
Solution-state NMR offers distinct advantage in providing structure and dynamics 
information at atomic resolution for highly-populated ground states as well as transient minor 
populations in bio-macromolecules. A range of NMR methods are available for studying 
protein folding events which occur at different timescales and for probing the properties of 
low-population folding intermediates, hence yielding detailed insights into folding landscapes, 
misfolding, aggregation and function [227]. In Chapter 3, SDS-denatured pSRII, 
acid-denatured pSRII and apo-sensory opsin obtained by hydroxylamine-mediated bleaching 
of pSRII were characterised by solution-state NMR. Small changes in the chemical 
environment of backbone amides were detected, consistent with the view that denatured 
pSRII remains embedded in detergent micelles. Changes in backbone amide dynamics, 
specifically increased observation of intermediate timescale exchange, was an important 
feature of SDS- and acid-denatured pSRII and apo-sensory opsin. This chapter has shed 
insight on differences in unfolding pathways induced by SDS and acidic pH, and the crucial 
roles of the retinal chromophore in governing the structural integrity and dynamics of the 
pSRII helical bundle. 







Different methods for measuring 1JNH scalar coupling were explored in Chapter 4 with the 
vision of applying these methods for detecting H-bond formation during membrane protein 
folding. During protein folding, the possible presence of stable and transient H-bonds might 
contribute differently towards stabilising native-like or non-native structures in intermediate 
states. Existing studies in literature (see Section 1.3.2) have been limited to small soluble 
proteins of < 10 kDa. RalA, a 20.9 kDa small GTPase with a mixed α + β fold, was used in 
proof-of-concept studies for extending the molecular weight limit and assessing the precision 
and accuracy of different scalar coupling measurement methods. The applications of 1JNH 
scalar coupling measurements for studying hydrogen bonds in folded and denatured 
membrane proteins were then investigated using OmpX reconstituted in DPC micelles and in 
the urea-denatured state. The applicability of the explored methods for measuring 1JNH in 
detergent-solubilised membrane proteins was limited by large errors attributable to excessive 
cross-correlated relaxation. Further optimisation of NMR experiments and utilisation of 
deuterated samples will be required in future studies. 
 
The two-stage model and the long-range interactions model for α-helical membrane protein 
folding are both supported by studies on protein assembly using different complementary 
fragments. Assembling isolated protein fragments requires solvent conditions which are 
suitable for solubilising all fragments and maintaining functionality of the native state. 
Naturally-occurring split inteins can mediate spontaneous trans-splicing of protein fragments 
both in vivo and in vitro, hence offering discernible advantages over protein assembly from 
isolated fragments in terms of versatility of the method and potential comparability to folding 
in vivo. Successful assembly of correctly-folded and functional proteorhodopsin has been 
achieved by in vivo trans-splicing of two complementary fragments which are co-expressed 
in E. coli [228]. With the vision of applying this method toward understanding the roles of 
helices and loops in the folding of pSRII and other membrane proteins, in Chapter 5, pSRII 
assembly in vivo was attempted by introducing a splice site in the loop region of the β-hairpin 
constituting the BC loop of pSRII. Despite attempts at optimising the conditions for protein 
expression, further optimisation is required for successful in vivo trans-splicing of pSRII to 





2 Biophysical characterisation of 
denatured states and reversible 
unfolding of sensory rhodopsin II 
 
2.1 Introduction 
Protein denaturation in vitro offers an avenue for accessing conformations represented in the 
ensemble of unfolded states. While early studies of proteins unfolded with high 
concentrations of chemical denaturants or at high temperatures initially led to the impression 
that unfolded states are essentially random coils, subsequent detailed studies on denatured 
states under a variety of solvent conditions have highlighted the influence of both native and 
non-native clustering of aliphatic and aromatic side-chains on the folding landscape [229]. 
Understanding the residual structure in the chemically denatured state of membrane proteins 
might provide mechanistic clues to how they fold. While different folding models are 
accepted for soluble proteins, only the two-stage model [86] and the long-range interactions 
model [140] have been proposed so far for helical membrane proteins. Simulated thermal 
unfolding experiments suggest that pSRII is stabilised by some combination of native-like 
secondary structure in a subset of helices and a folding core involving tertiary structure 
interactions between other helices and loops [139]. 
 
To address the knowledge gap on how different membrane proteins traverse their folding 
landscapes, this chapter focuses on biophysical characterisation of the SDS-denatured states 
and the kinetics for unfolding and refolding pSRII in SDS/c7-DHPC mixed detergent 
micelles, with the vision of proposing unfolding and folding mechanisms for pSRII. 
Experimental results on pSRII are compared against those in literature for bacteriorhodopsin 
and bovine rhodopsin, with the aim of comparing the unfolding and folding pathways of the 
three retinal-binding proteins. 
 
Characterisation of the denatured states and the unfolding and folding pathways require 
maximal unfolding of the protein with minimal amount of aggregation. However, these 
conditions are difficult to fulfil for membrane proteins, since in vitro studies require 






membrane proteins to be functionally reconstituted in a membrane mimetic, which often also 
renders them resistant to denaturation. It is particularly challenging to minimise the 
aggregation of denatured membrane proteins given their high composition of hydrophobic 
residues and the exposure of hydrophobic regions during denaturation. Moreover, 
experimental conditions that have been successfully applied to unfold a protein might not be 
applicable to others; hence, no uniformly-suited approach has been established. This chapter 
therefore begins with extensive screening of denaturants and additives to identify the most 
suitable solvent conditions for studying the unfolding of pSRII (see Section 2.3.1). 
 
To understand the unfolding mechanism, various biophysical techniques, including circular 
dichroism, UV/visible spectroscopy and tryptophan fluorescence were used to characterise 
changes in the secondary and tertiary structures and the timescales at which these changes 
occur upon SDS-denaturation of pSRII (see Sections 2.3.2, 2.3.3 and 2.3.6).  
 
The refolding pathway was examined in Sections 2.3.4–2.3.5. The reversibility of SDS 
denaturation and refolding kinetics were studied by monitoring changes in the absorbance of 
the retinal chromophore using UV/vis spectroscopy. Refolding was initiated from 
SDS-denatured pSRII with covalently attached retinal chromophore and from the apo-protein 
state. These studies would shed insight on the reversibility of protein folding and retinal 
Schiff base hydrolysis, respectively. 
 
Overall, this study has established pSRII as a new model protein for membrane protein 
folding studies, and has shown that pSRII possibly has a unique folding mechanism which is 











2.2.1 Circular dichroism 
Circular dichroism (CD) spectroscopy is a well-established tool for the structural 
characterisation of different biopolymers, including proteins, carbohydrates and nucleic acids. 
The physical basis for CD is the differential absorption of left- and right-handed circularly 
polarised light (Figure 2.1) by asymmetric (chiral) molecules with a chiral centre or a 3D 
structure that provides a chiral environment. The difference in absorption (∆Ç) of left- (Ç¥) 
and right-handed (Çµ) circularly polarised light is measured as a function of wavelength to 
yield the CD spectrum of the sample: 
 ∆Ç = Ç¥ − Çµ (2.1) 
 
CD data is commonly reported in terms of mean residue ellipticity (MRE or [θ]; degree cm2 
dmol-1 residue-1) or delta epsilon (Δ∑; M-1 cm-1). Ellipticity (the machine unit) measures the 
difference in molar extinction coefficients between left- and right-handed circularly polarised 
light, and needs to be corrected for the amount of protein in the sample. 
 
Δ∑ is the difference in molar extinction coefficients: 
 ∆∑ = ∏π∫×º×#×Ω×æ´ø¿ (2.2) 
where θ is the observed ellipticity (millidegrees), l the path length (cm), c the protein 
concentration (M) and n the number of peptide bonds. 
 
MRE ([θ]) is calculated as: 
 [θ] = 3298 × Δ∑ (2.3) 
 
Information on protein secondary structure can be derived from CD signals in the far UV 
(190–240 nm) wavelength range due to the amide chromophores of the peptide bonds. The 
two types of electron transitions responsible for the CD signals in this wavelength region are 
nàπ* transitions at around 222 nm and πàπ* transitions at around 208 nm and 190 nm. 
 






Figure 2.1b shows the far-UV CD spectra of the secondary structures which are commonly 
found in proteins and peptides. α-helices are characterised by two minima at 222 nm and 
208 nm, and β-strands are characterised by a single minimum at 218 nm [230]. 
 
 
Figure 2.1: Circular dichroism 
(a) Schematic diagram showing the differences between unpolarised (randomly polarised) light, 
linearly polarised light and circularly polarised light. Unpolarised light contains oscillations of the 
electronic component in all directions perpendicular to the direction of propagation. The direction of 
the electronic component is restricted to a plane perpendicular to the direction of propagation in 
linearly polarised light. In circularly polarised light, the magnitude of oscillation is constant and the 
direction oscillates in a clockwise or anti-clockwise manner. Retrieved from [231]. (b) CD spectra of 
polypeptides and proteins with representative secondary structures: poly-L-lysine in the α-helical (1) 
and antiparallel β-sheet conformations (2) at pH 11.1, and in the extended conformation (3) at pH 5.7; 
placental collagen in its native triple-helical (4) and denatured (5) forms. Retrieved from [230]. 
 
Far-UV CD is commonly used to assess protein secondary structural changes across various 
applications, such as ligand binding, mutations, protein denaturation and refolding by 
chemical and thermal methods. Changes in ellipticity at the characteristic wavelengths of 
different secondary structure elements can be monitored as a function of temperature, 
concentration of denaturants or stabilising agents, ligands or time. 
 
Measurements at single wavelengths are useful for following the kinetics and 
thermodynamics of the folding of polypeptides and proteins, for example, calculating helical 
content from ellipticity values at 222 nm and 208 nm. Monitoring changes at a single 






wavelength enables data to be collected rapidly, although the information content is limited 
and other conformations may interfere with the estimation of α-helical content [232]. 
 
Information on tertiary structure can be obtained from CD spectra of protein aromatic 
residues in the near UV (250–300 nm) wavelength range. CD bands in the near UV and 
visible region (> 300 nm) are also attributed to extrinsic chromophores. While the extrinsic 
chromophores may not be chiral or may exist as enantiomeric mixtures, their interactions 
with the chiral environment of a protein binding site generates optical activity [233]. 
Analyses of CD bands using a combination of computational and experimental methods can 
therefore yield information about the conformation of the chromophore and the binding 
pocket. An extensively studied example is the Soret CD band in the 400-nm region arising 
from the porphyrin ring in heme proteins, where the CD band can be explained by the 
combined effects of porphyrin-protein coupling and structural distortions of porphyrin [234]. 
Computational studies on visual rhodopsins show that nonplanar distortions in the polyene 
chain of retinal protonated Schiff base (PSB) are dominant over coupling of the retinal-PSB 
to the peptide backbone and aromatic side chains of the protein [235]. 
 
Whereas soluble proteins form uniform isotropic solutions in aqueous environments, 
membrane proteins are usually reconstituted into membrane mimetics to yield large 
hydrophobic, anisotropic particles. The physical nature of these samples might give rise to 
spectral artifacts which could present problems during data collection, analysis and 
interpretation [232]. Membrane, lipid and detergent environments tend to be hydrophobic 
and/or amphipathic. Hence, membrane protein samples have different physical properties and 
produce different spectral characteristics compared to soluble proteins. Secondary structure 
analyses usually entail empirical methods based on reference datasets of spectra derived from 
proteins of known structures. Peak positions in CD spectra can be affected by solvent 
dielectric. This is relevant for membrane proteins, due to the considerably lower dielectric 
constant of the hydrophobic core in a detergent micelle, lipid or membrane bilayer 
environment compared to that of aqueous solution. The extent and nature of this shift 
depends on the electronic transition in the peptide and on the relative position of the peptide 
bond inside the membrane environment. The wavelength dependence on solvent dielectric is 
thus non-linear. Shifts in peak positions can have significant effects on secondary structure 






analyses, and tend to produce inaccurate results with reference datasets derived from soluble 
proteins for spectra deconvolution. An effective solution is to use a reference dataset 
containing the spectra of membrane proteins, for example the SMP56 reference set from 
CDPro [236] and the SMP180 reference dataset [237] available on the DichroWeb server. 
 
The software CDPro was used in this chapter to analyse secondary structure composition of 
pSRII in different solvent conditions. All methods of deconvoluting CD spectra assume that 
the spectrum can be represented by a linear combination of its secondary structural elements 
plus a noise term. Protein conformation is generally evaluated against the spectra of 
references – a set of proteins with known conformations determined by X-ray crystallography 
[238]. CDPro includes 3 different programs for modelling CD spectra of unknown samples 
against the references: CDSSTR, CONTIN and SELCON3. The versions of these programs 
provided in CDPro have been modified to accept any given set of reference proteins, 
including the provided reference sets. In the variable selection method implemented in 
CDSSTR, protein spectra are eliminated systematically from the set of standards to create 
reduced data sets – effectively, a reduced set is created to include only reference proteins that 
fulfill the selection criteria for a good fit. Proteins in the reference set can also be weighed 
variably in a least-squares fitting of the analysed CD spectrum, as is done in the ridge 
regression method implemented in CONTIN [236]. 
 
2.2.2 UV/visible spectroscopy 
UV/visible (UV/vis) absorbance spectroscopy is routinely used in analytical chemistry for 
quantitative analyses of different samples, including biological macromolecules. Molecules 
containing π-electrons or non-bonding electrons can absorb energy in the form of ultraviolet 
or visible light to excite these electrons to higher anti-bonding molecular orbitals via πàπ* 
and nàπ* transitions, respectively. An absorption spectrum thus measures the transition of 
these electrons from the ground state to the excited state. A chromophore is the part of a 
molecule which absorbs light at a particular frequency to impart colour to the molecule. The 
wavelengths of absorption peaks can be correlated with the chemical structure. The energy 
gap and maximum absorbing wavelength (λmax) associated with the πàπ* transition vary 
with the substituents on the double bonds and the length of conjugation. For example, 






lycopene and β-carotene have extended conjugated systems of 11 double bonds and absorb at 
~500 nm [239]. 
 
Free all-trans retinal absorbs at 381 nm in ethanol [240] due to the conjugated system formed 
by its polyene chain. Retinal is bound to the ϵ-amino group of lysine via a protonated Schiff 
base (PSB) linkage. PSB of both the cis- and trans-forms of retinal absorb at 440 nm in 
methanol [241]. The “opsin shift” is defined as the difference in the absorption maxima 
between free retinal and the corresponding protonated Schiff base model compound in 
methanol [242]. The value of the opsin shift depends on the conformational differences 
between protein-bound retinal and free retinal in solution, as well as contributions of the 
protein binding pocket towards the absorption properties of the chromophore. Hence, the 
sensitivity of the UV/vis absorption profile of retinal to the local environment can be used as 
a probe for specific protein-chromophore interactions. 
 
Figure 2.2 shows the absorption spectra of different retinal isomers bound to visual and 
bacterial rhodopsins. All-trans retinal bound to pSRII absorbs at 498 nm, along with two 
vibronic side bands at 460 and 420 nm, and a third vibronic side band at 370 nm which is 
derived from multi-Gaussian deconvolution of the spectrum [224]. Gaussian band-shape 
simulation with vibrational frequencies of polyene stretching modes reproduces the 
structured absorption spectra of native pSRII pigment and the analogue 3,4-dehydroretinal 
[243]. The absorption spectra of 11-cis retinal in bovine rhodopsin (λmax = 498 nm)  [244] 
and all-trans retinal in light-adapted bacteriorhodopsin (λmax = 568 nm) [245] appear as 
simple bell shapes with no vibrational fine structures. 
 
Studies on absorption shifts produced by different retinal analogues indicate that 
planarisation of the retinal ring with respect to the polyene chain is the dominant factor in 
wavelength tuning of retinal pigments in the rhodopsin protein family. The small opsin shift 
in pSRII compared to those of other bacterial rhodopsins is due to both the lack of 
electrostatic perturbation of the chromophore and the relatively strong proton-counterion 
interaction at the Schiff base nitrogen atom [243]. 
 







Figure 2.2: Absorbance spectra of pSRII, bovine rhodopsin and bacteriorhodopsin 
(a) Purified pSRII in 0.28% octyl glucoside, 2 M NaCl, 25 mM PIPES, pH 7.2 [246]. (b) Bovine 
rhodopsin in 0.04 M CTAB, 0.066 M potassium phosphate, pH 6.5: (—) unbleached; (---) bleached; 
(-•-) photosensitivity curve [247]. (c) Purple membrane of Halobacterium halobium: (—) 
light-adapted membrane; (---) dark-adapted membrane [248]. 
 






2.2.3 Spectral deconvolution 
Resolving a complex spectrum into individual bands is useful for yielding information about 
each band. Spectral deconvolution involves fitting of a nonlinear model to the input data 
followed by iterative refinement. With each iteration the input is approximated by a linear 
combination of its components. The least squares method is used in regression analysis to 
approximate the solution of overdetermined systems (sets of equations in which there are 
more equations than unknowns). The solution minimises the sum of the squares of the 
residuals. 
 
The Levenberg-Marquardt algorithm [249,250] is an iterative technique which locates the 
minimum of a multivariate function expressed as the sum of squares of non-linear real-valued 
functions. The algorithm can be thought of as a combination of two minimisation methods: 
the steepest descent method and the Gauss-Newton method. In the steepest descent method, 
the local minimum is located by reducing the sum of the squared errors whilst taking steps 
proportional to the negative of the gradient at the current point. The steepest descent method 
is relatively slow near the local minimum. The Gauss-Newton method reduces the sum of the 
squared errors by assuming the least squares function is locally quadratic, and searches for 
the minimum point of the quadratic. The Levenberg-Marquardt method behaves more like the 
steepest descent method when the starting parameters are far from their optimal values and 
more like the Gauss-Newton method when the parameters are close to their optimal values 
[251].  
 
A symmetrical spectral band is described by three parameters: position (maximum absorbing 
wavelength or λmax), intensity, and width (usually the bandwidth at half-height). The band 
shapes most commonly used for deconvolution are the Gaussian function and the Lorentzian 
function, both of which are symmetrical functions. UV/vis absorbance spectra generally have 
Gaussian band shapes, while the Lorentzian function is usually used for simulating NMR 
spectra [252]. The result of a multi-gaussian fit of the absorbance spectrum of pSRII is shown 
in Figure 2.3 [224]. 
 







Figure 2.3: Multi-Gaussian fit of the absorbance spectrum of purified pSRII 
Spectrum of purified pSRII reconstituted in n-octyl-β-D-glucopyranoside (OG). The spectra of 
individual fitted components are shown as dashed lines, and the sum of all components are shown as 
solid line. Adapted from [224]. 
 
2.2.4 Tryptophan fluorescence 
Fluorescence is the re-emission of light leading to the return of a molecule to a lower energy 
level after the absorption of electromagnetic radiation (e.g. visible light). In terms of the 
Jablonski diagram (Figure 2.4a), the initial absorption of a photon by a fluorophore leads to 
promotion from the ground vibrational state of S0 to various excited vibrational states of S1. 
Such transitions are said to be vertical, in the language of the Franck-Condon principle. 
Non-radiative relaxation to the ground vibrational state of S1 then takes place. Fluorescence 
arises when a photon is emitted during the transition from the ground vibrational state of S1 
down to various vibrational states of S0. Since energy is lost through non-radiative 
mechanisms before reaching the emitting state, the fluorescence spectrum is shifted to higher 
wavelengths (lower energies) compared to the absorption spectrum. The quantum yield (η), a 
measure of how efficiently absorbed photons are converted into emitted light, determines 
how “fluorescent” a fluorophore is: 
 η = üEƒHbú	GF	bƒûùùb≈	ï∆GùGüIüEƒHbú	GF	«HIGúHb≈	ï∆GùGüI (2.4) 
 







Figure 2.4: Tryptophan fluorescence 
(a) Jablonski diagram illustrating possible transitions between electronic states of a fluorophore 
during absorption (solid blue) and emission (solid red) of a photon. Non-radiative relaxation is shown 
in dashed blue, and intersystem crossing/phosphorescence in gray. (b) Absorption and emission 
spectra of tryptophan (excitation wavelength = 280 nm). Retrieved from [253]. (c) Electronic 
absorption transitions of tryptophan, 1La and 1Lb. The nomenclature for atoms in the tryptophan indole 
ring are labelled in blue and the directions of the dipole moments in the 1La and 1Lb state are shown by 
the dotted arrows. Adapted from [254]. 
 
The fluorescence emission spectrum is usually recorded by exciting the sample at a fixed 
wavelength and then measuring the emission at different wavelengths. The emitted light is 
detected perpendicular to the direction of the exciting beam to avoid swamping the detector 
with very intense radiation normally used for excitation. Similarly, the fluorescence 
excitation spectrum can be recorded by scanning the wavelengths of exciting radiation while 
detecting at a fixed wavelength. 
 
Fluorophores can be available intrinsically through the presence of fluorescent amino acids 
(phenylalanine, tryptophan and tyrosine) or chromophores, or extrinsically by covalent or 
non-covalent attachment of fluorescent dyes or fluorescent proteins. Proteins from the 
rhodopsin family have two intrinsic fluorophores – the covalently-bound retinal chromophore 
and tryptophan residues. Bound retinal is weakly fluorescent due to its low quantum yield on 






the order of 10-4 to 10-5, originating from the fast return to the ground state in the ps–fs 
timescale after retinal excitation [255]. 
 
Tryptophan is the most abundant (up to 3% in membrane proteins) amongst the three 
fluorescence amino acid constituents [254]. Most retinal proteins contain several tryptophan 
residues, for example bovine rhodopsin has five and pSRII has six tryptophan residues. The 
indole ring of tryptophan has two absorption/emission transitions, 1La and 1Lb (Figure 2.4c). 
The current consensus is that tryptophan fluorescence emission originates from only the 1La 
state, except when the local environment is completely nonpolar [254]. Upon excitation of 
tryptophan, there is large redistribution of electron density from the Ne1 and Cg atoms to the 
Ce3, Cz2, and Cd2 atoms of the asymmetric indole ring, causing a large dipole moment in the 
1La excited state. The photophysical properties of tryptophan are influenced by the polarity of 
its local environment, hydrogen bonding and other non-covalent interactions. This is 
primarily attributed to interaction of the induced dipole moment in tryptophans with dipoles 
in the local environment influenced by solvent or protein side-chains. Computational studies 
suggest that the relative orientation of the charge or dipole to the ring determines whether 
there will be a red shift: positively charged moieties near the benzene end or negative charged 
moieties near the pyrrole end of the tryptophan ring system will produce a red shift (longer 
wavelengths) [256]. The emission λmax is blue-shifted for tryptophans in non-polar 
environments, for example Trp-45 of azurin is buried deep into a hydrophobic pocket and has 
λmax of 308 nm [257]. In contrast, solvent-exposed tryptophans have the most red-shifted 
emission, for example, Trp-25 in glucagon monomer emits with λmax of 352 nm [258].  
 
In comparison, other fluorescent amino acids have smaller contributions towards the intrinsic 
fluorescence emission of a protein. The contribution of phenylalanine is negligible due to its 
very low quantum yield. Tyrosine has similar quantum yield and absorption wavelength as 
tryptophan [259]. Illumination at 280 nm excites both tyrosine and tryptophan residues. 
Selective excitation of mostly tryptophan residues can be achieved by using excitation 
wavelengths within the range of 295–305 nm. This is because the absorption properties of 
tryptophan are governed by large redistribution of electron density in the asymmetric ring 
system upon excitation, whereas little redistribution of electron density occurs in the 
symmetric ring systems of tyrosine and phenylalanine [260,261]. 







Tryptophan fluorescence in retinal proteins is quenched due to efficient energy transfer to the 
retinal by Förster resonance energy transfer (FRET), as there is considerable overlap between 
tryptophan fluorescence emission and the absorbance spectrum of retinal in different states 
(free, PSB and protein-bound native pigment) [107]. Studies on bacteriorhodopsin excited at 
280 nm indicate that energy transfer from excited tyrosines and tryptophans to the 
chromophore takes place with a quantum yield of 0.7–0.8. All tyrosine residues and most 
tryptophan residues are completely quenched by the transfer process, with one tryptophan 
remaining unquenched and another being about 80% quenched [262]. 
 
The high dependency of tryptophan fluorescence on its local environment has been utilised 
extensively to study protein conformational changes and interactions with binding partners. 
Unfolding and refolding studies monitored by tryptophan fluorescence were performed for 
bacteriorhodopsin and bovine rhodopsin to study membrane protein folding. Information 
about the residual structure in SDS-denatured states of bovine rhodopsin suggest two 
different stages of unfolded structures at low and high concentrations of SDS, respectively 
[135]. Tryptophan fluorescence kinetics studies on the refolding of bacteriorhodopsin reveal 
discrete steps for retinal binding to an apo-protein intermediate and for subsequent formation 
of the covalent Schiff base linkage [120]. 
 
Although tryptophan fluorescence is highly utilised to study protein conformational changes, 
the interpretation of tryptophan fluorescence spectra can be challenging since different 
factors are coupled to yield the observed spectral changes. Moreover, most proteins possess 
multiple tryptophan residues, and the overall emission yields only averaged information on 
the protein structure. Extracting the contribution of each tryptophan reporter to obtain 
structural information on different parts of the protein is difficult. 
 
Correlation of the observed changes in tryptophan fluorescence with protein structural 
changes is not necessarily straightforward. A study on a fragment of bacteriorhodopsin 
containing helices A and B using tryptophan fluorescence and molecular dynamics 
simulation shows that the observed decrease in FRET efficiency between Tyr-57 on helix B 
and Trp-10 and Trp-12 on helix A is due to a decrease in the quantum yield of tryptophans, 






attributed to a cluster of water molecules forming a hydrogen-bond network with Tyr-57, 
rather than disruption of interhelical interactions [263]. This study indicates that changes in 
tryptophan fluorescence does not necessarily indicate structural changes, but may also be 
explained by changes in the photophysics of the fluorophores. 
 
Another major concern when studying retinal proteins is that probing the fluorophore with 
excitation light could cause photoactivation of the retinal. The exact effect depends on the 
nature of the photocycle. Visual rhodopsin is bleached even under continuous illumination of 
low (sub-µW/cm2) light intensity for up to 1 h [264], causing the chromophore to convert 
from the dark-state (λmax = 498 nm) to the active meta-II state (λmax = 380 nm). The light 
sensitivity of visual rhodopsin relates to its function of enabling vision in low-light conditions 
[253]. Bacteriorhodopsin photobleaches after continuous illumination for at least 30 min by 
yellow light with an intensity of 100–400 mW/cm2, although there is little bleaching at up to 
30 °C at pH 7 [265]. Continuous illumination of pSRII reconstituted in n-octyl-β-D-
glucopyranoside (OG) leads to a stable M-like state which binds 13-cis retinal and absorbs at 
386 nm. Overall, it is therefore recommended to use very tight excitation slits to achieve low 
excitation and wide emission slits of > 10 nm (bandpass) to maximise the amount of captured 
emission and to obtain reliable signal-to-noise ratios [253]. 
 
2.2.5 Chemical kinetics, curve fitting and model selection 
Chemical kinetic reactions can be characterised by extracting the rate constant from the time 
dependence of reactant disappearance or product formation. 
 
An example of first order kinetics data is a reaction where reactant A is converted to product 
B, and the rate of reaction (v) is proportional to the concentration of reactant A. 
 Ç d→ ™ (2.5) 
 » = ≈[…]≈ù = −
≈[ ]
≈ù = +[A] (2.6) 
 [A] = [A]∫e0dÃ (2.7) 
The customary method for analysing first order kinetics data is to take the natural logarithms 
of both sides of Equation 2.7. 
 ln[A] = ln[A]∫ − +Õ (2.8) 






A plot of ln[A] vs. t is linear with a slope of –k and intercept of ln[A]∫. However, this 
analysis is problematic because the data are heteroskedastic, meaning that the error is not 
constant across the range. The error increases as ln[A] decreases, as shown in Figure 2.5 
[266]. The consequence is that logarithms of values lower than the hypothetical ones deviate 
more than those higher than the hypothetical, leading to a steeper calculated slope, as can be 
seen from comparing the solid and dashed lines in Figure 2.5. 
 
Rate constants can also be derived from measuring the formation of product B (Equation 2.9). 
For example, rate constants for unfolding reactions can be obtained by monitoring the 
formation of unfolded species. 
 [™] = [Ç]∫[1 − É0dÃ] (2.9) 
The advantage of measuring product formation compared to measuring reactant 
disappearance is the higher signal-to-noise ratio when the reaction is reaching its equilibrium, 
thus enabling small changes in signal to be confidently detected. To obtain an equation which 
is linear with respect to t, Equation 2.9 can be solved for [Ç]∫ − [™]:  
 ln([Ç]∫ − [™]) = ln[Ç]∫ − +Õ (2.10) 
However, linear least squares fitting would be problematic, as [Ç]∫ must be known, and small 
errors in [Ç]∫ can cause large errors in k due to the increasing error as ln([Ç]∫ − [™]) 
decreases [266]. 
 
Similar problems arise if reactant A does not react completely (Equations 2.11 & 2.12), for 
example when partially denaturing conditions are applied for studying protein unfolding and 
yields a mixture of folded species (the reactant) and unfolded species (the product). This 
leads to a non-zero amount of reactant at infinite time ([Ç]Œ). 
 [Ç] − [Ç]Œ = ([Ç]∫ − [Ç]Œ)É0dÃ (2.11) 
 ln([Ç] − [Ç]Œ) = ln([Ç]∫ − [Ç]Œ) − +Õ (2.12) 
[Ç]∫ and [Ç]Œ must be known, and small errors in these values can cause large errors in k due 
to the increasing error as ln([Ç] − [Ç]Œ) decreases [266]. 
 
One solution for dealing with heteroskedasticity is to use a weighted linear least-squares fit, 
where the values are weighted inversely to their variance. A problem with this method is that 
the weighting factor must be estimated from the data, which are unreliable [266]. 







The nonlinear least squares method is a more elegant way of fitting experimental data 
directly. Unlike the linear least squares method, there are no general analytical solutions 
available for non-linear least squares fitting. Instead, parameters are estimated through 
iterative calculations while minimising the sum of the squares of errors with minimisation 
algorithms such as the Levenberg-Marquardt algorithm. As illustrated in Figure 2.5, a 
comparison of linear least-squares fit against nonlinear least-squares fit of first order reaction 
kinetics data shows that better fitting of the simulated data and a more accurate rate constant 




Figure 2.5: Comparison of linear vs. non-linear least squares analysis of kinetic data 
(a) Plot of the best linear fit of Equation 2.8 (solid line) to simulated data (×), along with hypothetical 
values (dashed line). Error bars are shown to increase as [A] and ln[A] decrease. (b) Plot of the 
nonlinear least-squares fit of Equation 2.11 to simulated data (×), along with hypothetical values 
(dashed curve) and constant error bars representing the average error in [A]. Adapted from [266]. 
 
Two consecutive first-order reactions can be used for modelling more complex reaction 
schemes, for example the reaction of reactant X to form product Z via an intermediate Y, 
where each step in the reaction can be treated as a simple exponential. This scheme was 
employed in this chapter to describe the unfolding reaction of pSRII. The changes in [X], [Y] 
and [Z] over time are simulated in Figure 2.6a [267]. 
 œ d–→ — d3→ “ (2.13) 
 [œ] = [œ]∫É0d–Ã (2.14) 






 [—] = [”]‘d–(d30d–) (É
0d–Ã − É0d3Ã) (2.15) 
 [“] = [œ]∫ ’1 + π(d–0d3) (+´É
0d–Ã − +πÉ0d3Ã)÷ (2.16) 
where k1 and k2 are first-order rate constants.  
 
 
Figure 2.6: Estimating reaction rate constants from a two-step consecutive first-order reaction 
(a) Simulated changes in concentrations of X (reactant), Y (intermediate), and Z (product) following 
the scheme in Equation 2.13, with k1 = 6 × 10-2 s-1, k2 = 3 × 10-2 s-1, and [X]0 = 1 mM. Retrieved from 
[267]. (b) Changes at different wavelengths over time in the absorption spectra of bacteriorhodopsin 
upon addition of 0.882 ΧSDS: 600 nm (open circles), 490 nm (filled triangles), and 440 nm (open 
triangles). Retrieved from [116]. (c–d) Residuals from curve-fitting of absorbance at 600 nm with a 
double exponential equation (c) or with a single exponential equation (d) for bacteriorhodopsin 
unfolding in 0.73 ΧSDS. Retrieved from [118]. 
 
The unfolding of bacteriorhodopsin has been modelled with the double first-order reaction 
scheme [116,118]. Upon mixing bacteriorhodopsin with denaturing concentrations of SDS, 
the native absorption band at 560 nm broadens and shifts to 600 nm (bR600) within 16 ms. 






The decay of bR600 coincides with the appearance of a band at 490 nm (bR490), which is 
arises from retinal isomerisation to predominantly the 9-cis form. bR490 subsequently decays 
to a band at 440 nm (bO440), an unfolded form of bacteriorhodopsin in which the retinal 
remains covalently-bound but most native protein-retinal interactions are lost. The retinal 
PSB is hydrolysed, and bO440 decays to bO390. This scheme [116] is summarised as: 
 bR◊ÿ∫ ⇌ bRÿ∫∫ ⇌ bRŸø∫ ⇌ bOŸŸ∫ → bOæø∫ + retinal (2.17) 
and can be further simplified as [118]: 
 bRÿ∫∫ d⁄⇄
d‹ bOŸŸ∫
d›ôõ bOæø∫ + retinal (2.18) 
 
Under unfolding conditions (+E ≫ +F), the equilibrium between bR600 and bO440 can be 
simplified as an irreversible reaction to yield a double first-order reaction scheme. The 
unfolding of bacteriorhodopsin, monitored by the change in absorbance at 600 nm, consists 
of two kinetic phases (Figure 2.6c–d). Global analysis of the spectra performed using singular 
value decomposition showed that the data were best fitted to a sequential reaction model with 
three species corresponding to bR600, bR490 and bO440, respectively [116]. 
 
Choosing an appropriate fitting model is paramount to extracting accurate rate constants and 
making correct interpretations from kinetics data. A good model should balance the 
competing objectives of maximising both goodness-of-fit (conformation of fitted model to 
the data) and parsimony (model simplicity). Under-fitting excludes key variables or effects 
and induces bias. Over-fitting unnecessarily complicates the model by including extra 
variables. 
 
The Akaike Information Criterion (AIC) [268] estimates the relative quality of different 
statistical models for a given set of data in order to provide a means for model selection. AIC 
is an implementation of Occam’s razor, in which parsimony or simplicity is balanced against 
goodness-of-fit. 
 AIC = 2q − 2 logL (2.19) 
where q is the number of model parameters and L is the likelihood (probability of the 
observed data coming from the estimated model). Given any two estimated models, the 
model with a smaller (or more negative) AIC value is more desirable. 







One caveat with model comparison methods is that information about the quality of each 
model is not provided, meaning it is possible that none of the models fit the data adequately. 
Hence, model-based statistical analyses (i.e. testing a null hypothesis) are still required to 
assess the quality of a chosen model. 
 
 







2.3.1 Denaturant and additives screening identify SDS as the most 
suitable denaturant for unfolding pSRII 
Characterisation of the denatured states and the unfolding and refolding pathways require 
maximal and reversible unfolding of the protein with minimal aggregation. To identify the 
most suitable denaturant for unfolding pSRII, the extent of protein unfolding was determined 
by monitoring changes in the UV/vis absorbance of the retinal chromophore. The results are 
summarised in Figure 2.7 and Table 2.1. The exquisite sensitivity of the retinal UV/vis 
absorbance fine structure enables facile monitoring of structural changes in the retinal 
binding pocket and detection of unfolding intermediates. In pSRII, all-trans retinal is 
covalently linked to Lys-205 via a PSB (Figure 2.7a) and gives rise to a main absorbance 
peak at 498 nm, with vibronic side bands at 460, 420 and 370 nm (Figure 2.7b) [224]. Retinal 
PSB devoid of native protein interactions absorbs at 440 nm (SR440) [269]. Schiff base 
hydrolysis leads to the release of free all-trans retinal, which absorbs at 390 nm (SO390) [240], 
from the sensory opsin apo-protein. 
 
pSRII was subjected to denaturation for one day at room temperature in the presence of 
different denaturants (Figures 2.7c–e). These included chaotropic denaturants urea and 
guanidium hydrochloride (GdmCl), trifluoroacetic acid (TFA), 2,2,2-trifluoroethanol (TFE), 
anionic detergents N-lauroylsarcosine and sodium dodecyl sulphate (SDS), cationic detergent 
cetyltrimethylammonium bromide (CTAB), zwitterionic detergent lauryldimethylamine-
N-oxide (LDAO), and non-ionic detergents polyoxyethylene (20) sorbitan monolaurate 
(Tween-20) and polyoxyethylene octyl phenyl ether (Triton X-100). 
 







Figure 2.7: Denaturant screening for unfolding pSRII 
(a) Retinal binding pocket of pSRII, where the all-trans retinal chromophore is covalently linked to 
Lys-205 via a PSB. (b) Changes in the UV/vis absorbance of the retinal chromophore during 
denaturation of pSRII. The insets show schematic representations of the binding pocket and the 
corresponding photographs of 90 µM pSRII in different spectral states. (c–e) Loss of retinal binding, 
determined by monitoring changes to the retinal absorbance peak by UV/vis spectroscopy, is taken as 
the hallmark of pSRII unfolding. All spectra are scaled to the 280-nm peak of the native spectrum 
(red). Only the 300- to 600-nm spectral range is displayed to illustrate changes in the retinal 
absorbance peak. pSRII was exposed to denaturation for one day in water-soluble denaturants (c), 
anionic and cationic detergents (d), and zwitterionic and non-ionic detergents (e). Only SDS, an 
anionic detergent, led to complete loss of native retinal-protein contacts (λmax = 390 nm). 













8 M Urea Bovine rhodopsin [270] 
No change (Native-like major peak at 498 nm 
with side bands at 460 nm, 420 nm and 370 nm) 
Orange; clear Does not unfold 
6 M GdmCl Bovine rhodopsin [270] No change Orange; clear Does not unfold 
50% (v/v) TFE 
KcsA potassium 
channel 
























[271] No change Orange; clear Does not unfold 
Cationic 
detergent 
1.5% (w/v) CTAB 
(0.952 ΧCTAB) 


















2% (v/v) Triton X-100 
(0.941 ΧTriton X-100) 
5-HT1A receptor [274] No change Orange; clear Does not unfold 




[275] No change Orange; clear Does not unfold 
 
Table 2.1: Effects of different denaturants on 7 µM pSRII after a one-day incubation at room temperature 
TFE, 2,2,2-trifluoroethanol; TFA, trifluoroacetic acid; SDS, sodium dodecyl sulphate; CTAB, cetyltrimethylammonium bromide; LDAO, 
lauryldimethylamine-N-oxide; Triton X-100, polyoxyethylene octyl phenyl ether; Tween-20, polyoxyethylene (20) sorbitan monolaurate.






Amongst the denaturants screened, only SDS yielded complete unfolding and Schiff base 
hydrolysis, with only SO390 being observed (Figure 2.7d). Like bacteriorhodopsin [276], 
pSRII cannot be denatured by urea and GdmCl, whereas bovine rhodopsin is susceptible to 
both denaturants [270]. TFA led to the formation of SR440 which slowly decayed to form 
SO390 over the course of two weeks, indicating that the rate of Schiff base hydrolysis is 
reduced considerably in an acidic environment. TFE led to aggregation which was observable 
by naked eye, and the sample was therefore not analysed by UV/vis spectroscopy. pSRII 
cannot be denatured by LDAO, even though it is a relatively harsh detergent, and it has been 
proposed that only ~20% of membrane proteins are resistant to its denaturing effects [277]. 
 
Aggregation was assessed by SDS-PAGE without boiling of the samples. Native loading dye 
(see Materials and Methods) was used so that no additional SDS was introduced from the 
sample buffer. Figure 2.8a shows a silver-stained SDS-PAGE gel for pSRII in 0%, 0.5% and 
3% SDS in the presence of 0.1% c7-DHPC for 0–72 h. Native pSRII in 0.1% c7-DHPC ran 
as a major monomeric band and a minor dimeric band. Sedimentation velocity analytical 
ultracentrifugation of 4.9 µM pSRII in 0.1% c7-DHPC confirmed that the monomeric species 
accounts for more than 90% of the total loading sample, while the dimeric species accounts 
for about 4% [278], consistent with the relative intensities of the two bands on SDS-PAGE 
gel. The amount of oligomerisation increased over prolonged unfolding time (Figure 2.8a) 
and correlated with the loss of α-helical structure and increase in β-sheet structure over time 
(Figure 2.8c). While dimers and higher-order oligomeric species were observed in both 0.5% 
and 3% SDS, the amount of higher oligomeric states was lower in 3% SDS (Figures 2.8a–b). 
This suggests that 0.5% SDS induced slow or partial unfolding, and the exposed protein 
surfaces led to preferential formation of higher oligomers. pSRII remained predominantly 
monomeric, and the amount of aggregation did not show noticeable increase after 2 h in SDS, 
which is the typical timeframe for the biophysics and kinetics studies in this chapter. The 
amounts of dimers and higher-order oligomers steadily increased from 24 h onward in both 
0.5% and 3% SDS (Figure 2.8a). 
 







Figure 2.8: Detection of aggregates for pSRII unfolded in SDS + 0.1% c7-DHPC at pH 6.0 
(a) Silver-stained 12% SDS-PAGE gel showing increased aggregation over prolonged unfolding time 
of pSRII in 0% (lanes 2–5), 0.5% (lanes 6–9) and 3% SDS (lanes 10–13) at pH 6.0 for 0 min, 2 h, 24 
h and 72 h at 25 °C. Lanes 1 and 14, molecular weight marker; lane 15, pSRII boiled in 3% SDS + 9 
M urea (3S9U) for 5 min at 95 °C. (b) Silver-stained 12% SDS-PAGE gel of pSRII unfolded in 
different concentrations of SDS + 0.1% c7-DHPC at pH 6.0 for 14 h at 25 °C. Lane 1, molecular 
weight marker; lane 2, pSRII; lanes 3–13, pSRII in 0.1–30% SDS. In panels a and b, the arrows 
indicate the expected migration of monomeric (M), dimeric (D) and trimeric (T) pSRII. (c) CD 
spectra of 7 µM (0.2 mg/ml) native pSRII and pSRII unfolded in 0.998 ΧSDS (30% SDS in 0.1% 
c7-DHPC) at pH 6.0 for up to 148 h, showing loss of α-helical structure and gain of β-sheet structure 
over time. 
 
The oligomerised species were hypothesised to represent off-pathway species that cannot be 
refolded to restore the native chromophore. To optimise the unfolding condition, different 






additives were explored with the goal of eliminating or reducing aggregation, and the results 
are summarised in Table 2.2. Protein aggregation was monitored by SDS-PAGE and the 
extent of protein unfolding was determined by UV/vis spectroscopy (Figure 2.9). Additives 
commonly used for reducing protein aggregation [279] were added to unfolding buffers 
containing 3% SDS, including non-detergent sulfobetaines NDSB-201 (3-(1-Pyridinio)-1-
propanesulfonate) and NDSB-256 (3-(Benzyldimethylammonio)propanesulfonate), 
L-arginine, polyethylene glycol PEG-8000, LDAO (Lauryldimethylamine-N-oxide) and urea. 
Different solvent conditions, including salt concentration (0–500 mM NaCl) and pH (pH 1.0–
6.0, adjusted using TFA or phosphoric acid), were also explored. 
 
Additive/Buffer Final Conc. Ref. 
Aggregation 
after 1 day 
Conclusion 
NaCl 0–500 mM [279] Yes 
More oligomeric species than in the 
absence of additive 
PEG-8000 0–30 mg/ml [279] Yes 
More oligomeric species than in the 
absence of additive 
LDAO 0.18% [280] Yes 
Similar amount of oligomeric 
species as in the absence of additive 
NDSB-201 1 M [279] Yes 
More oligomeric species than in the 
absence of additive 
NDSB-256 1 M [279] Yes 
More oligomeric species than in the 
absence of additive 
L-arginine 0.5 M [279] No 
pSRII did not unfold (see 
Figure 2.9d) 
Urea 0–8 M [270] Yes 
More oligomeric species than in the 
absence of additive 
TFA 0–200 mM [87,281,282] Yes 
Amount of oligomerisation depends 
on pH or [TFA] 
Sodium phosphate, 
pH 2.0 
50 mM [283] Yes 
Less oligomeric species than at 
pH 6.0 
 
Table 2.2: Aggregation of pSRII unfolded for one day at room temperature in 3% SDS + 
different additives or buffer conditions. 
 







Figure 2.9: Denaturation of pSRII in SDS leads to some extent of aggregation over time 
(a) Silver-stained 12% SDS-PAGE gel of pSRII unfolded for 16 h in SDS in the presence of different 
additives, in attempt to decrease oligomerisation. (b) SDS-PAGE of pSRII unfolded for 14.5 h in 
SDS + urea. (c) SDS-PAGE of pSRII unfolded in 3% SDS + varied concentrations of TFA for 62.5 h 
shows pH-dependent unfolding, aggregation and degradation. In panels a–c, the arrows indicate the 
expected migration of monomeric (M), dimeric (D) and trimeric (T) pSRII. (d) UV/vis spectra of the 
retinal chromophore of pSRII in the native condition (black trace), 3% SDS (blue trace) and 3% SDS 
+ 0.5 M L-arginine (red trace) show that L-arginine has prevented the protein from unfolding. 






Non-detergent sulfobetaines (NDSBs) are amphiphilic molecules with a short hydrophobic 
alkyl chain and a zwitterionic sulfobetaine group. NDSBs are not detergents since their short 
hydrophobic tails preclude micelle formation. Concentrations of NDSBs in the 1–2 M range 
have been used for refolding chemically- and thermally-denatured proteins. Renaturation 
studies on hen egg white lysozyme and bacterial β-D-galactosidase suggest that NDSBs 
interact with early folding intermediates and weaken abortive hydrophobic interactions which 
would have promoted misfolding and aggregation. The mechanism is proposed to be 
aromatic stacking interactions of the cyclic moiety of NDSBs with exposed aromatic groups 
of denatured proteins [284]. NDSBs are attractive addititves for SDS-mediated unfolding 
reactions, since they mediate a balance between protein folding and aggregation whilst 
preventing non-specific interactions. pSRII denatured with 3% SDS in the presence of 1 M 
NDSB-201 or 1 M NDSB-256 (Figure 2.9a, lanes 10–11) both led to the formation of more 
dimer and higher oligomers, with more pronounced aggregation observed in the presence of 
NDSB-256. This indicates that neither NDSBs were effective in reducing the aggregation of 
unfolded pSRII, causing worse shielding of exposed aggregation-prone surfaces. 
 
Arginine hydrochloride (L-Arg) is commonly used as an aggregation suppressor in protein 
refolding [279,285]. L-Arg increases the solubility of aggregation-prone unfolded species and 
intermediates of hen egg white lysozyme [286]. Computational studies show that L-Arg 
stabilises partially unfolded intermediates by interacting with aromatic residues through 
cation−π interaction and also with charged residues through salt bridges. The self-interaction 
of L-Arg leads to cluster formation, crowding out protein-protein interactions to eliminate 
aggregation [287]. SDS-PAGE of pSRII denatured in 3% SDS + 0.5 M L-Arg shows minimal 
amount of aggregation, but the protein has not unfolded (λmax = 498 nm; Figure 2.9d). 
L-Arg’s mechanism of action is thought to be complex, as its effects are concentration- and 
protein-dependent. It is speculated that L-Arg simultaneously affects the stability of the 
native state and the unfolded states, as demonstrated with the protein KMP-11 [288]. For the 
case of pSRII, L-Arg might have led to an overall greater destabilisation of the unfolded 
states. 
 
Polyethylene glycols (PEGs) are polymers with a variety of polymer chain lengths and 
molecular weights. Such water-soluble biopolymers could lead to either accelerated or 






reduced protein aggregation through a complex interplay of macromolecular crowding 
(decreasing the effective volume of a protein and stabilising more compact conformations) 
and non-specific protein-polymer interactions (electrostatic, hydrophobic and/or van der 
Waals) [289]. 1D 1H NMR and WATERGATE-TOCSY NMR data indicate that PEG-4000 
binds in a hydrophobic cleft on the surface of hen egg-white lysozyme formed by Arg-61, 
Trp-62, Trp-63, Arg-73, Lys-96 and Asp-101 [290]. pSRII showed more pronounced 
aggregation in the presence of increasing concentrations of PEG-8000 (0.4, 3 and 30 mg/ml) 
with 3% SDS (Figure 2.9a lanes 7, 8 & 13). Since the properties and effects of PEGs on 
aggregation and protein structure are highly dependent on their molecular weights [291], it is 
unknown whether using PEGs of other molecular weights could reduce the aggregation of 
pSRII more effectively than PEG-8000. 
 
As SDS is an anionic detergent, SDS concentration-dependent oligomerisation during pSRII 
denaturation might be mediated by interactions between detergent micelle surfaces [292]. 
Slight adjustments of surface charges can be achieved by using mixed micelles. Zwitterionic 
surfactants can have strong interactions with anionic surfactants in solution [293]. The 
zwitterionic detergent LDAO was chosen, given its similar chain length as SDS. Size 
exclusion chromatography of pSRII shows a double peak corresponding to monomer and 
dimer in DDM, whereas only monomer peak is observed in 0.1% LDAO [280], suggesting 
possible compatibility of LDAO with reducing pSRII oligomerisation. Moreover, LDAO has 
been shown to prevent aggregation and allow functional folding of unfolded MamC, a 
magnetosome-associated membrane protein from the magnetotactic bacterium 
Magnetococcus marinus MC-1 [294]. pSRII denatured in 3% SDS + 0.18% LDAO showed 
similar oligomerisation patterns on the SDS-PAGE gel (Figure 2.9a, lane 14), suggesting that 
LDAO was insufficient to perturb surface charges at the concentration tested. Further tests 
with higher LDAO concentrations were not attempted given potential difficulties in reliably 
replicating the properties of mixed micelles containing three detergents (c7-DHPC, SDS and 
LDAO) in further biophysical studies. 
 
A combination of SDS and urea (3% SDS + 8 M urea) is shown to be the most effective 
condition for denaturing bovine rhodopsin [270], where the amphiphilic SDS shields 
aggregation-prone surfaces which are exposed by urea. Fluorescence measurements using the 






probes pyrene-3-carboxaldehyde (PCA) localised to the surface of SDS micelles and 
diphenylbutadiene (DPB) solubilised in SDS micellar phase show that urea interacts with the 
polar headgroups and hydrocarbon chains of SDS micelles, leading to a more rigid 
microenvironment and displacement of some water molecules from the solvation layer of the 
surfactant hydrophobic chains in the micelle [295]. pSRII denatured in different 
concentrations of urea (0.5–8 M) in the presence of 0.5% or 3% SDS (Figure 2.9b) showed 
more pronounced oligomerisation with increasing urea concentration, with more 
oligomerisation being observed with 0.5% SDS than with 3% SDS. These results suggest that 
structural perturbation to SDS micelles by urea is inversely dependent on SDS concentration 
and leads to more unfavourable exposure of aggregation-inducing surfaces on pSRII. 
 
Changing the salt concentration perturbs surface charges and the strength of electrostatic 
interactions. 50 mM NaCl is already present in the unfolding buffer without additives. 
Denatured pSRII aggregated faster in unfolding buffers with higher salt concentrations 
(Figure 2.9a lanes 2 & 4–6). Hence, increasing the ionic strength was unfavourable for 
maintaining the monomeric state of SDS-denatured pSRII. 
 
TFA is a harsh organic acid which is routinely used for solubilising peptides [296]. SDS in 
the presence of different concentrations of TFA at different pHs were also explored 
(Figure 2.9c). Changing the pH affects both the surface charge distribution and the net charge 
of the protein, hence modulating electrostatic interactions which could have contributed 
towards aggregation. As pH decreases with increasing TFA concentrations, oligomeric bands 
became fainter, indicating that lower pH slows down aggregation. However, protein 
degradation was observed in SDS at pH 1.60 and pH 0.96, indicating that further optimisation 
is required to balance oligomerisation and acid-mediated proteolysis. 
 
Controls against possible protein modifications by TFA, such as trifluoroacetylation [296], 
were accounted for by unfolding pSRII at pH 2.0, adjusted using phosphoric acid, both in the 
absence and presence of SDS (Figure 2.10). The formation of oligomers in SDS at pH 2.0 
showed similar dependence on time and SDS concentration as in SDS at pH 6.0. 
 







Figure 2.10: Detection of aggregates for pSRII unfolded in SDS at pH 2.0 
(a) SDS-PAGE of pSRII unfolded in different concentrations of SDS + 0.1% c7-DHPC at pH 2.0 for 
14 h at 25 °C. Lane 1, pSRII at pH 6.0; lane 2, molecular weight marker; lanes 3–14, pSRII in 0–30% 
SDS at pH 2.0. (b) SDS-PAGE showing time-dependent aggregation of pSRII unfolded in SDS at pH 
2.0. Lane 1, pSRII at pH 6.0; lane 2, molecular weight marker; lanes 3–14, pSRII unfolded for 0 min, 
2 h, 24 h and 72 h in 0% (lanes 2–5), 0.5% (lanes 6–9) and 3% SDS (lanes 10–13), pH 2.0. In both 
panels, the arrows indicate the expected migration of monomeric (M), dimeric (D) and trimeric (T) 
pSRII. 
 
In summary, despite extensive efforts, none of the tested additives and buffer conditions 
offered decreased oligomerisation without compromising the unfolding rate (see Figure 2.9d). 






Results interpretation was complicated by unknown effects of different additives on pSRII 
and SDS/c7-DHPC mixed micelles. SDS-denaturation of pSRII at pH 6.0 and at pH 2.0 were 
identified as conditions which yield maximal unfolding and the least amount of aggregation. 
Further biophysical studies were therefore pursued in different SDS concentrations at pH 6.0 
and pH 2.0 to study structural changes and kinetics of pSRII unfolding. 
 
Figure 2.11: pSRII unfolding in SDS + 0.5% c7-DHPC at pH 6.0 
(a) Silver-stained 12% SDS-PAGE gel of pSRII unfolded in different concentrations of SDS + 0.5% 
c7-DHPC at pH 6.0 for 14 h at 25 °C. Lane 1, molecular weight marker; lane 2, pSRII; lanes 3–13, 
pSRII in 0.1–30% SDS. (b) Silver-stained 12% SDS-PAGE gel showing increased aggregation over 
prolonged unfolding times of pSRII in 0% (lanes 2–5), 2.5% (lanes 6–10) and 15% SDS (lanes 11–15) 
+ 0.5% c7-DHPC at pH 6.0 for 0–72 h at 25 °C. In panels a–b, the arrows indicate the expected 
migration of monomeric (M), dimeric (D) and trimeric (T) pSRII. (c–d) CD spectra (c) and 
tryptophan fluorescence emission spectra (d) for 7 µM (0.2 mg/ml) pSRII in 0–0.990 ΧSDS (0–30% 
SDS in 0.5% c7-DHPC). 
 






2.3.2 Characterisation of denatured states: SDS at pH 6.0 
Based on the combined criteria of the largest degree of denaturation and the least amount of 
aggregation, in the subsequent sections, structural properties of SDS-denatured pSRII were 
studied at a maximum of 2 h after initial exposure to SDS, thus ensuring complete unfolding 
and negligible amounts of aggregates accumulated across all conditions. All biophysics data 
in this chapter were correlated with the bulk mole fraction of SDS (ΧSDS), as this parameter 
describes the local environment to which the protein is being exposed in terms of the amount 
of SDS available in solution relative to the total amount of detergent (SDS + c7-DHPC). 
Since the extent of membrane protein unfolding correlates with ΧSDS [116], high ΧSDS in low 
c7-DHPC concentration (0.1% c7-DHPC) was used in order to obtain maximally unfolded 
pSRII for biophysical characterisation of SDS-denatured states. The kinetics of unfolding and 
refolding reactions were studied in the presence of excess concentrations of SDS/c7-DHPC 
mixed micelles (SDS + 0.5% c7-DHPC) to obtain accurate rate constants while avoiding 
multiple micelle occupancy. Control experiments show that similar extents of aggregation, 
and similar secondary and tertiary structure changes were yielded for SDS-denatured pSRII 
in the presence of 0.1% c7-DHPC vs. 0.5% c7-DHPC (Figure 2.11). 
 
2.3.2.1 Secondary structure changes 
The loss of secondary structure in pSRII, unfolded for 2 h at pH 6.0 with 0–0.998 ΧSDS (0–30% 
SDS in 0.1% c7-DHPC), was monitored by CD spectroscopy. Little change was observed, 
suggesting that α-helical content was largely preserved in SDS-denatured pSRII at pH 6.0 
(Figure 2.12a). Similar changes in α-helical content were observed for pSRII unfolded in 
SDS + 0.5% c7-DHPC (Figure 2.11c). Changes in mean residue ellipticity (MRE) at 222 nm 
from folded pSRII can be divided into two distinct stages: ΧSDS up to 0.980 (3% SDS in 0.1% 
c7-DHPC) led to a decrease in MRE magnitude by up to 12.6 ± 1.0%; further increase in 
ΧSDS reversed this trend, with only 9.3 ± 1.6% decrease in MRE magnitude observed at 
0.998 ΧSDS (30% SDS in 0.1% c7-DHPC) (Figure 2.12b). This slight increase in helicity at 
high ΧSDS could be attributed to SDS favouring the formation of non-native helical structures 
[297]. 
 
Changes in different secondary structure elements calculated using CDPro software [298] are 
shown in Table 2.3 and Figure 2.13. The fraction of regular helix (H(r)) showed significant 






decrease in > 0.834 ΧSDS. The fraction of distorted helix (H(d)) increased in > 0.893 ΧSDS, 
while the content of other secondary structure elements (regular sheet, distorted sheet, turn 
and unordered) only showed slight increases in > 0.834 ΧSDS. 
 
 
Figure 2.12: Secondary structure changes in SDS-denatured pSRII at pH 6.0 
(a) CD spectra and (b) MRE at 222 nm for 7 µM (0.2 mg/ml) pSRII in 0–0.998 ΧSDS (0–30% SDS in 
0.1% c7-DHPC). Inset in panel b shows expanded view for the 0.75–1.00 ΧSDS region. Error bars 
represent the standard deviation of three independent measurements. 
 
ΧSDS H(r) H(d) S(r) S(d) T U 
0 47.3 ± 1.3% 17.0 ± 0.7% 0.6 ± 0.1% 3.1 ± 0.4% 10.4 ± 0.6% 21.6 ± 0.3% 
0.625 47.5 ± 1.2% 17.4 ± 0.3% 0.4 ± 0.2% 2.7 ± 0.2% 10.6 ± 0.5% 21.4 ± 0.4% 
0.834 45.6 ± 0.7% 17.4 ± 0.4% 0.8 ± 0.3% 3.3 ± 0.2% 11.6 ± 0.3% 21.3 ± 0.2% 
0.893 38.1 ± 0.4% 18.6 ± 0.2% 2.2 ± 0.2% 3.9 ± 0.1% 13.9 ± 0.3% 23.2 ± 0.2% 
0.943 38.7 ± 0.3% 19.0 ± 0.1% 1.7 ± 0.2% 3.9 ± 0.1% 13.6 ± 0.2% 23.0 ± 0.1% 
0.980 38.9 ± 1.8% 19.1 ± 0.8% 1.4 ± 0.4% 4.0 ± 0.2% 13.6 ± 0.5% 23.0 ± 0.6% 
0.994 40.7 ± 2.6% 20.3 ± 2.1% 2.4 ± 1.9% 3.0 ± 1.0% 8.9 ± 7.8% 24.5 ± 3.3% 
0.997 41.1 ± 0.5% 20.0 ± 0.7% 1.5 ± 1.0% 3.6 ± 0.3% 12.1 ± 1.7% 21.7 ± 2.8% 
0.998 40.3 ± 1.4% 19.6 ± 0.4% 0.8 ± 0.7% 3.6 ± 0.3% 13.1 ± 0.4% 22.5 ± 0.6% 
 
Table 2.3: Deconvolution of CD spectra for pSRII unfolded for 2 h in SDS at pH 6.0 
Deconvolution was performed using CDPro with CONTINLL algorithm and basis set no. 10 (contains 
soluble and membrane proteins). H(r), regular helix; H(d), distorted helix; S(r), regular strand; S(d), 
distorted strand; T, turns; U, unordered. Errors are reported as standard deviations of three 
independent measurements. 
 







Figure 2.13: Changes in secondary structure composition of pSRII in SDS at pH 6.0 
CD spectra were deconvoluted using CDPro with CONTINLL algorithm and basis set no. 10 
(contains soluble and membrane proteins). H(r), regular helix; H(d), distorted helix; S(r), regular 
strand; S(d), distorted strand; T, turns; U, unordered. Errors are reported as standard deviations of 
three independent measurements. 






2.3.2.2 Changes in the retinal binding pocket 
UV/vis spectra of the retinal chromophore were recorded to monitor structural changes at the 
retinal binding pocket. In low ΧSDS (≤ 0.893 ΧSDS; 0.5% SDS in 0.1% c7-DHPC), an 
isosbestic point at ~420 nm was observed. A spectral intermediate absorbing at 440 nm 
(SR440), characteristic of a PSB devoid of native retinal-protein contacts, appeared in 
³ 0.943 ΧSDS (1% SDS in 0.1% c7-DHPC). Schiff base hydrolysis occurs over the course of 
2 h, leading to the release of free all-trans retinal, which absorbs at 390 nm (SO390) [240], 
yielding the sensory opsin apo-protein (Figure 2.14a). 
 
To accurately determine the unfolding transition, equilibrium unfolding measurements were 
performed by unfolding pSRII in SDS in the presence of 0.5% c7-DHPC and monitoring the 
loss of absorbance at 498 nm after 10 min (Figure 2.14b). 0.5% c7-DHPC was used to avoid 
multiple micelle occupancy by ensuring an excess molar ratio of detergent micelles to protein 
across all ΧSDS. The transition midpoint was around 0.81 ΧSDS, higher than those reported for 
bacteriorhodopsin [116,299], indicating that pSRII in c7-DHPC is more stable than 
bacteriorhodopsin. 
 
Each UV/vis spectrum was deconvoluted by nonlinear least squares fitting of the 
chromophore absorbance peaks to a model of Gaussian peaks (Figure 2.15). Gaussian-fitted 
λmax of dead-time spectra in different ΧSDS (dead-time = 25 s) revealed ΧSDS-dependent red 
shift of the chromophore absorbance peak which closely matches the increase in unfolded 
protein fraction obtained from equilibrium unfolding measurements (Figure 2.14b). Since the 
λmax values of protonated retinylidene model Schiff bases are sensitive to the proximity of the 
counteranion [300], spectral red shift of the retinal chromophore could suggest an increase in 
the separation of the Schiff base counterion, Asp-75, from the PSB upon denaturation of 
pSRII in SDS. The fitted λmax remained constant beyond 0.943 ΧSDS (5% SDS in 0.5% 
c7-DHPC), suggesting that further increases in ΧSDS did not yield further separation of 
Asp-75 from the PSB, and the binding pocket is already fully opened. 
 







Figure 2.14: Loosening of the retinal binding pocket in SDS-denatured pSRII at pH 6.0 
(a) Time-resolved UV/vis spectra of pSRII unfolded in 0.980 ΧSDS (3% SDS in 0.1% c7-DHPC). (b) 
SDS-induced equilibrium unfolding of pSRII in the presence of 0.5% c7-DHPC monitored by UV/vis 
spectroscopy. λmax of the retinal chromophore at t = 0 min, obtained by nonlinear least squares fitting, 
is also plotted against ΧSDS, showing that the chromophore λmax is dependent on ΧSDS. Error bars 
represent the standard deviation of three independent measurements. 
 
 
Figure 2.15: Nonlinear least squares fitting of UV/vis spectra 
Time-resolved UV/vis spectra of pSRII unfolded in 0.980 ΧSDS (3% SDS) are shown for (a) t = 0 min 
(dead-time = 25 s), (b) t = 20 min, and (c) t = 60 min. Nonlinear least squares fitting was used to 
deconvolute the spectra into three spectral components (red, lime and blue lines). Goodness-of-fit can 
be assessed from the residual and the total model taken as the sum of the three spectral components. 
(d) The concentration of each fitted component is plotted against time. 
 






2.3.2.3 Tertiary structure changes 
pSRII contains six tryptophan residues, which are mainly located in close proximity to the 
retinal chromophore (Figure 2.16a). Their intrinsic fluorescence is quenched due to very 
efficient energy transfer to the retinal by Förster resonance energy transfer (FRET) [301]. 
Figure 2.16b shows the emission spectra of pSRII denatured in different ΧSDS at pH 6.0 for 
2 h. Increased tryptophan fluorescence intensities were observed, as Schiff base hydrolysis 
leads to the removal of retinal from its binding pocket and away from the tryptophan residues. 
Tryptophan fluorescence of folded pSRII (0 ΧSDS) has λmax of 337 nm, which became 
gradually red-shifted with increasing ΧSDS up to 343 nm in 0.998 ΧSDS (30% SDS in 0.1% 
c7-DHPC). This indicates that some tryptophan residues have become more solvent-exposed 
upon protein unfolding. pSRII unfolded in SDS + 0.5% c7-DHPC (i.e. the conditions chosen 
for the kinetic studies) yielded similar observations (Figure 2.11d). 
 
 
Figure 2.16: Tryptophan fluorescence of SDS-denatured pSRII at pH 6.0 
(a) Solution-state NMR structure of pSRII (PDB 2KSY), with tryptophan residues shown as pink 
spheres. (b) Tryptophan fluorescence emission spectra of 7 µM pSRII unfolded for 2 h in 0–0.998 
ΧSDS (0–30% SDS in 0.1% c7-DHPC). Emission λmax of pSRII in 0 ΧSDS is shown as dotted line. 
 
2.3.2.4 The unfolding transition 
The unfolding transition of pSRII in the presence of SDS + 0.1% c7-DHPC vs. SDS + 0.5% 
c7-DHPC was compared using CD, UV/vis spectroscopy and tryptophan fluorescence 
(Figure 2.17). The unfolding transition for pSRII was ~0.81 ΧSDS in SDS + 0.5% c7-DHPC, 
and ~0.86 ΧSDS in SDS + 0.1% c7-DHPC. These values were very comparable across the 






three biophysical techniques. Notably, pSRII unfolded to the same extent in SDS + 0.1% 
c7-DHPC vs. in SDS + 0.5% c7-DHPC, thus justifying the comparison of biophysical data 
obtained under these conditions. 
 
 
Figure 2.17: Unfolding transition of pSRII in SDS/c7-DHPC determined by (a) CD, (b) UV/vis 
spectroscopy, and (c) tryptophan fluorescence 
Error bars represent the standard deviation of three independent measurements. 
 






2.3.2.5 Solvent accessibility of the binding pocket 
Hydroxylamine serves as a probe for monitoring protein conformational changes near the 
Schiff base in retinal-binding proteins [302,303]. Hydroxylamine becomes the preferred 
nucleophile for Schiff base cleavage instead of water, leading to cleavage of the PSB and 
formation of retinal oxime, which absorbs at 360 nm (Figure 2.18a) [304]. In the presence of 
10 mM hydroxylamine, pSRII in 0 ΧSDS at pH 6.0 exhibited slow retinal PSB hydrolysis, 
suggesting that the retinal binding pocket is relatively solvent-inaccessible (Figure 2.18b(i)). 
The rate of chromophore bleaching increased significantly in the presence of 0.980 ΧSDS 
(3% SDS), with complete formation of retinal oxime within 30 min (Figure 2.18b(ii)). This 
indicates that SDS leads to an increase in solvent accessibility of the retinal binding pocket. 
Tryptophan fluorescence spectra of hydroxylamine-bleached pSRII, both in the absence and 
presence of SDS, showed an increase in fluorescence intensity and ΧSDS-dependent red shift 
of the peak (Figure 2.18c), consistent with the release of retinal oxime and increase in solvent 
accessibility of the binding pocket. In contrary to bacteriorhodopsin and bovine rhodopsin 
where the bleaching of purple membranes and bovine rod outer segment disk membrane in 
the presence of hydroxylamine did not lead to appreciable changes in the far-UV CD spectra 
[305,306], the presence of hydroxylamine led to greater loss of pSRII secondary structure 
beyond the unfolding transition while the transition point remained the same (Figure 2.18d). 
This suggests that some non-native secondary structure elements of pSRII are being 
stabilised by SDS/c7-DHPC mixed micelle in the absence of hydroxylamine but not in the 
presence of hydroxylamine, possibly due to changes in detergent micelle structure and/or 
protein-micelle interactions in the presence of hydroxylamine. 
 







Figure 2.18: Assessing solvent accessibility of the retinal binding pocket using hydroxylamine at 
pH 6.0 
(a) Reaction mechanism of hydroxylamine with pSRII PSB to form retinal oxime. Structures were 
drawn using MolView. (b) Time-resolved UV/vis spectra of pSRII in (i) 10 mM hydroxylamine 
(0 ΧSDS) and (ii) 0.980 ΧSDS (3% SDS) + 10 mM hydroxylamine in 0.1% c7-DHPC. (c) Emission 
spectra of 7 µM pSRII unfolded for 2 h in 0–0.998 ΧSDS + 10 mM hydroxylamine in 0.1% c7-DHPC. 
Emission λmax (338.5 nm) of pSRII in 0 ΧSDS + 10 mM hydroxylamine is shown as dotted line. (d) 
MRE at 222 nm for pSRII in 0–0.998 ΧSDS + 10 mM hydroxylamine. Inset shows expanded view for 
the 0.75–1.00 ΧSDS region. Error bars represent the standard deviation of three independent 
measurements. 
 






2.3.3 Kinetic measurements of pSRII unfolding 
The results from biophysical studies show that pSRII unfolds in SDS at pH 6.0 to form SO390 






where ku, kf and kh are the first-order rate constants for unfolding, folding and retinal Schiff 
base hydrolysis, respectively. 
 
In the SO390 state, most of the secondary structure remains while tertiary structure is 
disrupted. 
 
Since high ΧSDS were used for the unfolding reactions ('( ≫ '*), the unfolding model could 
be further simplified to yield Equation 2.21: 
 pSRII
+,-. SR440
+/-. SO390 (2.21) 
 
To gain further insights into the unfolding pathway, the kinetics of pSRII unfolding were 
monitored by UV/vis spectroscopy and the time courses fitted using nonlinear least squares 
methods (see Materials and Methods). Kinetic studies were done in the presence of excess 
concentrations of SDS/c7-DHPC mixed micelles (SDS + 0.5% c7-DHPC) to obtain accurate 
rate constants and to avoid multiple micelle occupancy. 
 
Two rate constants, ku and kh, were extracted, describing changes in retinal chromophore 
absorbance when pSRII was unfolded in SDS at pH 6.0 (no hydroxylamine). ku, the 
first-order rate constant for the formation of SR440, increases with increasing ΧSDS (Table 2.4). 
ku is (44 ± 9) × 10-4 s-1 in 0.893 ΧSDS (2.5% SDS in 0.5% c7-DHPC), about 120-fold smaller 
than the unfolding rate constant of 0.54 s-1 for bacteriorhodopsin in 0.882 ΧSDS in 
SDS/DMPC/CHAPSO micelles [116]. Bovine rhodopsin unfolds in 0.972 ΧSDS (1% SDS in 
0.05% DDM) with the time constant 0.32 ± 0.01 s [135], corresponding to ku of 3.125 s-1, 
which is about 700-fold larger than that for the unfolding of pSRII. Plotting the natural 
logarithm of ku against ΧSDS yields the unfolding arm of the chevron plot (see Section 2.3.4), 
where ln ku increases linearly against ΧSDS. Minor non-linearity observed in high ΧSDS can be 
attributed to the formation of cylindrical micelles at high SDS concentrations [307,308]. 







kh, the rate constant of Schiff base hydrolysis, is independent of SDS concentration 
(Table 2.4). kh is (4.2 ± 0.6) × 10-4 s-1 in 0.834–0.971 ΧSDS (1.5–10% SDS in 0.5% c7-DHPC), 
similar to but slightly smaller than ~9×10-4 s-1, the rate constant for free retinal formation 
from the 440-nm state of bacteriorhodopsin (bR440) [116]. This suggests that SR440 and bR440 
could have similar solvent accessibility to their binding pockets, but kh might also be 
rate-limited by other factors such as the reactivity of the Schiff base, possibly due to different 
unfolding conditions being used in these studies. 
 
ΧSDS 
Rate constants (×10-4 s-1) 
ku kh 
0.834 18 ± 3 3.7 ± 0.2 
0.870 36 ± 11 3.9 ± 0.3 
0.893 44 ± 9 4.5 ± 0.3 
0.909 62 ± 12 3.8 ± 0.4 
0.930 73 ± 4 4.1 ± 0.9 
0.943 106 ± 8 4.2 ± 0.9 
0.962 98 ± 17 4.5 ± 0.8 
0.971 111 ± 24 4.4 ± 0.6 
 
Table 2.4: Rate constants for pSRII unfolding in SDS/c7-DHPC mixed micelles 
ku is the first-order rate constant for the formation of SR440, and kh is the rate constant for Schiff base 
hydrolysis. Errors are reported as standard deviations of three independent measurements. 
 
To compare results across different conditions and biophysical techniques, changes over time 
of MRE at 222 nm, retinal UV/vis absorbance, and tryptophan fluorescence emission at 
335 nm were recorded for pSRII unfolded in different ΧSDS in 0.1% c7-DHPC at pH 6.0, both 
in the absence and presence of 10 mM hydroxylamine. The time courses were fitted to the 
appropriate models using nonlinear least squares fitting (see Materials and Methods, 
Figures 2.15 and 2.19) and the rate constants were extracted (Figure 2.20). 
 
These rate constants differ slightly from those for pSRII unfolding in SDS + 0.5% c7-DHPC 
(see Table 2.4) due to possible complications with multiple micelle occupancy under low 
c7-DHPC concentrations. Nevertheless, good consistency was obtained across the three 






techniques, indicating that rate constants extracted by UV/vis spectroscopy for pSRII 
unfolding in SDS + 0.5% c7-DHPC would have been comparable to those determined by CD 
and tryptophan fluorescence. 
 
 
Figure 2.19: Examples of nonlinear least squares fitting for time-courses recorded by (a) far-UV 
CD, and (b) tryptophan fluorescence. 
(a) Far-UV CD timecourse data (white circles) were adequately fitted with a single exponential model 
(blue line), as judged by the residual (green line). (b) Tryptophan fluorescence timecourse data (black 
dots) could not be adequately fitted with a single exponential (blue line), as judged by the non-random 
residual trace (green line), while a double exponential model (red line) fits the data adequately, as 
determined from the corresponding residual (orange line). 
 
 







Figure 2.20: ΧSDS-dependence of the rate constants for pSRII unfolding 
(a) In the presence of SDS only (no hydroxylamine), two rate constants, ku and kh, were extracted to 
describe protein unfolding and retinal Schiff base hydrolysis, respectively. (b) In the presence of 
10 mM hydroxylamine, only one rate constant was extracted. Error bars in both panels represent the 
standard deviation of three independent measurements. 
 
Secondary structure changes occur as a one-step process, as evidenced by good 
monoexponential fits of changes in MRE at 222 nm (Figure 2.19a). Similar rate constants 
were obtained regardless of the absence or presence of hydroxylamine (Figure 2.20). Tertiary 
structure changes, monitored by UV/vis spectroscopy and tryptophan fluorescence 
time-courses, occur in two steps: protein unfolding to form SR440 and Schiff base hydrolysis 
to yield SO390, respectively. The rate constants extracted from tryptophan fluorescence 
time-courses were similar to those from UV/vis time-courses for most ΧSDS, hence 
confirming that the increase in fluorescence intensity during unfolding was primarily due to 
un-quenching of tryptophan fluorescence while retinal was being removed from its binding 
pocket (Figure 2.20). At 0.893 ΧSDS (0.5% SDS + 0.1% c7-DHPC) and 0.943 ΧSDS (1% SDS 
+ 0.1% c7-DHPC), the unfolding rate constant measured by tryptophan fluorescence was 
smaller than that measured by UV/vis spectroscopy, suggesting that fluorescence remains 
partially quenched for one or more tryptophan residues near the partially loosened retinal 
binding pocket. Schiff base hydrolysis was fast in the presence of hydroxylamine and SDS at 
pH 6.0, such that retinal oxime formed rapidly without accumulation of the SR440 






intermediate, and only one rate constant was extracted across all biophysical techniques 
(Figure 2.20b). 
 
In summary, exposure of pSRII to SDS led to ΧSDS-dependent protein unfolding followed by 
ΧSDS-independent retinal Schiff base hydrolysis. The rate limiting step depends on the relative 
rates of these two processes, and determines the rate constant(s) that can be extracted from 
the time-courses. 
 
2.3.4 Refolding from SR440 
Reversibility of in vitro unfolding is important for determining whether the denatured states 
are on-pathway species. SDS-denatured pSRII constitutes the starting point of in vitro 
refolding experiments. The reversibility of unfolding and the kinetics of refolding reactions 
were characterised in order to understand the folding pathway of pSRII. As there are two 
stages (protein unfolding and retinal Schiff base hydrolysis) involved in obtaining 
SDS-denatured apo-sensory opsin, the reversibility of pSRII unfolding was examined with 
refolding reactions initiated from SDS-denatured pSRII with covalently-attached retinal 
(SR440) or from SDS-denatured apo-sensory opsin (SO390). Successful refolding was assessed 
by the recovery of the native chromophore absorbance at 498 nm with characteristic vibronic 
side bands at 460, 420 and 370 nm. 
 
SR440 was first attained by incubating pSRII in 0.943 ΧSDS (5% SDS + 0.5% c7-DHPC) for 
4 min. Refolding was then initiated by 12-fold dilution of SR440 into refolding buffer 
containing different ΧSDS and monitored by UV/vis spectroscopy. All refolding kinetics were 
measured in the presence of 0.5% c7-DHPC to minimise the effects of multiple micelle 
occupancy. Refolding buffer included 0.500–0.700 ΧSDS (0.30–0.70% SDS) for measuring 
refolding rates in 0.698–0.779 ΧSDS (0.69–1.06% SDS). 
 
Absorption spectra were taken at fixed time points during refolding, and deconvoluted by 
nonlinear least squares fitting in order to assess the rate at which the native chromophore is 
being reformed (Table 2.5). 
 






Figure 2.21a shows the spectra recorded in 0.698 ΧSDS, where the rate constant of folding (kf) 
was significantly greater than the rate constant of retinal hydrolysis (kh), and in 0.779 ΧSDS, 
where kf was similar to kh. In both cases, as the reaction progressed, absorbance at 440 nm 
decreased, while absorbance at 390 nm and ~500 nm increased simultaneously, albeit at 
different rates. This indicates that formation of folded pSRII is fast, whereas formation of 
SO390, either directly from SR440 or from slow unfolding of refolded pSRII, is slow and 
observable within 2 h only in ≥ 0.745 ΧSDS. 
 
 
Figure 2.21: Refolding of pSRII from the unfolded state (SR440) 
(a) Absorption spectra for refolding from SR440 in (i) 0.698 ΧSDS and (ii) 0.779 ΧSDS, both in 
0.5% c7-DHPC. Both regeneration of native chromophore (498 nm) and formation of SO390 can be 
observed, with the rate of refolding being dependent on ΧSDS. (b) Changes in absorbance at ~500 nm 
in high ΧSDS can be fitted to a double exponential to yield two macroscopic rate constants, R1 and R2. 
(c) Chevron plot summarising the extracted microscopic unfolding and refolding rates, ku and kf. Error 
bars in panels b and c represent the standard deviation of three independent measurements. 
 
 







Rate constants × 10-4 (s-1) 
R1 R2 kf ku 
0.698 - - 199 ± 52 - 
0.723 - - 110 ± 10 - 
0.745 81 ± 18 0.16 ± 0.05 74 ± 18 3.5 ± 1.4 
0.755 46 ± 7 0.32 ± 0.01 39 ± 7 4.0 ± 0.6 
0.763 31 ± 10 0.41 ± 0.18 25 ± 10 3.3 ± 1.8 
0.772 23 ± 3 0.76 ± 0.09 15 ± 3 4.7 ± 0.8 
0.779 19 ± 5 0.87 ± 0.62 12 ± 6 3.9 ± 2.9 
 
Table 2.5: Rate constants extracted for refolding pSRII from SR440 
Under conditions where the rate of retinal hydrolysis is very slow compared to the rate of folding 
(0.698–0.723 ΧSDS), changes in the fitted absorbance at ~500 nm over time were approximated to a 
monoexponential model (Equation 2.22). In higher ΧSDS, changes in the fitted absorbance at ~500 nm 
over time were fitted to a double exponential model to yield the macroscopic rate constants R1 and R2 
(Equation 2.23). The microscopic rate constants kf and ku were extracted using experimentally 
determined values of R1, R2 and kh (Equations 2.24–2.26). Errors are reported as standard deviations 
of three independent measurements. 
 
For ≤ 0.723 ΧSDS, where the rate of retinal hydrolysis is very slow compared to the rate of 
folding ('0 ≪ '*), the time dependence of pSRII recovery was approximated with a single 
exponential model (Figure 2.22a–c): 
 2344~2671 − :;+<=> + @ (2.22) 
where the observed rate constant was approximated as the de novo refolding rate kf. 
 
For ≥ 0.745 ΧSDS, a double exponential model would be required (Figure 2.22d–f): 
 2344~26(1 − :;BC=) + 2E(:;BF=) + @ (2.23)  
where A1 and A2 are the amplitudes of the fast phase and the slow phase, respectively, and R1 
and R2, the apparent rate constants (Figure 2.21b), are the solutions to the following quadratic 
equation [118]: 
 GE − 7'H + 'I + 'J>G + 'I'J = 0 (2.24) 
 
kf and ku were calculated using the following relationships and experimentally determined 
values of R1, R2 and kh (Table 2.5): 
 G6GE = 'I'J (2.25) 
 G6 + GE = 'H + 'I + 'J (2.26) 







Based on experimental unfolding kinetic measurements, kh is independent of ΧSDS (Table 2.4), 
and is taken as (3.72 ± 0.17) × 10-4 s-1 for 0.834 ΧSDS in 0.5% c7-DHPC. It is noted that 
values of ku obtained from refolding kinetic measurements tend to be unreliable, as they are 
dominated by errors in kf and kh. 
 
In contrast to the unfolding arm of the chevron plot (ln kf and ln ku against ΧSDS), which is 
essentially linear, the folding arm showed clear deviation from a linear trend (‘roll-over’) 
(Figure 2.21c). This result strongly indicates that the formation of tertiary structure packing 
during refolding of SR440 is more complex than the two-state kinetics that has been observed 
for the equivalent process in bacteriorhodopsin [116,309]. 
 
For a protein that has a tendency to oligomerise, non-linearities in chevron plots could be 
attributed to multiple micelle occupancy, transient aggregates or kinetic intermediates [6]. To 
determine whether non-linearity in the folding arm is due to any of these factors, unfolding 
and refolding time-courses were recorded in increased detergent-to-protein ratios [310], 
obtained by increasing the detergent concentration and/or decreasing the protein 
concentration. The unfolding and refolding rate constants obtained (Figure 2.23a–b) were 
superimposable with those in Figure 2.21c. SDS-PAGE on samples taken at various time 
points up to 2 h of refolding in different ΧSDS also showed no increase in the amount of 
stably-formed oligomers compared to folded pSRII (Figure 2.23c). These results indicate that 
there is no evidence for aggregation or multiple micelle occupancy being the origins of 
non-linearity in the chevron plot, suggesting a more complex refolding mechanism for pSRII. 
 







Figure 2.22: Examples of nonlinear least squares fitting for UV/vis time-courses of refolding 
from SR440 in 0.723 ΧSDS (a–c) and 0.806 ΧSDS (d–f) 
Time-resolved UV/vis spectra of refolding from SR440 are shown for t = 0 min (dead-time = 20 s) (a, 
d), and t = 80 min (b, f). The spectra were deconvoluted by nonlinear least squares (NLS) fitting to 
yield three spectral components (red, lime and blue lines). Goodness-of-fit can be assessed from the 
total model taken as sum of the three spectral components. The absorbance of each fitted spectral 
component is plotted in panels c and f. Changes in absorbance at ~500 nm during refolding in 
0.723 ΧSDS was fitted to a mono-exponential model to yield one rate constant for the recovery of the 
native chromophore. A double exponential model was used to describe refolding in 0.806 ΧSDS to 
yield two rate constants (R1 and R2) for the fast recovery of the native chromophore and slow decay to 
form SO390, respectively. 
 







Figure 2.23: SR440 refolding kinetics were not influenced by aggregates or multiple micelle 
occupancy 
(a) Normalised changes in A498 for pSRII unfolding in 0.893 ΧSDS and (b) nonlinear least squares 
fitted A500 for SR440 refolding in 0.698 ΧSDS, both showing that unfolding and refolding rates are not 
dependent on protein concentration or detergent concentration. 1.2 µM pSRII was used in refolding 
experiments shown in panel b. Insets in both panels show expanded views of the earliest time points. 
(c) SDS-PAGE for refolding from SR440 for different durations (0 min, 20 min, 1 h, 2 h) in the 
presence of different ΧSDS in 0.5% c7-DHPC, showing no evidence for the formation of stable 
aggregates. Lane 1, molecular weight marker; lanes 2–3, pSRII unfolded in 0.893 ΧSDS for 0 min and 
2 h, respectively; lanes 4–15, pSRII was first unfolded for 4 min in 0.893 ΧSDS to obtain SR440, 
followed by refolding for 0 min, 20 min, 1 h and 2 h in 0.698 ΧSDS (lanes 4–7), 0.755 ΧSDS (lanes 8–11) 
and 0.779 ΧSDS (lanes 12–15). The arrows indicate the expected migration of monomeric (M) and 
dimeric (D) pSRII. 
 






2.3.5 Refolding from SO390 
Refolding from the SO390 apo-protein state was explored to determine whether retinal Schiff 
base hydrolysis is reversible. For retinal-binding proteins, formation of the retinal Schiff base 
linkage and correct protein folding (see Section 2.3.4 on refolding from SR440) are both 
crucial for formation of the native chromophore in a functional binding pocket. 
 
SO390 was first attained by incubating pSRII in 0.893 ΧSDS (2.5% SDS in 0.5% c7-DHPC) for 
2 h at room temperature. Retinal was not removed after unfolding and no additional retinal 
was introduced. Refolding was initiated by 12-fold dilution of SO390 into refolding buffer and 
monitored for 2 h by UV/vis spectroscopy. The refolding buffer included 0–0.294 ΧSDS (0–
0.125% SDS in 0.5% c7-DHPC) to enable measurement of refolding kinetics in 0.410–0.519 
ΧSDS (0.208–0.323% SDS in 0.5% c7-DHPC). 
 
Time-courses of refolding from SO390 showed an isosbestic point at 420 nm (Figure 2.24a), 
suggesting that the rate-limiting step of the reaction is the reformation of retinal Schiff base, 
assuming that the reaction proceeds through SR440 (i.e. the same pathway as unfolding). 
 
The time-courses were modelled to Equation 2.27 as pseudo first-order reactions: 
 SO390
kapp-. pSRII (2.27) 
where kapp is the apparent rate for the reconstitution of the native chromophore, taking into 
account both retinal re-attachment (reformation of the Schiff base) and protein folding. 
 
kapp in 0.410–0.519 ΧSDS ranged from 1.7 × 10-4 to 12.9 × 10-4 s-1 (Table 2.6), similar to the 
rate constant of 17 × 10-4  s-1 for the refolding of bacteriorhodopsin from bO390 in 0.472 ΧSDS 
[116]. This suggests that the rate of refolding from SO390 is limited by Schiff base 
reformation. The natural logarithm of kapp (ln kapp) appeared to be linearly-dependent against 
ΧSDS in 0.410–0.519 ΧSDS (Figure 2.24b), though the fast kapp in < 0.4 ΧSDS precludes its 
measurement by means of manual mixing. 
 







Figure 2.24: Refolding of pSRII from the apo-protein state (SO390) 
(a) Absorption spectra for refolding from SO390 in (i) 0.410 ΧSDS and (ii) 0.519 ΧSDS, both in 0.5% 
c7-DHPC. (b) Natural logarithm of the apparent refolding rate (ln kapp) from SO390 is linearly 
dependent on ΧSDS. (c) Refolding yield of SO390 decreases with increasing amount of time spent in the 
unfolded state, suggesting that only the monomeric species might be capable of rebinding retinal and 
regenerating the native chromophore. Error bars in panels b and c represent the standard deviation of 
three independent measurements. Results from one representative gel is shown for estimating the 
monomeric content by SDS-PAGE (see Figure 2.11b: lanes 6–10). 
 
ΧSDS kapp × 10-4 (s-1) 
0.410 12.9 ± 2.0 
0.436 5.1 ± 1.5 
0.459 4.6 ± 1.2 
0.480 3.0 ± 0.7 
0.500 2.0 ± 0.6 
0.519 1.7 ± 0.2 
 
Table 2.6: Apparent rate constants (kapp) for refolding pSRII from SO390. 
kapp takes into account both retinal re-attachment (reformation of the Schiff base) and protein folding. 
Errors are reported as standard deviations of three independent measurements. 







Overnight incubation of the refolding reaction at room temperature led to a substantial 
increase in the amount of refolded pSRII compared to the recovery yield obtained after 2 h 
(Figure 2.25a). This additional slow phase for native chromophore recovery might suggest 
that (1) there is a small population of misfolded SO390 which requires some structural 
rearrangements to be capable of rebinding retinal and thus refolds at a much slower timescale, 
and/or (2) retinal has diffused out of a subpopulation of detergent micelles and the 
regeneration of SO390 apo-protein molecules which are embedded in such micelles would 
depend on the resolubilisation of retinal into these micelles. 
 
 
Figure 2.25: Additional recovery of the native chromophore after overnight refolding of SO390 
(a) Example time-course for the refolding of SO390 in 0.480 ΧSDS in 0.5% c7-DHPC, showing 
additional recovery of the native chromophore (red trace) after refolding at room temperature 
overnight. (b) The apparent rate constant for refolding remains the same regardless of the time spent 
in the SO390 state. Error bars represent the standard deviation of three independent measurements. 
 
Refolding yields were estimated by calculating the concentration of free retinal at the 
projected plateau of the single exponential fitted for the decrease in SO390 over the two-hour 
refolding time-course (Figure 2.26). Refolding yields decreased with increasing amount of 
time (2–72 h) during which pSRII remained unfolded in 0.893 ΧSDS, and correlated well with 
the monomeric population left in the unfolded reaction assessed by SDS-PAGE (Figure 2.11b: 
lanes 6–10) and quantified using ImageJ (Figure 2.24c). Hence, only monomeric SO390 was 
capable of refolding to yield the native chromophore, while the oligomeric species were 






irrecoverable misfolded off-pathway species. The apparent refolding rate constant was 
independent of the time spent in the SO390 state and the extent of aggregation (Figure 2.25b). 
 
 
Figure 2.26: Examples of nonlinear least squares fitting of UV/vis time-courses for the refolding 
of SO390 in 0.745 ΧSDS (a–c) and 0.806 ΧSDS (d–f) 
Time-resolved UV/vis spectra of refolding from SO390 are shown for t = 0 min (dead-time = 20 s) (a), 
and t = 120 min (b). The spectra were deconvoluted by nonlinear least squares fitting to yield two 
spectral components (red and lime lines) for the retinal chromophore. Goodness-of-fit can be assessed 
from the total model taken as the sum of the fitted spectral components. The absorbance of each fitted 
spectral component is plotted in panel c. Changes in absorbance at ~390 nm during refolding was 
fitted to a monoexponential model to yield one apparent rate constant for the decay of SO390. 
 
2.3.6 Characterisation of denatured states: SDS at pH 2.0 
2.3.6.1 Secondary structure changes 
pSRII unfolded in SDS at pH 2.0 also showed little loss in α-helical content (Figure 2.27). 
Essentially no difference in MRE at 222 nm was observed even after exposing pSRII to 
acidic pH for 19 h, suggesting slow unfolding in the absence of SDS (Figure 2.27a(i)). 
0.998 ΧSDS (30% SDS in 0.1% c7-DHPC) at pH 2.0 led to fast loss of α-helicity within 
seconds (Figure 2.27a(ii)), contrasting against pSRII unfolding in SDS at pH 6.0, where the 
loss of secondary structure occurs on timescales ranging from seconds to hours, with the rate 
constant being dependent on ΧSDS (Figure 2.20). Further loss of α-helicity beyond 20 h in 






SDS at pH 2.0 is attributed to aggregation, as evidenced by SDS-PAGE (Figure 2.10) and the 
appearance of a local minimum at 218 nm in the CD spectrum, which is characteristic of an 
increase in β-sheet content (Figure 2.27a(ii)). Changes in different secondary structure 
elements at pH 2.0 were calculated using CDPro software (Table 2.7 and Figure 2.28). Like 
at pH 6.0 (Table 2.3 and Figures 2.12–2.13), the fraction of regular helix (H(r)) showed 
significant decrease in > 0.834 ΧSDS at pH 2.0. While the fraction of distorted helix (H(d)) 
and regular strand (S(r)) did not show significant changes, the fraction of distorted strand 
(S(d)), turns (T) and unordered (U) structures showed slight increases. 
 
ΧSDS H(r) H(d) S(r) S(d) T U 
0 46.0 ± 1.4% 17.3 ± 0.7% 1.1 ± 0.2% 3.1 ± 0.4% 11.5 ± 0.6% 21.0 ± 1.2% 
0.769 47.6 ± 1.0% 18.6 ± 0.4% 0.8 ± 0.4% 2.8 ± 0.3% 10.9 ± 0.4% 19.3 ± 0.3% 
0.893 42.2 ± 1.3% 18.6 ± 0.6% 1.7 ± 0.4% 3.4 ± 0.2% 12.7 ± 0.3% 21.4 ± 0.5% 
0.980 37.8 ± 3.3% 17.7 ± 0.2% 3.0 ± 1.8% 4.5 ± 0.2% 13.7 ± 0.9% 23.2 ± 0.7% 
0.994 39.6 ± 0.6% 18.3 ± 0.3% 1.9 ± 0.4% 4.1 ± 0.2% 13.4 ± 0.1% 22.7 ± 0.1% 
0.998 41.2 ± 0.7% 19.5 ± 1.6% 1.4 ± 0.5% 3.5 ± 0.8% 11.3 ± 2.4% 23.0 ± 0.9% 
 
Table 2.7: Deconvolution of CD spectra for pSRII unfolded for 30 min in SDS at pH 2.0 
Deconvolution was performed using CDPro with CONTINLL algorithm and basis set no. 10 (contains 
soluble and membrane proteins). H(r), regular helix; H(d), distorted helix; S(r), regular strand; S(d), 
distorted strand; T, turns; U, unordered. Errors are reported as standard deviations of three 
independent measurements. 







Figure 2.27: Circular dichroism of pSRII in SDS + 0.1% c7-DHPC at pH 2.0 
(a) CD spectra of 7 µM (0.2 mg/ml) native pSRII and pSRII unfolded in (i) 0 ΧSDS and (ii) 0.998 ΧSDS 
(30% SDS) at pH 2.0 for up to 160 h. (b) MRE at 222 nm for pSRII in 0–0.998 ΧSDS (0–30% SDS) at 
pH 2.0 in the absence (black trace) and presence (red trace) of 10 mM hydroxylamine. Inset shows 











Figure 2.28: Changes in secondary structure composition of pSRII in SDS at pH 2.0 
CD spectra were deconvoluted using CDPro with CONTINLL algorithm and basis set no. 10 
(contains soluble and membrane proteins). H(r), regular helix; H(d), distorted helix; S(r), regular 
strand; S(d), distorted strand; T, turns; U, unordered. Errors are reported as standard deviations of 
three independent measurements. 
 
2.3.6.2 Changes in the retinal binding pocket 
Acid denaturation of pSRII at pH 2.0 (without SDS) led to very slow protein unfolding and 
Schiff base hydrolysis, with the reaction taking between 5 and 24 h to reach completion 
(Figure 2.29a). pSRII in ³ 0.625 ΧSDS (0.1% SDS in 0.1% c7-DHPC) at pH 2.0 led to the 
formation of SR440 within the dead-time of 25 s, followed by very slow release of free retinal 
over a period of more than 6 days (Figure 2.29b). This indicates that in an acidic environment, 






the retinal binding pocket is structurally disrupted within seconds after initial exposure to 
SDS but Schiff base hydrolysis is significantly slowed down. These observations are 
consistent with previous reports of bacteriorhodopsin in DMPC/CHAPSO micelles being 
unfolded at pH 1.2 in the presence of 6 mM SDS [276]. pSRII unfolded in SDS at pH 2.0 
also showed less aggregation than at pH 6.0 (Figures 2.8, 2.10 & 2.11). Altogether, the 
results suggest that the attached retinal chromophore might be exerting a stabilising effect 
against protein aggregation. Hence, compared to at pH 6.0 (Figure 2.14), acid denaturation of 
pSRII at pH 2.0 (without SDS) led to very slow protein unfolding and Schiff base hydrolysis, 
and addition of SDS led to disruption of the retinal binding pocket within seconds but Schiff 
base hydrolysis is significantly slowed down. 
 
 
Figure 2.29: Time-resolved UV/vis spectra of pSRII unfolded in SDS at pH 2.0 
(a) pSRII in 0 ΧSDS at pH 2.0. Spectra were recorded at 5-min intervals. (b) pSRII in 0.980 ΧSDS 
(3% SDS + 0.1% c7-DHPC) at pH 2.0. Spectra were recorded at 1-min intervals. In both panels, 
spectra recorded after prolonged periods of unfolding (≥ 20 h) are plotted in different shades of red. 
 
2.3.6.3 Tertiary structure changes 
Tryptophan fluorescence of pSRII in the absence of SDS at pH 2.0 also has λmax of 337 nm, 
indicative of a similar environment surrounding the tryptophan residues as that at pH 6.0. The 
presence of 0.769 ΧSDS at pH 2.0 led to the burial of tryptophan residues into a more 
hydrophobic environment, as evidenced by the spectral blue shift to 332 nm. Further addition 
of SDS led to a spectral red shift to 340 nm at 0.998 ΧSDS (30% SDS in 0.1% c7-DHPC) as 
the tryptophan residues become more solvent-exposed (Figure 2.30a), similar to pSRII 






unfolded in SDS at pH 6.0. Akin to the results at pH 6.0 (Figure 2.16), pSRII in SDS at 
pH 2.0 also showed higher fluorescence intensities with increasing ΧSDS. Fluorescence 
intensities remained constant over 30 min (Figure 2.30b), consistent with the lack of tertiary 
structure changes over the same timescale observed by UV/vis spectroscopy (Figure 2.29b). 
On the other hand, fluorescence intensities increased slowly in 0 ΧSDS at pH 2.0, consistent 
with the very slow protein unfolding and Schiff base hydrolysis in 0 ΧSDS observed by UV/vis 
spectroscopy (Figure 2.29a). 
 
 
Figure 2.30: Tryptophan fluorescence of pSRII unfolded in SDS at pH 2.0 
Emission spectra (a) and time-courses (b) of 7 µM pSRII unfolded for 30 min in 0–0.998 ΧSDS (0–30% 
SDS) at pH 2.0. In panel a, the emission λmax (337 nm) of pSRII in 0 ΧSDS at pH 2.0 is shown using 
dotted line. 
 
2.3.6.4 Solvent accessibility of the binding pocket 
10 mM hydroxylamine at pH 2.0 led to near-complete formation of retinal oxime after 5 h 
(Figure 2.31a), indicating greater solvent accessibility of the retinal binding pocket than at 
pH 6.0. The loss of native chromophore in the presence of hydroxylamine at pH 2.0 was 
faster than in the absence of hydroxylamine (Figure 2.31c). Addition of SDS also led to fast 
denaturation such that only the SR440 intermediate was observed within the experimental 
dead-time (Figure 2.31b). However, the reaction did not reach completion even after 90 h 
(cf. complete reaction within 30 min at pH 6.0 shown in Figure 2.18b(ii)), as both retinal 






oxime (360 nm) and retinal PSB (440 nm) were visible, manifesting as a very broad 
absorbance peak at ~410 nm. This suggests that the reaction of hydroxylamine with the 
retinal Schiff base is significantly slowed down at pH 2.0, likely due to a decrease in the 
reactivity of the hydroxylamine at low pHs [311]. The presence of hydroxylamine at pH 2.0 
led to smaller loss of secondary structure within 30 min (Figure 2.27b), possibly due to 
incomplete Schiff base cleavage by hydroxylamine at pH 2.0 within this time frame, hence 
resulting in partial stabilisation of some elements of pSRII secondary structure as 
hypothesised above for pSRII molecules which still harbour PSB. The same unfolding 
transition point was observed, regardless of the absence or presence of hydroxylamine 
(Figure 2.27b). Fluorescence intensities increased very slowly over time, with slower rates 
being observed at higher ΧSDS (Figure 2.32b), suggesting that SDS might create a ‘shielding’ 
effect at pH 2.0, either by occluding the access of hydroxylamine to the retinal binding 
pocket or by causing a decrease in the reactivity of hydroxylamine. 
 
In summary, the reaction of hydroxylamine with retinal Schiff base at both pH 6.0 and pH 2.0 
were dependent on the accessibility of hydroxylamine to the binding pocket, which increased 
in the presence of SDS. However, this reaction was significantly slowed down at pH 2.0 due 
to a decrease in the reactivity of hydroxylamine, leading to incomplete Schiff base cleavage 
and smaller secondary and tertiary structure changes. 
 
 







Figure 2.31: Time-resolved UV/vis spectra of pSRII unfolded in SDS at pH 2.0 with 10 mM 
hydroxylamine 
(a) pSRII in 0 ΧSDS + 10 mM hydroxylamine pH 2.0. Spectra were recorded at 5-min intervals. (b) 
pSRII in 0.980 ΧSDS (3% SDS + 0.1% c7-DHPC) + 10 mM hydroxylamine, pH 2.0. Spectra were 
recorded at 1-min intervals. In both panels, spectra recorded after prolonged periods of unfolding 
(≥ 20 h) are plotted in different shades of red. (c) Time-course for the decrease in folded fraction 
(monitored by the decay in absorbance at 498 nm) for pSRII in 0 ΧSDS in the absence (black trace) or 
presence (red trace) of 10 mM hydroxylamine. 
 







Figure 2.32: Tryptophan fluorescence of pSRII unfolded in SDS + 10 mM hydroxylamine at pH 
2.0 
Emission spectra (a) and time-courses (b) of 7 µM pSRII unfolded for 30 min in 0–0.998 ΧSDS (0–30% 
SDS) + 10 mM hydroxylamine at pH 2.0. In panel a, the emission λmax (337 nm) of pSRII in 0 ΧSDS + 
10 mM hydroxylamine at pH 2.0 is shown using dotted line. 
 
 







Membrane proteins are notoriously difficult to denature due to their inherent stability once 
functionally reconstituted into membrane mimetics and their tendency to aggregate if the 
hydrophobic mimetic environment were perturbed. The studies presented in this chapter first 
employed the screening of different denaturants and additives to simultaneously maximise 
the extent of unfolding in pSRII and minimise aggregation of the unfolding intermediates and 
unfolded states. SDS was identified as the most suitable condition for pSRII unfolding 
studies, causing non-specific aggregation only after prolonged exposure of the protein to SDS 
over several days. Using various biophysical techniques (CD, UV/vis spectroscopy, 
tryptophan fluorescence), the molecular properties of the denatured states were characterised 
within 2 h of SDS exposure, which is the minimum time required to fully denature pSRII 
across all ΧSDS with minimal aggregation. SDS-denatured pSRII preserved much of its helical 
secondary structure while its tertiary structure was largely disrupted, as evidenced by loss of 
the retinal chromophore and changes in tryptophan fluorescence intensities. The kinetics of 
unfolding and refolding reactions were characterised, yielding the chevron plot and showing 
pSRII to be a model protein with a complex folding mechanism. 
 
2.4.1 Denaturant screening 
SDS was identified as the most suitable condition for unfolding pSRII. Non-specific 
aggregation was not observed within the typical two-hour timeframe for biophysical and 
kinetics studies, despite being visible in the form of soluble oligomers over much longer 
timescale of days. While some guidelines are available for minimising aggregation mostly in 
the contexts of globular proteins, intrinsically disordered proteins, and protein refolding 
[279,283,312], general recommendations for minimising aggregation of membrane proteins 
under denaturing conditions are lacking. 
 
The motivation behind screening different denaturants and additives is to find conditions 
which favour unfolding and disfavour aggregation. Protein aggregation consists of several 
steps: (1) structural changes within monomers lead to the formation of partially-folded 
species with aggregation-prone regions being exposed to solvent; (2) nucleation and/or 
formation of oligomers; and (3) formation and growth of fibrils or amorphous aggregates 






[313]. Structural changes in unfolded monomers are typically attributed to attraction between 
hydrophobic patches from different protomers to replace intramolecular contacts which have 
been disrupted during denaturation and to offer structural stabilisation. Multiple aggregation 
pathways might exist, yielding a complex ensemble of different partially-folded and 
aggregated structures. This chapter has explored the typical methods for shielding exposed 
hydrophobic surfaces and balancing surface charges, but the case of SDS-denatured pSRII 
proved to be more complex. This is a challenging problem because the same driving forces, 
namely formation of hydrogen bonds and burial of hydrophobic surfaces, are involved in 
both aggregation and protein folding [283]. A compromise was found in which aggregation 
was minimised without limiting the extent of unfolding by conducting biophysical and 
kinetics investigations at shorter time periods of 2 h. 
 
Previous unfolding studies of bacteriorhodopsin and bovine rhodopsin also identify SDS as 
the most suitable denaturant, and give rise to many biophysical and structural studies on the 
SDS-denatured states of these two proteins. The striking similarities in the properties of 
bacteriorhodopsin and pSRII in the presence of different denaturants (urea, GdmCl, SDS 
mixed micelles at neutral and acidic pHs) suggest that the two proteins might have 
comparable unfolding mechanisms [276]. In contrast, the effects of denaturants on bovine 
rhodopsin are very different: urea and GdmCl both unfold rhodopsin but lead to aggregation, 
while SDS alone and 3% SDS + 8 M urea unfold rhodopsin to different extents, both without 
causing aggregation [270]. These differences in the responses to different denaturants and the 
presence of aggregates in pSRII but not rhodopsin upon denaturation in SDS suggest 
different folding/unfolding pathways of pSRII vs. rhodopsin. 
 
2.4.2 SDS-denatured states of pSRII at pH 6.0 
Far-UV CD, UV/vis absorbance spectroscopy, tryptophan fluorescence and kinetics studies 
were used in this chapter to characterise the SDS-denatured states of pSRII at different ΧSDS. 
Structural changes in pSRII upon denaturation in SDS at pH 6.0 included an increase in 
accessibility of the retinal binding pocket with concomitant larger exposure of this region to 
solvent up to 0.943 ΧSDS. Most of the transmembrane helical structure was preserved, and the 
small loss of α-helicity was attributed to fraying of helix ends. Beyond 0.994 ΧSDS, 
non-native helical structure and burial of tryptophan residues were observed, likely because 






of the helix-inducing effect of the cylindrical SDS micelle environment wrapping around the 
protein [119,308]. The unfolding transition was comparable across the three biophysical 
techniques. Extensive comparison of the unfolding rate constants extracted using different 
biophysical techniques was also done for pSRII unfolding in SDS + 0.1% c7-DHPC. 
 
It is noticeable that pSRII unfolded much slower than both bacteriorhodopsin and bovine 
rhodopsin. This appears to contradict existing knowledge on the compactness of the native 
states of these proteins. Rhodopsin is the most compact and has limited susceptibility to 
bleaching even in the presence of 50 mM hydroxylamine [314], while micellar suspensions 
of monomeric bacteriorhodopsin [303] and pSRII (Figure 2.18b) showed detectable 
bleaching. While the utilisation of different detergent mixed micelle systems complicates a 
direct comparison of studies on the three proteins (c7-DHPC for pSRII, DMPC/CHAPS for 
bacteriorhodopsin, and DDM for bovine rhodopsin), this factor is unlikely to solely account 
for the large differences in unfolding rate constants. Preliminary studies of SDS-mediated 
unfolding of pSRII reconstituted in DDM yielded comparable rate constants for protein 
unfolding and Schiff base hydrolysis as those for pSRII in SDS/c7-DHPC (Figure 2.33). 
 
Altogether, comparative studies on the SDS-denatured states of pSRII, bacteriorhodopsin and 
bovine rhodopsin point toward differences in stability, unfolding mechanisms and 
protein-SDS interactions among the three proteins. More systematic comparisons using 
comparable conditions and membrane mimetics will be necessary to make more assertive 
conclusions on differences in kinetic and thermodynamic parameters between these proteins. 
Further investigation into the properties of mixed micelles and high-resolution studies on 
protein-detergent interactions in SDS-denatured pSRII will provide further valuable insights 
into the molecular nature of the denatured states and the unfolding/folding pathway. 
 







Figure 2.33: Time-resolved UV/vis spectra of pSRII unfolded in (a) 0.6% SDS + 0.1% c7-DHPC 
(0.909 ΧSDS) and (b) 0.3% SDS + 0.05% DDM (0.914 ΧSDS) 
 
2.4.3 SDS-denatured states of pSRII at pH 2.0 
Acid denaturation of pSRII in 0 ΧSDS led to small structural changes, as evidenced by the 
small increase in solvent accessibilities of retinal and tryptophan residues and also the slow 
bleaching of pSRII in the presence of hydroxylamine. Similarly, acid-denatured 
bacteriorhodopsin studied by oxidative labelling suggests the absence of large-scale 
unfolding [315], and the crystal structure reveals subtle changes in the retinal binding pocket 
and across the protein [316]. 
 
pSRII in SDS at pH 2.0 showed very fast loosening of the retinal binding pocket within 
seconds, but extremely slow retinal Schiff base hydrolysis on the timescale of days, rather 
than minutes to hours as in pH 6.0. The increase in solvent accessibility of tryptophan 
residues and bound retinal were also slowed down to timescales matching that of retinal 
Schiff base hydrolysis, whereas loss in α-helicity was accelerated to within minutes. In 
comparison to pH 6.0, a greater extent of α-helical content was preserved at pH 2.0. A 
detailed comparison between the apo-protein states (SO390) in SDS at pH 2.0 and pH 6.0, 
however, would be complicated by changes in Schiff base reactivity at acidic pH and 
aggregation over prolonged time. 
 
Although the presence of retinal in retinal-binding proteins enables convenient monitoring of 
unfolding and refolding by spectroscopic techniques, this also leads to complications with 






further studies of SR440 due to fast protein conformational changes and very slow retinal 
Schiff base hydrolysis occurring simultaneously. SR440 in SDS at pH 2.0 was particularly 
interesting because its decay due to retinal Schiff base hydrolysis was significantly slowed 
down, enabling SR440 to remain observable for days rather than minutes. Further structural 
studies are required to understand to what extent SR440 at pH 6.0 and at pH 2.0 are 
structurally similar to each other, and whether SR440 at pH 2.0 could be used as a substitute 
for further structural characterisation. 
 
It was also noted that pSRII in SDS at pH 2.0, which is predominantly SR440, aggregated 
slower than pSRII in SDS at pH 6.0, which is predominantly SO390. This suggests possible 
roles of the bound retinal in preventing the exposure of aggregation-prone surfaces and in the 
folding of pSRII. In fact, retinal binding is the rate-limiting step in bacteriorhodopsin folding 
[317]. More detailed structural studies will hopefully clarify whether there are protein 
conformational changes during retinal Schiff base formation in pSRII. 
 
2.4.4 Folding model for pSRII 
The main challenge for refolding kinetic studies is identifying solvent conditions in which 
refolding occurs with good efficiency (good yield of refolded material) and on a timescale 
which is amenable for biophysical techniques (seconds to minutes). Many studies of 
refolding kinetics in literature [18] and those presented in this chapter utilise a simple 
one-step dilution of the unfolded protein into a buffer devoid of denaturants. Additional 
detergents, lipids or additives may be introduced to facilitate refolding [18]. It is also 
important to establish assays for assessing the functionality of the refolded protein. For pSRII, 
reformation of the native chromophore monitored by UV/vis spectroscopy is indicative of a 
functional protein. 
 
Although the SDS-denatured apo-protein states of bacteriorhodopsin and pSRII both retain 
significant amounts of secondary structure and no native retinal-protein interactions, there are 
fundamental differences in their unfolding/folding pathways and protein-SDS interactions. 
This is most notably exemplified by non-linearity of the folding arm in the pSRII chevron 
plot, suggesting either transient aggregation or the presence of “kinetically invisible” 
intermediate(s) in the folding of pSRII but not in bacteriorhodopsin. Given that there is no 






dependence of the refolding rate constant on protein or detergent concentrations (Figure 2.23), 
transient aggregation and multiple micelle occupancy are unlikely, suggesting a complex 
folding pathway between SR440 and pSRII with on/off-pathway intermediate(s). It is difficult 
to reach a definitive conclusion about the existence and properties of the putative folding 
intermediate(s). Even for soluble proteins, interpretations of non-linear chevron plots and 
conclusions about the presence and properties of intermediate states are often elusive and 
require extensive ϕ-value analysis of different mutants, with the choice of mutants being 
carefully guided by the protein structure. Nevertheless, it is evident that the folding pathway 
between SR440 and folded pSRII, which predominantly involves the formation of native 
tertiary packing, shows clear deviations from the two-state model exemplified by 
bacteriorhodopsin. 
 
Retinal binding was shown to be reversible, and the refolding yield from SO390 correlated 
with the amount of monomeric SO390 left after prolonged incubation in SDS over several 
days. Reversible unfolding of the apo-protein state can be achieved for bacteriorhodopsin and 
pSRII, both of which retain significant portions of α-helicity in SDS. While refolding of 
SO390 was not studied in considerable detail here, kinetic studies of refolding 
apo-bacterioopsin from SDS into lipid/detergent micelles have enabled detection of multiple 
folding intermediates in the folding pathway [120,132,317]. In comparison, despite extensive 
efforts, chemically-denatured rhodopsin, the apo-protein state of which is characterised by 
largely disrupted secondary and tertiary structures, has thus far resisted refolding [318]. 
Opsin formed upon bovine metarhodopsin II decay in DDM micelles is capable of rebinding 
11-cis retinal to regenerate functional rhodopsin, but prolonged (up to 24 h) incubation in 
DDM leads to time-dependent increase in misfolding and decrease in regeneration yield, 
although the retinal-binding form of opsin can be reformed slowly when incubated in the 
presence of 11-cis retinal [319]. Refolding studies on these three proteins thus suggest that a 
minimal amount of correctly folded, stabilising structural elements might be required for 
reversible protein folding, and that the retinal chromophore might have roles in influencing 
the equilibrium between different apo-protein states or even the refolding of non-native 
apo-protein states. Once again, it must be emphasised that it is very challenging to obtain 
denatured states of membrane proteins which show minimal aggregation and are amenable to 
both biophysical characterisation and refolding studies. 






2.5 Summary and further studies 
By using various biophysical techniques, this chapter has led to the characterisation of the 
denatured states of pSRII in SDS/c7-DHPC mixed micelles and the kinetics of unfolding and 
refolding from both the unfolded state with a covalently-attached chromophore (SR440) and 
the apo-protein state (SO390). Similar to SDS-denatured bacteriorhodopsin, SDS-denatured 
pSRII retains a high α-helical content and loses most of its native retinal-protein contacts. 
The SDS-denatured states of pSRII, bacteriorhodopsin and bovine rhodopsin have different 
refolding properties, although refolding of bacteriorhodopsin and pSRII both involve 
predominantly the formation of native tertiary packing. Refolding of SDS-denatured 
bacteriorhodopsin with bound retinal adheres to two-state folding kinetics; the refolding 
kinetics of the equivalent SR440 state showed clear deviations from the two-state folding 
regime; and refolding of bovine rhodopsin remains elusive even from partially denatured 
states. It was also found that only monomeric SDS-denatured pSRII was capable of refolding 
from the apo-protein (SO390) state to reconstitute the native chromophore. 
 
This chapter presents a low resolution model for the unfolding and folding pathways of pSRII 
(Figure 2.34). Taking into consideration the different behaviours under unfolding and/or 
refolding conditions amongst the three retinal-binding proteins, pSRII is therefore proposed 
as a new model protein for membrane protein folding studies. 
 
Further studies by techniques such as NMR (see Chapter 3) will be needed to (1) obtain 
residue-specific information on SDS-induced structural changes in pSRII and SDS-protein 
interactions; and (2) to probe for different species in the denatured states ensemble of pSRII. 
While CD is widely used for elucidating secondary structure changes, SDS has been reported 
to change the extinction coefficient of the peptide carbonyl group, leading to underestimation 
of the helical content of SDS-bound proteins (as is the case for bovine serum albumin) 
[320,321]. The α-helical content of SDS-denatured pSRII could be confirmed by measuring 
through-space nuclear Overhauser effects (NOEs), looking for sequential NH/NH NOEs. 
Although tryptophan fluorescence results clearly indicate increased solvent exposure of 
tryptophan residues upon SDS-mediated denaturation, it is difficult to determine the 
contribution from each of the six tryptophans since the fluorescence spectra are averages 






across all tryptophans. Systematic studies on the dynamics and chemical environment of the 
backbone amide and side-chain indole of tryptophans by NMR could be achieved through 
[1H,15N]-correlated experiments or using fluorinated tryptophan analogues (see Chapter 3). 
 
The conditions utilised in in vitro unfolding and refolding studies tend to be far removed 
from the conditions found in live cells. It is therefore important to explore methods which 
enable protein folding studies to be conducted in a biological context (see Chapter 5).  
 
 
Figure 2.34: Summary model for the unfolding and folding pathways of pSRII 
pSRII unfolds reversibly in SDS/c7-DHPC mixed micelles to form the retinal-bound, 
partially-unfolded SR440 state, followed by Schiff base hydrolysis to form apo-sensory opsin (SO390). 
SO390 in high ΧSDS has non-native structures due to the helix-inducing properties of SDS. Unfolded 
pSRII aggregates slowly over the timescale of days. The aggregated species cannot be refolded to 







3 Characterisation of denatured 




The structure and dynamics of denatured and unfolded proteins have been studied by various 
methods including single-molecule fluorescence spectroscopy, NMR, neutron scattering and 
computer simulations amongst other methods. Simulated thermal unfolding experiments 
suggest that pSRII is stabilised by a combination of mechanisms found for rhodopsin and 
bacteriorhodopsin [139], with a subset of helices breaking off early in the simulation and a 
core involving residues from other helices and loops remaining until late. 
 
Solution-state NMR has established itself as one of the key methods for atomic resolution 
studies of the structure, function and dynamics of membrane proteins. Since unfolded 
proteins usually constitute an ensemble of different conformations, NMR is a highly suitable 
technique for characterising changes in structure and dynamics. 
 
In this chapter, solution-state NMR was used for detailed characterisation of SDS-denatured 
pSRII. 1D 1H and 19F NMR were first used to characterise global changes in backbone amide 
protons and tryptophan side-chains (see Section 3.3.1). To understand residue-specific 
structural and dynamics changes, 2D [1H,15N]-SOFAST-TROSY-HSQC were recorded and 
changes in chemical shifts and peak intensities were analysed (see Sections 3.3.2–3.3.5). 
Having identified that changes in backbone amide dynamics is an important feature of 
denatured pSRII, 15N relaxation experiments were performed to study backbone amide 
dynamics reflecting motions on different timescales, including fast fluctuations of NH bond 
vectors on the ps–ns timescale and exchange contribution on the ns timescale (see Section 
3.3.6). In Sections 3.4–3.5, changes in chemical shifts and peak intensities were studied for 
acid-denatured pSRII and sensory opsin obtained by hydroxylamine-mediated bleaching of 
the retinal protonated Schiff base. 







Overall, the NMR studies in this chapter have shed insight on differences in the unfolding 
pathways in the presence of different denaturants and the crucial role of the retinal 
chromophore in governing the structural integrity and dynamics of the pSRII helical bundle. 
 
 






3.2 Theory: Nuclear Magnetic Resonance (NMR) 
3.2.1 Overview 
For all forms of spectroscopy, the spectrum arises from transitions between different energy 
states of a molecule. NMR spectroscopy arises from the fact that nuclei have a property 
known as spin, an intrinsic form of angular momentum carried by elementary particles and 
atomic nuclei. In the presence of an external magnetic field, the degeneracy of the nuclear 
spin energy levels is broken, allowing transitions between these energy levels. The ground 
and excited states in NMR arise from the interaction between the external magnetic field and 
a nuclear magnetic dipole moment, which describes the magnetic strength and orientation of 
a magnetic field generated by the nucleus in the presence of an external magnetic field. 
Nuclei with an odd mass number (e.g. 1H, 13C, 15N, 31P) have spin angular momentum (M⃗) due 
to the presence of an unpaired proton. All nuclei with an even mass number and an odd 
charge (e.g. 2H, 14N) also have spin angular momentum. 
 
In the absence of an applied magnetic field, a collection of nuclear spins will adopt all 
possible orientations of the magnetic dipole. Once the spins are placed in a magnetic field, 
the nuclear magnetic moment and the applied field interact. The direction of the applied field 
is defined as the z-axis. The energy of the interaction depends on the angle between the 
magnetic moment and the applied field. The lowest energy arrangement is when the magnetic 
moment is parallel to the field, and the highest energy is when the magnetic moment is 
opposed to the field. There is an energetic preference for more spins to be aligned with the 
applied magnetic field, leading to the build-up of a bulk magnetisation vector which is in 
equilibrium with the applied field and pointing along the z-axis. The process by which the 
spins come to equilibrium in a magnetic field is called relaxation (see Section 3.2.5). 
 
To obtain transitions between different nuclear spin states, radiofrequency (RF) waves with 
energy matching the difference in energy levels of these spin states must be applied. 
Hamiltonian operators are operators which represent the observable quantised energy in 
quantum mechanics. For a nuclear spin in a magnetic field of strength O4 applied along the 
z-axis, the energy of interaction between the spin and the magnetic field is: 
 PQ = −RO4STU (3.1) 






where R is the gyromagnetic ratio and STU is an operator which represents the z-component of 
the nuclear spin angular momentum. 
 
The eigenvalues of the Hamiltonian are the energy levels available to the system [199]. STU has 
(2S + 1) eigenfunctions, where S is the spin quantum number which is specific to a given 
nucleus, meaning the nuclear spin angular momentum is quantised. Each eigenfunction (WX) 
of the operator STU is characterised by Y, another spin quantum number, which can only take 
values from –	S to S in integer steps. For spin-1/2 nuclei [S = 6
E
\, STU has two eigenfunctions 
characterised by Y = +6
E
 or − 6
E
:  
 STUW±6 E⁄ = YℏW±6 E⁄  (3.2) 
 
The eigenfunctions of STU are also eigenfunctions of the Hamiltonian in Equation 3.1, with 
eigenvalues:  
 `X = −YℏRO4 (3.3) 
 
The two energy levels of a spin-half nuclei in a magnetic field are:  
 `a = −
6
E




where `a is the ground state and b̀  is the excited state by convention. 
 
The energy of the allowed transition from the ground (α) state to the excited (β) state is:  
 ∆`a→b = b̀ − `a = ℏRO4 (3.5) 
 
The frequency corresponding to this energy gap is therefore:  
 da→b = ∆`a→b/ℎ = RO4/2g (3.6) 
 
The Larmor frequency (d4) is defined as:  
 da→b = −d4 (3.7) 
 
For a single spin-1/2 nucleus, there is one allowed transition which results in a line in the 
spectrum at –v0. 







To record a spectrum, the magnetisation vector must be moved away from the z-axis and 
towards the xy (transverse) plane. To achieve this, a very small radiofrequency field (O6) is 
applied along the transverse plane. Since the magnetisation is no longer aligned with the O4 
field, it would precess about the O4 field at the Larmor frequency, sweeping out a cone with a 
constant angle β. Even though O4 is many times stronger than O6, the magnetisation would 
move away from the z-axis provided that an on-resonance pulse is applied (i.e. the transmitter 
frequency is the same as the Larmor frequency). 
 
This excitation field can be applied to the sample in two ways, either by scanning through 
wavelengths (continuous wave NMR) or as a short burst of high power RF to excite a broad 
range of transitions (pulsed NMR) [322]. The most simple pulsed NMR experiment is the 
pulse-acquire experiment (Figure 3.1a). Equilibrium magnetisation first builds up along the 
z-axis. The short 90°(x) RF pulse rotates this magnetisation onto the –y-axis. The 
magnetisation precesses at the Larmor frequency and cuts the receiver coil, which is wound 
around the sample with its axis aligned in the xy-plane, thereby inducing a current in the coil. 
This current is then amplified, sampled at discrete times and digitised to give the free 
induction decay (FID) (Figure 3.1b). 
 
This linearly oscillating FID can be decomposed into two counter-rotating fields. By adopting 
a rotating frame which rotates at the same frequency and in the same sense as the Larmor 
precession, the apparent Larmor frequency becomes zero. The precessing magnetisation is 
detected in the rotating frame. The observed frequency, Ω, is ij − i , where ij  is the 
precessional frequency of the spin and i is the rate of rotation of the coordinate frame (or 
equivalently, the frequency of the applied O6 pulse). 
 







Figure 3.1: Pulse sequence (a) and schematic diagram showing changes in the magnetisation 
vector (b) for the pulse-acquire experiment. 
(a) The experiment comes in three periods: 1 – the sample is allowed to reach equilibrium; 2 – a 90° 
pulse is applied to rotate the magnetisation into the xy plane; 3 – the RF power is switched off and 
signal is detected as it arises from the magnetisation while rotating in the xy plane. (b) (i) At 
equilibrium, a sample has net magnetisation along the direction of the magnetic field (z-axis) 
represented by the magnetisation vector (blue arrow). (ii) When the magnetisation vector is tilted 
away from the z axis, it executes a precessional motion, sweeping out a cone of constant angle and 
cutting a coil (red wave) wound around the x axis, thereby inducing a current in the coil. Figures 
adapted from [199]. 
 
Effectively, in the rotating frame, the magnetisation precesses in the transverse plane at the 
offset Ω, rotating through an angle Ωk  during time t. The x- and y-components of the 
magnetisation evolve as follows:  
 lm = l4 sin(Ωk) :;=/qF    and   lr = −l4 cos(Ωk) :;=/qF  (3.8) 
where Ω is the resonance frequency in the rotating frame and :;=/qF  represents the decay of 
the excited state due to relaxation, with a time constant of uE (see Section 3.2.5). 
 
Fourier transformation of the FID converts time-domain data into frequency-domain data, 
yielding a single line in the spectrum at minus the Larmor frequency. Peaks in NMR spectra 
typically have Lorentzian lineshape. 
 
3.2.2 1D NMR 
A plot of intensity against resonance frequency is known as a 1D NMR spectrum. Resonance 
frequencies are typically reported as ‘chemical shifts’ in units of ppm (parts per million), 
which accounts for the measured frequencies (in MHz) relative to a reference frequency and 
the strength of the applied magnetic field. 
 






The resonance frequency of a nuclear spin depends on the magnetic field strength at the 
nucleus. This magnetic field usually differs slightly from the applied field because the 
magnetic field at each nucleus is shielded by the electron density surrounding it. The electron 
density depends on the chemical environment of the nuclear spin, for example the presence or 
absence of electronegative atoms in close proximity. As the electron density around the 
nucleus increases, the effective field decreases, leading to lower resonance frequencies 
(chemical shifts). Chemical shifts differ between atoms and between molecules. 
 
In proteins, amide protons resonate at ~ 8 ppm, Hα protons at ~ 4 ppm and methyl protons 
(e.g. Hβ and others) at ~ 1 ppm (Figure 3.2a). The amide proton has a high chemical shift 
because the nitrogen atom is more electron-withdrawing than carbon. The reduced electron 
density at the amide proton decreases the shielding and therefore increases the effective field 
and resonance frequency. Similarly, the Hα shifts are higher than the methyl H shifts and 
tryptophan side-chain Hε chemical shifts are ~ 10 ppm because of their proximity to the 
electronegative nitrogen. Similar ordering of chemical shifts can also be observed in carbon 
atoms in proteins. Nitrogen atoms also have distinct chemical shifts (Figure 3.2b). For 
example, glycine HN resonate at ~ 110 ppm whereas tryptophan HN resonate at ~ 120 ppm, 
and tryptophan side-chain Nε at ~ 130 ppm. 
 
In practical NMR spectroscopy, several resonances are usually expected in the spectrum, 
each of which has a different Larmor frequency. A separate magnetisation vector can be 
associated with each detected NMR-active nucleus, and the detected signal will be the sum of 
contributions from each vector. Given the modest range of chemical shifts, even a small 
protein of around 50 residues will yield a complex spectrum containing many overlapping 
peaks. One solution to this problem is to increase the dimensionality of the NMR experiment, 
so that peak positions are defined by two or more resonance frequencies. Multi-dimensional 
NMR along with other techniques (see Section 3.2.3) have been applied to resolve spectra for 
proteins in the 30–50 kDa range. 
 
 







Figure 3.2: 1H and 15N chemical shift distribution from the BMRB 
Distribution of 1H chemical shifts of Ala and Trp residues (a) and 15N chemical shifts of Gly and Trp 
residues (b) reported on the Biological Magnetic Resonance Bank (BMRB). Note that distributions of 
Trp side-chain Hε and Nε are also shown. Plots are generated using the RBMRB package on R. 
 
The presence of multiple signals in the spectrum indicates that not all nuclei can be 
resonating at the same frequency as the O6 field, meaning these signals are off-resonance. 
With a modern spectrometer, the O6 field strength is sufficiently large such that the effective 
field for a range of resonances lies very close to the x-axis, although minor off-resonance 
excitation outside the bandwidth and phase errors could still affect measurements which 
require very high sensitivity. 
 
For 1H NMR on aqueous samples, solvent suppression is typically required as the water 
signal can be several orders of magnitude stronger compared to the signals of interest due to 






the presence of non-deuterated protons. The solvent signal needs to be selectively perturbed 
such that the associated magnetisation is not in the transverse plane during signal detection. 
 
3.2.3 2D NMR 
The motivation of multidimensional NMR are to improve signal separation, and to filter out 
certain signals through their connections to other nuclei. One of the key features which 
differentiates NMR from many other forms of spectroscopy is that the excited states are 
relatively long lived, with lifetimes in the ms–s range. Consequently, the excited state can be 
manipulated to pass magnetisation from one nucleus to another. The frequencies can be 
measured for each of the nuclei through which magnetisation is passed. As a result, signals 
which correlate the frequencies between multiple nuclei can be obtained. In such correlated 
spectra, each transfer can be visualised as an independent nuclear frequency dimension (axis). 
This forms the basis of multi-dimensional NMR. Signals in the spectra occurring at the 
intersection of two or more frequencies indicate a correlation between the corresponding 
nuclei. 
 
The HSQC (heteronuclear single-quantum coherence) experiment is widely used for 
recording one-bond correlation spectra for covalently bonded 1H-15N groups and 1H-13C 
groups. These functional groups are abundant in molecules of biological interest (peptides, 
proteins and nucleic acids). Given the low natural abundance of 13C and 15N isotopes, 
isotopically-labelled recombinant proteins can be produced by using minimal medium 
containing nutrients enriched with the desired isotope, for example using 15NH4Cl as the 
nitrogen source and 13C-glucose as the carbon source for E. coli cultures. 
 
In the 2D [1H,15N] HSQC experiment (Figure 3.3), magnetisation is transferred from 1H spin 
to the covalently bonded 15N spin. The 15N spin magnetisation evolves for t1, during which it 
acquires a frequency (offset) label (the chemical shift evolves). Finally, this magnetisation is 
transferred back to 1H, where it is observed. The resulting spectrum has peaks centred at the 
offset of the 1H spin in the ω1 dimension and at the offset of the 15N spin in the ω2 dimension. 
 
 







Figure 3.3: Basic pulse sequence for the 2D [1H,15N] heteronuclear single quantum correlation 
(HSQC) experiment 
The pulse sequence starts with equilibrium magnetisation on the 1H spin, which is transferred to the 
15N spin using an INEPT sequence (periods A–B). The 15N magnetisation evolves during the t1 period, 
with the centrally placed 180° 1H pulse refocusing the evolution of the one-bond 1JNH coupling 
(period C). This magnetisation is transferred back to the 1H spin (periods D–E), where it is observed 
in the presence of broadband decoupling (grey box). 90° pulses are represented by black lines and 180° 
pulses are represented as white boxes. Pulses are applied with phase x unless indicated otherwise. 
 
The 2D [1H,15N] HSQC spectrum shows a signal for each covalently bonded 1H-15N group. 
The spectrum is plotted like a topographic contour map. Each signal has an intensity, a 1H 
chemical shift and a 15N chemical shift. For proteins, the 15N-HSQC spectrum contains one 
peak for each backbone amide proton except those of Pro residues, a peak for each indole 
side-chain of Trp residues, and pairs of peaks for the side-chain amide groups of Asn and Gln 
residues. Signals from the HεNε guanidine groups of arginine may also be observed. In 
essence, the 15N-HSQC provides a high-resolution fingerprint of the amide backbone and 
side-chain atoms of selected residues of a protein. 
 
Several factors affect the intensities and dispersion of signals in the [1H,15N] HSQC, 
including whether the protein is folded, the size of the protein and its dynamics. 
 
Completely unfolded proteins show poor signal dispersion since all amide protons are 
exposed to the solvent and are in similar chemical environments. Residues in proteins which 
are rich in β-sheets are exposed to a wider variety of chemical environments, and therefore 
give rise to better signal dispersion than proteins which are rich in α-helices. 
 






Narrow linewidths require long-lived excited states in NMR experiments. Factors which lead 
to rapid decay of excited states back to the ground state via relaxation give rise to broader 
lines (see Section 3.2.5). Folded proteins give well-defined signals. Completely unfolded 
proteins tend to exhibit sharp lines. Partially folded proteins often give rise to poor spectra 
quality. Interconversion of a protein between different conformations on the µs–ms timescale 
can cause additional line broadening due to chemical exchange (see Section 3.2.4). 
 
Slow molecular reorientation is also a major cause of rapid signal decay and broad lines. This 
is usually apparent for samples with large molecular size, or when the molecule of interest 
interacts with binding partners, oligomerises or aggregates. 
 
3.2.4 Titration and chemical exchange 
Solution-state NMR spectroscopy is a powerful tool for analysis of structural and dynamical 
aspects of biomolecular interactions and equilibria. Systematic studies of changes in chemical 
shifts and lineshapes of NMR signals upon titration of an interaction partner can yield 
valuable structural, thermodynamic and kinetic information on the interaction. The 
appearance of resonances in NMR spectra during a titration experiment depends on the 
number of different species (e.g. free and bound forms) and the rate of exchange between 
these species relative to the frequency difference between them. 
 






There are three distinguished exchange regimes for a two-state exchange system (Figure 3.4). 
In the slow exchange regime, the exchange rate (k) is much smaller than the frequency 
difference (Δω) between the two species (k << Δω). In the fast exchange regime, where k >> 
Δω. Slow exchange gives rise to two resonances centred at ωA and ωB, the chemical shifts of 
species A and B, respectively. The intensity of each peak reflects the concentration of the 
corresponding species. Fast exchange allows the observation of a single resonance with an 
average chemical shift xyzj  positioned at the population weighted average of the two 
resonance frequencies: 






 xyzj = {|x| + {}x} (3.10) 
where { and x are the populations and chemical shifts of the two species. 
 
When the proportions of the two species are varied, for example in a titration experiment, the 
signal will move gradually from the exchange-free chemical shift of one species to that of the 
other. 
 
In the intermediate exchange regime, where k and Δω are comparable, signals broaden 
considerably and shift at the same time in a titration. 
 
 
Figure 3.4: Chemical exchange regimes 
Schematic diagrams showing the effects of chemical exchange between two species, A and B, 
assuming the populations of A and B are equal. In the slow exchange regime, where the rate of 
exchange is much smaller than the frequency separation between the two species (k << Δω), two lines 
are observed. As the exchange process accelerates so that k becomes similar to the frequency 
separation (k ≈ Δω), the lines first broaden and merge into one (intermediate exchange regime). 
Further increase in the exchange rate constant (k >> Δω) causes the merged line to narrow. Figure 
adapted from [199]. 
 






The populations of species A and B and the corresponding exchange rates, kA and kB, are 
often different, leading to asymmetric exchange. The consequences are: in the slow exchange 
regime, peak broadening of the minor state becomes much more significant; in the fast 
exchange regime, the population-weighted average peak position would be more biased 
towards the chemical shift of the major state. These factors further complicate spectral 
analysis and identification of chemical exchange regimes. 
 
In a HSQC titration experiment with exchange between two species, an NH signal in 
superimposed HSQC spectra would move in a straight line. Nonlinear plots indicate the 
presence of multiple species and the titration affects the chemical shifts of each species 
differently. The presence of multiple species could be due to multiple binding interactions or 
multiple conformational changes [323].  
 ~ +  ⟷ ~∗ +  ↔ ~ (3.11) 
 ~ +  ⟷ ~ ↔ ~∗ (3.12) 
where P is the protein, P* is the protein with conformational change(s) and L is an interacting 
partner (e.g. non-specific or specific small molecule, ligand, binding partner). 
 
In the context of protein unfolding, interactions of the denaturant with folded protein, folding 
intermediates and unfolded protein could be very different, leading to possible observation of 
different exchange rates (broadened signals) and nonlinear changes in chemical shifts. Hence, 
spectral analysis becomes increasingly challenging with multiple states in exchange and 
increasing numbers of exchange mechanisms, which often give rise to nonlinear titrations 
with broadened signals, leading to intractable changes in chemical shifts and signal intensities. 
 
3.2.5 Molecular motion and nuclear spin relaxation 
Relaxation is the process by which, over time, the bulk magnetisation returns to its 
equilibrium position. At equilibrium, there is z-magnetisation along the direction of the 
applied magnetic field and no transverse magnetisation. Transverse relaxation drives the 
transverse magnetisation to zero and longitudinal relaxation drives the longitudinal 
magnetisation to a particular steady state value. 
 






Three parameters are typically measured for each nucleus to assess the dynamics of a protein: 
the longitudinal (R1) and transverse (R2) relaxation rate constants and the magnitude of the 
NOE between each amide proton and its attached nitrogen. R1 and the {1H}-15N NOE report 
directly on the existence of motions on the ps–ns timescale, whereas R2 additionally depends 
on slower motions on the µs–ms timescale. These data can be analysed to separate 
contributions from internal motion and overall Brownian motion. Internal motion on the ps–
ns timescale is described by the generalised order parameter, S2, often called an ‘entropy 
meter’, which describes the rigidity of each residue and it can have a value between zero 
(nucleus undergoing completely unrestricted motion) and one (nucleus moves only with the 
whole molecule). 
 
3.2.5.1 Relaxation mechanisms 
Depending on sample conditions, there are several molecular mechanisms which drive 
relaxation, including chemical shift anisotropy (CSA) and dipole-dipole (DD) interactions. 
Relaxation by DD interactions is due to coupling between the observed nucleus and the 
magnetic dipole of another spin. For example, a local magnetic field at the 15N nucleus is 
produced by the magnetic moment of the attached 1H nuclear spin. As the molecule rotates, 
the effect from the field of the attached 1H nucleus varies in an orientation-dependent manner. 
The DD interaction also depends on the gyromagnetic ratio (γ) and the distance (r) between 
the two attached spins:  
 ÉÑÖ(k) ∝ RÑRÖ (3 cosE à − 1) âÑÖä⁄  (3.13) 
With the r3 distance dependence, the DD effect is only effective over very short distances 
(< 5 Å between two protons). 
 
Chemical shift anisotropy arises from the fact that chemical shifts are determined by local 
magnetic fields, and asymmetric electron distributions lead to orientation-dependent changes 
in local fields experienced by the nuclei: 
 @ = RO4(ã∥ − ãç) (3.14) 
where (ã∥ − ãç) represents the difference between the parallel and orthogonal components of 
the chemical shift anisotropy tensor and O4 is the external magnetic field. Tumbling in liquid 
samples usually averages this effect, producing an isotropic chemical shift in the spectra. The 
local field depends on the orientation of the molecule (anisotropic), meaning it is not 






necessarily parallel to the applied field. Molecular reorientation modulates the local magnetic 
field and can act as a source of relaxation, provided that the frequencies of the modulating 
fields are in the range of those required for NMR transitions to occur. The extent to which the 
local field varies as the molecule tumbles depends on the anisotropy of the chemical shift (the 
extent to which the shift varies with orientation). 
 
The 15N nucleus in an N–H group is relaxed by two mechanisms: DD interaction with the 
attached 1H and CSA of the 15N itself. In both cases, the local field experienced by the 15N 
fluctuates with rotational reorientation of the molecule due to thermal motion. Such motion 
alters the orientation of both the N–H vector and the 15N shift anisotropy tensor with respect 
to the applied field. Variations of local fields arising from these two mechanisms must be 
correlated as they are modulated by the same motion. This is known as cross correlation 
between CSA and DD relaxation mechanisms. Cross correlation results in different relaxation 
rate constants and linewidths for different lines of the 15N doublet. This effect is particularly 
pronounced for 15N–1H pairs in large molecules when the spectra are recorded at high field. 
For the studies in this chapter, TROSY experiments enable detection of only the 15N–1H 
multiplet component for which DD and CSA have almost cancelled, yielding narrow 
linewidths. Further detailed description of cross correlation and its effects on coupling 
constant measurements are given in Chapter 4. 
 
3.2.5.2 Correlation function and spectral density function 
In order to be effective at causing longitudinal relaxation, the local field must be oscillating 
at/close to the Larmor frequency. The correlation function is a way of characterising the time 
dependence of the random motion in a sample, and hence determining how much of the 
motion is present at the Larmor frequency. For a particular spin i experiencing a local field 
Oéyè,ë(k) which varies in time, at a later time, the local field is expressed as Oéyè,ë(k + í). The 
local field varies due to thermal motion in the sample, so Oéyè,ë(k) is a random function of 
time. The correlation function ì(k, í)  is defined as the average of the product 
Oéyè,ë(k)Oéyè,ë(k + í) across all spins in the sample: 
 ì(k, í) = 6
Ñ
∑ Oéyè,ë(k)Oéyè,ë(k + í)Ñëï6 = Oéyè(k)Oéyè(k + í) (3.15) 
where N is the number of spins in the sample. 







Since the correlation function is a stationary random function (i.e. does not depend on the 
point t from which time is measured but only depends on the time interval í, the function can 
be simplified as ì(í). ì(í) starts at a maximum at τ = 0, and decays exponentially with 
decay rate determined by the correlation time íè: 
 ì(0) = Oéyè(k)Oéyè(k) = OéyèE  (3.16) 
 ì(í) = OéyèE exp(− |í| íè⁄ ) (3.17) 
 
The correlation is a function of time. Fourier transformation of the correlation function yields 
the spectral density function, J(ω), which is dependent on frequency and from which the 
amount of motion that is at the Larmor frequency can be determined. 




ö(i) has its maximum value of 2OéyèE íè at ö(0) (i.e. when ω = 0), and decays steadily as ω 
increases, with the decay rate being determined by íè (Figure 3.5a). An important feature of 
the spectral density is that the area under the curve is independent of íè. 




E  (3.19) 
Hence, as íè  becomes smaller, ö(0) decreases and at the same time the spectral density 
spreads out to higher frequency (see Figure 3.5a). 
 
As previously mentioned, longitudinal relaxation is driven by modulation of the local field at 
the Larmor frequency, and the rate of longitudinal relaxation is therefore determined by 
ö(i4), the spectral density at the Larmor frequency. 





A plot of ö(i4) against íè (Figure 3.5b) shows that ö(i4) is at its maximum when íè~ 1 i4⁄ . 
This indicates that the rate of longitudinal relaxation will also be at its maximum when 
íè~ 1 i4⁄ . Correlation times which are shorter or longer than íè = 1 i4⁄  will yield slower 
relaxation. 
 







Figure 3.5: Spectral densities 
(a) Plots of the spectral density function, J(ω), for different values of the correlation time, íè = ímin , 
2ímin  and 4ímin , showing that the shorter íè  becomes, the higher the frequencies to which ö(i) 
spreads. (b) A plot of the spectral density at the Larmor frequency, ö(i4), as a function of the 
correlation time, íè, indicating that the rate of longitudinal relaxation reaches a maximum at íè =
1 i4⁄ . 
 
For simplicity, it is conventional to introduce the reduced spectral density,	•(i): 
 ö(i) = OéyèE •(i) (3.21) 




In the fast motion regime, where i4íè ≪ 1, such as would be the case for small molecules, 




≈ 2íè (3.23) 
This indicates that in the fast motion limit, the spectral density is independent of the Larmor 
frequency. 
 
In the slow motion regime, such as would be the case for proteins, i4íè ≫ 1, (1 + i4EíèE) ≈







As i4íè ≫ 1, this means •(i4) ≪ •(0). 
 






The longitudinal relaxation rate constant, GU or G6, is given by: 
 G6 = REö(i4) (3.25) 
 
R1 is typically estimated by an inversion-recovery experiment (Figure 3.6a): 
 
 
Figure 3.6: Pulse sequence (a) and typical set of spectra (b) for the inversion-recovery 
experiment 
90° pulses are represented by black lines and 180° pulses are represented as white boxes. Pulses are 
applied with phase x unless indicated otherwise. The spectrum recorded at Δ = 0 is phased so that the 
peak is negative, and the same phase correction has been applied to all other spectra. The peak 
intensities, S(Δ), are measured as a function of Δ. 
 
The magnetisation is first inverted by a 180° pulse. The inverted magnetisation is then 
allowed to relax for a time Δ, after which a 90° pulse is applied to enable FID detection in the 
transverse plane. The peak intensity, S(Δ), as a function of longitudinal relaxation time Δ is: 
 S(Δ) = S4(2:;BC© − 1) (3.26) 
where I0 is the initial peak height, and R1 the longitudinal relaxation rate. 
 
Spectra are recorded with increasing Δ, and R1 is estimated from peak heights measured as a 
function of Δ (Figure 3.6b). 
 






There are two contributions to transverse relaxation: secular and non-secular. The secular 
contribution arises from there being a distribution of local fields along the z-axis with 
different Larmor frequencies, and depends on the spectral density at zero frequency, ö(0). 
The non-secular contribution involves reorientation of the magnetic moments of individual 
spins and hence, similar to longitudinal relaxation, depends on the spectral density at the 












The non-secular contribution is precisely half the value of the longitudinal rate constant, 
suggesting that the field is half as effective at causing transverse relaxation as it is at causing 
longitudinal relaxation. 
 
R2 can be estimated by measuring the width of the peak at half height, as Fourier 
transformation of the FID yields a peak with width at half-height of 2R2 rad s-1 or R2/π Hz. 
However, R2 can only be reliably estimated from linewidths if the line is homogeneously 
broadened. Such broadening is a fundamental property of the molecule, its environment and 
motion. Another contribution to rapid relaxation (broad linewidths) is inhomogeneous 
broadening, which refers to different parts of the sample precessing at slightly different 
Larmor frequencies (e.g. due to slight differences in magnetic field strength across the sample 
volume), and the increasing mismatch in magnetisation orientations across the sample over 
time leads to cancellation and decay of the total magnetisation. 
 
To circumvent the problem of inhomogeneous contribution, R2 is typically estimated using 
the Carr-Purcell-Meiboom-Gill (CPMG) relaxation experiment, where the decay of 
transverse magnetisation is monitored in a series of spin-echo pulse sequence elements. Any 
effects of inhomogeneous broadening would be refocused at the end of each spin-echo, 
whereas effects of homogeneous broadening cannot be refocused by spin-echos. Thus, the 
size of transverse magnetisation only depends on transverse relaxation which has taken place 
during the experiment. 
 






R1 and R2 have different values in different motional regimes. In the fast motion limit, 
•(i4) = •(0) = 2íè: 








= REOéyèE íè + REOéyèE íè 
 = 2REOéyèE íè (3.29) 
Therefore, in the fast motion limit (e.g. for small molecules), R1 and R2 are equal. 
 
In the slow motion limit, •(i4) ≈
E
û¢Fõú
 and •(0) = 2íè, where •(i4) ≪ •(0): 











REOéyèE •(i4) = REOéyèE íè (3.31) 
 
Hence, as íè increases, R1 reaches a maximum at íè = 1/i4. As íè increases further, R1 
decreases steadily. In contrast, R2 continues to increase steadily with íè (Figure 3.7). For 
large molecules (e.g. proteins) which tumble slowly and have long íè, R2 > R1. The practical 
consequence of these observations is that transverse magnetisation decays to zero much more 
quickly than the z-magnetisation recovers to equilibrium. 
 
15N R1 depends on ö(iÑ), ö(iÖ − iÑ) and ö(iÖ + iÑ): 
 G6 = [
∂F
64
\ {3ö(iÑ) + ö(iÖ − iÑ) + 6ö(iÖ + iÑ)} + @Eö(iÑ) (3.32) 
 




{4ö(0) + 3ö(iÑ) + ö(iÖ − iÑ) + 6ö(iÖ) + 6ö(iÖ +iÑ)} + ∫
@E
6 ª
{4ö(0) + 3ö(iÑ)} + Gºm 
 (3.33) 




, @E = E
63
[RÑO4(ã∥ − ãç)]E, and are coefficients for dipolar and CSA 
interactions, respectively, and Rex is the chemical exchange contribution to R2 value [324]. 
 







Figure 3.7: Variations in R1 and R2 with overall rotational correlation time, τc 
 
There are various mathematical models for mapping the spectral density functions, of which 
the Lipari-Szabo model-free analysis [325,326] is widely used to obtain information about 
site-specific internal motions of proteins. However, without any assumptions, the spectral 
density functions at five frequencies cannot be determined from experimentally determined 
relaxation rate constants. According to the model-free formalism of Lipari and Szabo, the 
global motion of the whole molecule and internal motions of 15N-1H bond vectors are 
assumed to be independent. Internal motion is defined by two parameters: the square of the 
order parameter, S2, for describing the amplitude, and a characteristic correlation time of the 
motion íë. 
 
ö(i) depends on both the overall motion of the macromolecule as a whole and on the internal 
motions of the 15N-1H bond vector. The formalism enables simplification of the spectral 
density function: 









where íº is the effective internal correlation time and íè is the isotropic global correlation 















In the limit íº ≪ íè  (effective internal correlation time is much smaller than the isotropic 
global correlation time) and S2 à 1 (relaxation dominated by global motion), the simplified 
spectral density function is: 






Under this limit, expressions for 15N R1 and 15N R2 can be approximated as follows: 





 GE ∝ 	ö(0) ≅ MEíè (3.38) 
R1 is sensitive to the dynamics on the timescale of ps–µs, whereas R2 is sensitive to motions 
on both the ps–µs and µs–ms timescales. 
 
The above assumption is also made in the R2/R1 ratio method, so that R2/R1 is essentially 
independent of S2 and íº: 
 GE/G6 ∝ iÑE íèE (3.39) 





×  ÀBFBC − 7 (3.40) 
 
Accurate assessment and interpretation of spin-relaxation data requires careful consideration 
of anisotropic rotational diffusion and chemical exchange. While R2/R1 is a commonly used 
approach for identifying residues undergoing chemical exchange and estimation of global 
correlation times, this approach does not distinguish between motional anisotropy and 
chemical exchange. This leads to error due to potential contribution from Rex terms to the R2 
relaxation rate, since GE = GE4 + Gºm . Kneller et al. recommend the use of the R1R2 value, 
which significantly attenuates the effects of motional anisotropy [328], as anisotropic 
tumbling has opposing effects on R1 and R2. 
 G6GE ∝ ö(0)ö(iÑ) ≅
√Õ
ûΩ
F  (3.41) 
 






3.2.5.3 Spin relaxation in the rotating frame (R1ρ) 
Spin relaxation in the rotating frame (R1ρ) is another method for measuring transverse 
relaxation. In the R1ρ experiment, an RF field (B1) is applied to spin-lock the magnetisation 
along the direction of the effective field in the rotating frame. This can be performed using 
near-resonance or off-resonance RF fields, and are called on-resonance (Figure 3.8b) or 
off-resonance (Figure 3.8a) R1ρ experiments, respectively. The result is that there is relaxation 
but no precession. Figure 3.8c illustrates the geometrical relationship between the laboratory 
and tilted rotating frames. R1ρ is the relaxation rate constant for magnetisation which is 
spin-locked along the direction of the effective field in the rotating frame using a spin-lock 
with field strength i6. R1ρ contains contributions from R1 and R2 due to transformation from 
the laboratory frame to the rotating frame [329]: 
 G6Œ = G6 cosE à + GE sinE à (3.42) 
where the tilt angle in the rotating frame is 
 à = tan;6 [ûC
–—
\ (3.43) 
the average resonance offset is 
 Ω— = ∑ {ëΩëÑëï6  (3.44) 
and the average effective field in the rotating frame is 
 iº = “(Ω—E + i6E) (3.45) 
 
To obtain accurate R2 from R1ρ, it is advantageous to use a strong B1 field strength, thereby 
making à close to 90°. 
 
The accessible range of effective magnetic field strengths determines the timescale of 
processes that can be studied by different relaxation experiments. The effective field 
strengths typically employed in CPMG relaxation experiments are 25–500 Hz; hence CPMG 
experiments are often used for characterising slower ms timescale chemical exchange 
processes. Chemical exchange kinetics are obtained from the variation in R2 as a function of 
the time delay between refocusing pulses in the spin-echo sequence. The effective field 
strengths employed in R1ρ experiments are 1–6 kHz, although weaker fields can be utilised to 
provide overlap with the CPMG experiment. Thus, R1ρ experiments are most often used for 






characterising faster µs timescale chemical exchange processes. Chemical exchange kinetics 
are obtained from the variation of R1ρ as a function of the effective field in the rotating frame. 
 
 
Figure 3.8: Basic pulse sequence elements for the measurement of R1ρ and geometric 
representation of the laboratory and rotating frames 
Basic pulse sequence elements for off-resonance (a) and on-resonance (b) 15N R1ρ measurements. 
Wide white bars indicate 180° pulses. Pulses are applied with phase x unless indicated otherwise. 
Grey rectangles represent 15N spin-lock periods, which are applied with phase x for a total length of T. 
In both the off-resonance and on-resonance experiments, adiabatic sweeps (grey triangles) are used to 
rotate the magnetisation from the z-axis to the direction of the effective field, and vice versa. (c) 
Geometric representation of the laboratory frame (Sx, Sy, Sz) and the tilted rotating frame (S’x, S’y, S’z), 
where S’z is parallel to the average effective field, iº. The relative orientation of the laboratory and 
rotating frames is given by the tilt angle à. The rotating frame and à are different for each spin. The 
orientations of the effective fields of two different spins, iº6  and iºE , are given by à6 and àE , 
respectively. Figure adapted from [329]. 
 






An advantage of the R1ρ experiment is that off-resonance effects can be corrected using 
Equation 3.42, provided that R1 data is available. The accuracy of R1ρ measurements 
decreases for signals located far off-resonance. Compared to CPMG R2, R1ρ values do not 
need to be recorded at different carrier frequencies without discarding any data. 
 
In CPMG R2, off-resonance error is significant at high magnetic field strength. The CPMG 
pulse train accumulates error caused by a combination of pulse imperfections and 
off-resonance effects. The main disadvantage is that there is no simple equation to correct for 
CPMG R2 off-resonance effects. In practice, it is recommended to discard R2 data obtained at 
”/2í‘’ frequency (í‘’ is half the duration of CPMG interpulse delay and n is an integer), 
and to record the data at two different carrier frequencies [330]. Alternatively, phase cycling 
can be used to average out off-resonance effects [199]. 
 
3.2.5.4 Other relaxation parameters 
In addition to the R1 and R2 relaxation rate constants, relaxation behaviour in two-spin 
systems introduces additional features which are not present in one-spin systems, particularly 
cross relaxation which gives rise to nuclear Overhauser effect (NOE). Relaxation via the 
NOE occurs between two spins which are interacting via DD coupling. Each spin is described 
by two energy levels corresponding to the α state and the β state. DD coupling leads to 
relaxation-induced transitions between any of the four levels. The rate constant σ12 describes 




÷6ö7i4,6 + i4,E> − ö7i4,6 − i4,E>◊ (3.46) 
where ÿ = Ÿ¢≥C≥Fℏ
«»ø¿
, and ië,ß is the frequency needed to cause transitions between two levels i 
and j. 
 
For slow tumblers, σ12 is negative, as 6ö7i4,6 + i4,E> < ö7i4,6 − i4,E>. 
For rapid tumblers, σ12 is positive, as 6ö7i4,6 + i4,E> > ö7i4,6 − i4,E>. 
 
σ12 is inversely proportional to r6, where r is the distance between the two spins. Hence, σ12 
falls off very rapidly with distance, and is detectable for inter-spin distances within 5 Å for 
the case of two protons. 







Heteronuclear NOE experiments were not pursued in this chapter, as experimental results on 
pSRII (see Section 3.3.6) and published studies on SDS-solubilised proteolytic fragment of 
bacteriorhodopsin [331] indicate that the timescales of NH bond vector motions and chemical 
exchange are not within the ps–ns timescale, for which heteronuclear NOE experiments are 
most suited. Moreover, the signal-to-noise ratio is low for big proteins and artifacts are 
common due to cross correlation when measured at high static magnetic field strengths, 
which are required to provide sufficient spectral dispersion for unfolded proteins. 
 
 






3.3 Results: SDS at pH 6.0 
In Chapter 2, denaturant screening and extensive biophysical characterisation identified SDS 
at pH 6.0 and pH 2.0 as the most suitable conditions for unfolding pSRII. Chemically 
denatured states constitute an ensemble of rapidly interconverting conformations which are 
present at the beginning of the folding pathway. NMR is therefore highly suited for yielding 
atomic resolution information on structure and dynamics represented by a heterogeneous 
ensemble of unfolded protein conformations. 
 
3.3.1 SDS-denatured pSRII remains partially structured, with 
conformations in the denatured states ensemble interconverting on 
the µs–ms timescale 
NMR spectra of pSRII in c7-DHPC at pH 6.0 are typically recorded at 35 °C or higher 
temperatures of up to 60 °C to yield good spectral resolution [280]. This is because higher 
temperatures lead to lower viscosity and a decrease in transverse relaxation rate, hence 
yielding narrower linewidths [332]. Due to the higher pSRII concentrations necessary for 
NMR samples, 0.5% c7-DHPC was included in NMR samples of unfolded pSRII to ensure 
the presence of at least 40-fold excess [333] of c7-DHPC detergent molecules. 
 
Circular dichroism (Figure 3.9a) and tryptophan fluorescence (Figure 3.9b) were first 
recorded for pSRII in SDS + 0.5% c7-DHPC at 35 °C, pH 6.0 for comparable studies against 
biophysical measurements done at 25 °C (see Chapter 2). The extent of unfolding was 
assessed by changes in MRE at 222 nm and fluorescence intensity at 335 nm, showing that 
unfolding occurs to the same extent at 35 °C. This indicates that results from the biophysical 
studies in Chapter 2 would be directly comparable to pSRII unfolded in SDS at 35 °C for 
NMR experiments. The rate of aggregation appears to be faster at 35 °C, since decrease in 
α-helical content and oligomerisation are already observable by 6 h (Figures 3.9a & 3.9c). 
 







Figure 3.9: Circular dichroism (a), fluorescence emission (b) and SDS-PAGE (c) of pSRII in 
different SDS + 0.5% c7-DHPC at 35 °C 
(a) MRE at 222 nm for 7 µM (0.2 mg/ml) pSRII in 0.971 ΧSDS (10% SDS + 0.5% c7-DHPC) at 25 or 
35 °C for up to 6 h. (b) Tryptophan fluorescence emission at 335 nm. Error bars represent the 
standard deviation of three independent measurements. (c) Silver-stained 12% SDS-PAGE showing 
increased aggregation of pSRII with increasing ΧSDS over prolonged unfolding time (0 min, 2 h, 6 h, 
24 h). Lane 1, molecular weight marker; lanes 2–3, 0 ΧSDS (0.5% c7-DHPC); lanes 4–7, 0.728 ΧSDS 
(0.8% SDS + 0.5% c7-DHPC); lanes 8–11, 0.870 ΧSDS (2.0% SDS + 0.5% c7-DHPC); lanes 12–15, 
0.971 ΧSDS (10% SDS + 0.5% c7-DHPC). The arrows indicate the expected migration of monomeric 
(M), dimeric (D) and trimeric (T) pSRII. 
 
1D 1H NMR spectra were recorded to assess the structural properties of SDS-denatured 
pSRII (Figure 3.10). Folded pSRII (0 ΧSDS) showed wide chemical shift dispersion from 
about 6 to 10 ppm. The dispersion remained equally wide in the presence of increasing ΧSDS, 






indicating that many backbone amide residues still experience unique chemical environments. 
This supports the results from circular dichroism experiments (see Chapter 2) showing that 
large portions of helical structure were preserved across all ΧSDS studied. An obvious drop in 
peak intensities was observed for pSRII in 0.834 ΧSDS (1.5% SDS in 0.5% c7-DHPC), 
indicating substantial changes in protein backbone dynamics, either due to a slower tumbling 
rate in the presence of more detergent or due to conformational exchange in the µs–ms 
timescale (intermediate exchange regime). This coincides with the onset of full unfolding 
characterised by biophysical studies (see Chapter 2). Tryptophan side-chain indole groups 
also experience changes in dynamics, as evidenced by a similar drop in peak intensities in the 
9.5–10.5 ppm region (Figure 3.10, left inset). Increased peak overlap was observed upon 
further increase in ΧSDS up to 0.971 ΧSDS (10% SDS + 0.5% c7-DHPC), suggesting that as the 
protein is further denatured more residues become exposed to similar chemical environments. 
Beyond 0.971 ΧSDS, more residues undergo conformational exchange in the µs–ms timescale, 
as a decrease in peak intensities was observed in 0.990 ΧSDS (30% SDS in 0.5% c7-DHPC). 
Similar observations were made for the 5.5–7.0 ppm region (Figure 3.10, right inset), part of 
which possibly shows changes in arginine side-chain amide proton signals. 
 
To understand how spectral quality is affected by pSRII unfolding and aggregation, 
time-dependent changes in 1H NMR spectra were studied for pSRII in 0.834 ΧSDS (1.5% SDS 
in 0.5% c7-DHPC) (Figure 3.11a) and in 0.971 ΧSDS (10% SDS in 0.5% c7-DHPC) 
(Figure 3.11b). Spectra were recorded at 10 min, 5.3 h and 21.3 h after initial exposure of 
pSRII to SDS, and the samples were kept at 35 °C throughout. Both samples showed 
complete retinal Schiff base hydrolysis and became pale yellow in colour (absorbance 
λmax = 390 nm) after 21 h. Comparison of 1H spectra recorded at 10 min and 5.3 h showed a 
very small decrease in peak intensities, with different signals showing different amounts of 
changes, indicating differential changes in protein backbone dynamics across the protein. A 
more pronounced decrease in peak intensities was observed between 5.3 h and 21.3 h, 
indicative of aggregation. In 0.834 ΧSDS (1.5% SDS in 0.5% c7-DHPC), several peaks 
(indicated by arrows in Figure 3.11a) were noted to show higher intensities at 21.3 h than at 
the earlier time points, including a tryptophan side-chain indole signal at 10 ppm. This 
indicates that residue-specific changes in protein structure and dynamics might have occurred 
as well. Similar conclusions could be drawn from the time-dependent spectral changes in 






0.971 ΧSDS (10% SDS in 0.5% c7-DHPC), as peaks at 6.0–6.5 ppm have very similar 
intensities at 5.3 h and 21.3 h whereas other peaks show pronounced decrease in intensities. 
 
 
Figure 3.10: 1D 1H NMR of pSRII in different ΧSDS 
All samples contain ~ 83 µM pSRII and 0.5% c7-DHPC. All spectra were recorded at 308 K, with 
512 scans, at ~ 10 min after initial exposure to SDS. All spectra were processed by apodization of the 
FID using a squared sine window function shifted by 90° followed by an exponential line broadening 
of 1 Hz. Insets show expanded views for the 9.0–11.0 ppm region (left) and the 5.5–7.0 ppm region 
(right). All samples contained TSP as internal reference. 
 
 







Figure 3.11: Changes in 1H NMR spectra over time 
1H NMR of backbone amides and side-chain NH groups for 83 µM pSRII in 0.834 ΧSDS (1.5% SDS in 
0.5% c7-DHPC) (a) or 0.971 ΧSDS (10% SDS in 0.5% c7-DHPC) (b) for 10 min, 5.3 h or 21.3 h. All 
spectra were recorded at 308 K with 512 scans, and processed by apodization of the FID using a 
squared sine window function shifted by 90° followed by an exponential line broadening of 1 Hz. All 
samples contained TSP as internal reference. 
 
Residue-specific information on SDS-denatured pSRII could not be obtained from 1D 1H 
NMR spectra due to the large number of overlapping backbone amide proton signals. The 19F 
nucleus is highly sensitive (has a high gyromagnetic ratio comparable to that of 1H), shows a 
broad chemical shift range, and does not occur naturally in biomacromolecules. Selective 
19F-labelling of specific amino acids would significantly decrease the number of overlapping 
signals and enable facile spectral interpretation.  
 
19F-tryptophan labelling of pSRII was accomplished using the method outlined by Crowley et 
al [334]. As fluorine is not identical to the replaced proton, structural perturbations were 
assessed by circular dichroism and 2D [1H,15N] SOFAST-TROSY-HSQC. No secondary 
structure changes were detected in the absence of SDS (Figure 3.12a), but 19F-5-Trp labelled 






pSRII was more α-helical than unlabelled pSRII in the presence of 0.943 ΧSDS (1.0% SDS in 
0.1% c7-DHPC) (Figure 3.12b), indicating that 19F-labelling is not completely inert. Previous 
reports suggest that fluorinated amino acid incorporation could affect protein stability 
through increased hydrophobicity and even alter the pKa of exchangeable protons [335].  
 
From the 2D [1H,15N] SOFAST-TROSY-HSQC spectra (Figure 3.12c) of uniformly 
15N-labelled pSRII and 15N,19F-5-Trp-labelled pSRII, the combined chemical shift difference 
was calculated as the square root of the scaled sum of squares of chemical shift changes in 
the 1H and 15N dimensions: 





Most backbone amides experience Δδ(1H,15N) smaller than 0.1 ppm, indicating that 19F-5-Trp 
labelling does not affect the overall protein structure. Residues with Δδ(1H,15N) ≥ 0.1 ppm 
are mainly localised near the sites of fluorine incorporation (Figure 3.12d). Interestingly, 
tryptophan side-chain indoles were unobservable, suggesting that fluorine incorporation 
might have led to changes in the relaxation properties of the side-chain indole groups. 
 








Figure 3.12: 19F-5-Trp labelling of pSRII leads to minor changes in protein structure 
(a–b) Circular dichroism. (c) [1H,15N] SOFAST-TROSY-HSQC (80 scans, 308 K) of 83 µM 
15N-pSRII (black) in 0.5% c7-DHPC and 157 µM 15N,19F-5-Trp-pSRII in 1.8% c7-DHPC (blue), 
showing good spectral overlap indicative of limited structural changes induced by 19F-labelling. Trp 
side-chain indoles have become unobservable (red dashed box). Spectra were recorded with TSP as 
internal reference. (d) Combined chemical shift differences, Δδ(1H,15N), are small across most 
backbone amides, except for selected residues which are located close to the sites of fluorine 
incorporation. 
 






A 1D 19F NMR spectrum of pSRII in 0 ΧSDS shows six well-resolved peaks corresponding to 
the 6 tryptophan residues (Figure 3.13a). In the presence of increasing ΧSDS up to 0.834 ΧSDS 
(1.5% SDS in 0.5% c7-DHPC), increased peak overlap and line broadening were observed 
(Figure 3.13a), indicating that some tryptophan residues became exposed to similar chemical 
environments while slow-to-intermediate conformational exchange appeared to affect all 
tryptophan residues, consistent with the observations from 1D 1H NMR. Only one resonance 
corresponding to the sum of peaks 5 and 6 could be observed in 0.870 ΧSDS (2.0% SDS in 0.5% 
c7-DHPC), suggesting that the tryptophan residues are exposed to similar chemical 
environments. The chemical environments of tryptophans corresponding to peaks 5 and 6 
became different again in 0.971 ΧSDS (10% SDS in 0.5% c7-DHPC), manifesting as a small 
shoulder peak. This could be correlated with the formation of non-native helical structures 
due to the helix-inducing effect of SDS (see Chapter 2). Assignment of the 19F NMR signals 
was not pursued given the low information content of this approach due to substantial peak 
overlaps. Comparison of 19F spectra recorded at 1 h, 4 h and 23 h showed more pronounced 
decrease in peak intensities in 0.834 ΧSDS (1.5% SDS in 0.5% c7-DHPC) than in 0.400 ΧSDS 
(0.2% SDS in 0.5% c7-DHPC) (Figure 3.13b), consistent with time-dependent aggregation of 
denatured pSRII beyond the unfolding transition. 
 
In summary, only a limited amount of residue-specific information could be derived from 1D 
1H and 19F NMR spectra due to: 
1) a large number of backbone amide proton signals in 1D 1H NMR spectra across all ΧSDS, 
2) peak overlap in 1D 19F NMR spectra in high ΧSDS as the tryptophan residues were 
exposed to similar chemical environments upon protein unfolding, and 
3) line broadening which could be attributed to conformational exchange on the µs–ms 
timescale and/or aggregation at ≥ 6 h after initial exposure to SDS. 
 







Figure 3.13: 1D 19F NMR of 19F-5-Trp pSRII in different ΧSDS (a) and over time (b) 
All spectra were recorded at 308 K, at ~ 10 min after initial exposure to SDS, with 512 scans. All 
spectra were processed by apodization of the FID using a squared sine window function shifted by 90° 
followed by an exponential line broadening of 1 Hz. All spectra were referenced externally to CFCl3 
(0 ppm). 
 
3.3.2 Chemical shift: Structural properties of SDS-denatured pSRII 
Given the spectral overlap observed for backbone amide protons in 1D 1H NMR and at high 
ΧSDS in 1D 19F NMR, 2D NMR will likely be more suitable for resolving overlapped signals 
to obtain residue-specific information on SDS-unfolded pSRII. 
 
2D [1H,15N] SOFAST-TROSY-HSQC experiments were recorded to investigate the effects of 
SDS-mediated unfolding on the backbone amides of pSRII. Assignments for backbone amide 
resonances and the solution-state NMR structure of pSRII in 0 ΧSDS at pH 6 were available 
from previous work in the Nietlispach lab [216]. 
 
Figure 3.14 shows an overlay of [1H,15N] SOFAST-TROSY-HSQC spectra recorded in the 
presence of 0–0.990 ΧSDS (0–30% SDS in 0.5% c7-DHPC). Increasing ΧSDS led to 
progressive changes in chemical shifts (see arrows in Figure 3.14b). Peak intensities 
generally decreased with increasing ΧSDS, as evidenced by most residues being no longer 
observable in ≥ 0.870 ΧSDS (Figure 3.14b). The overall decrease in peak intensities with 






increasing ΧSDS is attributed predominantly to intermediate (µs–ms timescale) exchange 
between different backbone amide conformations represented by the ensemble of denatured 
states, and also to minor amounts of aggregation (Figure 3.9c). Residues in the C-terminal tail 
of pSRII remained significantly more flexible than the rest of the protein, as evidenced by the 
strong intensities of these peaks across all ΧSDS. Big differences in peak intensities between 
transmembrane vs. C-terminal residues also indicate that the transmembrane helices are 
likely to remain embedded in SDS/c7-DHPC mixed micelles across all ΧSDS and that there is 
little/no stable interaction of the C-terminal tail with detergent micelles. 
 
To understand whether backbone amide chemical shifts are determined by ΧSDS or the molar 
concentration of SDS, 2D [1H,15N] SOFAST-TROSY-HSQC spectra of pSRII were recorded 
in 1% SDS + 0.45% c7-DHPC and in 2% SDS + 0.90% c7-DHPC, both corresponding to 
0.769 ΧSDS but with different molar concentrations of c7-DHPC and SDS (Figure 3.15). The 
peaks in both spectra have almost identical chemical shifts, indicating that chemical shifts are 
determined by ΧSDS. This observation justifies correlating results from the biophysics studies 
in Chapter 2 against ΧSDS, as this parameter is representative of the immediate micellar 
environment experienced by the protein. It is noted that peak intensities are slightly lower in 
2% SDS + 0.90% c7-DHPC because the presence of higher detergent concentrations leads to 
higher viscosity and slower molecular tumbling, thus yielding slightly broader linewidths. 
 
To understand how spectral quality is affected by pSRII unfolding and aggregation at 35 °C, 
time-dependent changes were studied in 2D [1H,15N] SOFAST-TROSY-HSQC spectra of 
pSRII in 0.834 ΧSDS (1.5% SDS in 0.5% c7-DHPC) (Figure 3.15b), which is beyond the 
unfolding transition. Comparison of the TROSY spectra over time showed very small 
decrease in peak intensities within 6 h of initial exposure to SDS, while more pronounced 
decrease in peak intensities was observed from 6 h onwards, indicative of aggregation. After 
being kept at 35 °C for 21 h, the sample showed complete retinal Schiff base hydrolysis 
(clear but pale yellow in colour, with absorbance λmax = 390 nm). 
 







Figure 3.14: 2D [1H,15N] SOFAST-TROSY-HSQC spectra of ~ 90 µM 15N-labelled pSRII in 0–
0.990 ΧSDS (0–30% SDS in 0.5% c7-DHPC). 
All spectra were recorded on an 800 MHz spectrometer at 308 K, with 240 scans. All samples 
contained TSP as internal reference. Panel (b) shows an expanded view of the glycine residues (boxed 
region of panel a). Chemical shift changes are represented using arrows next to each peak. 
 







Figure 3.15: 2D [1H,15N] SOFAST-TROSY-HSQC spectra recorded in different molar 
concentrations of SDS and c7-DHPC (a) and at different timepoints (b) in 0.834 ΧSDS (1.5% SDS 
in 0.5% c7-DHPC) 
All spectra were recorded on an 800 MHz spectrometer at 308 K, with 240 scans. All samples 
contained TSP as internal reference. 
 






For a systematic understanding of structural changes of pSRII upon exposure to SDS, the 
combined chemical shift difference (Δδ(1H,15N)) relative to pSRII in 0 ΧSDS was calculated 
for each observable backbone amide signal across different ΧSDS (Figure 3.16). Δδ(1H,15N) 
increases with increasing ΧSDS, albeit to different extents for different residues. To identify 
individual residues or stretches of residues which experience substantial structural changes, 
residues with a large Δδ(1H,15N) are typically defined using a cut-off at one standard 
deviation above the average Δδ(1H,15N) across all residues [323]. Taking this cut-off, 
however, was not suitable for SDS-unfolded pSRII, as significant changes were only detected 
at the ends of helices (results not shown). On the one hand, this confirms the results from 
circular dichroism experiments, where the small changes in helicity were interpreted as 
fraying of helix ends and the transmembrane helices were thought to remain embedded in 
mixed micelles. On the other hand, this cut-off precludes a detailed study of the fine changes 
in tertiary structure occurring in the transmembrane region, including loosening of the retinal 
binding pocket and Schiff base hydrolysis. These considerations highlight the difficulties 
with interpreting backbone amide chemical shift changes, especially those from titration 
experiments using a molecule which interacts with the protein in a non-specific manner. 
 







Figure 3.16: Combined chemical shift differences (Δδ(1H,15N)) of pSRII in 0.625, 0.769 and 
0.834 ΧSDS 
 
Figure 3.17a shows Δδ(1H,15N) mapped onto the solution-state NMR structure of pSRII, with 
the values indicated by a gradual colour change from blue to red with every 0.1 ppm 
increment. In addition to identifying the big Δδ(1H,15N) occurring at helix ends, this approach 
has also enabled detailed study of fine structural changes in the transmembrane regions and 
the retinal binding pocket. 
 






A 3 Å cut-off was taken around the retinal chromophore to identify residues which constitute 
the retinal binding pocket (Figure 3.17b). In 0–0.625 ΧSDS, Δδ(1H,15N) of residues in the 
binding pocket are generally less than 0.1 ppm, indicating that there is little perturbation of 
the binding pocket. A notable exception is Trp-178, which has Δδ(1H,15N) between 0.1 and 
0.2 ppm starting from 0.400 ΧSDS (0.2% SDS in 0.5% c7-DHPC). This observation can be 
attributed to the residue being located near the extracellular end of helix F and is indicative of 
helix fraying rather than substantial disruption of the binding pocket. In ≥ 0.625 ΧSDS (0.5% 
SDS in 0.5% c7-DHPC), several other residues show Δδ(1H,15N) > 0.1 ppm. Starting from 
Trp-76 in the middle of helix C, residues with Δδ(1H,15N) > 0.1 ppm gradually spread across 
helices C and D as ΧSDS was increased, suggesting that the packing of helices C and D against 
the retinal binding pocket is beginning to loosen even before the unfolding transition 
(determined to be ~ 0.81 ΧSDS for SDS + 0.5% c7-DHPC in Chapter 2). Δδ(1H,15N) > 0.1 
ppm was detected for Phe-208 and Gly-209 in helix G starting from 0.728 ΧSDS and 0.769 
ΧSDS, respectively. Both residues are located around one helical turn away from the site of 
retinal attachment (Lys-205), indicating that small structural changes were beginning to 
appear near the retinal Schiff base before the unfolding transition. In comparison, Δδ(1H,15N) 
remained generally small (< 0.1 ppm) for other residues in helices F and G (including 
Lys-205) within the retinal binding pocket. In 0.834 ΧSDS (just beyond the unfolding 
transition), Val-206 experienced Δδ(1H,15N) > 0.1 ppm whereas Lys-205 still retained 
Δδ(1H,15N) < 0.1 ppm. Hence, although retinal Schiff base hydrolysis can be associated with 
small structural changes in helix G up to one helical turn away from the Schiff base, Lys-205 
itself experienced little structural changes. It is noted that Lys-205 was unobservable beyond 
0.834 ΧSDS. In fact, the number of observable residues gradually decreased from 0.728 ΧSDS 
onwards, showing the necessity of studying changes in signal intensities and protein 
backbone dynamics (Sections 3.3.3–3.3.5). 
 







Figure 3.17: Δδ(1H,15N) of pSRII backbone amides in different ΧSDS 
Δδ(1H,15N) are mapped onto the solution-state NMR structure of pSRII (PDB 2KSY) [216]. (a) 
Residues are coloured from blue to red according to Δδ(1H,15N) values, showing greater structural 
changes at the ends of helices than in the transmembrane region. Unassigned residues are coloured 
white. 
 







Figure 3.17: Δδ(1H,15N) plotted on the PDB structure of pSRII (cont.) 
(b) Surface representation of residues within 3 Å of retinal coloured according to Δδ(1H,15N) values to 
show structural changes at the retinal binding pocket. 
 






Overall, analysis of backbone amide chemical shift changes suggests that disruption of the 
binding pocket initiates with disrupted packing of helices C and D against retinal before the 
unfolding transition followed by small changes in helix G near the site of retinal attachment 
both before and beyond the unfolding transition. Conformational changes in other parts of the 
binding pocket were limited in comparison. 
 
Under the fast exchange regime, the presence of more than two exchanging conformations in 
SDS-unfolded pSRII can be detected by examining the trajectories of peak shifts [323]. Many 
residues showed non-linear peak shift trajectories, indicating the presence of more than two 
species which are undergoing conformational exchange. Ser-44 is shown as an example in 
Figure 3.18a: a linear trajectory was observed in 0–0.625 ΧSDS, indicating fast-to-intermediate 
conformational exchange between the folded and unfolded conformations and an increase in 
the population of the unfolded conformation with increasing ΧSDS. The peak showed little to 
no changes in chemical shift between 0.625 and 0.769 ΧSDS, suggesting that the chemical 
environment of Ser-44 remains similar in this ΧSDS range. Ser-44 was unobservable in 0.834–
0.870 ΧSDS, indicating exchange broadening. The peak reappeared in 0.893 and 0.909 ΧSDS, 
with peak shifts showing a different trajectory to that observed in 0–0.625 ΧSDS, indicating 
that further increase in ΧSDS led to the formation of alternative conformation(s) and its 
exchange with the conformation observed in 0.625–0.769 ΧSDS. Such complex peak 
trajectories were only observed for a very limited number of residues, and no further 
conclusions could be drawn. Backbone amides with non-linear peak trajectories are mapped 
onto the solution-state NMR structure of pSRII in Figure 3.18b. Residues showing 
conformational exchange between more than two conformations are spread out across all 
seven transmembrane helices. This suggests that SDS-mediated unfolding of pSRII has led to 
widespread “softening” of the transmembrane helical bundle, as the ends of the helices are 
beginning to unravel (helix fraying) and the tertiary structure becomes less tightly packed. 
 
In summary, pSRII progressively unfolds in increasing ΧSDS to yield an ensemble of different 
unfolded conformations. 
 







Figure 3.18: Non-linear peak shift trajectories indicate exchange amongst more than two 
conformations 
(a) Examples of peaks exhibiting non-linear peak shift trajectories (Ser-44) vs. a linear trajectory 
(Met-117). (b) Backbone amides with non-linear peak shift trajectories are mapped onto the pSRII 
structure as blue spheres, showing widespread conformational exchange across the protein. 
 
3.3.3 Peak intensities: Backbone dynamics of SDS-denatured pSRII 
Decreases in peak intensities with increasing ΧSDS led to difficulties with analysing chemical 
shift changes due to fewer observable signals. 1D 1H NMR spectra already illustrate that 
pSRII in ≤ 0.769 ΧSDS showed no changes in peak intensities over time, whereas intensity 
loss over time was observed in spectra of pSRII beyond the unfolding transition (in 
≥ 0.834 ΧSDS) (Figure 3.11). These observations indicate that backbone amide conformational 
exchange in the µs–ms timescale only occur in unfolded pSRII. Detailed understanding of 
peak intensity changes would yield information on how changes in backbone dynamics and 
conformational exchange relate to pSRII unfolding. 
 







Figure 3.19: Intensity changes in 0.625 and 0.834 ΧSDS 
Intensity changes are shown as S S4⁄ , the ratio between peak intensity at a given ΧSDS relative to the 
intensity at 0 ΧSDS, and are represented as blue bars. Unobservable residues are represented as unfilled 
bars of arbitrary height. Unassignable residues are shown as unfilled diamonds. The cut-off values of 
S S4⁄ = 1 and S S4⁄  at the bottom 10th percentile are shown as lime and magenta dashed lines, 
respectively. α-helices and β-sheet secondary structures are shown as grey rods and black arrows, 
respectively, at the top of each plot. 






Changes in peak intensities were calculated by taking the ratio of the peak intensity at a given 
ΧSDS against the peak intensity in 0 ΧSDS: 





Peak intensities in the presence of SDS were generally lower than those in 0 ΧSDS (S S4⁄ < 1), 
and decreased with increasing ΧSDS (Figure 3.19). To identify peaks with big changes in 
intensities, cut-off values at S S4⁄ > 1 or S S4⁄  below the 10th percentile were applied. A few 
individual residues in the middle of helices C, D, E and G and in the loop regions showed 
S S4⁄ > 1, indicating that these backbone amides became more flexible in the presence of 
SDS. In 0.625 ΧSDS, residues with S S4⁄  below the 10th percentile were mostly located in helix 
C and the extracellular half of helix E. This appears to be consistent with the relatively 
greater number of unobservable residues in these two helices compared to other helices at 
0.834 ΧSDS (seven residues in helix C and six residues in helix E). Figure 3.19 did not show 
any obvious stretches of residues with prominent intensity changes, possibly suggesting that 
significant changes in backbone dynamics might be occurring at only several specific 
residues which are spatially (rather than sequentially) close to each other. 
 
To better visualise the distribution of residues with prominent intensity changes, S S4⁄  are 
mapped onto pSRII and coloured by value (Figure 3.20). Residues with S S4⁄ < 1 are further 
classified as being above or below the average taken across all helical residues. 
Solvent-exposed residues, determined by titration with the spin label reagent gadoteridol 
[216], are highlighted in blue in Figure 3.20a. Most of the micelle-embedded residues 
showed below-average S S4⁄ , indicating that backbone amides in the transmembrane region 
are less flexible than those in the loop regions. A few residues at the micelle/solvent interface 
showed above-average S S4⁄ . Residues with S S4⁄ > 1 appear to form clusters. In 0.625 ΧSDS, 
most residues with S S4⁄ > 1 are solvent-exposed or located at the micelle/solvent interface. 
There are two notable exceptions: Trp-76 in the middle of helix C and Val-203 in the middle 
of helix G, both of which are located within the binding pocket. It must be emphasised that 
the reported peak intensities for Trp-76 contained a small contribution from Thr-218 in 
≥ 0.728 ΧSDS due to overlap of the two peaks in the spectra. Nevertheless, it is clear from 
assessing the peak shapes that Trp-76 remained observable up to 0.870 ΧSDS. A few residues 






within the binding pocket on helices D and G also show above-average S S4⁄ , possibly 
suggesting preliminary loosening of the binding pocket. This is further supported by residues 
with above-average S S4⁄  being found in the same regions of helices D and G in 0.834 ΧSDS. 
 
In 0.834 ΧSDS, there was a marked decrease in the number of residues with S S4⁄ > 1, 
indicating that there is a general decrease in peak intensities across the protein, including 
residues in solvent-exposed regions and micelle/solvent interfaces. Interestingly, most 
residues in helix D with above-average S S4⁄  (Asn-105 & Met-109) or S S4⁄ > 1 (Phe-113) are 
facing the interface between helices C and D. Asn-105 and Met-109 showed further increase 
in peak intensities to yield S S4⁄ > 1 in 0.870 ΧSDS, indicating increase in backbone amide 
flexibility and gradual disruption of inter-helical interactions between helices C and D. In 
contrast, most residues on helix C were unobservable in 0.870 ΧSDS. This indicates that 
backbone amides on adjacent faces of the two helices show different degrees of flexibility, 
hence lending further support towards the proposal of inter-helical interactions between 
helices C and D being disrupted. 
 
Residues within the binding pocket (Figure 3.20b) also showed a general decrease in peak 
intensities, and the number of observable residues also decreased beyond the unfolding 
transition. Between 0.834 and 0.870 ΧSDS, residues disappeared from the cytoplasmic halves 
of helices B and C, the middle of helix E, and the extracellular half of helix F. On the other 
hand, residues on helix G packing against Lys-205, the Schiff base and up to C13–C14 of the 
retinal polyene chain remained observable at 0.834 ΧSDS, albeit with low peak intensities 
(below average). These observations indicate that at just above the unfolding transition, 
conformational exchange occurs throughout the binding pocket but to a smaller extent for 
residues surrounding the Schiff base, suggesting that the Schiff base is disrupted later 
compared to the rest of the binding pocket. In 0.870 ΧSDS, observable residues in the binding 
pocket were mostly clustered on helix D and showed S S4⁄ > 1, further indicating that the 
extracellular half of helix D exhibits faster backbone dynamics in high ΧSDS. 







Figure 3.20: Intensity ratios mapped onto pSRII structure 
(a) Residues with S S4⁄ > 1 are shown as lime spheres. Other residues are coloured according to S S4⁄  
values. An average S S4⁄  value is calculated across helical residues. Residues with below-average S S4⁄  
are coloured in purple, and residues with above-average S S4⁄  in teal. Solvent-exposed regions, 
determined from NMR signal attenuation in the presence of the soluble spin label reagent gadoteridol 
[216], are shaded in pale blue. (b) Surface representation of residues within 3 Å of retinal coloured 
according to S S4⁄  values to show changes in pSRII backbone dynamics at the retinal binding pocket. 
 







Figure 3.21: Unobservable residues at different ΧSDS mapped onto pSRII structure 
(a) Residues which disappear at 0.769, 0.834 and 0.870 ΧSDS are shown as red, yellow or cyan spheres, 
respectively. Residues which remain observable at ≥ 0.893 ΧSDS are coloured in blue. (b) Surface 
representation of residues within 3 Å of retinal coloured according to ΧSDS at which the residues 
become unobservable, showing changes in pSRII backbone dynamics at the retinal binding pocket. (c) 
Extracellular and cytoplasmic views, showing a greater proportion of inward-facing helical residues 
amongst residues which disappear at lower 0.769 and 0.834 ΧSDS. Residues are represented using the 
same scheme as in panel a. 
 






Disappearing peaks are interpreted as intermediate conformational exchange in the µs–ms 
timescale leading to line broadening and very low peak intensities. The first unambiguous 
peak disappearance (Thr-80) occurred at 0.728 ΧSDS. Unassignable residues in 0.400 and 
0.625 ΧSDS were assumed to either be significantly overlapped with other peaks or 
unassignable due to intractably large chemical shift changes. Residues which became 
unobservable in 0.769–0.870 ΧSDS are mapped onto the pSRII structure and shown as 
coloured spheres (Figure 3.21). 
 
The number of unobservable residues increased with increasing ΧSDS. Thr-80 (red spheres) on 
helix C, which packs against C9–C12 in the middle of the retinal polyene chain, was the first 
residue to become unobservable at 0.728 ΧSDS. In 0.834 ΧSDS (just above the unfolding 
transition), a major inter-helical cluster was formed between unobservable residues in the 
cytoplasmic halves of helices C, E, F and G, and much smaller clusters were formed between 
unobservable residues in the extracellular halves of helices A and B and between helices F 
and G. The chi-squared test (Table 3.1) shows that residues which have become unobservable 
at 0.769 ΧSDS and 0.834 ΧSDS are significantly populated in helical regions (P = 0.026). Out of 
such helical residues, there is significant preference for residues which face inwards towards 
the protein core (P = 0.003). This indicates that the backbone amides of helical residues 
facing the protein core were the earliest to experience prominent conformational exchange in 
the µs–ms timescale. Within the binding pocket, unobservable residues include Met-15 from 
helix A, Ala-47 from helix B, Thr-79 and Ile-83 from helix C and Gly-207 and Phe-208 from 
helix G, all of which are located near the Schiff base, packing against Lys-205 and up to 
C13–C14 of the retinal polyene chain. Tyr-51 from helix B, which is involved in the 
hydrogen-bond network of ordered water molecules in pSRII (PDB 1H68; [336]), also 
disappeared in 0.834 ΧSDS. To summarise, in 0.834 ΧSDS (just above the unfolding transition), 
prominent amounts of conformational exchange in the µs–ms timescale was observed for 
residues involved in inter-helical interactions amongst the cytoplasmic halves of helices C, E, 
F and G, residues around the Schiff base, and a small number of residues on the extracellular 
side of pSRII. It could therefore be hypothesised that loosening of inter-helical packing is 
initiated from the cytoplasmic side, likely amongst helices C, E, F and G, and propagated 
towards the Schiff base. 
 






Residues which became unobservable at 0.870 ΧSDS were spread across the entire protein. 
The slight bias in the distribution of such residues towards the extracellular side could be 
because many residues in the cytoplasmic side have already disappeared in lower ΧSDS. The 
chi-squared test showed no significant difference in the distribution of unobservable residues 
between helical vs. loop residues or helical residues which face inwards (towards protein core) 
or outwards (towards detergent micelle). Except for Gly-112 on helix D, residues within the 
binding pocket which became unobservable at 0.870 ΧSDS were solely found on helix G, 
including Asp-201, Thr-204, Lys-205, Val-206 and Gly-209, all of which are within one 
helical turn away from the Schiff base. Asp-201 and Thr-204 are also involved in the water 
network, possibly suggesting that the water network is also being progressively disrupted 
with increasing ΧSDS. 
 
 0.769 & 0.834 ΧSDS 0.870 ΧSDS 
Helical vs. Loop P = 0.026 (*) P = 0.093 
Inward-facing vs. Outward facing 
(helical residues only) 
P = 0.003 (*) P = 0.481 
 
Table 3.1: P-values from chi-squared test on the distribution of residues which have become 
unobservable at different ΧSDS 
 
Combining the observations from analysing chemical shift changes, peak intensity ratios and 
peak disappearance, it is interpreted that loosening of the binding pocket before the unfolding 
transition involves widespread backbone amide conformational exchange in the µs–ms 
timescale throughout the binding pocket. Residues in helices C and D showed disrupted 
packing against retinal (chemical shift changes). Residues in helix D showed increased 
backbone flexibility (S S4⁄ > 1). Inter-helical interactions between helices C and D were 
likely disrupted (different backbone dynamics). Prominent conformational exchange (peak 
disappearance) of backbone amides first began in the cytoplasmic halves of helices C, E, F 
and G. Disruption of the binding pocket was along the retinal polyene chain with the 
disappearance of Thr-80 packing against the middle (C9–C12) of retinal followed by several 
residues from helices A, B, C and G which pack against C13–C14 of retinal and Lys-205. 
The middle of helix G in general, including Lys-205 and neighbouring residues, showed 
smaller amounts of µs–ms timescale conformational exchange in 0.834 ΧSDS compared to the 






rest of the binding pocket. Except for the aforementioned residues in helices C and D, these 
residues on helix G near Lys-205 only became unobservable at 0.870 ΧSDS. These results 
indicate that the Schiff base and neighbouring residues on helix G were the last parts of the 
binding pocket to be disrupted. Schiff base hydrolysis, which occurs from 0.834 ΧSDS 
onwards, was also accompanied by small structural changes in helix G up to one helix turn 
away from the Schiff base. Lys-205 itself experienced little changes in chemical environment, 
and hence changes in backbone flexibility likely had a greater contribution towards Schiff 
base hydrolysis. While the analysis of backbone amide peak disappearance points towards 
progressive disruption of the hydrogen-bond network of ordered water molecules in pSRII, it 
must be noted that since the hydrogen-bond network is held together by side-chains rather 
than backbone amides, changes detected in backbone amides might be small and could 
contain other contributions. 
 
While most backbone amides experience predominantly conformational exchange in the 
intermediate (µs–ms) timescale leading to line broadening, the backbone amides of at least 
two residues exhibit conformational exchange at more than one timescale (Figure 3.22a). In 
0.728–0.834 ΧSDS, the backbone amides of Val-17 and Phe-98 each had two resonances, 
indicating slow exchange between the two corresponding backbone conformations. A shift in 
the relative populations of the two conformations can be seen between 0.728 and 0.834 ΧSDS. 
In ≥ 0.870 ΧSDS, both peaks of the two residues showed decreased intensities, indicating a 
transition from slow exchange towards intermediate exchange as the peaks became 
broadened beyond detection. From 0.909 ΧSDS onwards, several other backbone amides were 
also found to undergo slow exchange, as evidenced by difficulties in assigning several peaks 
in the glycine region of the spectrum due to big chemical shift changes (Figure 3.22b). The 
conclusions which could be drawn from Val-17 and Phe-98 were limited by the small number 
of residues involved and their lack of obvious functional relevance (i.e. not in the binding 
pocket). Nevertheless, these observations highlight the heterogeneous nature of the ensemble 
of unfolded states with different modes of backbone amide conformational exchange being 
observed at different ΧSDS. 
 







Figure 3.22: Examples of residues showing changes in conformational exchange regime with 
increasing ΧSDS 
(a) Val-17 and Phe-98 backbone amides (peaks with crosses) show transition from fast exchange 
regime in 0 ΧSDS to slow exchange regime in 0.728–0.870 ΧSDS to intermediate exchange regime 
in > 0.870 ΧSDS. Chemical shift changes are represented using dotted arrows. (b) Several backbone 
amides (in regions defined by dotted lines) show slow timescale conformational exchange and big 
chemical shift differences in high ΧSDS, leading to difficulties with peak assignment. 
 






3.3.4 Solvent accessibility: Hydrogen/deuterium exchange 
Tryptophan fluorescence studies in Chapter 2 showed that changes in tertiary structure also 
involve increases in solvent accessibility of certain tryptophan residues. Hydrogen/deuterium 
(H/D) exchange measurement by NMR was pursued to explore changes in solvent 
accessibility of backbone amides across pSRII. Spectra were measured in protonated solvent 
(9% D2O was included for lock stabilisation) or deuterated solvent (90% D2O). Concentrated 
SDS stock (25% SDS + 0.5% c7-DHPC in protonated or deuterated solvent) was added 
directly to pSRII in 0 ΧSDS to yield 0.769 ΧSDS (1% SDS + 0.5% c7-DHPC). Measurements 
must be done in low ΧSDS (below the unfolding transition) to ensure that loss in peak intensity 
is solely due to deuterium incorporation, without contributions from changes in backbone 
dynamics or aggregation over time (experimental time = 6 h). 
 
Deuterium incorporation was quantified for each assignable backbone amide in 0 ΧSDS and 
0.769 ΧSDS by calculating the intensity ratio in deuterated solvent vs. in protonated solvent 
(SË SÈ⁄ ). Comparison of SË SÈ⁄  in 0 ΧSDS (white bars) and 0.769 ΧSDS (orange dots) plotted in 
Figure 3.23a shows that peak intensity loss was smaller in 0.769 ΧSDS, meaning less 
deuterium has been incorporated and solvent accessibility is generally lower in the presence 
of SDS. This difference in deuterium incorporation is more prominent in transmembrane 
helical regions, possibly because of a “shielding” effect conferred by the presence of more 
detergent molecules and larger micelle sizes. Several residues are noted to have greater 
deuterium incorporation, and hence greater solvent accessibility, in 0.769 ΧSDS. For easier 
visualisation of different degrees of deuterium incorporation, the difference in intensity ratios, 













Positive values indicate greater solvent accessibility in 0 ΧSDS; negative values indicate 
greater solvent accessibility in 0.769 ΧSDS. The average ∆(SË SÈ⁄ ) across helical residues was 
0.045, meaning on average helical residues showed less solvent accessibility in 0.769 ΧSDS. 
 








Figure 3.23: Hydrogen/deuterium exchange in 0 ΧSDS vs. 0.769 ΧSDS 
(a) Deuterium incorporation is quantified by the ratio of peak intensities measured in deuterated 
solvent vs. in protonated solvent (SË SÈ⁄ ), where higher SË SÈ⁄  indicates less deuterium incorporation 
and hence less solvent exposure. Comparison of SË SÈ⁄  in 0 ΧSDS (white bars) vs. in 0.769 ΧSDS (orange 
dots) shows that backbone amides are generally less solvent-exposed in the presence of SDS. 
 








Figure 3.23: Hydrogen/deuterium exchange in 0 ΧSDS vs. 0.769 ΧSDS (cont.) 
(b) The difference in SË SÈ⁄  at different ΧSDS, ∆(SË SÈ⁄ ), is calculated for each assigned residue and 
coloured by value. Residues which are more solvent-exposed in 0.769 ΧSDS (negative ∆(SË SÈ⁄ )) are 
coloured in red; residues which are less solvent-exposed in 0.769 ΧSDS (positive ∆(SË SÈ⁄ )) are 
coloured in cyan. Residues with significant changes in SË SÈ⁄  are identified by taking cut-off values of 
one standard deviation above or below the mean ∆(SË SÈ⁄ ) taken across helical residues. 
 






To identify residues with significant differences in solvent accessibility between different 
ΧSDS, cut-off values were taken at one standard deviation above or below the average taken 
across the helical residues. Such residues are mapped onto the pSRII structure as coloured 
spheres, and the other residues are coloured according to ∆(SË SÈ⁄ ) value (Figure 3.24). 
Residues with good solvent accessibility (unobservable in deuterated solvent) in both 0 ΧSDS 
and 0.769 ΧSDS are represented as grey spheres; these residues are located exclusively in 
solvent exposed regions. 
 
Most residues within the binding pocket showed less solvent accessibility in 0.769 ΧSDS. 
Thr-80 in the middle of helix C and Thr-204 in the middle of helix G were the only two 
residues with significant differences in solvent accessibility (greater than one standard 
deviation away from the mean), both of which became less solvent accessible in the presence 
of SDS. Trp-178 on the extracellular end of helix F and Thr-79 in the middle of helix C 
experienced minor increases in solvent accessibility. Trp-178 is located at the micelle/solvent 
interface, hence explaining its slight increase in solvent exposure due to helix fraying. Thr-79 
is hydrogen-bonded to Asp-75, which is the Schiff base counterion and hydrogen-bonded to 
the water network via its side-chain. Asp-75 also showed a small increase in solvent 
accessibility, suggesting that the water network might have started to loosen. 
 
To summarise, the presence of SDS has led to a general decrease in solvent accessibility of 
backbone amides in the transmembrane region, likely reflecting the increase in detergent 
concentration. A few residues show increased solvent accessibility in 0.769 ΧSDS, most of 
which are located at the micelle/solvent interface or at solvent-accessible regions. Slight 
increases in solvent accessibility observed for residues which are hydrogen-bonded to the 
internal water network could suggest preliminary loosening of the water network. Changes in 
solvent accessibility are small in the transmembrane region and within the binding pocket, 
consistent with the tertiary structure of pSRII remaining largely intact in 0.769 ΧSDS 
(i.e. before the unfolding transition; see Chapter 2). 
 







Figure 3.24: Differences in solvent accessibility in 0 ΧSDS vs. 0.769 ΧSDS mapped onto pSRII 
structure 
Difference in solvent accessibility is quantified for each residue using the parameter ∆(SË SÈ⁄ ). 
Residues are coloured according to ∆(SË SÈ⁄ ) values. Residues with high ∆(SË SÈ⁄ ) are shown as cyan 
spheres, and residues with low ∆(SË SÈ⁄ ) are shown as red spheres. Residues which are unobservable 
in deuterated solvent in both 0 ΧSDS and 0.769 ΧSDS are shown as grey spheres. 
 






3.3.5 Tryptophan side-chain indoles 
Studying tryptophan residues by NMR provides invaluable information on both backbone 
amide and side-chain indole groups. Side-chains are exposed to different chemical 
environments compared to backbone amides (Figure 3.25a), and are directly involved in 
inter-helical interactions, hydrogen-bond networks and protein-retinal packing. Monitoring 
changes in tryptophan side-chain indoles by NMR therefore provides an extra probe for 
monitoring tertiary structure changes. 
 
Like the backbone amides, pSRII tryptophan side-chain indole resonances showed complex 
chemical shift changes during unfolding mediated by different ΧSDS (Figure 3.25b). 
Non-linear chemical shift trajectories and alternative resonances were observed, indicating 
the presence of different side-chain conformations exchanging at several different timescales. 
  
Side-chain Δδ(1H,15N) correlate with the locations of the tryptophan residues (Figure 3.25c): 
Trp-76 and Trp-171 which pack directly against retinal show the smallest Δδ(1H,15N); the 
solvent-exposed Trp-60 and Trp-178 show bigger Δδ(1H,15N), possibly due to small changes 
in the solution phase with increasing ΧSDS; Trp-9 and Trp-24, both of which face the 
detergent micelle, experience the biggest Δδ(1H,15N) since SDS is incorporated into the 
micellar phase. The lack of obvious correlation of side-chain Δδ(1H,15N) with SDS-mediated 
unfolding could reflect that the side-chains are generally maintained in very similar chemical 
environments. 
 
Decreased peak intensities were observed with increasing ΧSDS for most tryptophan 
side-chain indoles (Figure 3.25d). Consistent decreases in peak intensities were observed, 
indicating that with increasing ΧSDS, side-chain motions are becoming increasingly dominated 
by µs–ms timescale conformational motions. Only Trp-24 side-chain indole initially became 
more flexible than it was in 0 ΧSDS. Since Trp-24 is located around one helix turn away from 
the cytoplasmic end of helix A, this observation could reflect fraying at the end of helix A. 
Beyond 0.834 ΧSDS, the alternative conformations of Trp-9 and Trp-24 side-chain indoles 
showed increasing flexibility with further increases in ΧSDS. This highlights the 
heterogeneous nature of the unfolded ensemble. 
 







Figure 3.25: 2D [1H,15N] SOFAST-TROSY-HSQC of tryptophan side-chain indoles 
(a) Tryptophan side-chains are shown as sticks, with the indole N atoms shown as spheres. (b) 
Expanded view of the tryptophan side-chain indole region from an overlay of 2D [1H,15N] 
SOFAST-TROSY-HSQC spectra recorded in different ΧSDS. Changes in peak shifts are indicated by 
black arrows, with large shift changes indicated using dashed lines. Inset shows the Trp-178 
resonance. Alternative conformations (labelled as b and c) are observed for Trp-9 and Trp-24 
side-chain indoles. (c–d) ΧSDS-dependence of Δδ(1H,15N) (c) and S S4⁄  (d) for tryptophan side-chain 
indoles. 
 
H/D exchange data are displayed as bar charts showing SË SÈ⁄  for tryptophan side-chain 
resonances in 0 ΧSDS and 0.769 ΧSDS (Figure 3.26). Only one resonance is shown for each 
tryptophan, as alternative conformations have not appeared at 0.769 ΧSDS. Statistical analysis 
could not be done for side-chain studies, since there are only six tryptophan side-chain 
resonances. A threshold of 5% difference in SË SÈ⁄  between 0 ΧSDS and 0.769 ΧSDS was taken 






to identify residues with important changes in solvent accessibility. Since tryptophan 
fluorescence is mediated by induced dipole moment and redistribution of electron density 
across the indole ring, changes in tryptophan fluorescence might be correlated with changes 
in the local environment of the side-chain detected by H/D exchange. H/D exchange 
measurements on tryptophan side-chain indoles were therefore compared against those of 
fluorescence intensity to understand the origins of tertiary structure changes detected by 
tryptophan fluorescence. 
 
In 0 ΧSDS, Trp-76 and Trp-171, both of which pack directly against the retinal polyene chain, 
incorporate less deuterium than other tryptophan side-chains. Out of the six tryptophan 
residues, only Trp-76 showed a significant increase in deuterium incorporation and solvent 
accessibility in 0.769 ΧSDS. Since changes in tryptophan fluorescence are dominated by 
unquenching of tryptophan fluorescence due to retinal liberation and increase in solvent 
accessibility due to denaturation, it can therefore be deduced that Trp-76 is likely to have the 
greatest contribution towards the increases in fluorescence intensity and λmax upon 
SDS-mediated unfolding as detailed in Chapter 2. Less H/D exchange was observed for 
Trp-171 side-chain indole in 0.769 ΧSDS than in 0 ΧSDS, suggesting lower solvent accessibility 
in the presence of SDS. The other tryptophan side-chain indoles, all of which either face the 
detergent micelle or are located at solvent-exposed regions, experience little changes in 
solvent accessibility. Altogether, the results from H/D exchange suggest that changes in 
tryptophan fluorescence (see Chapter 2) are likely dominated by changes at Trp-76, with a 
smaller contribution from Trp-171, and are thus reflective of the direct packing of Trp-76 and 
Trp-171 against the retinal chromophore in the folded state of pSRII.  
 
Summarising the above analyses, tryptophan side-chains generally experience little changes 
in chemical environment, consistent with the protein remaining embedded in a micellar 
environment. Only side-chains which are facing the detergent micelle experience bigger 
changes in chemical environment due to incorporation of SDS into the micelles. Side-chain 
motions become increasingly dominated by µs–ms timescale motions in increasing ΧSDS. 
Side-chains which pack against the retinal (Trp-76 and Trp-171) show the biggest changes in 
solvent accessibility, and are likely to also dominate changes in tryptophan fluorescence (see 
Chapter 2). 








Figure 3.26: H/D exchange of tryptophan side-chain indoles 
(a) Deuterium incorporation at each tryptophan side-chain indole is quantified by ID/IH. Residues 
which are unobservable are represented using asterisks (*). (b) Tryptophan side-chains are shown as 
spheres on the pSRII structure and coloured according to differences in SË SÈ⁄  in 0 ΧSDS vs. 0.769 ΧSDS. 
 
3.3.6 Backbone dynamics of pSRII in SDS/c7-DHPC mixed micelles 
SDS unfolding of pSRII leads to changes in backbone dynamics, with some residues even 
experiencing motions at different timescales in different ΧSDS (see Section 3.3.3). 
15N Relaxation NMR experiments were recorded to determine the timescales at which 
different motions occur. pSRII unfolding begins to occur in > 0.700 ΧSDS, as determined by 






increase in the unfolded fraction and λmax of dead-time UV/vis spectra (see Chapter 2). Given 
the long timeframes of relaxation experiments (up to weeks), a low ΧSDS of 0.728 ΧSDS was 
used to avoid potential complications with aggregation and mixtures of unfolded and folded 
species. 
 
15N R1 and R1ρ relaxation dispersion experiments were recorded for pSRII in 0 ΧSDS (sample 
preparation and NMR experiment performed by Dr. Mark Bostock) and 0.728 ΧSDS on a 
600 MHz spectrometer, corresponding to a magnetic field strength of 14.1 T. R2 values were 
extracted from R1ρ values using Equation 3.42. The relaxation rate constants for each 
assignable residue are plotted in Figure 3.27. High 15N R1 or low 15N R2 are indicative of 
increased motions on the fast sub-ns timescales typically related to a reduction in the order 
parameter S2. Consistent with previous studies [337], most residues in the structured 
transmembrane regions of the protein show an R1 of around 0.47 Hz, indicative of relaxation 
which is dominated by the overall molecular tumbling motion. Residues with high R1 are 
identified by taking a cut-off at one standard deviation above the mean across helical residues. 
These residues are populated at the N-terminus, helix ends, loops AB, BC, and EF, and the 
C-terminal tail. Two residues located at the solvent/micelle interface, namely Gly-12 on helix 
A and Gly-136 on helix E, also have high R1 (Figure 3.28). A similar distribution of residues 
is found for residues with low R2, with the cut-off taken as one standard deviation below the 
mean across helical residues (Figure 3.28). Hence, based on R1 and R2, most of the 
transmembrane region backbone amide moieties are well-ordered with relaxation dominated 
by overall tumbling, while increased motional amplitude related to faster ps–ns motion is 
detected at helix ends and solvent exposed regions of the protein.  
 







Figure 3.27: R1 and R2 relaxation rate constants for 15N-pSRII in 0 ΧSDS and 0.728 ΧSDS 
measured at 14.1 T 
R1 and R1ρ experiments were recorded at 308 K on a 600 MHz spectrometer with a magnetic field 
strength of 14.1 T. R2 values were extracted from R1ρ experiments. R2/R1 values were plotted to assess 
the overall rotational correlation time, and R1R2 values were determined to identify residues with Rex 
contributions. Each sample contains ~ 525 µM 15N-pSRII. 







As shown in Equation 3.40, R2/R1 values are proportional to the rotational correlation time 
(íè). Average R2/R1 values taken across each helix were found to be similar within error 
(Table 3.2), indicating that the overall rotational correlation times of all helices remain 
similar regardless of the presence of SDS. This confirms that all helices remain structured 
and embedded in a micellar environment. 
 




(0.8% + 0.5% c7-DHPC) 
R2/R1 Ò (ns) R2/R1 Ò (ns) 
Helix A 4–28 91 ± 17 30 ± 13 88 ± 16 30 ± 12 
Helix B 33–55 93 ± 17 31 ± 13 87 ± 16 30 ± 13 
Helix C 70–92 95 ± 26 31 ± 16 95 ± 15 31 ± 12 
Helix D 94–117 89 ± 15 30 ± 12 84 ± 20 29 ± 14 
Helix E 122–150 91 ± 18 30 ± 13 89 ± 17 30 ± 13 
Helix F 153–181 89 ± 13 30 ± 11 85 ± 15 29 ± 12 
Helix G 189–222 86 ± 25 30 ± 16 86 ± 21 30 ± 14 
Strands in BC loop 60–63, 66–69 71 ± 21 27 ± 14 73 ± 25 27 ± 16 
 
Table 3.2: Average R2/R1 and Ò values taken across secondary structure elements in pSRII at 
0 ΧSDS and 0.728 ΧSDS 
Values are presented as the average ± standard deviation across the residues specified for each 
secondary structure element. 
 
Variations in R2/R1 are obscured by the lack of distinction between effects of chemical 
exchange and anisotropic motion, whereas variations in R1R2 values are much less sensitive 
to effects from motional anisotropy [328]. The presence of fast ps–ns motions reduces R1R2; 
slower motions associated with Rex increase R1R2. Calculations by Kneller et al. [328] show 
that for molecules with τc > ~ 5 ns in the absence of Rex at a magnetic field strength of 14.0 T, 
R1R2 is ~ 20 s-2. 0.9 mM pSRII in 1.6% c7-DHPC at 35 °C gives τc = 25.7 ns, corresponding 
to a molecular weight of pSRII-c7 protein-detergent complex to be around 70–80 kDa [337]. 
The cut-off of 20 s-2 was therefore applied to identify backbone amides of pSRII which might 
have Rex contributions. Given the strong spin-lock field used in the R1ρ experiment, the 
extracted R2 values are therefore sensitive to Rex contribution in the µs timescale. 
 






In 0 ΧSDS, residues with high R1R2 are found in solvent-exposed regions and at the 
micelle/protein interface. There also appears to be a cluster of transmembrane residues in the 
interface between helices A and B, on helix E facing helix D, suggesting possible µs motions 
indicative of helix-helix interactions. A few residues packing against the six membered ring 
of the retinal Schiff base, including Met-109, Gly-130 and Phe-134, and also Gly-207 and 
Gly-209 on helix G, show potential Rex contributions (Figure 3.28). In the presence of SDS, 
very few residues with high R1R2 are in the transmembrane region. Some residues appear in 
the micelle/solvent interface at the extracellular side, including Trp-178 on the outer rim of 
the binding pocket (Figure 3.28). Notably residues in the interface between helices A and B 
no longer have high R1R2, suggesting a possible smaller contribution of µs motion in this 
region in the presence of SDS. It is difficult to make conclusions about the region on helix E 
due to lack of assignments and/or reliable relaxation rate constants in this region. 
 
The lack of µs timescale Rex contributions in the transmembrane region in 0.728 ΧSDS likely 
indicates that chemical exchange at these backbone amides has transitioned to the slower µs–
ms timescale directly related to line broadening, as evidenced by decreasing peak intensities 
in higher ΧSDS. Since the strong spin-lock field used in R1ρ experiments only permits the 
investigation of low/sub-µs timescale motions, other motional regimes would not be 
accessible in this study. Further confirmation for the presence of ms–µs timescale motions 
can be done using CPMG relaxation dispersion experiments. Rex contributions of different 
frequencies are removed by altering the frequency at which the 180° refocusing pulses are 
applied (vCPMG). The size of Rex contribution towards R2 at each backbone amide is obtained 
by plotting the observed R2 against vCPMG. Once R2 values are corrected for any Rex 
contribution, R1, R2 and NOE measurements can then be used for characterising internal 
molecular motions on the sub-nanosecond timescale by calculating order parameters using 
the Lipari-Szabo formalism. 
 







Figure 3.28: Residues experiencing backbone dynamics on different timescales 
Residues with motions on the ps–ns timescale are identified as those having high 15N R1 of at least 
one standard deviation above the average across all helical residues. Residues with potential Rex 
contributions to 15N R2 are identified by taking a threshold of R1R2 > 20 s-2 [328]. 






3.4 Results: Loss of retinal chromophore alters the 
backbone dynamics of transmembrane helices 
Hydroxylamine-mediated Schiff base hydrolysis in the absence of SDS takes several hours to 
reach completion. Light illumination accelerates hydroxylamine-mediated Schiff base 
hydrolysis [304]. To obtain sensory opsin apo-protein, pSRII was illuminated for 1 h using a 
524-nm green LED (300 µmol m-2 s-1) in the presence of 100 mM hydroxylamine at 4 °C. 
Hydroxylamine was then removed by buffer exchange, and the resulting sample concentrated 
and studied by NMR. 
 
Hydroxylamine-treated sensory opsin showed a large loss in helical content (Figure 3.29a), 
supporting the proposed role of retinal in pSRII secondary structure formation (see Chapter 
2). 1D 19F NMR on 19F-5-Trp-labelled pSRII shows one single broad peak, suggesting 
several tryptophan side-chains are experiencing a similar chemical environment and are 
undergoing conformational exchange in the µs–ms timescale (Figure 3.29c). 1H NMR of 
sensory opsin showed several strong peaks in the 7.0–8.5 ppm region while peaks in other 
regions had very low intensities (Figure 3.29e). These observations further suggest a key role 
of retinal in the structure and dynamics of backbone amides. Irreversible aggregation is 
unlikely within the short timeframe of the experiments (within 12 h). Addition of 0.943 ΧSDS 
(1% SDS in 0.1% c7-DHPC) to sensory opsin restores the α-helical content to similar levels 
observed in pSRII unfolded in 0.769 ΧSDS without hydroxylamine (Figure 3.29b). However, 
19F NMR of sensory opsin in 0.834 ΧSDS shows one single broad peak, albeit with narrower 
apparent linewidth than that observed for sensory opsin without SDS (Figure 3.29d). 
Likewise, the 1H NMR profile for sensory opsin in 0.834 ΧSDS was different compared to that 
for pSRII unfolded using 0.834 ΧSDS (Figure 3.29f), indicating structural and dynamic 
differences between hydroxylamine-treated sensory opsin vs. SDS-unfolded pSRII despite 
both samples harbouring a hydrolysed Schiff base and solubilised in SDS/c7-DHPC micelles. 
This indicates that although the total secondary structure content appears to be similar for 
SDS-unfolded pSRII and hydroxylamine-treated sensory opsin in 0.834 ΧSDS, the structural 
properties and dynamics of tryptophan side-chains and backbone amides in the respective 
samples are different. Further conclusions could not be drawn from 2D NMR spectra either 






because of significant peak broadening. The observed resonances likely correspond to the 
residues in the flexible C-terminal tail (Figure 3.29g–h). 
 
Altogether, these results suggest that the retinal chromophore underpins the structural and 
dynamic properties of pSRII. Disruption of native protein-retinal interaction by Schiff base 
hydrolysis leads to µs–ms timescale motions across the protein, possibly suggesting the 
uncoupling of the seven helices from each other. Studies using other techniques in which data 
quality is not affected by µs–ms timescale motion will be helpful for understanding the role 
of retinal in the folding pathway and discerning structural differences in sensory opsin 
apo-protein obtained from hydroxylamine-mediated Schiff base hydrolysis vs. SDS-mediated 
protein unfolding. 
 








Figure 3.29: Structural characterisation of apo sensory opsin in different ΧSDS 
Circular dichroism (a–b) and 19F NMR (c–d) of apo sensory opsin are overlaid with those measured 
for pSRII in different ΧSDS. 
 








Figure 3.29: Structural characterisation of apo sensory opsin in different ΧSDS (cont.) 
1H NMR (e–f) and 2D [1H,15N] SOFAST-TROSY-HSQC (g–h) of 162 µM apo sensory opsin are 
overlaid with those measured for 90 µM pSRII in different ΧSDS. 






3.5 Results: Structural properties of acid-denatured 
pSRII 
Denaturant screening and biophysics studies (see Chapter 2) showed that SDS at pH 2.0 led 
to rapid unfolding of pSRII within seconds followed by very slow Schiff base hydrolysis 
occurring over the course of several days. This enabled prolonged observation of the SR440 
species, which is characteristic of protein with retinal remaining covalently attached via the 
protonated Schiff base but devoid of native retinal-protein packing. Taking into consideration 
the previously proposed role of retinal in stabilising pSRII (see Chapter 2 and Section 3.4), 
pSRII at pH 2.0 is an interesting candidate for NMR studies to further understand the 
structural properties of SR440 in relation to folded and SDS-denatured pSRII. 
 
 
Figure 3.30: Acid denaturation of pSRII in 0 ΧSDS 
(a) 2D 1H,15N TROSY-HSQC spectra of pSRII at different acidic pHs. All spectra were recorded on a 
800 MHz spectrometer at 308 K with 240 scans. All samples contained ~ 90 µM 15N-pSRII and TSP 
as internal reference. (b) Photos of ~ 90 µM 15N-pSRII at different acidic pHs after one week at room 
temperature. 
 






2D [1H,15N] SOFAST-TROSY-HSQC spectra were recorded for pSRII in progressively 
lower pHs (pH 6.0, pH 4.7, pH 3.7, pH 2.6, pH 2.0) in the presence of 0.5% c7-DHPC 
(no SDS) (Figure 3.30a). Δδ(1H,15N) were generally small (Figure 3.31a), with Δδ(1H,15N) 
< 0.1 ppm at pH 4.7 and pH 3.7 for most transmembrane residues. Larger Δδ(1H,15N) were 
observed across all residues at lower pH. Only two residues within the binding pocket had 
Δδ(1H,15N) > 0.1 ppm: Thr-80 on helix C (pH 4.7 and pH 3.7) and Met-15 on helix A (pH 3.7) 
(Figure 3.31c). This indicates that mildly acidic pHs led to minimal disruption of the binding 
pocket, consistent with the samples remaining orange in colour after one week at room 
temperature (Figure 3.30b). Several residues which span three helical turns at the cytoplasmic 
end of helix D facing helix E showed Δδ(1H,15N) > 0.1 ppm at pH 4.7, while 
Δδ(1H,15N) > 0.1 ppm in other helices are within one turn from helix ends (Figure 3.31b), and 
helix ends continued to show greater Δδ(1H,15N) than transmembrane residues. 
 
Acid denaturation also led to line broadening, hence residues become increasingly 
unobservable (Figure 3.32a). Such residues were easily identified especially since Δδ(1H,15N) 
were small across the protein. Residues which became unobservable at pH 4.7 are located in 
the extracellular half, of which Trp-76, Thr-78, Met-109 and Trp-178 are residues within the 
binding pocket (Figure 3.32b). An extensive stretch of helix C and Val-206 and Gly-207 on 
helix G are also noted to have become unobservable, suggesting increased µs–ms timescale 
motion for residues facing the retinal binding pocket and residues near the Schiff base. At 
pH 3.7, almost the entire helix C became unobservable, suggesting concerted changes in 
amide backbone dynamics across the entire helix. More residues within the binding pocket 
disappeared, including Ala-47 on helix B, Ile-83 on helix C, Gly-112 on helix D, Thr-204, 
Lys-205 and Phe-208 on helix G, indicating further loosening of the binding pocket and the 
Schiff base attachment site. Interestingly, many residues which are unobservable at pH 4.7 or 
pH 3.7 are hydrogen-bonded to the internal water network in the crystal structure of pSRII 
(PDB 1H68; [336]) (Figure 3.32c). This suggests that acid denaturation leads to disruption of 
the internal water network. The abolishment of key hydrogen-bonds uncouples the key 
residues from each other, enabling the backbone amides to sample different conformations on 
a µs–ms timescale. At pH 2.6 and pH 2.0, most helical residues became unobservable, 
indicating altered backbone dynamics across the entire protein. This is noted to be correlated 
with the samples appearing pale yellow (complete Schiff base hydrolysis) and pronounced 






precipitation over several days (Figure 3.30b), suggesting extensive exposure of 
aggregation-prone surfaces and/or decreased protein stability. 
 
 
Figure 3.31: Chemical shift perturbation of acid-denatured pSRII relative to folded pSRII at 
pH 6.0 
(a) Combined chemical shift differences (Δδ(1H,15N)) of pSRII at pH 4.7 and pH 3.7. Helices are 
shown as grey bars and β-strands as black arrows. (b) Δδ(1H,15N) are mapped onto the pSRII structure. 
Residues are coloured from blue to red according to Δδ(1H,15N) values, showing greater structural 
changes at the ends of helices than in the transmembrane region. Unassigned residues are coloured 
white. (c) Surface representation of residues within 3 Å of retinal coloured according to Δδ(1H,15N) 
values to show structural changes at the retinal binding pocket. 







Figure 3.32: Residues which are unobservable at different pHs mapped onto pSRII structure 
(a) Residues which become unobservable at pH 4.7 and pH 3.7 are shown as red and yellow spheres, 
respectively. Residues which become unobservable at pH 2.6 are coloured cyan. Residues which 
remain observable at pH 2.0 are coloured blue. (b) Surface representation of residues within 3 Å of 
retinal coloured according to the pH at which the residues become unobservable, showing changes in 
pSRII backbone dynamics at the retinal binding pocket. (c) Residues which are hydrogen-bonded to 
the internal water network are shown as sticks on the crystal structure of pSRII (PDB 1H68) and 
coloured according to the pH at which the residue becomes unobservable. The hydrogen-bonds in the 
internal water network are shown as grey dashed lines. Water molecules are shown as spheres, with 
internal water molecules coloured blue. 







High-resolution studies on intact unfolded membrane proteins are scarce in the literature. In 
view of NMR studies, this likely reflects the challenges in studying a heterogeneous 
ensemble of unfolded structures with extensive µs–ms timescale motions, and obtaining 
uniformly isotopically-labelled membrane protein samples. This chapter presents detailed 
NMR studies on backbone amides and tryptophan side-chain indoles of pSRII under different 
conditions (SDS-unfolded, acid-denatured, and retinal Schiff base hydrolysed by 
hydroxylamine). Combined analyses of chemical shifts, peak intensities and H/D exchange 
were performed to investigate structural and dynamics changes. 
 
3.6.1 Unfolding mechanism of pSRII 
pSRII has a rotational correlation time of ~30 ns, and the transmembrane helices are 
well-ordered. Unfolding pSRII in SDS or at acidic pHs along with hydroxylamine-mediated 
retinal Schiff base hydrolysis reveals a backbone amide NMR fingerprint that is dominated 
by µs–ms timescale conformational exchange dynamics. 
 
For pSRII denatured in increasing ΧSDS, loosening of the binding pocket correlates with 
increasing µs–ms timescale motion in backbone amides beginning at the cytoplasmic 
interface of helices C, E, F and G and spreading across the protein, while the extracellular 
half of helix D adopts faster motion in high ΧSDS. Changes in chemical shifts are generally 
small, but clearly show that disruption in the packing of helices C and D against the retinal 
chromophore begins before the unfolding transition and is followed by small changes in helix 
G near the site of retinal attachment beyond the unfolding transition. Out of the six 
tryptophan residues, an increase in solvent accessibility was observed at Trp-76. 
Transmembrane helices in DDM-reconstituted bacteriorhodopsin have a rotational 
correlation time of ~35 ns [338], similar to that of pSRII. A previous study of the backbone 
dynamics of a proteolytic fragment containing residues 1–71 of bacteriorhodopsin 
reconstituted in SDS micelles shows that backbone NH vectors are involved in two types of 
internal motion: fast motion (< 20 ps), which is attributed to thermal fluctuations of atoms; 
and intermediate motion (~ 1 ns), which is attributed to helix bending. In addition, most 
backbone amide groups are involved in co-operative exchange processes over the rate range 






103–104 s-1, indicative of dynamic helix-helix interactions, such as helix tilting, the helices 
sliding past each other, extending or shortening [331]. Such µs–ms timescale motions were 
also observed for many backbone amides of pSRII unfolded in SDS/c7-DHPC mixed 
micelles, suggesting SDS-unfolded pSRII might be experiencing broadly similar dynamics as 
the bacterioopsin fragment. Further confirmation of the timescales of pSRII NH bond vector 
internal motions can be derived from order parameters if heteronuclear NOE experiments 
were recorded. 2D [1H,15N] HSQC spectra of folded [α-15N]-Lys-labelled rhodopsin in DDM 
suggests that µs–ms timescale motions are observed for most lysine backbone amides except 
for a C-terminal lysine which shows motion on the ns timescale. Rhodopsin has multiple 
backbone conformations, as more resonances with variable intensities were observed than the 
number of lysines in [α-15N]-Lys-labelled rhodopsin [339]. In contrast, each tryptophan 
indole side-chain appears to be restricted to one conformation [340]. SDS denaturation leads 
to increased flexibility of backbone amides in unfolded regions, as evidenced by an increase 
in the number of observable signals in 30% SDS. Electron paramagnetic resonance (EPR) 
spectroscopy experiments show that the extracellular domain retains more rigidity than 
cytoplasmic residues in SDS-denatured rhodopsin, consistent with the proposed location of 
residual structure in denatured states of rhodopsin [138]. 
 
To summarise, SDS denaturation leads to changes in protein backbone flexibility across the 
three proteins. Backbone amides of folded pSRII are well-ordered, with relaxation dominated 
by overall tumbling. Widespread µs–ms timescale conformational dynamics are observed 
during the unfolding of pSRII and bacteriorhodopsin due to changes in helix-helix 
interactions. In comparison, folded dark-state rhodopsin experiences slow µs–ms timescale 
motions, and SDS leads to increases in flexibility and faster ns timescale dynamics in 
unfolded regions while residues constituting the residual structure in the extracellular domain 
retain more rigidity. Once again, the NMR studies presented in this chapter are consistent 
with the corresponding biophysics and kinetic studies, and point towards differences in the 
unfolding mechanisms and protein-SDS interactions amongst the three proteins: 
SDS-denatured bacteriorhodopsin and pSRII undergo mainly changes in tertiary structure 
(helix packing) whereas SDS-denatured rhodopsin shows changes in both secondary and 
tertiary structures. 
 






For acid-denatured pSRII, changes in chemical shifts were very small in the transmembrane 
region, consistent with the protein remaining embedded in a micellar environment and little 
changes in α-helical content even at pH 2.0. Various residues which are hydrogen-bonded to 
the internal water network exhibit µs–ms timescale motion, suggesting disruption of the 
retinal binding pocket and the internal water network. The internal water network integrates 
the seven helices into a tight bundle. Crystal structures of ground state and the light-activated 
M-state pSRII show that signal transduction during light activation is mediated by 
protonation of Asp-75 and charge rearrangement of the active site, leading to breaking of 
hydrogen bonds in the internal water network and loss of connectivity between helices C and 
G [341]. It is interesting to speculate whether the acid denatured state could be somewhat 
similar to the light-activated state. The pKa of Asp-75 is 3.4 for pSRII in phosphatidylcholine 
and DDM, and different membrane mimetics could lead to slight changes in pKa [342]. The 
acidic pHs used in this study could lead to light-independent protonation of Asp-75, followed 
by charge rearrangement of the active site and breaking of the internal water network in a 
comparable manner to light activation. Disruption of the internal water network could be 
further evidenced by the observation of µs–ms timescale motion across almost the entire 
helix C at pH 3.7, suggesting that helix C is the first to be uncoupled from the helix bundle, 
somewhat analogous to the loss of connectivity between helices C and G in the 
light-activated state. Further lowering of the pH leads to µs–ms timescale motion across the 
entire transmembrane region, indicating widespread changes in helix-helix interactions. 
 
Large changes in backbone dynamics were observed when retinal was removed by 
hydroxylamine, such that only one single broad peak was observed in 1D 19F NMR spectra, 
both in the absence and presence of SDS. This indicates that the retinal chromophore exerts a 
key role in restricting the movements of the seven transmembrane helices, and liberation of 
the retinal chromophore enables more sliding movement of the helices to occur on a µs–ms 
timescale. However, further conclusions could not be drawn due to poor spectral quality. 
Bacterioopsin (bO) produced from a retinal-deficient E1001 Halobacterium salinarum strain 
gave rise to very broad 13C solid-state NMR signals at 20 °C, whereas bO from 
hydroxylamine-bleached bacteriorhodopsin shows similar spectral features to folded 
bacteriorhodopsin except for lower peak intensities [343]. It is speculated that the trimeric 
conformation is retained in hydroxylamine-bleached bO even after retinal is removed, 






enabling stabilisation by hydrophobic packing through helix-helix interactions between 
neighbouring protomers and hence certain secondary structures and backbone dynamics are 
retained [343]. In contrast, bO from the retinal-deficient strain has more similar spectral 
properties to hydroxylamine-bleached pSRII. While it remains unclear how the backbone 
conformation of bacteriorhodopsin is altered upon Schiff base formation, it has been 
speculated that bO from the retinal-deficient strain represents a partially folded apo-protein 
undergoing slow chemical exchange among various slightly different conformers on the ms 
timescale, and these slow motions are speculated to be essential for entry of retinal into bO 
[343]. Dark-state rhodopsin does not react with hydroxylamine [314], and the retinal 
becomes accessible to hydroxylamine only upon formation of the Meta II state. Hence, 
comparison on the effect of retinal across the three proteins can only be done using light-
activated rhodopsin. Light activation of rhodopsin triggers isomerisation and movement of 
the retinal on the ps–ns timescale. These fast motions are proposed to initiate collective 
fluctuations of helices H5 and H6 and cytoplasmic loops in the Meta I-Meta II equilibrium on 
the µs–ms timescale, priming the receptor for G protein activation [344]. It is noted that more 
transmembrane helices in bacterioopsin and sensory opsin experience movements on the µs–
ms timescale than in bovine opsin. This could perhaps reflect functional differences between 
the photocycles of microbial vs. mammalian rhodopsins – the retinal chromophore remains 
covalently attached during the photocycles of microbial rhodopsins, whereas retinal 
dissociates from mammalian rhodopsins and the chromophore is subsequently regenerated. It 
might therefore be inferred that liberation of the retinal chromophore from microbial 
rhodopsins could lead to more prominent changes in protein structure and dynamics. It is 
tempting to speculate that the retinal chromophore might influence the protein folding energy 
landscape by perturbing the equilibrium amongst different backbone conformations of the 
apo-protein state. Formation of the Schiff base (covalent linkage to Lys-205) and other native 
retinal-protein interactions during protein folding could, for example, stabilise particular 
conformations to favour folding and generation of the native chromophore. Hypotheses on 
the possible influence of the retinal chromophore on protein folding has already emerged 
from studies on bovine rhodopsin by Sakamoto and Khorana [319], and the kinetics and the 
extent of retinal-binding during the regeneration of bacteriorhodopsin from bacterioopsin 
have been studied using UV/vis spectroscopy [87,107,133,317,345], circular dichroism 
[107,132], tryptophan fluorescence [120,317,345] and calorimetry [346]. 







To summarise, retinal plays a key role in restricting helix movements in pSRII, 
bacteriorhodopsin and bovine rhodopsin. Liberation of the retinal enables the protein to 
sample different conformations through helix movements on the µs–ms timescale. These 
motions could be important for retinal binding and downstream biological functions (light 
activation or signalling). More detailed studies on the structure and dynamics of the 
apo-protein are expected to yield further insights on the roles of the retinal chromophore in 
the folding of pSRII and other retinal-binding proteins, and potentially open new avenues for 
investigating the importance of ligand-binding in the folding of other ligand-binding 
membrane proteins (e.g. GPCRs). 
 
Summarising the NMR studies in this chapter, SDS-denaturation, acid-denaturation and 
hydroxylamine-bleaching all led to widespread observation of slow µs–ms timescale motions 
across pSRII backbone amides, as constraints on protein backbone motions originally 
imposed by retinal become relaxed upon liberation of the chromophore. Precisely which 
retinal-protein interactions are being disrupted and the final structural state would depend on 
the denaturation/solvent condition employed. This conclusion is most clearly exemplified by 
the different distribution of unobservable residues in acid-denatured vs. SDS-denatured pSRII, 
suggesting different unfolding pathways. A similar conclusion has been obtained from 
mapping the unfolding processes of bovine α-lactalbumin in SDS, acid, GdmCl, TFE and 
heat by 1D 1H NMR combined with principal component analysis (GPS-NMR), showing that 
these denaturants move the protein away from the folded state in different directions [347], 
hence indicating different unfolding pathways. 
 
3.6.2 Challenges and limitations of analysis 
The NMR studies presented in this chapter have provided considerable insights into structural 
and dynamics changes to pSRII denatured by different methods. NMR, especially the 15N 
relaxation experiments, were originally envisioned to provide information on the unfolding 
pathway by verifying whether individual helices or groups of helices constitute the folding 
core, as individual helices or helical segments which retain residual structure are expected 
have different backbone dynamics compared to other unfolded regions. However, a number 
of challenges prevent clear interpretation of the data in this light, mostly due to: 






1) Small changes observed in the transmembrane region – this can be attributed to unfolded 
pSRII remaining embedded in detergent micelles, thus restricting tertiary structure 
changes in the transmembrane region, and most NMR analysis being done on backbone 
amides whereas tertiary structure changes are mediated by side-chains; 
2) Resonances becoming unobservable at high ΧSDS due to conformational exchange on the 
µs–ms timescale and possible complications with aggregation over prolonged experiment 
time. 
 
Exchange processes taking place on the µs–ms timescale are particularly detrimental to 
spectral quality. This is because coherence transfer steps become inefficient in the presence 
of fast relaxation and the additional exchange contribution to transverse relaxation leads to 
very strong line broadening which very likely affects both correlated dimensions. Future 
studies could involve recording spectra at higher static magnetic fields to push the 
conformational exchange towards the slow exchange regime. 
 
Simplified treatment of NMR titration experiments (e.g. only analysing chemical shift 
changes) could lead to incorrect mechanistic interpretations. Multi-state systems demonstrate 
unique features and ambiguous spectral features. Quantitative lineshape analysis must be 
performed for stringent identification of molecular mechanism. Considerable efforts have 
been devoted in NMR lineshape analysis for quantitative analysis of titration data based on 
the fitting of 1D spectra or cross-sections of 2D spectra [348]. Despite the wealth of 
information (binding model, interaction kinetics, lifetimes of different species) which could 
be offered by quantitative 2D NMR lineshape analysis, this option was not pursued as 
deriving rate constants for different backbone amides and obtaining a unified unfolding 
mechanism for pSRII would have been difficult. Apart from the aforementioned problems 
with small spectral changes, µs–ms dynamics and aggregation, it is uncertain whether 
0.990 ΧSDS (30% SDS + 0.5% c7-DHPC), the highest SDS concentration used in the titration 
series, represents the end-point of the titration. While the binding pocket is fully opened by 
0.943 ΧSDS (5% SDS + 0.5% c7-DHPC) (see Chapter 2), structural and dynamics changes 
might still be occurring at other parts of the protein in higher ΧSDS. Incomplete titration series 
might distort interpretation of lineshape analysis. 
 






Although the steady-state NMR methods employed in this chapter have enabled 
characterisation of equilibrium molecular dynamics occurring on a sub-second time scale, 
processes which are far-removed from equilibrium (e.g. protein unfolding in high ΧSDS) are 
best studied by techniques with excellent time resolution. Real-time NMR combines rapid 
sample injection and mixing inside the magnet with fast data acquisition to record a series of 
NMR spectra during the kinetic reaction. Real-time NMR has been used to investigate the 
unfolding and folding pathways and conformational dynamics of small proteins. For example, 
SOFAST real-time 2D NMR studies on the backbone amides of α-lactalbumin confirm that a 
single transition state ensemble controls folding from the molten globule state to the native 
state [349]. Biophysics and kinetic studies in Chapter 2 indicate that native retinal-protein 
interactions are abolished within seconds to minutes, depending on ΧSDS and pH. Studying 
changes in retinal-protein interactions at short unfolding times using real-time NMR would 
enable more advanced understanding on the sequence and timescale of structural and 
dynamics changes in SDS- and acid-denaturation. 
 
3.6.3 Future work 
Considering the challenges and limitations listed above, the results and interpretations 
derived from this chapter would be of greater value to the membrane protein field should 
these be successfully backed up by complementary experimental techniques in the future. In 
particular, experimental techniques which permit the study of µs–ms timescale motions 
would be particularly helpful in extending our knowledge on pSRII folding, considering the 
functional importance of helix motions on the µs–ms timescale. 
 
3.6.3.1 Further characterisation of the structure and dynamics of denatured pSRII 
It is clear from biophysics (see Chapter 2) and NMR studies that SDS-denaturation, 
acid-denaturation and hydroxylamine-bleaching lead to disruption of interhelical interactions 
and tertiary structure, yielding a heterogeneous ensemble of backbone amide conformations 
undergoing µs–ms timescale motions. More precise characterisation of structure and 
dynamics changes can be achieved using various different methods. 
 
The heterogeneous ensemble of structures represented by denatured pSRII can be studied 
using double electron-electron resonance (DEER) spectroscopy [350], laser-induced 






oxidative labelling of methionine side-chains coupled with mass spectrometry [315], or 
pulsed H/D exchange coupled with mass spectrometry (HDX-MS) [351]. These techniques 
have been used for studying bacteriorhodopsin under a range of solvent conditions (e.g. 
folded, SDS, acid, heat-denatured). DEER spectroscopy of SDS-unfolded bacteriorhodopsin 
has enabled observation of small subpopulations with different intra-helical end-to-end 
distances and broad distributions of inter-helical distances, suggesting a small degree of 
heterogeneity in secondary structures but a high degree of heterogeneity in tertiary structures, 
hence confirming that little native tertiary structure remains in SDS-unfolded 
bacteriorhodopsin [350]. Kinetic folding experiments of SDS-denatured bacteriorhodopsin in 
bicelles using pulsed HDX-MS has enabled studying of secondary structure reformation by 
monitoring the number of protected backbone amides over different folding times ranging 
from milliseconds to hours, showing that secondary structure formation occurs quite late (on 
the timescale of > 10 s) on the folding pathway [352]. Oxidative labelling suggests partial 
unfolding of helices A and D in SDS, and refolded bacterioopsin shows native-like structure 
but with partial unfolding of helix D, suggesting the importance of retinal in stabilising the 
structure of this helix [315].  
 
The number and properties of different conformations, the timescales of the sampling 
motions and the fraction of pSRII population in each conformation can be studied using 
single-molecule FRET experiments. Millisecond protein-folding dynamics of the small 
membrane-adhering protein, Mistic, in detergent have been studied using single-molecule 
FRET. Mistic was labelled with fluorescence donors and acceptors and driven to unfold with 
urea. A small confocal volume was illuminated, and FRET measurements were performed as 
single molecules floated in and out of the confocal volume by diffusion. Population peaks at 
high FRET (folded) and low FRET (unfolded) are observed, with the relative populations 
changing with different urea concentrations. A significant population of Mistic molecules 
show a range of intermediate FRET values, suggesting rapid folding/unfolding transitions 
while passing through the confocal volume. The rates of these folding/unfolding transitions 
are also measured [353]. An additional advantage of single-molecule approaches is the 
infinite dilution significantly reduces the potential for aggregation, which is a common 
problem in membrane protein denaturation studies. Whether single-molecule FRET 
experiments are able to resolve structural changes in SDS- or acid-denatured pSRII must be 






carefully assessed, considering that large amplitude structural changes are unlikely to occur 
with the protein remaining embedded in micelles under these denaturing conditions. 
 
3.6.3.2 How do retinal binding and Schiff base hydrolysis occur? 
Obtaining more detailed structural information on the denatured states and apo sensory opsin 
could provide clues as to how retinal binding occurs in pSRII. Molecular dynamics 
simulations suggest a possible binding pathway of retinal through a window between helices 
E and F of bacteriorhodopsin, through which the β-ionone ring is visible from the outside 
[354]. 
 
Whether Schiff base hydrolysis in SDS- and acid-mediated denaturation of pSRII is 
facilitated by external or internal water molecule(s) remains unknown. Previous studies have 
used radioactive 18O incorporation quantified by mass spectrometry to determine that Schiff 
base hydrolysis of light-activated rhodopsin is mediated by external water molecules [355]. 
To investigate whether bulk water or small molecules (e.g. hydroxylamine) enter from the 
extracellular or cytoplasmic side, proteoliposomes are prepared, containing unlabelled 
hydroxylamine in the liposomal lumen and rhodopsin preferentially oriented with its 
N-terminus facing the lumen and its C-terminus towards the liposome exterior which is 
enriched with 15N-labelled hydroxylamine. This experimental set-up shows that small 
molecules enter rhodopsin exclusively from the extravesicular space (the cytoplasmic side of 
rhodopsin) [355]. Confirming the mechanism of Schiff base hydrolysis in pSRII would yield 
further insight onto this important reaction. 
 
It would also be interesting to determine whether retinal binding is reversible for 
hydroxylamine-bleached sensory opsin, and whether protein dynamics are restored if the 
protonated Schiff base can be reformed. 13C solid-state NMR on hydroxylamine-bleached bO 
shows that retinal Schiff base hydrolysis is reversible, and rebinding of the retinal in what 
was proposed to be trimeric bO leads to restoration of backbone dynamics to yield a 
comparable spectrum to that of bacteriorhodopsin [343]. 
 






Summarising the above, future work building upon the NMR studies in this chapter will 
require further characterisation of the structures of denatured states and apo sensory opsin, 





4 Assessment of hydrogen bonding 




Hydrogen bonds (H-bonds) play fundamental roles in stabilising protein secondary and 
tertiary structure, and regulating protein function. Successful detection of transient H-bonds 
in denatured states and H-bond formation during protein folding would contribute towards 
our understanding on the structural properties of residual structures and folding/unfolding 
intermediates. 
 
Several scalar coupling (J-coupling) constants report on the presence of H-bonds in proteins. 
The backbone amide 1JNH couplings have typical sizes of about −93 Hz. Upon H-bond 
formation, 1JNH becomes more negative than the amino acid-specific random coil value, 
whereas residues which are not H-bonded tend to show positive deviations in 1JNH values. 
For ubiquitin, the difference in 1JNH (Δ1JNH) against random coil values are small and range 
from −1.3 Hz to +2.3 Hz [201]. Previous studies have demonstrated residue-specific 
detection of transient [208] and stable [201] H-bonds in small globular proteins by measuring 
1JNH using NMR. As J-couplings were traditionally only observed in covalently-bonded 
systems, initial observation of the cross H-bond 3hJNC’ coupling sparked remarkable interest 
[207,356]. 3hJNC’ are small, ranging from −0.1 to −0.9 Hz. 3hJNC’ can be measured by 
“long-range” HNCO-COSY (correlation spectroscopy), enabling identification of the H-bond 
donor, proton and acceptor atoms in one experiment [357]. 3hJNC’ shows strong dependence 
on H-bond length [356] and dihedral angles [358], and has been used for monitoring the 
progressive formation of H-bonds during trifluoroethanol-induced secondary structure 
formation in an N-terminal segment of Ribonuclease A [359]. One of the drawbacks is that 
3hJNC’ cannot be measured in 310-helices due to unfavourable geometry [207]. 
 
Like any solution-state NMR studies on bio-macromolecules, accurate detection and 
characterisation of H-bonds require methods which provide high resolution and sensitivity. 






However, this is potentially very challenging for membrane protein systems, since 
detergent-protein complexes can have very large molecular weights of up to ~100−200 kDa. 
The slow tumbling motion of such large molecules leads to fast decay of the NMR signal and 
reduction of data quality. 
 
In this chapter, proof-of-concept studies for measuring 1JNH and correlating Δ1JNH with 
H-bonding patterns were performed in soluble proteins and membrane proteins. 1JNH and 
Δ1JNH were chosen for their larger magnitudes compared to 3hJNC’, hence potentially serving 
as better readouts during the process of optimising different parameters in NMR pulse 
sequences in order to obtain good resolution and sensitivity. Different experimental methods 
(and variations thereof) for measuring 1JNH were first explored using RalA, a small GTPase 
with a mixed α/β fold. Detection of H-bonds was then attempted with OmpX, a β-barrel 
membrane protein, both in its folded state in DPC micelles and in the urea-denatured state, in 
order to evaluate the accuracy and precision of such measurements in the context of 
membrane protein folding. 
 







Various methods are available for measuring scalar coupling constants. J-couplings can be 
determined directly by measuring resonance splitting (J-resolved methods) [360] e.g. the 
IPAP experiment. In quantitative J methods, J-couplings are allowed to evolve over a certain 
amount of time in the pulse sequence, and J values are measured by monitoring the 
modulation of signal intensity originating from a single operator (J-modulation) or by 
obtaining the ratio of the in-phase and antiphase operators after a fixed J evolution period 
(J-correlation) [361]. 
 
4.2.1 Origins of systematic errors in J-coupling measurements 
One source of error in J-coupling measurements is the differential relaxation rates of in-phase 
and antiphase magnetisation. The relaxation rate constant of heteronuclear anti-phase 
magnetisation includes a contribution from longitudinal relaxation of the coupled 1H spin, 
and is thus greater than the rate constant for in-phase magnetisation [362]. Due to the 
differential relaxation rates of in-phase and antiphase magnetisation, the observed J-coupling 
(Japp) tends to be smaller than the real coupling constant (J). This affects J measured by 
resonance splitting and quantitative J-correlation (where J is extracted from the intensity ratio 
between in-phase and antiphase operators). The larger the difference between the relaxation 
rates of the 15N doublet components, the smaller the value of the apparent J [363]: 




where ΔG  is the difference of the relaxation rate constants for antiphase and in-phase 
transverse magnetisation. 
 
On the other hand, quantitative J modulation of a single operator is less sensitive to 
differential relaxation provided that J is large compared to the relaxation rates. 
 
Another main source of systematic error in J-coupling measurements is cross-correlated 
relaxation (CCR). CCR occurs when the random fields from two separate relaxation sources 
are not independent, hence altering the relaxation rate constants. Chemical shift anisotropy 
(CSA) and dipolar interactions (DD) are the two dominant relaxation mechanisms (see 
Chapter 3 for definitions). The time dependence of the local field experienced by the 






15N magnetisation derives from thermal motion altering the orientations of the NH bond 
vector and the 15N CSA tensor relative to the applied magnetic field.  
 
There are two main CCR mechanisms for transverse 15N magnetisation in an amide group: 
(1) Chemical shift anisotropy of the 15N with dipolar interaction of the 15N-1H 
(CSA(15N)/DDNH) or nearby 1H which are not attached to 15N (CSA(15N)/DDNR) 
(2) Dipolar interaction of the 15N-1H with dipolar interaction of the amide 15N and nearby 1H 
which are not attached to the 15N (DDNH/DDNR). 
 
In the presence of CSA/DD CCR, the relaxation of the 15N magnetisation depends on the spin 
state of the 1H magnetisation. The random fields from the DD and CSA interactions are 
correlated in such a way that they partly cancel each other for the downfield component of 
the 15N doublet, whereas the two fields reinforce for the upfield component. The downfield 
component of the 15N doublet relaxes at the difference of autorelaxation (DD + CSA) and 
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(3 cosE à − 1)  in which à  is the angle between the principal axis of the 
chemical shielding tensor and the N-H vector. 
 
CSA(15N)/DDNH CCR results in an asymmetric 15N doublet, in which the upfield resonance is 
broader and shorter (i.e. the anti-TROSY line) while the downfield resonance is sharper and 
taller (i.e. the TROSY line). The asymmetry increases as the correlation time becomes greater. 
This phenomenon can be used advantageously in transverse relaxation optimised 
spectroscopy (TROSY) [364], in which selection of the narrow line in one or both 
dimensions of the doublet results in spectral resolution enhancement. J-couplings derived 






from measuring resonance splitting are affected by inaccuracies in determining the frequency 
values of broad anti-TROSY lines [365]. CSA(15N)/DDNR CCR arises in the presence of 
dipolar interaction between 15N and a remote proton, HR, leading to observation of a doublet 
of doublets. Given the small magnitude of 15N-1HR dipolar interactions, the effects of 
CSA(15N)/DDNR CCR usually manifests as slight skewing of the peaks in the 15N doublet. 
 
While it is assumed in the above discussion that only the 15N has a significant CSA, in 
practice, the 1H also has a CSA. Although the magnitude of the 1H CSA is about one-tenth of 
that for the 15N CSA, the larger 1H gyromagnetic ratio entails that CSA(1H)/DD contributes 
to a similar extent as CSA(15N)/DD [199]. However, since 1H is only present as longitudinal 
magnetisation (PU), CSA(1H)/DD is effectively negligible in the slow tumbling limit. 
 
The imaginary component of the spectral density function associated to CSA/DD CCR also 
induces a change in the J-coupling, known as dynamic frequency shift (DFS). DFS arises 
from a differential shift of the chemical shifts of the two spin states [366]. DFS decreases 
with increasing rotational correlation time and greater magnetic field strength, and 
contributes additively to the apparent J-coupling [367] measured by both the resonance 
splitting and the quantitative J methods [368]: 











Unlike CSA/DD CCR, which can be suppressed by judicious choice of 180° pulses, DFS 
cannot be suppressed [366]. In view of the high magnetic field strengths utilised and the 
rotational correlation times (~20 ns) of the proteins studied in this chapter, DFS is expected 
to be constant at about –0.5 Hz [369]. 
 
DDNH/DDNR CCR refers to relaxation interference between the amide 15N-1H dipolar 
interaction and dipolar interaction between 15N and a remote proton, HR, which is not directly 
bonded to 15N [365,370]. In order for DDNH/DDNR CCR to affect 1JNH measurements, HR 
must be J-coupled to 15N (JN-HR). For protein backbone amides, the most plausible candidates 
for HR are the side-chain Hα and Hβ atoms. As a result of JN-HR, the 15N multiplet for the 
three-spin system (HN-N!HR) is a doublet of doublets (Figure 4.1). The impact of 






DDNH/DDNR CCR on J-coupling measurements depends on the size of JN-HR and geometry of 
the HN-N!HR three-spin system. The dipolar contributions to the relaxation rates of the 15N 










'  (4.5) 
where rNH is the N-H bond length, rN-HR is the N-HR internuclear distance, and à is the angle 
between the 15N-1HN and 15N-1HR vectors. 
 
 
Figure 4.1: The impact of dipole/dipole cross-correlated relaxation on 1JNH measurements 
(a) In the presence of a remote proton, HR, which is J-coupled to but not attached to the amide 15N, 
dipole/dipole cross-correlated relaxation between 1HR-15N and 1H-15N gives rise to asymmetric peaks 
(top spectrum). For visual purposes, the outer and inner linewidths were set as 17 and 33 Hz, 
respectively, JN-HR was set as 20 Hz, and relaxation interference was exaggerated. The lower spectrum 
was simulated in the absence of relaxation interference and with linewidth of 15 Hz. Retrieved from 
[370]. (b) Schematic diagram showing the E.COSY-type fine structure in 1H-15N HSQC correlations 
due to the presence of both JHNHR and JN-HR. Adapted from [370]. 
 
Depending on the backbone ϕ and side-chain χ1 torsion angles, intraresidue Hβ can be 
proximate to 15N and 3JNHβ can be as large as 4 Hz, resulting in a dominant effect of 
N-HN/N-Hβ DD/DD CCR on 1JNH measurements. In comparison, the effects of N-HN/N-Hα 
are small, because intraresidue 2JNHα and interresidue 3JNHα are small and interresidue N-Hα 
are > 3Å in helices. 
 






HR can also be J-coupled to the amide 1H (JHNHR). Under isotropic conditions, only the 
intraresidue 3JHNHα might be sufficiently large to be resolved. Combined with JN-HR, this gives 
rise to an E.COSY-type fine structure (Figure 4.1b). JN-HR, JHNHR and the combined fine 
structure are often unresolved. In principle, both 15N doublet components receive equal 
contributions. However, in practice, the difference in the linewidths of doublet components 
due to CSA(15N)/DDNH, combined with the unresolved fine structure due to DDNH/DDNR, 
leads to asymmetry of the lineshape in the 15N dimension. The skewed peak shapes could 
give rise to problems with peak fitting, thereby adversely impacting the accuracy of 1JNH 
measurements. 
 
To summarise, for isotropic samples, errors due to DDNH/DDNR depend on 2JNHα, 3JNHβ and 
3JHNHα and internuclear distances and vector angles involved in 15N(i)-1Hα(i-1), 15N(i)-1Hα(i) and 
15N(i)-1Hβ(i) dipole interactions. 
 
In addition, magnetisation can be transferred between operators by CCR. Coherence transfer 
is typically mediated by J-coupling evolution. For a spin-system with two spin ½ nuclei, 
coherence transfer via J-coupling results in the generation of single quantum in-phase and 
antiphase magnetisation, the ratio of which depends on the duration of evolution. Coherence 
transfer can also occur via relaxation, whereby “forbidden” multiple-quantum and 
zero-quantum coherences are generated, giving rise to J-independent coherence transfer. 
Some of these “forbidden” terms can be subsequently transferred back to yield observable 
terms. For example, N-HN/N-Hβ DD/DD CCR in the presence of 3JNHβ can cause the 




− +m (4.6) 
 −2+r,U ⟶
DD/DD	
− 2+rPU (4.7) 
 
This mechanism could lead to undesirable 1JNH-independent contribution towards signal 
intensities, and under-/over-estimation of the measured J value in Quantitative J experiments 
(see Section 4.2.3 for product operators). 
 






The simplest method to avoid contamination of one-bond coupling measurements by 
relaxation interference effects would be to utilise perdeuterated sample with back-exchanged 
amide protons, or to suppress CCR using the appropriate selective pulse sequence. 
 
4.2.2 15N IPAP-HSQC 
The original 1H-15N IPAP-HSQC experiment records two [1H,15N] HSQC spectra in an 
interleaved manner without 1H decoupling in the 15N dimension [373]. The first spectrum, 
known as in-phase (IP), is a regular HSQC with 1H coupled to 15N, and the two components 
of each 15N doublet have the same sign. The second spectrum, known as antiphase (AP), is 
generated by inserting a 15N refocusing period Δ ≈ (2ö·È);6 before the t1 evolution period, 
and the 15N doublet components have opposite signs. A suitable scaling factor is applied to 
the AP spectrum to account for differences in peak intensities. Sub-spectra containing either 
only the upfield or the downfield 15N doublet component is generated by adding or 
subtracting the IP and AP spectra. 
 
While perdeuteration is the easiest method to achieve high accuracy in J-coupling 
measurements, Yao et al. have demonstrated that 1JNH measurements of comparable accuracy 
can be achieved in protonated samples. Several modifications have been introduced in the 
implementation reported by Yao et al. [370]: 
1) utilise pulse sequences of similar lengths for recording the IP and AP spectra to 
reduce differences in peak intensities (see yellow box in Figure 4.2); 
2) band-selective decoupling of aliphatic protons to refocus JN–HR, thereby suppressing 
DD/DD CCR; and 
3) gradient-enhanced coherence transfer for better spectral quality. 
 
 







Figure 4.2: Pulse sequences for 15N-IPAP-HSQC (a) and 15N-SOFAST-IPAP-HSQC (b) 
Narrow black pulses and wide white pulses correspond to 90° and 180° flip angles, respectively. 
Pulses for which the RF phase is not indicated are applied along the x axis. Pulses in the yellow box 
are executed for the in-phase (IP) and antiphase (AP) spectra of 15N-IPAP-HSQC (a) and 
15N-SOFAST-IPAP-HSQC (b). The grey shaped 1H pulses are IBURP inversion pulses with duration 
of 1.62 ms, and serve to decouple Hα from 15N. The black and white shaped 1H pulses in the reverse 
INEPT are EBURP 90° excitation pulses with duration of 2.304 ms and 180° Q3 gaussian cascade 
pulses with duration of 1.76 ms. Delay durations: τ = 2.69 ms (a) or 2.75 ms (b); Δ = 5.38 ms; ε = 
0.227 ms. Pulsed field gradients G0,1,3,4,6,7 are smooth square shaped with 39%, 11%, 25%, 27%, 29%, 
29% strength, and G2i,2a,5 are rectangular with 7%, 7%, 2.1% strength, where 100% is 60 G/cm. 
Gradient durations: G0,1,2i,2a,3,4,5,6,7 = 1.5, 0.7 (a) or 0.3 (b), 1.345, 2.69, 1.5, 1, t1/4, 0.5, 2.5 ms. Delay 
and gradient durations are quoted for 1H frequency of 500 MHz. The phase cycling is: ϕ1 = x, –x; ϕ2 = 
2(x), 2(y), 2(–x), 2(–y); receiver = 2(x, –x, –x, x). Quadrature detection in the t1 dimension is achieved 
by incrementing ϕ1. (a) The shaped water flip-back pulse in IP is g3.800 with duration of 2.1 ms. The 
bold hatched bars are 90y–210x–90y composite 180° pulses. (b) The black and white shaped 1H pulses 
in the INEPT element are amide-selective PC9 90° excitation pulses with duration of 3 ms and 180° 
Q3 gaussian cascade pulses with duration of 1.76 ms, respectively. 







The initial INEPT magnetisation transfer followed by 90° pulses on 1H and 15N yields 
antiphase transverse 15N magnetisation: 2PU+r for the IP pulse sequence and −2PU+m for the 
AP pulse sequence. During the Δ period, the magnetisation remains as 2PU+r in the IP pulse 
sequence because both J-coupling and chemical shift evolution are refocused, whereas 
−2PU+m evolves into −+r in the AP pulse sequence: 
 −2PU+m⟶−2PU+m cos(göΔ) −./ 012(345) (4.8) 
where Δ ≈ (2ö·È);6. 
 




cos(gök6) ÷+r cos(ΩÑk6) −+m sin(ΩÑk6)◊ 
 −sin(gök6) ÷2PU+m cos(ΩÑk6) + 678./ 012(9.:;)◊ (4.9) 
IP: −2PU+r⟶
=C
cos(gök6) ÷−678./ <=0(9.:;) + 2PU+m sin(ΩÑk6)◊ 
 +sin(gök6) ÷+m cos(ΩÑk6) + +r sin(ΩÑk6)◊ (4.10) 
where only the terms shown in bold result in the desired signals. 
 
Band-selective 1H decoupling of aliphatic protons during the t1 evolution period removes the 
net evolution of JN-HR couplings, thereby removing the unresolved E.COSY-type fine 
structure and associated lineshape asymmetry in the 15N dimension resulting from protons 
with non-zero 3JHNHR to 1HN and nJNH to 15N. In principle, DD/DD CCR effects could be 
removed by the application of one band-selective 1H inversion pulse at the mid-point of the 
t1 evolution. However, in practice, applying a selective pulse on aliphatic proton spins leads 
to off-resonance effects on the amide proton spins, leading to a decrease in the apparent 
magnitude of 1JNH. To first order approximation, the off-resonance effects can be refocused 
with an additional selective 180° pulse. Hence, two selective 180° pulses were applied to 
decouple JN-HR, and 15N evolves with opposite coherence orders during each of these pulses. 
 
 







Figure 4.3: IPAP 
(a) Schematic diagram of the generation of IPAP sub-spectra by the addition of the in-phase (IP) and 
anti-phase (AP) data sets. (b) Selected region of an IPAP-HSQC spectrum of OmpX. The red and 
blue sub-spectra of the 15N doublets were generated through addition and subtraction, respectively, of 
the recorded in-phase (IP) and anti-phase (AP) data sets. 
 
Magnetisation contributing towards the desired signals (see Equations 4.9–4.10) are 
transferred back to 1H for detection via a reverse INEPT. The observable signals are: 
AP: Pm sin(ΩÑk6) sin(gök6) =
6
E
Pm{cos[(ΩÑ − gö)k6] − cos[(ΩÑ + gö)k6]} (4.11) 
IP: Pm cos(ΩÑk6) cos(gök6) =
6
E
Pm{cos[(ΩÑ − gö)k6] + cos[(ΩÑ + gö)k6]} (4.12) 
 
Addition of the IP and AP spectra yields the subspectrum with only the upfield 15N doublet 
component with 15N chemical shift of (ΩÑ − gö); subtraction of the IP and AP spectra yields 
the subspectrum with only the downfield component at (ΩÑ + gö) (Figure 4.3). 
 
Quadrature detection is achieved by simultaneously incrementing the phases for ϕ1. 
 
Various modifications were introduced by Dr. Daniel Nietlispach to further improve the 
sensitivity. Amide-selective shaped pulses were used during magnetisation transfer in 
SOFAST-IPAP-HSQC. Combined with the pulsed field gradients, this entails that the spin 
states of protons which are not attached to 15N do not produce detectable signals. 






The product operators for the desired magnetisation transfer pathway are the same for 
SOFAST-IPAP-HSQC and IPAP-HSQC. 
 
Optimal sensitivity also relies on active restoration of the water signal to the z-axis during 
execution of the pulse sequence. For IPAP-HSQC, this is achieved using water flip back 
pulses at the end of the J-coupling evolution period as detailed by Yao et al. [370]: a 
water-selective 90° sine-bell-shaped pulse is applied to restore water magnetisation to +z in 
the IP experiment, whereas a non-selective 1H 90°(–x) purge pulse is applied in the AP 
experiment. The utilisation of amide-selective pulses in SOFAST-IPAP-HSQC indicates that 
the water signal is not excited. Hence, water flip back pulses were removed by Dr. Daniel 
Nietlispach. 
 
4.2.3 Quantitative J modulation 
Quantitative J methods can be classified as J-correlation or J-modulation methods. J is 
determined from J-correlation experiments by obtaining the ratio of the in-phase and 
antiphase operators after a fixed J evolution period, or by comparing peak intensities against 
a separately acquired reference spectrum. The constant J evolution period would ensure that 
the length of the pulse sequence and signal intensities are consistent across all experiments. 
However, large errors could result from difficulties in accurately determining low signal 
intensities derived from magnetisation which are antiphase at the end of the J evolution 
period. In J-modulation experiments, J values are measured by monitoring modulation of the 
signal intensity originating from a single operator (J-modulation). An advantage is that only 
signal derived from in-phase magnetisation after the J evolution period is required, hence 
broad linewidths associated with antiphase operators can be circumvented. Moreover, errors 
in the derived J-couplings can be easily estimated based on the quality of the multi-point 
fitting of intensities. However, multiple experiments with different J evolution times are 
required to obtain signal intensity modulation, indicating that error would primarily originate 
from sensitivity loss from transverse relaxation over prolonged J evolution times. 
 
 







Figure 4.4: Pulse sequence for 1JNH-modulated HSQC (a) and 1JNH-modulated TROSY-HSQC (b) 
Narrow black pulses and wide white pulses correspond to 90° and 180° flip angles, respectively. 
Pulses for which the RF phase is not indicated are applied along the x axis. The black shaped 1H 
pulses are ESNOB water flip back pulses with duration of 2.1 ms. The white shaped 1H pulse during 
the J evolution period Δ is a REBURP pulse with duration of 1.92 ms. The low power 1H 90° pulses 
are part of the WATERGATE water suppression scheme, and are applied for 1.4 ms each. Delay 
durations: τ = 2.65 ms (a) or 2.75 ms (b). 15 data points within the ranges 11.60–37.20 ms, 22.24–
47.84 ms, or 32.88–58.48 ms were taken for Δ period. (a) The bold hatched bars are 90x–210y–90x 
composite 180° pulses. Pulsed field gradients G0,1,3,4,6,7,8 are smooth square shaped with 37%, 17%, 
23%, 25%, 35%, 39%, 27% strength, and G5,6 are rectangular with 1.1%, 2.1% strength, where 100% 
is 60 G/cm. Gradient durations: G0,1,2,3,4,5,6,7,8 = 1.5, 0.7, 1.3, 1.5, 1.9, t1/4, t1/4, 2.5, 0.6 ms. The phase 
cycling is: ϕ1 = 2(x), 2(y), 2(–x), 2(–y); ϕ2 = x, –x; ϕ3 = 2(x), 2(y), 2(–x), 2(–y); receiver = 2(x, –x, –x, 
x). Quadrature detection in the t1 dimension is achieved by simultaneously incrementing the phases ϕ2 
and ϕ3. (b) Pulsed field gradients G0,1,2,3,4,5,6 are smooth square shaped with 39%, 13%, 37%, 27%, 
39%, 27%, 39% strength, where 100% is 60 G/cm. Gradient durations: G0,1,2,3,4,5,6 = 1.3, 0.7, 2.5, 1.3, 
2.5, 0.5, 0.6 ms. The phase cycling is: ϕ1 = 4(–y), 4(y); ϕ2 = y, –y, –x, x, y, –y, x, –x; receiver = x, –x, y, 
–y, –x, x, –y, y. Quadrature detection in the t1 dimension is achieved by incrementing ϕ2. 
 
Tjandra et al. used a pulse sequence in which the peak intensity is modulated as an 
exponentially decaying cosine function with respect to the 1JNH couplings and the T2 
relaxation rate of 15N nuclei [369]. Slight modifications to the pulse sequence were made by 
Dr. Daniel Nietlispach such that the peak intensity is modulated as an exponentially decaying 






sine function (Figure 4.4). Rather than detecting signal generated from antiphase 
magnetisation at the end of the variable J evolution period (Δ in Figure 4.4), the modified 
pulse sequence allows selective detection of signal originating from magnetisation which is 
in-phase after Δ. It was hypothesised that detecting only the signal that originates from this 
refocused magnetisation will minimise the effects of pulse imperfections. 
 
The INEPT element and 90° pulses on 1H and 15N enable magnetisation transfer from 1H to 
antiphase 15N magnetisation. The resulting operator 2PU+r undergoes J coupling evolution 
during Δ: 
 2PU+r⟶ 2PU+r cos(göΔ) −.> 012(345) (4.13) 
 
The REBURP pulse in the mid-point of Δ selectively inverts 1HN, hence eliminating JN–HR 
coupling and the associated DD/DD CCR effects. 
 
Only the −+m sin(göΔ) term is carried through the rest of the pulse sequence. After two 15N 
90° pulses and an INEPT element to generate antiphase magnetisation, the 15N chemical shift 
is then evolved during t1: 
 2PU+m sin(göΔ)⟶ sin(göΔ) ÷678.> <=0(9.:;) ++r sin(ΩÑk6)◊ (4.14) 
 
The 2PU+m cos(ΩÑk6) sin(göΔ) term is transferred back to 1H via the reverse INEPT element 
and the observable signal is: 
 Pm cos(ΩÑk6) sin(göΔ) (4.15) 
 
Quadrature detection in the t1 dimension is achieved by simultaneously incrementing the 
phases of the 15N 90° and 180° pulses in the τ period before t1 evolution. 
 






In the presence of pulse imperfections, DD/DD CCR would arise due to incomplete 
refocusing of JN–HR. The magnetisation would evolve during the J-coupling evolution period 
as follows: 
 2PUÑ+r cos(göÑΔ) cos(göBΔ) − +m sin(göÑΔ) cos(göBΔ)	
−2PUB+r sin(göÑΔ) sin(göBΔ) − 4PUÑPUB+m cos(göÑΔ) sin(göBΔ) (4.16) 
where JN is the amide 1JNH and JR is the J-coupling between amide 15N and Hα or Hβ. 
 
As a result, the collected operator is modulated as a function of: 
 −+m[sin(göÑΔ) cos(göBΔ) cosh(ΓΔ) + cos(göÑΔ) sin(göBΔ) sinh(ΓΔ)] (4.17) 
where Γ is the DD/DD CCR rate between the amide 15N-1H dipole and the 15N-Hα/β dipole.  
 
Water suppression is achieved by Tjandra et al. by a single WATERGATE water suppression 
scheme incorporated in the reverse INEPT. Additional ESNOB water flip back pulses were 
applied after the initial INEPT and before the reverse INEPT to improve water suppression. 
 
While the pulse sequence has been discussed above with references to the 1JNH-modulated 
HSQC implementation, these general principles would also apply to the TROSY 
implementation, which takes advantage of the TROSY effect due to CSA/DD CCR to obtain 
narrow linewidths for accurate intensity determination. The salient features of the pulse 
sequence remain similar except for utilisation of the TROSY effect during t1 evolution and 
acquisition (t2). The lack of refocusing 1H pulse during t1 evolution in 1JNH-modulated 
TROSY-HSQC enables simultaneous chemical shift and coupling evolution under the 
influence of CSA/DD CCR. Only the sharp 15N line in the t1 dimension is maintained and 
correlated with the sharp 1H line in the t2 dimension. This is achieved through the 
single-transition to single-transition polarisation transfer element (ST2PT) [364], which 
transfers 15N coherence back to 1H before acquisition. 
 






15 experiments were acquired in which the Δ period for J evolution is varied. The resulting 
exponentially-decaying sinusoidal modulation of signal intensity (I) goes through three 
maxima/troughs and two zero-crossings as a function of Δ: 
 S = 2 sin(göΔ) :;‘© (4.18) 
where J is the 1JNH coupling constant, C is the decay rate (R2) of the 15N magnetisation as a 
result of transverse relaxation, and A is a signal amplitude scaling factor. 
 
Figure 4.5 shows the fitted sinusoidal intensity modulation for three residues from OmpX in 
DPC and a data table listing the fitted parameters, J, A and C. Residue Tyr-95 shows the best 
fit, whilst Arg-133 represents an average fit compared to other residues in the data set. 
Residues such as Tyr-30 are omitted from further analysis due to insufficient number of data 
points and inadequate sampling of only one zero-crossing in the intensity modulation curve. 
The goodness-of-fit is expressed in terms of the 2.5% and 97.5% confidence intervals of J 
(denoted as J2.5% and J97.5%, respectively, in Table 4.1), where a small difference between J2.5% 
and J97.5% indicates a good fit of the data with the sinusoidal decay function. Table 4.1 shows 
the output values for J, J2.5%, J97.5%, A and C from the data fitting. 
 
 J J2.5% J97.5% A C 
Arg-133 –93.657 –92.250 –95.261 2079407 50.057 
Tyr-30 –95.522 –88.035 –106.888 967689 42.757 
Tyr-95 –92.389 –92.220 –92.562 7432110 30.518 
 
Table 4.1: Examples of fitted 1JNH parameters 
Output values for J, A and C from the data fitting of 1JNH-modulated signal intensities of Arg-133, 
Tyr-30 and Tyr-95. J2.5% and J97.5% denote the 2.5% and 97.5% confidence intervals for the fitted J 
value, respectively. 
 
Quantitative J modulation is theoretically less prone to error than frequency-based 
measurements, since CSA/DD CCR affects accurate determination of peak positions but not 
signal intensity modulation. This makes quantitative J modulation methods preferable for the 
measurement of small homo- and heteronuclear couplings. Sensitivity loss from transverse 
relaxation and the effects of transfer of “forbidden” terms adversely affect the accuracy of 
J values determined by both IPAP and quantitative J modulation methods. 
 







Figure 4.5: 1JNH-modulated HSQC 
(a) Small sections of the 2D [1H-15N] HSQC spectra of OmpX showing the peak for Arg-133 
recorded at different J evolution periods (Δ) ranging 11.6–37.2 ms. (b) Modulation of peak intensity 
as a function of Δ. Measured peak intensities are shown as dots, and are overlaid with the fitted 
sinusoidal decay function. 







4.3.1 Proof-of-concept & optimisation: 1JNH of RalAΔC-GDP 
GDP-bound C-terminally truncated RalA (RalAΔC), consisting of residues 1–184, was 
chosen for proof-of-concept studies on 1JNH measurements in proteins with molecular weight 
of >10 kDa. The sample was made by Dr. Arooj Shafiq [374]. RalAΔC contains five 
α-helices and six β-sheets, and has a molecular weight of 20.9 kDa. As H-bonds in α-helices 
and β-sheets have different geometries and bonding strengths, the mixed α/β structure of 
RalAΔC enables the accuracy and precision of 1JNH values to be assessed for different 
secondary structures. 
 
Backbone-to-backbone H-bonds were predicted from the crystal structure of RalA (Ingrid 
Vetter, Max Planck Institute of Molecular Physiology) using the “Optimal Hydrogen 
Bonding Network” option of the WhatIf server [202] (Figure 4.6). WhatIf locates the 
positions of polar hydrogen atoms in protein structures by optimising the total H-bond energy 
by means of an empirical H-bond force field. This method takes into account one-to-one and 
bifurcated H-bonds. WhatIf accounts for potential crystallographic mis-assignments of His, 
Gln and Asn side-chain conformations by allowing 180° change in the last χ angle of these 
residues during H-bond energy optimisation. 
 
Figure 4.6: H-bonds predicted by the WhatIf server based on the crystal structure of RalAΔC 
Backbone-to-backbone H-bonded residues are coloured yellow, and residues which are not involved 
in backbone-to-backbone H-bonds are coloured in blue. Crystal structure was provided by Ingrid 
Vetter (Max Planck Institute of Molecular Physiology). 







Different implementations of IPAP-HSQC were recorded (Table 4.2): 
IPAP-HSQC implementation 
No. (%) of residues 
with reliable 1JNH 
measurements 
IPAP-HSQC 
32 scans [A] 121 (72%) 
32 scans [B] 122 (72%) 
112 scans 119 (70%) 
SOFAST-IPAP-HSQC 
64 scans [A] 118 (70%) 
64 scans [B] 118 (70%) 
 
Table 4.2: Residues with reliable 1JNH measurements in different IPAP-HSQC implementations 
[A] and [B] denote separate repeats of the same implementation for empirical assessment of the error. 
All experiments were recorded at 298 K on a 500 MHz spectrometer. 
 
90° square excitation pulses are used in IPAP-HSQC, whereas the SOFAST implementation 
utilises 90° shaped excitation pulses. Different number of scans were used to determine the 
effects of increased signal-to-noise ratio (SNR) on error in 1JNH measurements. 
 
Since resonance splitting methods rely heavily on accurate determination of peak positions, 
overlapping resonances for which peak positions cannot be obtained by automatic parabolic 
fitting by CCPN Analysis [375] were excluded from further analysis. Applying this criterion, 
reliable 1JNH values were obtained for ~120 out of the 169 assignable backbone amide 
resonances [374] across different IPAP-HSQC implementations (Table 4.2), providing 
acceptable coverage (~70%) across the protein. 
 
1JNH for RalAΔC-GDP ranged from –90 to –96 Hz (Figure 4.7a), similar to the range of 
−91.1 to −95.6 Hz obtained from previous studies on ubiquitin [201]. Δ1JNH values spanned 
between ± 2.9 Hz. The experimental precision of IPAP-HSQC experiments was assessed by 
calculating the sum of the combined {1H,15N} chemical shift differences for both components 
of the 15N doublet between two experimental repeats (Figure 4.7b). The chemical shift 
difference for each component of the 15N doublet is calculated as outlined in Chapter 3. Most 
residues showed a total chemical shift difference (summed across the 15N doublet) of 2–3 Hz 






between experimental repeats. These errors are very big, considering that Δ1JNH, the 
parameter of interest, is typically between –0.5 Hz and +0.5 Hz [201]. 
 
To ascertain the origin of large errors, the sum of the root mean squared deviation (RMSD) in 
peak positions for both components of the 15N doublet was calculated (Figure 4.7c). Peak 
position RMSD for each component of the 15N doublet was calculated using signal-to-noise 
ratios and transverse relaxation rates of individual residues: 




+ 0.067HI (4.19) 
where SNR is the signal-to-noise ratio of a peak, t1max is the maximum increment of the t1 
evolution period in seconds, and C is the transverse relaxation rate constant of the 15N 
magnetisation estimated from 1JNH-modulated HSQC. 
 
The relationship was derived by Dr. Daniel Nietlispach based on simulated resonances 
reported by Kontaxis et al [376]. 2D resonances were simulated with Gaussian noise added in 
the time domain to yield consistent SNR = 20. The accuracy for determining peak position 
increases linearly with SNR and with R2. It is important to use relaxation rates derived from 
spin-echo type experiments rather than CPMG, because relaxation in spin echo-type 
experiments occurs at the average relaxation rate of in-phase and antiphase operators, 
whereas relaxation occurs at the rate of in-phase operator in CPMG experiment. This is 
clearly illustrated by the lower R2 derived from CPMG [374] compared to the decay rate (C) 
obtained by fitting peak intensities from 1JNH-modulated HSQC peak using 
exponentially-decaying sinusoidal function (Figure 4.7d). 
 
For IPAP-HSQC (32 scans), most residues yielded RMSD of ~ 0.1 Hz, although a few select 
residues showed higher RMSD of up to ~ 0.5 Hz. The RMSD is almost an order of 
magnitude smaller than the total chemical shift difference between experimental repeats. This 
indicates that the differential relaxation rates gave rise to very broad 15N-anti-TROSY 
linewidths, such that Equation 4.19 cannot fully account for the error in peak position for 
anti-TROSY lines even with SNR > 20 observed for all residues in IP sub-spectrum and for 
most residues in AP sub-spectrum. 
 








Figure 4.7: Example of 1JNH for RalA and the associated errors obtained from IPAP-HSQC 
(a) 1JNH from IPAP-HSQC (32 scans). (b) Experimental error for 1JNH is calculated as the sum of 
chemical shift difference for each component of the 15N doublet. (c) 1JNH RMSD value for a residue 
was calculated as the sum of RMSD for the position of each peak in the 15N doublet. Peak position 
RMSD was calculated as RMSDpos = {1/SNR (0.26/t1max + 0.067 R2)}, where R2 was taken as the 
decay rate (C) from the sinusoidal decay function fitted to 1JNH-modulated HSQC (32 scans, 
Δ = 11.60–37.20 ms). Residues without error bars were due to missing C value. (d) Transverse 
relaxation rate constants measured by Dr. Arooj Shafiq using CPMG [374] or by fitting 
1JNH-modulated HSQC peak intensities with sinusoidal decay function. 
 






To identify H-bonds, Δ1JNH values were calculated as the difference between 1JNH of 
RalAΔC-GDP and random coil values reported by Xiang et al. [201]. Δ1JNH values from 
IPAP-HSQC (32 scans) were plotted against the secondary structure and coloured by value 
on the crystal structure (Figure 4.8). Similar results were obtained for other implementations 
of IPAP-HSQC. Taking the reported error of ± 0.35 Hz [201], residues with Δ1JNH < –0.35 
Hz are therefore hypothesised to be H-bonded while residues with Δ1JNH > 0.35 Hz are not 
H-bonded. Overall, the Δ1JNH values showed good correlation with the H-bonding patterns 
determined by WhatIf. Residues with Δ1JNH values < –0.35 Hz are mostly located in the 
central regions of α-helices and β-strands. Residues with Δ1JNH > 0.35 Hz tend to be at the 
ends of α-helices and in loops. 
 
Several residues showed mismatches against backbone-to-backbone H-bond predictions by 
WhatIf. Most of the mismatches could be accounted for once H-bonds from backbone amides 
to side-chains (as in the approach by Xiang et al.) and GDP were considered. The validity of 
this approach requires further assessment of the geometry and strength of the H-bond in 
question, as scalar coupling is mediated through electron cloud polarisation. Nevertheless, 
several Δ1JNH values still showed persistent mismatches against WhatIf predictions 
(Figure 4.8c). Such residues are mostly located at the ends of helices, ends of β-strands, loops 
and tight turns. While these mismatches are hypothesised to largely reflect the large 
experimental errors in IPAP-HSQC experiments, they might also be due to slight differences 
in the single conformation captured by the crystal structure and the ensemble of slightly 
different conformations in an aqueous protein sample. Since backbone amides with more 
internal motion of the N-H vector might have weaker H-bonds which lead to mismatch 
against WhatIf prediction, attempts were made to correlate these mismatches against the 
order parameter determined from 15N relaxation experiments (R1, R2 and heteronuclear NOE) 
[374]. The order parameter predicts spatial restriction of the N-H vector and has values 
between 0 (unrestricted internal motion) and 1 (no internal motion). However, no correlation 
can be found between Δ1JNH mismatch and low order parameter values of < 0.85, thus 
indicating that the mismatches are most likely due to large experimental errors. 
 








Figure 4.8: Example of Δ1JNH values for RalAΔC-GDP from IPAP-HSQC 
(a) Δ1JNH determined by IPAP-HSQC (32 scans) are plotted against residue number and secondary 
structure. The grey dotted lines indicate the ± 0.35 Hz error range for the amino acid-specific random 
coil values reported by Xiang et al [201]. Several residues did not yield reliable data due to lack of 
assignments or were excluded from analysis due to peak overlap. (b) Δ1JNH values are mapped onto 
the crystal structure of RalAΔC-GDP and coloured by value. Δ1JNH <  –0.35 Hz (yellow) is predictive 
of the presence of H-bond; Δ1JNH > 0.35 Hz predicts the lack of H-bond; –0.35 Hz < Δ1JNH < 0.35 Hz 
is within the reported error range and H-bond presence cannot be definitively determined. (c) 
Coloured residues show mismatch between presence/absence of H-bonds determined from Δ1JNH 
values vs. prediction by WhatIf. 
 
 






Different implementations of Quantitative J modulation experiments were recorded to 
evaluate the impacts of SNR and lineshape on the measured 1JNH values (Table 4.3). 
 
Quantitative J modulation implementation 
No. (%) of 
residues assigned 
No. (%) of 
residues with ≥ 13 
reliable Δ periods 
1JNH-modulated 
HSQC 
8 scans, Δ = 11.60–37.20 ms 133 (79%) 124 (73%) 
16* scans, Δ = 11.60–37.20 ms 135 (80%) 132 (78%) 
32 scans, Δ = 11.60–37.20 ms 133 (79%) 128 (76%) 
32 scans, Δ = 32.88–58.48 ms 133 (79%) 116 (69%) 
8* scans, Δ = 32.88–58.48 ms 133 (79%) 104 (62%) 
1JNH-modulated 
TROSY-HSQC 
64* scans, Δ = 32.88–58.48 ms 129 (76%) 101 (60%) 
48* scans, Δ = 22.24–47.84 ms 130 (77%) 117 (69%) 
 
Table 4.3: Residues with reliable 1JNH measurements in different 1JNH-modulated HSQC 
implementations 
* indicates that different number of scans were recorded for different Δ periods (referred to as “scan 
multiplier”). All experiments were recorded at 298 K on a 500 MHz spectrometer. 
 
SNR was varied by recording experiments with different numbers of scans (Figure 4.9 insets). 
Since the signal intensity is modulated as an exponentially-decaying sinusoidal function of 
the J evolution period (Δ), the SNR at certain Δ are small and might lead to inaccuracies in 
the fitted peak intensities and errors in 1JNH measurements. Several implementations were 
attempted with different number of scans being recorded for different Δ periods (referred to 
as “scan multiplier”; see Table 4.4) in order to yield comparable SNR across all Δ. The effect 
of the scan multiplier is illustrated in Figure 4.9. The effects of lineshape on 1JNH 
measurements were evaluated by recording experiments in the absence vs. presence of 
TROSY effects. The lengths of Δ periods were also varied to examine how experimental 
error might be influenced by the averaging of relaxation rates of in-phase and antiphase 
operators at longer Δ. 
 







Figure 4.9: Example of the effect of the scan multiplier on peak intensities 
The raw intensities (with scan multiplier), adjusted intensities (effect of scan multiplier taken away), 
fitted decaying sinusoidal function and raw SNR (insets) are shown for Asp-65 of RalAΔC-GDP in 
1JNH-modulated HSQC recorded with (a) 16* scans, Δ = 11.60–37.20 ms, and (b) 8* scans, 
Δ = 32.88–58.48 ms vs. 32 scans, Δ = 32.88–58.48 ms. 







1JNH-modulated HSQC 1JNH-modulated TROSY-HSQC 
16* scans 
Δ = 11.60–37.20 ms 
8* scans 
Δ = 32.88–58.48 ms 
64* scans 
Δ = 32.88–58.48 ms 
48* scans 





























































11.60 4 64 32.88 2 16 32.88 2 128 22.24 2 96 
12.40 2 32 33.68 2 16 33.68 2 128 23.04 2 96 
13.00 2 32 34.28 2 16 34.28 2 128 23.64 2 96 
14.00 1 16 35.28 2 16 35.28 2 128 24.64 2 96 
15.80 1 16 37.08 2 16 37.08 2 128 26.44 2 96 
22.00 6 96 43.28 3 24 43.28 3 192 32.64 2 96 
22.60 3 48 43.88 3 24 43.88 3 192 33.24 2 96 
23.60 2 32 44.88 3 24 44.88 3 192 34.24 2 96 
24.40 2 32 45.68 3 24 45.68 3 192 35.04 2 96 
26.40 1 16 47.68 3 24 47.68 3 192 37.04 2 96 
33.20 4 64 54.48 4 32 54.48 4 256 43.84 3 144 
34.00 3 48 55.28 4 32 55.28 4 256 44.64 3 144 
34.80 2 32 56.08 4 32 56.08 4 256 45.44 3 144 
35.60 2 32 56.88 4 32 56.88 4 256 46.24 3 144 
37.20 2 32 58.48 4 32 58.48 4 256 47.84 3 144 
 
Table 4.4: Scans recorded for each Δ period in 1JNH modulation experiments with scan 
multiplier 
 
Stringent criteria must be employed to maximise the accuracy of fitting peak intensities as a 
function of Δ. The analysis therefore only includes residues with unambiguous and 
non-overlapping resonance assignments, and peak intensities determined for at least 13 
values of Δ spanning two zero-crossings on the intensity modulation graph. These selection 
criteria permitted the fitting of 1JNH for 60–78% of the 169 assignable residues for different 
implementations of 1JNH-modulated HSQC, hence providing similar coverage as IPAP-HSQC 
experiments (Table 4.3). Figure 4.10 shows that 1JNH-modulated HSQC (16* scans, 
Δ = 11.60–37.20 ms) yielded the greatest fraction of residues with reliable peak intensities in 
≥ 13 values of Δ. Increasing Δ to 22.24–47.84 ms or 32.88–58.48 ms gave decreased number 
of residues with reliable peak intensities across ≥ 13 values of Δ. 








Figure 4.10: Histogram showing distribution of residues with reliable peak intensities for 
different numbers of Δ periods for different implementations of 1JNH-modulated HSQC 
All experiments were recorded at 298 K on a 500 MHz spectrometer. 
 
In 1JNH-modulated HSQC (8 scans, Δ = 11.60–37.20 ms), 1JNH ranged from –91 to –95 Hz 
while Δ1JNH span from –1.8 to + 2.5 Hz (Figure 4.11). These ranges appear to be narrower 
than those observed from different implementations of IPAP-HSQC. 
 
The precision of IPAP-HSQC and 1JNH-modulated HSQC measurements were evaluated, and 
examples are shown in Figure 4.12. Figure 4.12a shows cross comparison of Δ1JNH from two 
experimental repeats of IPAP-HSQC (32 scans), showing that several residues were outside 
the ± 0.35 Hz error range (grey dashed lines). Figure 4.12b shows comparison of Δ1JNH from 
1JNH-modulated HSQC (8* scans vs. 32 scans, Δ = 32.88–58.48 ms), where all residues were 
within the ± 0.35 Hz error range. Note that since direct experimental repeats of 
1JNH-modulated HSQC were not recorded, data from 1JNH-modulated HSQC (8* scans, 
Δ = 32.88–58.48 ms) were compared against those from 1JNH-modulated HSQC (32 scans, 
Δ = 32.88–58.48 ms). Since longer Δ periods yield fewer data points for intensity modulation 






fitting (Figure 4.10), the longest Δ periods of 32.88–58.48 ms were chosen to estimate the 
upper limit of experimental error. 
 
 
Figure 4.11: Example of 1JNH and Δ1JNH values for RalAΔC-GDP from 1JNH-modulated HSQC 
(a) 1JNH and (b) Δ1JNH determined by 1JNH-modulated HSQC (8 scans, Δ = 11.60–37.20 ms) are 
plotted against residue number and secondary structure. In panel a, the vertical lines show the range 
between the 2.5% and 97.5% confidence limits of the 1JNH values obtained from fitting of peak 
intensities with the sinusoidal decay function. In panel b, the grey dotted lines indicate the ± 0.35 Hz 
error range for the amino acid-specific random coil values reported by Xiang et al [201]. Several 
residues did not yield reliable data due to lack of assignments or were excluded from analysis due to 
peak overlap or there were < 13 reliable peak intensities across different Δ periods. 
 
To cross-compare the precision across all experimental repeats and different implementations 
of IPAP-HSQC and 1JNH-modulated HSQC, the differences in residue-specific Δ1JNH 
between different experiments, referred to as ΔΔ1JNH, are summarised using box plots. 
Examples of ΔΔ1JNH box plots are shown in Figure 4.12c, showing that the range of ΔΔ1JNH 
values between experimental repeats of IPAP-HSQC and SOFAST-IPAP-HSQC are similar, 
but are consistently bigger than ΔΔ1JNH values between different implementations of 






1JNH-modulated HSQC. This indicates that to first-order approximation, 1JNH-modulated 
HSQC shows higher precision than IPAP-HSQC. 
 
 
Figure 4.12: Comparison of the precision of Δ1JNH values across experimental repeats and 
different implementations of IPAP-HSQC and 1JNH-modulated HSQC 
(a) Comparison of Δ1JNH between two experimental repeats (denoted [A] and [B]) of IPAP-HSQC (32 
scans). (b) Comparison of Δ1JNH from 1JNH-modulated HSQC (8* scans vs. 32 scans, Δ = 32.88–58.48 
ms). In panels a and b, the coordinates of each data point represent residue-specific Δ1JNH of the 
specified experimental repeats/implementations. The expected linear correlation with gradient = 1 is 
shown as bold grey dotted lines. The light grey dotted lines represent the ± 0.35 Hz error range 
reported by Xiang et al [201]. (c) Box plots showing the interquartile range and outliers in ΔΔ1JNH 
(differences in residue-specific Δ1JNH) between different experimental repeats/implementations. 
 






Δ1JNH values from 1JNH-modulated HSQC appear to show consistent positive offset compared 
to those from IPAP-HSQC, as exemplified in Figure 4.13a. Pairwise comparison of the 
average ΔΔ1JNH between different IPAP-HSQC and 1JNH-modulated HSQC experiments is 
shown in Figure 4.13b. Pairwise comparison of different IPAP-HSQC experiments (top left 
corner) shows that on average, residue-specific Δ1JNH values are within 0.05 Hz between 
different experimental repeats and implementations. Pairwise comparison of different 
IPAP-HSQC and 1JNH-modulated HSQC experiments (top right) shows that on average, 
Δ1JNH values are 0.22–0.39 Hz greater than those observed in IPAP-HSQC. For example, the 
Δ1JNH values from 1JNH-modulated HSQC (8 scans, Δ = 11.60–37.20 ms) are on average 0.36 
Hz greater than those from IPAP-HSQC (32 scans), providing a semi-quantitative measure of 
the positive offset shown in Figure 4.13a. Given the good correlation between Δ1JNH values 
from IPAP-HSQC experiments and H-bonds predicted by WhatIf, the positive offset in Δ1JNH 
from 1JNH-modulated HSQC experiments indicates the presence of systematic error. 
Lengthening the Δ period appears to decrease the systematic error, although it remains rather 
big. This is because the transverse magnetisation interconverts more times between in-phase 
and antiphase operators, and the effective decay rates for the in-phase and antiphase operators 
become closer to the average relaxation rate. The change in systematic error with the length 
of the Δ period likely explains the varied average ΔΔ1JNH values in pairwise comparison of 
different 1JNH-modulated HSQC implementations (bottom right corner). 
 
1JNH-modulated TROSY-HSQC (48* scans, Δ = 22.24–47.84 ms) yielded the smallest 
systematic errors. This suggests that the low SNR at long Δ also contributed towards 
experimental error, and a better balance between SNR and averaging of differential relaxation 
rates can be achieved with Δ = 22.24–47.84 ms. Other parameters including number of scans, 
the scan multiplier and TROSY implementation appeared to have minimal effect 
(ΔΔ1JNH ≤ 0.05 Hz) on the systematic error. 
 
Δ1JNH from 1JNH-modulated TROSY-HSQC (48* scans, Δ = 22.24–47.84 ms) are mapped 
onto the crystal structure (Figure 4.14a), showing some correlation with H-bonds predicted 
by WhatIf. Most residues with mismatches against H-bond prediction showed 
Δ1JNH > 0.35 Hz but were predicted to be non-H-bonded, despite H-bonds from backbone 






amides to side-chains and GDP having been taken into account (Figure 4.14b). This 
illustrates the presence of a positive systematic error in Δ1JNH values. 
 
The systematic error was crudely corrected by subtracting 0.23 Hz from all 
experimentally-determined Δ1JNH values. 0.23 Hz reflects the average difference in Δ1JNH 
between 1JNH-modulated TROSY-HSQC (48* scans, Δ = 22.24–47.84 ms) and the 
IPAP-HSQC experiments. This approach yielded better correlation with H-bonds predicted 
by WhatIf (Figure 4.14c–d). 
 
Summarising the proof-of-concept studies on RalAΔC-GDP, 1JNH measurements by 
IPAP-HSQC give good correlations with H-bonds predicted by WhatIf but are plagued by 
large experimental errors attributable to broad linewidths in the AP spectrum due to 
differential relaxation. On the other hand, 1JNH-modulated HSQC give small experimental 
deviations but yield big systematic errors which can only be partially reduced by increasing 
the duration of the J evolution period, provided that the concomitant decrease in SNR does 
not lead to increase in experimental error. 
 







Figure 4.13: Average pairwise difference in Δ1JNH across different IPAP-HSQC and 
1JNH-modulated HSQC experiments 
(a) Comparison of Δ1JNH from 1JNH-modulated HSQC (8 scans, Δ = 11.60–37.20 ms) vs. IPAP-HSQC 
(32 scans). The grey lines represent the ± 0.35 Hz error range reported by Xiang et al [201]. (b) The 
average differences in Δ1JNH across all assigned residues for pairwise comparisons of different 
IPAP-HSQC and 1JNH-modulated HSQC experiments. The yellow box shows the average pairwise 
difference in Δ1JNH illustrated in panel a. 
 







Figure 4.14: Example of Δ1JNH values for RalAΔC-GDP from 1JNH-TROSY-HSQC 
(a) Δ1JNH determined by 1JNH-modulated TROSY-HSQC (48* scans, Δ = 22.24–47.84 ms) are 
mapped onto the crystal structure of RalAΔC-GDP and coloured by value. (b) Mismatches between 
Δ1JNH values and H-bond prediction by WhatIf. (c) Δ1JNH corrected by –0.23 Hz. (d) Mismatches 
against H-bond prediction by WhatIf after –0.23 Hz correction. 
 






4.3.2 Expression, purification and NMR of OmpX 
15N-labelled OmpX was expressed in E. coli as inclusion bodies and purified using published 
methods [377] (Figures 4.15 & 4.16a–b), before being refolded by dropwise rapid dilution of 
the unfolded protein in the presence of detergent (DPC) and 0.5 M L-arginine-hydrochloride 
(see Materials and Methods). The denaturant was removed by several overnight dialyses 
[285]. The refolding efficiency was assessed by SDS-PAGE, where the folded species and 
the misfolded species migrated as separate bands on the gel (Figure 4.16c). The final sample 
contained ~ 90% 15N-labelled OmpX (995 µM, in 20 mM sodium phosphate pH 6.8, 
100 mM NaCl, 5 mM EDTA, 3.8% DPC, 90% H2O/10% D2O). 
 
 
Figure 4.15: Expression and purification of 15N-labelled OmpX 
Representative SDS-PAGE gel showing the expression and purification of 15N-OmpX. M: molecular 
weight marker; U: whole cell lysate of un-induced BL21(DE3); Induced 1 – 5.5: whole cell lysate of 
BL21(DE3) at 1, 2, 3, 4, 5.5 h post-induction; Media 1 + 5.5: culture media at 1 and 5.5 h 
post-induction; T1: flow-through from first Buffer TE wash; TX: flow-through from Buffer TE + 2% 
(v/v) Triton X-100 wash; T2: flow-through from second Buffer TE wash; P: insoluble pellet in 6 M 
Gdm-Cl; L: sample loaded onto a size exclusion column. 
 








Figure 4.16: Size exclusion chromatography and refolding of 15N-labelled OmpX 
(a) Representative size exclusion chromatography trace for OmpX purification using a Superdex 200 
10/300 GL column running at 0.12 ml/min. The volume of each eluted fraction is 1 ml. The total 
sample loaded onto the column is equivalent to 1 L of E. coli BL21(DE3) culture. (b) Representative 
SDS-PAGE gel for fractions 2−15 (boxed in panel a). OmpX (~ 16.5 kDa) is expected to migrate 
between 15 and 25 kDa (red arrow). (c) Representative SDS-PAGE gel for refolding of OmpX, 
overnight dialyses and concentration of the protein sample. Red and cyan arrows show different 
migrations for OmpX in its denatured (misfolded) conformation and refolded conformation, 
respectively. M: molecular weight marker; L: pre-gel filtration sample; GF: post-gel filtration sample; 
D1 & D2: samples after each round of overnight dialysis into Buffer D; N1 & N2: samples after each 
round of overnight dialysis into Buffer N; Fin: final 15N-OmpX NMR sample (995 µM). 
 






The quality of the sample was verified by comparing an acquired 2D [1H,15N] 
SOFAST-TROSY-HSQC (Figure 4.17a) against a synthetic spectrum generated using the 
chemical shifts from BMRB entry 18797 [285]. Extra peaks in the acquired spectrum arise 
from side-chain NH2 groups (not shown on the synthetic spectrum) or residual misfolded 
species within the sample. All backbone amide assignments can be unambiguously 
transferred from the synthetic spectrum to the acquired spectrum, with little differences in 
chemical shifts observed (Figure 4.17b). The sample remained stable at room temperature for 
more than 2 months, with no observable changes in the HSQC spectrum over this time period. 
 
A 3D 15N-separated NOESY-HSQC spectrum was recorded, and the NOE cross peak 
positions were used to confirm the BMRB deposited (BMRB 18797) resonance assignments. 
The presence of a large number of sequential, inter-β-strand and long-range HN-HN NOE 
interactions (Figure 4.18) was observed, confirming the integrity of the tertiary protein 
structure. Several intra-strand/intra-loop NOEs were also observed, especially in the loop 
regions of OmpX. 
 








Figure 4.17: 2D [1H,15N] SOFAST-TROSY-HSQC spectrum of 15N-OmpX 
(a) Overlay of a 2D [1H,15N] SOFAST-TROSY-HSQC 800 MHz spectrum recorded at 318 K against 
a synthetic spectrum generated using the chemical shifts from BMRB entry 18797 [285]. (b) 
Chemical shift differences Δδ(1H,15N) = [(Δδ1H)2 + (Δδ15N)2/6]0.5 in panel a are mapped onto the 
solution-state NMR structure of OmpX (PDB 2M07). 
 
 







Figure 4.18: Backbone amide NOE interactions in OmpX 
Backbone amide NOEs are shown as coloured lines. Sequential NOEs are shown in black, inter-strand 
NOEs in blue, long-range NOEs in orange, and intra-strand/intra-loop NOEs in magenta. (a) 1H-1H 
cross sections from a 3D 15N-separated NOESY-HSQC spectrum of 15N-OmpX taken at the 15N 
frequencies of residues 78−81, 112 and 114, showing sequential, inter-strand and long-range NOEs 
between these residues. (b) Inter-strand and long-range NOEs shown in panel a are mapped onto the 
solution-state NMR structure of OmpX (PDB 2M07). (c) Backbone amide NOE interactions are 
mapped onto a topology plot of OmpX. Coloured lines with arrowheads indicate the direction of the 
one-way NOE observed, whilst coloured lines without arrowheads indicate the observation of both 
forward and reverse NOEs. Unassigned residues in BMRB 18797 are highlighted in black, and 
residues with no peaks observed in the 1H-15N plane of the acquired 3D 15N-separated NOESY-HSQC 
spectrum are highlighted in red. Sequential HN-HN NOEs are omitted for clarity. 
 






4.3.3 1JNH of OmpX in DPC micelles 
The proof-of-concept studies on RalAΔC have demonstrated the feasibility of measuring 1JNH 
for a 20.9 kDa soluble protein. Further studies were conducted using OmpX in DPC micelles 
to assess the feasibility of 1JNH measurements in folded membrane proteins. Four experiments 
were recorded: 
1. 1JNH-modulated HSQC (40 scans, Δ = 11.60–37.20 ms) 
2. 1JNH-modulated HSQC (96 scans, Δ = 11.60–37.20 ms) 
3. 1JNH-modulated TROSY-HSQC (40 scans, Δ = 11.60–37.20 ms) 
4. SOFAST-IPAP-HSQC (64 scans) 
 
The number and fraction of residues with 1JNH measurements out of 128 assignable residues 
are evaluated in Table 4.5. All 1JNH-modulated HSQC experiments were recorded with 
Δ = 11.60–37.20 ms, as the large OmpX-DPC protein-detergent complex of 37.2 kDa will 
have fast transverse relaxation rates, yielding very low SNR at long Δ periods. 
 
Experiment 
No. (%) of 
residues assigned 
No. (%) of residues 
with ≥ 10 reliable 
Δ periods 
No. (%) of residues 




40 scans 125 (98%) 88 (69%) 44 (34%) 
96 scans 124 (97%) 90 (70%) 51 (40%) 
1JNH-modulated 
TROSY-HSQC 
40 scans 125 (98%) 95 (74%) 58 (45%) 
SOFAST-IPAP-HSQC 64 scans 112 (88%) N/A N/A 
 
Table 4.5: Residues with reliable 1JNH measurements in 1JNH-modulated HSQC and 
IPAP-HSQC implementations 
All experiments were recorded at 318 K on a 800 MHz spectrometer. 
 
Similar to the studies on RalAΔC, overlapping resonances were excluded from analysis to 
minimise error. Out of the 128 assignable backbone amide resonances [285], 1JNH values 
were obtained for 88% residues in the SOFAST-IPAP-HSQC experiment, and ≥ 97% 
residues in different implementations of 1JNH-modulated HSQC. However, subsequent 
selection of residues with measured peak intensities from ≥ 13 Δ periods in 1JNH-modulated 
HSQC would yield low protein coverage of only 34–45% (Table 4.5). Hence, a more lenient 






set of criteria was used to enable comparable coverage (~70%) as those obtained in the 
studies on RalAΔC: residues which were analysed have unambiguous assignments and peak 
intensities from ≥ 10 Δ periods spanning two zero-crossings on the intensity modulation 
graph, with at least three data points on either side of each zero-crossing. 
 
The measured 1JNH values ranged from −90.6 to −95.5 Hz for 1JNH modulation-based 
experiments, and from −86.7 to −98.2 Hz for the SOFAST-IPAP-HSQC experiment 
(Figure 4.19). 
 
Δ1JNH ranged from −2.5 Hz to +2.5 Hz for 1JNH modulation-based experiments, whereas a 
much larger range of about −5.0 Hz to +6.0 Hz was observed in the SOFAST-IPAP-HSQC 
experiment (Figure 4.20). The larger range of Δ1JNH indicates large experimental errors due 
to broad linewidths in the AP spectrum, similar to previous observations with RalAΔC. 
 
Figure 4.21a shows there is poor correlation between the expected H-bonding pattern based 
on Δ1JNH from different experiments and the H-bonding pattern predicted using WhatIf. 
Quite a few residues which are located in the middle of the β-barrel and are expected to be 
H-bonded show Δ1JNH > 0.35 Hz (Figures 4.21b–c). 
 
Pairwise comparison of Δ1JNH values from different 1JNH-modulated HSQC and 
SOFAST-IPAP-HSQC implementations against those from 1JNH-modulated HSQC (40 scans) 
show poor correlation (Figure 4.22). The observed errors are also much larger than the 












Figure 4.19: 1JNH for OmpX-DPC 
(a–c) 1JNH from 1JNH-modulated HSQC (40 scans) (a), 1JNH-modulated HSQC (96 scans) (b) and 1JNH-
modulated TROSY-HSQC (40 scans) (c). All implementations were recorded with Δ = 11.60–37.20 
ms. The vertical lines show the range between the 2.5% and 97.5% confidence limits of the 1JNH 
values obtained from fitting of peak intensities with the sinusoidal decay function. (d) Top panel: 1JNH 
from SOFAST-IPAP-HSQC (64 scans). Bottom panel: 1JNH RMSD, calculated as the sum of RMSD 
for peak position for each component of the 15N doublet. Residues without RMSD are due to missing 
information on the transverse relaxation rate derived from the three 1JNH-modulated HSQC 
experiments (no peak detected or inadequate fitting of intensity modulation). All experiments were 
recorded at 318 K on a 800 MHz spectrometer. 
 







Figure 4.20: Δ1JNH for OmpX-DPC 
Δ1JNH are plotted against residue number and secondary structure. The horizontal grey dotted lines 
indicate the ± 0.35 Hz error range for the amino acid-specific random coil values reported by Xiang et 
al [201]. Several residues did not yield reliable data due to lack of assignments or were excluded from 
analysis due to peak overlap or there were < 10 reliable peak intensities across different Δ periods. 
 







Figure 4.21: Comparison of experimental Δ1JNH values for OmpX-DPC against H-bond 
predictions using the WhatIf server 
(a) Each residue of OmpX is colour-coded according to the H-bond predictions using WhatIf 
(Predicted), and Δ1JNH from different implementations of 1JNH-modulated HSQC and 
SOFAST-IPAP-HSQC. B–B: backbone-to-backbone H-bond; B–S: backbone-to-sidechain H-bond. 
Δ1JNH from 1JNH-modulated HSQC (40 scans) (b) and SOFAST-IPAP-HSQC (64 scans) (c) are 
mapped onto the solution-state NMR structure of OmpX (PDB 2M07) and coloured by value. 
 







Figure 4.22: Poor correlation between Δ1JNH values derived from different 1JNH experiments 
Δ1JNH values from 1JNH-modulated HSQC (40 scans) are compared against those from 1JNH-modulated 
HSQC (96 scans) (a), 1JNH-modulated TROSY-HSQC (40 scans) (b), and SOFAST-IPAP-HSQC 
(64 scans) (c). The expected linear correlation with gradient = 1 is shown as bold grey dotted lines. 
The light grey dotted lines represent the ± 0.35 Hz error range reported by Xiang et al [201]. 
 






According to the classical theory of Ramsey [378], an isotropic spin-spin coupling constant 
(SSCC) is given as the sum of the diamagnetic spin orbit (DSO), paramagnetic spin orbit 
(PSO), Fermi contact (FC) and spin dipole (SD) terms: 
 PQ˜˜ˆˆ = PQË˜J + PQK˜J +PQLˆ + PQ˜Ë (4.20) 
 
One-bond scalar coupling is dominated by the FC term, which largely arises from an overlap 
between the s-orbital spin density of one nucleus and the coupled nucleus. The SD term 
arises from nuclear magnetic moments interacting via the magnetic field induced by the spins 
of surrounding electrons. The DSO and PSO terms arise from nuclear magnetic moments 
interacting via the magnetic field induced by the orbital motion of surrounding electrons 
[185]. In particular, the PSO term becomes significant with the presence of π-orbital electrons 
(e.g. from aromatic rings) in close proximity [378,379]. 
 
Xiang et al. have observed several residues in ubiquitin with Δ1JNH values which do not 
correlate well with H-bonding patterns predicted by WhatIf. These residues are mostly within 
6 Å away from an aromatic ring, which perturbs 1JNH measurements due to a significant PSO 
contribution. The distance cut-off employed to account for such deviations in 1JNH appears to 
be arbitrary, with Xiang et al. having employed a 6 Å cut-off from aromatic side-chains for 
ubiquitin [201] whereas Ma et al. have employed a 4 Å cut-off for GlnBP [379]. 
 
The distance between each backbone amide of OmpX from the closest aromatic ring was 
determined using Pymol (Figure 4.23). Given the abundance of aromatic side-chains, 
application of a 6 Å cut-off would yield only 9 out of 148 residues for further analysis. 
However, there is evident inconsistency between Δ1JNH and H-bond prediction for these 9 
remaining residues, suggesting that perturbations of 1JNH measurements by proximal aromatic 
rings are small compared to experimental and systematic errors. In fact, a computational 
study on the relative contributions of the Ramsey terms to J-coupling measurement has 
shown that the H-bonded residue pair 4–65 in ubiquitin, which are within the 6 Å cut-off 
distance applied by Xiang et al., only has 1.31% contribution from the PSO term whilst the 
Fermi contact term dominates (98.11% contribution) the 1JNH coupling [380]. 
 






In summary, the discrepancy in Δ1JNH values between the recorded experiments and WhatIf 
H-bond predictions likely reflect problems in the precision and accuracy of the measurements 
contributed by using a protonated sample of a large detergent-protein complex. 
In comparison, other factors which might also lead to perturbation of 1JNH measurements, 
e.g. close proximity of aromatic rings, play a smaller part in the existing data. 
 
 
Figure 4.23: Effects of proximal aromatic rings on the Δ1JNH values in OmpX-DPC 
(a) OmpX residues are colour-coded based on the distance of each backbone amide from the closest 
aromatic ring. Amide groups located beyond 4 Å, 5 Å and 6 Å away from an aromatic ring are 
represented using lime green, green and dark green spheres, respectively. Aromatic side-chains are 
shown using stick representation. (b) Residues remaining after application of a 6 Å distance cut-off 
are colour-coded according to the H-bond predictions using WhatIf (Predicted), and Δ1JNH from 
different implementations of 1JNH-modulated HSQC and SOFAST-IPAP-HSQC. B–B: backbone-to-
backbone H-bond; B–S: backbone-to-sidechain H-bond. 
 






4.3.4 1JNH of OmpX in urea 
The NMR chemical shifts of unfolded OmpX in 8 M urea [91] and the structures of folded 
OmpX in different membrane mimetics [285] have been published, hence permitting facile 
assessment of the feasibility and experimental error of 1JNH measurements in both unfolded 
and folded membrane proteins. 
 
To obtain OmpX in 8 M urea, OmpX in DPC was subjected to buffer exchange, gel filtration 
(Figure 4.24), dialysis and dilution/concentration with a 3 kDa MWCO centrifugal 
concentrator (see Materials and Methods). The final DPC concentration was determined to be 
< 0.02% by 1D 1H NMR (Figure 4.25a). The resulting sample contained 221 µM 15N-OmpX, 
in 8 M urea, 20 mM sodium phosphate pH 6.5, 0.1 mM NaN3, 95% H2O/5% D2O, and 
yielded comparable 2D [1H,15N] TROSY-HSQC spectrum to the 2D [1H,15N] HSQC 
spectrum obtained by Tafer et al [91]. 
 
Given the aim of studying H-bond formation during protein folding by measuring 1JNH, 
15N-OmpX in different urea concentrations was studied by NMR in order to access denatured 
states which sample folded conformations with increasing frequencies. However, 
precipitation of OmpX was observable by eye in < 6 M urea in the absence of detergent, thus 
limiting the range of this study to 6–8 M urea. Figure 4.26 shows the 2D [1H,15N] 
SOFAST-TROSY-HSQC spectra recorded for 15N-OmpX in 6 M, 7 M and 8 M urea. 
Addition of DPC was not considered, because of the large errors in Δ1JNH values for folded 
15N-OmpX attributable to the utilisation of a protonated sample containing a large 
detergent-protein complex (see Section 4.3.3). 
 








Figure 4.24: Size exclusion chromatography for exchange of 15N-OmpX from DPC into 8 M 
urea 
(a) Size exclusion chromatography trace for exchange of 15N-OmpX into 8 M urea using a HiPrep 
16/60 Sephacryl S-200 HR column running at 0.5 ml/min. The volume of each eluted fraction is 3 ml. 
(b) SDS-PAGE gel for fraction 1–12 from size exclusion chromatography. Red and cyan arrows show 
different migrations for OmpX in its unfolded conformation and folded conformation, respectively. 
M: molecular weight marker; L: pre-gel filtration sample; Folded: folded 15N OmpX in DPC. 
 







Figure 4.25: NMR spectra of 15N-OmpX in 8 M urea 
(a) 1D 1H NMR (0–4 ppm region) of 0.2% DPC in 95% H2O/5% D2O (blue) (recorded at 293 K) and 
221 µM 15N-OmpX in 8 M urea (recorded at 288 K), showing no/negligible presence of DPC in the 
protein sample. Both samples contained TSP as internal reference. Both spectra were recorded with 4 
scans and an acquisition time of 1 s, and processed with exponential window function and 
line-broadening of 2 Hz. Inset shows expanded view of the 0 – 2 ppm region, with the intensities of 
both spectra scaled according to the TSP peak. Chemical structure of DPC was drawn using 
ChemDraw (PerkinElmer). Assignments of DPC resonances are derived from [381]. (b) Overlay of a 
2D [1H,15N] SOFAST-TROSY-HSQC 800 MHz spectrum recorded at 288 K with 80 scans against a 
synthetic spectrum generated using the chemical shifts from BMRB entry 15201 [91]. 
 







Figure 4.26: 2D [1H,15N] SOFAST-TROSY-HSQC spectra of 15N-OmpX in different urea 
concentrations. 
166 µM 15N-OmpX in 6 M urea, 97 µM 15N-OmpX in 7 M urea, and 221 µM 15N-OmpX in 8 M urea. 
All samples contained TSP as internal reference. All spectra were recorded on a 800 MHz 
spectrometer at 288 K and with 80 scans. 
 
Three experiments were recorded, and 1JNH measurements were obtained for high fraction of 
residues out of the 144 reported assignable residues [91] (Table 4.6). 







No. (%) of residues 
assigned 
No. (%) of residues with 
≥ 13 reliable Δ periods 
8 M 
1JNH-modulated HSQC 
Δ = 22.24–47.84 ms 
40 scans 131 (91%) 128 (89%) 
SOFAST-IPAP-HSQC 64 scans 126 (88%) N/A 
6 M SOFAST-IPAP-HSQC 64 scans 124 (86%) N/A 
 
Table 4.6: Residues of OmpX in 8 M and 6 M urea with reliable 1JNH measurements 
All experiments were recorded at 288 K on a 800 MHz spectrometer. 
 
The measured 1JNH values ranged from −92.2 to −94.1 Hz across all three experiments 
(Figure 4.27). All Δ1JNH were > 0.35 Hz or were within the reported ± 0.35 Hz error range, 
with the exception of Gln-129, which has Δ1JNH = −0.44 Hz measured by 
SOFAST-IPAP-HSQC in the presence 6 M urea (Figure 4.28–4.29). Δ1JNH values of OmpX 
in 8 M urea from 1JNH-modulated HSQC (40 scans) show good correlation with those from 
SOFAST-IPAP-HSQC (64 scans) (Figure 4.28d), indicating the absence of systematic errors 
which were observed for RalAΔC. Δ1JNH values of OmpX in 6 M urea showed a general 
negative offset against those of OmpX in 8 M urea. It is unknown whether this difference 
reflects a genuine global shift towards H-bonded conformations or an artifact due to different 
buffer conditions. 
 
Based on Δ1JNH values, the lack of stable H-bonds for OmpX in 8 M urea is consistent with 
the amide proton exchange protection factors and structure calculations reported by Tafer et 
al [91]. 3D 15N-resolved [1H,1H]-NOESY spectrum of OmpX in 8 M urea shows long-range 
NOEs in segments comprising residues 73–82 (I) and 137–145 (II). Structure calculations 
performed on segments I and II showed non-random local conformations. At least one of the 
two backbone H-bonds, Trp76 NH–O Ile73 and Ala77 NH–O Asn74, is present in 17 of the 
20 conformers, of which 9 conformers show the presence of both H-bonds [91]. In 8 M urea, 
Δ1JNH of H-bond acceptors Ile-73 and Asn-74 were 0.41–0.51 Hz, and Δ1JNH of H-bond 
donor Ala-77 was slightly smaller (~ 0.20 Hz). Δ1JNH of Trp-76 could not be determined 
since the random coil 1JNH was not published by Xiang et al [201]. These results indicate that 
the backbone H-bonds determined by NMR structure calculations were below the detection 
limit of the methods for 1JNH measurement, due to the transient nature of the H-bonds and 
experimental errors which are expected to be larger than those reported by Xiang et al [201]. 







Figure 4.27: 1JNH values for OmpX in 8 M and 6 M urea 
(a–b) 1JNH for OmpX in 8 M urea obtained by 1JNH-modulated HSQC (40 scans, Δ = 22.24–47.84 ms) 
(a) and SOFAST-IPAP-HSQC (64 scans) (b, top panel). The vertical lines in panel a show the range 
between the 2.5% and 97.5% confidence limits of the 1JNH values obtained from fitting of peak 
intensities with the sinusoidal decay function. The bottom half of panel b shows the RMSD of 1JNH, 
calculated as the sum of RMSD for peak position for each component of the 15N doublet. Residues 
without RMSD are due to missing information on the transverse relaxation rate derived from the 
corresponding 1JNH-modulated HSQC (no peak detected or inadequate fitting of intensity modulation). 
(c) 1JNH for OmpX in 6 M urea obtained by SOFAST-IPAP-HSQC (64 scans). RMSD was not 
calculated because the corresponding 1JNH-modulated HSQC was not recorded. All experiments were 
recorded at 288 K on a 800 MHz spectrometer. 

















Figure 4.28: Δ1JNH values for OmpX in 8 M and 6 M urea 
(a–c) Δ1JNH are plotted against residue number. The horizontal grey dotted lines indicate the ± 0.35 
Hz error range for the amino acid-specific random coil values reported by Xiang et al [201]. Several 
residues did not yield reliable data due to lack of assignments or were excluded from analysis due to 
peak overlap or there were < 13 reliable peak intensities across different Δ periods. (d–e) Δ1JNH values 
of OmpX in 8 M urea from SOFAST-IPAP-HSQC (64 scans) are compared against those of OmpX in 
8 M urea from 1JNH-modulated HSQC (40 scans) (d), and OmpX in 6 M urea from 
SOFAST-IPAP-HSQC (64 scans) (e). The expected linear correlation with gradient = 1 is shown as 
bold grey dotted lines. The light grey dotted lines represent the ± 0.35 Hz error range reported by 





Figure 4.29: Δ1JNH values for OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC 
Δ1JNH are mapped onto the solution-state NMR structure of OmpX (PDB 2M07). 






4.4 Discussion and conclusions 
This chapter has explored the feasibility of studying H-bond formation during protein folding 
by measuring 1JNH using solution-state NMR. Proof-of-concept studies for extending the 
molecular weight limit of 1JNH measurements were first performed on the 20.9 kDa 
RalAΔC-GDP. Different implementations of IPAP-HSQC and 1JNH-modulated HSQC were 
explored to study how the accuracy and precision of 1JNH were affected by the signal-to-noise 
ratio (number of scans), differential relaxation rates of in-phase and antiphase magnetisation 
(altered by the duration of the J evolution period) and lineshape (TROSY scheme). 1JNH 
measurements by IPAP-HSQC gave good correlations with H-bonds predicted by WhatIf but 
are plagued by large experimental errors. 1JNH-modulated HSQC gave small experimental 
deviations but yielded big systematic errors. The large errors in both experiments arose from 
the utilisation of a protonated (rather than deuterated) protein sample. IPAP-HSQC and 
1JNH-modulated HSQC were subsequently attempted with OmpX-DPC, but both methods 
yielded poor correlation between experimentally-determined 1JNH and H-bonds predicted by 
WhatIf. 1JNH of OmpX in urea clearly indicate the lack of stable H-bonds, and no systematic 
deviation in 1JNH measured by 1JNH-modulated HSQC. 
 
In the IPAP-HSQC experiments, the predominant source of error is inaccuracies in 
determining the peak positions of the broad anti-TROSY lines (CSA(15N)/DDNH CCR), 
leading to inaccurate 1JNH measurements from resonance splittings. Although this problem 
would also have been present in previous studies on ubiquitin (8.5 kDa; [201]) using the 
same NMR pulse scheme, the much larger sizes of RalAΔC-GDP (20.9 kDa) and 
OmpX-DPC (39.2 kDa; [285]) complex appears to have exacerbated the problem due to the 
substantially increased linewidth of the 15N-anti-TROSY line, leading to much larger 
experimental errors. 
 
A positive offset of 0.2–0.4 Hz was observed in Δ1JNH values derived from 1JNH-modulated 
HSQC. This positive offset is consistent with and bigger than (as expected) the reported 
~0.1 Hz deviation in 1JNH values of 15N-labelled ubiquitin compared to those of 
[15N,2H]-enriched ubiquitin, and residues containing two vs. one β proton show greater 
discrepancy [367]. This discrepancy was not due to magnetisation evolution with CCR during 






the long selective pulse, because similar 1JNH were obtained for non-deuterated and 
deuterated ubiquitin at different magnetic fields, in which the length of the selective pulse for 
achieving the same inversion bandwidth was substantially different [367]. This would 
indicate that the discrepancy in 1JNH values observed for OmpX are likely to also be due to 
incomplete refocusing of certain CCR pathways or more complicated relaxation mechanisms, 
possibly attributable to “forbidden” magnetisation transfer pathways and concomitant change 
in peak intensities and periodicity of the intensity modulation. Closer examination of the 
pulse sequence suggests that CSA(15N)/DDNR was active in 1JNH-modulated HSQC (and 
variations thereof), and could be the major contributor towards the systematic error 
(Figure 4.30). A possible solution is to apply one aliphatic proton-selective inversion pulse on 




Figure 4.30: Active cross-correlated relaxation mechanisms in IPAP-HSQC and 1JNH-modulated 
HSQC implementations 
The J coupling evolution periods of the different experiments are extracted from Figures 4.2 and 4.4. 
CSA(15N)/DDNH is active in IPAP-HSQC experiments. CSA(15N)/DDNR is active in 1JNH-modulated 
HSQC experiments. Other CCR mechanisms are, in principle, refocused. 
 
Differential relaxation rates of in-phase and antiphase magnetisation also contributes towards 
inaccuracies in 1JNH-modulated HSQC. Although the final signal detected in the 1H channel 
originates from the refocused in-phase operator after the J evolution period, anti-phase 
magnetisation is still generated at various points in the pulse sequence. The larger relaxation 






rate constants of anti-phase magnetisation contribute towards faster signal intensity decay and 
an apparent leftward-shift of 1JNH-modulated intensity curves, hence giving an apparent 
positive deviation for most Δ1JNH of RalAΔC-GDP and OmpX-DPC measured by 
1JNH-modulated HSQC. 
 
Interestingly, the 0.2–0.4 Hz offset in Δ1JNH of the 20.9 kDa RalAΔC-GDP measured by 
1JNH-modulated HSQC were not observed in comparable measurements performed with 
OmpX in 8 M urea. This likely reflects that in denatured OmpX, (1) there is lack of 
correlation between rotational correlational time and molecular weight, and (2) CCR is 
reduced due to loosened restrictions on dihedral angles, in turn, less favourable internuclear 
distances and geometry in 15N-Hα/β dipoles. These observations can be supported by the small 
discrepancy in 1JNH of glycines and flexible residues reported for non-deuterated vs. 
deuterated ubiquitin [367]. 
 
It was initially conceived that method optimisation would enable measurement of 1JNH in 
folded and denatured pSRII. This would have provided a good foundation for complementary 
studies on identifying the donor and acceptor atoms of individual H-bonds and characterising 
H-bond geometries by measuring 3hJNC’ couplings. Such studies have not been pursued, since 
the results from this chapter indicate that very big experimental errors will be expected for 
protonated samples of pSRII in c7-DHPC (~70 kDa; [216]). Perdeuterated membrane protein 
samples, preferably reconstituted in deuterated detergents, must be utilised for future 1JNH 
studies. The methodology for optimising NMR pulse sequences in this chapter would provide 
a solid foundation for reassessing the effects of different parameters on the precision and 
accuracy of 1JNH measurements. Depending on the sensitivity of 1JNH measurements on 
perdeuterated samples, future studies could include correlation of experimentally-determined 
1JNH with different H-bond or protein backbone geometries from solution-state NMR 
structures, and other J-coupling constants. Future studies could also include determining the 













Studies on protein assembly from complementary fragments have underpinned the two-stage 
model and the long-range interactions model for α-helical membrane protein folding. The 
native chromophore and proton-pumping function of bacteriorhodopsin can be successfully 
reconstituted by assembling complementary combinations of proteolytic fragments [124,125] 
and/or complementary synthetic peptides [126,127], or complementary or overlapping 
fragments which have been individually expressed in and purified from E. coli [128]. 
Absence of any transmembrane segments results in abolishment of pigment formation. These 
results suggest that the transmembrane helices are indispensable in the folding of 
bacteriorhodopsin while the loop regions are dispensable, despite having some contribution 
towards the stability of folded bacteriorhodopsin [128]. On the other hand, refolding of 
rhodopsin from helical fragments has only been shown using fragments which are separated 
in the second or the third cytoplasmic loops, indicating the indispensability of the remaining 
loops in the folding process [136]. Extracellular loops are important for the folding of 
rhodopsin. In vitro folding studies [135,137,138] suggest that interactions between the 
extracellular and transmembrane domains constitute a “folding core” which is important in 
the early stages of folding. Moreover, most point mutations [382] which cause Retinitis 
Pigmentosa, a retinal degenerative disease due to misfolding of rhodopsin [383], are located 
in the extracellular loops [139]. 
 
The aim of this chapter is to establish a method for assembling pSRII from complementary 
fragments in vivo, with the vision of applying said method towards studying the roles of 
individual loops and helices in the folding pathway of pSRII. 
 
Inteins are proteins encoded within a precursor, and are capable of excising themselves from 
the precursor after translation and ligating the flanking amino acid sequences with a peptide 
bond. This process is called protein trans-splicing [384]. In their native biological contexts, 






inteins are embedded into the open reading frame of host proteins. The host protein 
sequences which flank the intein are called exteins. Full-length inteins contain the N- and 
C-terminal splicing domains which flank a homing endonuclease domain that is not required 
for splicing. Mini inteins lack the endonuclease domain [385,386]. 
 
Split inteins can be naturally-occurring or generated artificially by splitting contiguous inteins. 
They consist of separately-encoded N- and C-terminal fragments (IntN and IntC), which first 
assemble and are then excised, and the N- and C-exteins are joined together. 
Naturally-occurring split inteins generally have a relatively long IntN (~100–120 residues) 
and a short IntC (~35 residues) [386]. The cyanobacterial DnaE intein family is the largest 
known class of split inteins. In their biological contexts, DnaE split inteins assemble the 
catalytic subunit of DNA polymerase III (DnaE). Several members of this family, including 
DnaE from Synechocystis sp. strain PCC6803 (Ssp) and Nostoc punctiforme (Npu), have been 
well-characterised, and carry out protein trans-splicing with high efficiency, thus making 
them ideal tools for protein engineering [387]. 
 
Split intein fragments interact through a multiphase “capture and collapse” process [388]. 
The Npu DnaE IntC is highly flexible, based on NMR relaxation experiments and poor 
dispersion in the [1H,15N] HSQC. IntN is comprised of two structurally distinct lobes, formed 
by residues 1–50 (IntN1) and 51–102 (IntN2), respectively. The initial association (“capture”) 
between IntN and IntC is mediated by electrostatic interactions of the disordered and highly 
basic (pI = 9.7) IntC with the extended and highly acidic IntN2. The two disordered regions are 
hypothesised to provide larger capture radii for enhanced probability for association. The 
IntN2-IntC complex is an intermediate with secondary structure and intermolecular 
interactions resembling half of the native intein complex. The N- and C-terminal fragments 
associate with low nanomolar affinity for both Ssp [389] and Npu [390] split inteins. Next, 
the flexible regions “collapse” into an ordered state, as evidenced by the more compact nature 
of IntN2 upon binding to IntC as determined by SEC-MALS. The intermediate is further 
stabilised by hydrophobic interactions between IntC and the well-ordered IntN1, as IntC 
intercalates between IntN1 and IntN2 to form an interwoven topology. Effectively, the 
disordered regions of the precursors provide enhanced probability for association and access 
to an interwoven topology in trans, while the combination of electrostatic and hydrophobic 






interactions in the IntN-IntC complex contributes towards the fast on-rate and slow off-rate of 
the complex. Formation of a stable complex is crucial for the subsequent multistep splicing 
reaction. 
 
A self-catalysed mechanism was proposed based on mutagenesis and chemical cleavage 
studies on an in vitro splicing system which contains the contiguous intein from the DNA 
polymerase of the archaeon Pyrococcus species GB-D (Psp pol intein-1) [391]. In the study, 
mutations were used to block various steps in the protein splicing pathway, allowing each 
step to be studied independently by isolating and analysing the splicing precursors, 
intermediates and products. 
 
Upon association between IntN and IntC, a conserved Cys or Ser at the N-terminus of IntN 
initiates a nucleophilic attack on the carbonyl carbon of the C-terminal N-extein residue [384] 
(Figure 5.1). Next, an N-to-O/S acyl shift leads to the transfer of the N-extein to the 
side-chain of the first residue of the C-extein (the +1 residue), forming a linear (thio)ester 
intermediate. This acyl shift is mediated by a conserved threonine and histidine in the TxxH 
motif of IntN, along with the aspartate in the DHNF motif in IntC [392]. The nucleophilic +1 
residue of the C-extein attacks the (thio)ester bond of the linear intermediate, resulting in the 
formation of a branched ester intermediate, where the N-extein is linked to the C-extein by an 
(thio)ester bond. The last residue of IntC, typically Asn, forms a cyclic structure, whereby 
IntC is cleaved off from the branched intermediate. His-125 in the DHNF motif acts as the 
general acid/base in the resolution of the branched intermediate, and is completely conserved 
in the DnaE family [393,394]. Asn cyclisation is the rate-limiting step for trans-splicing by 
Ssp DnaE [395], whereas all steps occur with similar rates for Npu DnaE [394]. The last step 
is a spontaneous S–N acyl rearrangement between the (thio)esterified exteins because peptide 
formation is more energetically favourable, resulting in the final formation of the peptide 
bond and yielding the ligated host protein [384]. After trans-splicing, the three flanking 
amino acids at each end of the split intein are included in the ligated product, and are referred 
to as the intein “scar” [396]. 
 
There are several variations of the canonical trans-splicing mechanism [392]. Inteins which 
lack the nucleophilic Cys or Ser in IntN (e.g. KlbA family of inteins) cannot initiate splicing 






through formation of the linear (thio)ester intermediate. These inteins could directly form the 
branched intermediate upon N-terminal activation given that the N-terminal peptide bond of 
IntN is destabilised or twisted, making it more susceptible to nucleophilic attack [397]. 
Alternatively, a different branched thioester intermediate could be formed using a unique Cys 
in IntC [398]. A few inteins also have Glu or Asp rather than Asn as the last residue of IntC. 
The reaction would theoretically proceed through the same chemical mechanism [392], albeit 
with the formation of a different cyclic by-product and with different efficiency – molecular 
dynamics simulations suggest that an Asn side-chain samples the conformation required for 
nucleophilic attack more frequently than a Gln side-chain [399].  
 
There are two common side reactions which compete against protein trans-splicing [391] 
(Figure 5.2). N-extein cleavage can occur when an external nucleophile, commonly water or 
a thiol, attacks the linear or branched (thio)ester intermediates to yield free N-extein. C-extein 
cleavage can occur when the C-terminal Asn cyclises prior to formation of the branched 
intermediate, releasing the C-extein. Mutation of critical intein or extein residues, or 






Figure 5.1: Canonical protein trans-splicing mechanism utilised by split inteins 
The N-precursor (exteinN–inteinN fusion) and C-precursor (exteinC–inteinC fusion) proteins are 
expressed from separate plasmids. Upon association of inteinN and inteinC (step 1), an N–S acyl shift 
involving the first residue of inteinN occurs (step 2). The linear thioester intermediate is attacked by 
the first residue of exteinC (step 3), resulting in trans-thioesterification reaction and formation of a 
branched thioester intermediate. At this stage, inteinN is physically separated from exteinN. The last 
residue of inteinC (usually Asn) circularises to form a succinimide ring (step 4), effectively cleaving 
inteinC from the thioesterified exteins. A spontaneous S–N acyl shift between the esterified exteins 
leads to peptide bond formation between exteinN and exteinC (step 5). Figure adapted from [384]. 
 















Figure 5.2: Mechanisms for N-terminal and C-terminal cleavage side reactions 
(a) C-terminal cleavage results from cyclisation of Asn (last residue of inteinC) prior to formation of 
the branched intermediate. Asn cyclisation can also occur prior to or after N-terminal cleavage. (b) 
N-terminal cleavage results from ester bond hydrolysis in the linear or branched thioester 
intermediates. Figure adapted from [391]. 
 






Inteins are generally tolerant to a wide range of extein sequences, and can therefore be 
applied towards trans-splicing of different non-native protein fragments. Several extein 
residues which are proximal to the intein sequence can greatly influence the efficiency of the 
splicing reaction. The native splice site of Npu DnaE is Ala(–3)-Glu(–2)-Tyr(–1)/Cys(+1)-
Phe(+2)-Asn(+3), where residues with negative numbers are from the N-extein, residues with 
positive numbers are from the C-extein and the slash represents the splice junction. These six 
residues constitute the scar upon splicing. A study on different combinations of –3 to +3 
extein residues with the Npu DnaE intein has been done using genetic selection for 
kanamycin resistance conferred by successful assembly of C. diphtheriae aminoglycoside 
phosphotransferase (Aph) [396]. The range of N-terminal extein sequences is very broad, 
with the importance of flexibility being noted from the abundance of Gly hits at the –3 and –2 
positions. This is consistent with the importance of the disordered nature of Npu DnaE IntN2 
in mediating its association with IntC. Different amino acids, including Ser, Asn, Tyr, Phe, 
His, Asp, Glu, Lys and Gln, can be accommodated as the –1 residue with little influence on 
the splicing activity [400]. The +1 residue (the first residue in the C-extein) must contain a 
thiol or hydroxyl group (i.e. Cys, Ser or Thr) for successful formation of the linear and 
branched (thio)ester intermediates. Large specificity preferences have been observed at the 
+2 and +3 positions. Sequences containing Trp and Met at the +2 position can splice as 
efficiently as the native extein. The crystal structure of the Ssp DnaE intein (PDB 1ZDE) 
shows close packing of the native Phe(+2) against His-125 of the DHNF motif in IntC, 
thereby stabilising His-125. MD simulations show that mutations at the +2 position alter the 
dynamics and side-chain rotamer conformations of His-125, and positioning of the 
C-intein/C-extein junction relative to the His-125 loop. These changes affect the rate at which 
the branched intermediate can be resolved [394]. There is a preference at the +3 position for 
residues similar to the natural Asn, including Tyr, Asp, Gln and Glu [396]. Hence, 
trans-splicing using the Npu DnaE split intein can be performed for a range of extein 
sequences, suggesting the potential applicability of this split intein system with minimal/no 
introduction of scar sequences. 
 
Npu DnaE intein shows robust trans-splicing activity with an efficiency of >98% such that 
little precursor proteins remain, and is more efficient than that of Ssp DnaE. Npu DnaE also 
shows greater tolerance to extein sequence variations, hence widening its application [387]. 






Npu DnaE with native flanking extein sequences has fast trans-splicing kinetics, with an 
apparent rate constant (K) of 0.63 ± 0.07 min-1 and a t1/2 of 66 s at 30 °C. Several non-native 
extein sequences display comparable or faster trans-splicing rates relative to the native extein 
sequence. For example, the extein sequence used for studies in this chapter, Ala-Glu-
Lys/Cys-Trp-Leu is reported to have K = 0.9 ± 0.3 min-1 and t1/2 = 46 s at 30 °C [396].  
 
Protein trans-splicing can be performed both in vitro and in vivo because it is an 
auto-catalytic process which requires only the formation of active split intein for protein 
ligation. There are two approaches for in vitro protein trans-splicing. Precursor fragments can 
be purified in their denatured forms and refolded in vitro to restore protein trans-splicing 
activity. Alternatively, native chemical ligation involves ligation of a soluble precursor 
containing an α-thioester with the other precursor bearing an N-terminal cysteine. Both 
methods require separate preparation of precursor fragments and extensive optimisation of 
ligation conditions. 
 
In comparison, protein trans-splicing in vivo does not require individual preparation of 
precursor fragments nor any additional chemical reagents, and is therefore less 
labour-intensive. Given its convenience and versatility, in vivo protein trans-splicing has 
been used successfully in a wide range of applications [401], including segmental isotope 
labelling for NMR studies [400,402], ligation of synthetic molecules (e.g. fluorescent tags) to 
proteins (protein semi-synthesis) [403], selective chemical modification of proteins [404], 
and production of cyclic peptides and proteins [405]. 
 
The two precursors can be co-expressed or expressed sequentially (dual-expression) in E. coli. 
To function, the two split intein fragments must find one another efficiently and form a stable 
complex which can persist throughout the multistep protein trans-splicing reaction, which 
may vary from seconds to hours between different naturally and artificially split inteins 
[395,401,406–408]. The first crucial step is to define an appropriate location to divide the 
protein-of-interest into two segments [400]. The split site is usually taken as a linker region 
connecting domains within the protein-of-interest to minimise structural disruption. Since a 
short sequence corresponding to the intein scar would be inserted and these proximal extein 
residues greatly influence the splicing yield, appropriate sequences near the splicing junctions 






must be chosen for both the N- and C-exteins to ensure high splicing efficiency and rate 
whilst minimising disruption to the native structure of the protein-of-interest. 
 
The appropriate cloning strategy must then be applied in order to obtain the appropriate 
constructs. The expression system developed by the Iwai lab is a dual-expression system 
designed for in vivo segmental isotopic labelling [400]. The N- and C-terminal precursors are 
cloned into two separate plasmids such that their expression are induced by different inducers. 
It is important to optimise expression conditions to obtain high yields of the N- and 
C-terminal precursors. Protein trans-splicing must be tested in small-scale expression tests, in 
which the timing of inductions, growth temperatures and concentrations of inducers must be 
optimised for maximising ligation products in SDS-PAGE analysis [400]. While splicing of 
native host proteins is very rapid and precursor proteins are rarely detected in nature, splicing 
of heterologous host proteins often results in unreacted precursor or splice junction cleavage 
by-products, thus yielding multiple bands on SDS-PAGE.  
 
The solubility of precursor proteins fused with split intein fragments could be a limiting 
factor. At least one of the two precursors must be soluble for successful trans-splicing. 
Previous studies have assumed that protein trans-splicing might be more efficient in the 
cytosol since the intein segments would have higher degrees of freedom for achieving the 
required orientation to associate with each other. Trans-splicing of membrane proteins is 
particularly challenging. The precursors must remain stable and soluble in the cytosol until 
protein trans-splicing occurs, and the ligated protein must then translocate and insert into the 
membrane fraction to ensure functional folding [228]. It remains unclear whether protein 
trans-splicing could occur once the precursors have localised to the membrane fraction. The 
signal peptide sequence can be omitted to inhibit fast membrane insertion of the N-precursor. 
Solubility enhancement tags, such as yeast Smt3 protein [409], glutathione S-transferase 
(GST), B1 domain of the immunoglobulin-binding protein G (GB1) [410] and 
maltose-binding protein (MBP) [411], can be attached to enhance expression yield and 
solubility of each fragment. These tags should ideally be removed or produced in the 
unlabelled form for NMR studies to avoid spectral crowding. Potential structural perturbation 
of the fusion protein due to the presence of these tags must also be carefully evaluated [400]. 
 






Trans-splicing could also continue during protein purification under conditions which permit 
co-purification of the unspliced precursor proteins [402]. The Npu DnaE split intein is highly 
robust, and has been shown to give at least 65% yield at temperatures from 6 to 37 °C and in 
the presence of up to 6 M urea [401]. Optimisation of reaction conditions for longer 
incubation of precursor proteins in vitro could also help improve the yield of ligated product. 
 
In this chapter, assembly of functional pSRII was attempted in E. coli using two 
complementary fragments of pSRII which are fused with the N- and C-terminal Npu DnaE 
split intein. Successful production of ligated pSRII with covalently-bound retinal 
chromophore absorbing at the correct wavelength would indicate that the splice site has 
minimal effects on pSRII folding. The ligated pSRII should purify in a similar manner as 
WT-pSRII, hence circumventing the need for extensive optimisation of the purification 
protocol. With suitable control experiments and method for quantifying the yield of ligated 
pSRII, protein trans-splicing using split intein can be further applied towards studying the 
roles of individual loops and helices in the folding of pSRII in vivo. 
 
 







5.2.1 Construct design 
Design of precursor constructs involve selecting a split site in pSRII and appropriate residues 
which flank the intein fragments, both of which are critical in ensuring successful and 
efficient protein trans-splicing. Ideally, there should be minimal/no differences between the 
ligated product and full-length pSRII mutant which accounts for insertion of intein ligation 
scar residues. 
 
The loop regions in pSRII were assessed to identify a suitable splice site. Microbial 
rhodopsins have three extracellular and three intracellular loops. Several loops are known to 
have important roles in the structure and function of pSRII. For example, the interaction of 
pSRII with its cognate transducer, pHtrII, is directly mediated by the EF loop [412,413] and 
also leads to chemical shift changes in the FG loop of pSRII [278]. A study on chimeras of 
pSRII and bacteriorhodopsin shows important roles of the DE loop in the positioning of 
helix E and, in turn, colour tuning of the two proteins [414]. Splitting pSRII in loop regions 
with known involvement in the structure and function of pSRII could adversely affect protein 
stability, and are not ideal candidates for proof-of-concept studies on the application of split 
inteins. The stability of individual helices or helical fragments must also be considered. 
While this information is unavailable for pSRII, circular dichroism of individual fragments of 
bacteriorhodopsin in DMPC/DHPC bicelles shows that the C-terminal CD, CE, DE, DG, EG 
and FG fragments do not form helices of the expected lengths, with the FG fragment 
displaying high amount of non-native β-sheet conformation [415]. Splitting pSRII at 
N-terminal loops might be more preferable, although it must be noted that the stability of 
helical fragments depends on amino acid sequence and the membrane environment. 
 
The BC loop was chosen as the splice site in this study. The BC loop is usually the longest 
loop and its conformation is varied the most amongst different microbial rhodopsins. 
Superposition of the Cα traces of pSRII, bacteriorhodopsin and halorhodopsin shows marked 
differences in the BC loops of the three proteins [336]. The BC loops of pSRII and 
bacteriorhodopsin [214] are organised as β-hairpins and cap the extracellular side of the 
proteins. In pSRII, the hairpin is partially sealed by hydrogen bonds between Arg-66 and 






residues at the end of helix D (Figure 5.3b). The corresponding Arg-82 in Haloquadratum 
walsbyi bacteriorhodopsin shows unique a H-bonding network with Thr-201, which links the 
BC and FG loops to shield the retinal-binding pocket from the extracellular environment 
[416]. Amino acid sequence alignment shows that the BC loop of pSRII is one of the shortest 
amongst those of microbial rhodopsins from different halobacteria [417]. This might suggest 
that the BC loop of pSRII could be tolerant towards extra residues being inserted as the intein 
ligation scar. The sequences of the Npu DnaE splice junction is Ala-Glu-Tyr/Cys-Phe-Asn. 
To avoid disruption of H-bonds between the two β-strands of the hairpin structure, the splice 
site was introduced in the linker region between the strands. This linker region consists of the 
residues Ala-64, Glu-65 and Arg-66 in WT-pSRII. To minimise the number of inserted 
residues, the construct encoding for the N-precursor was designed such that Ala-64 and Glu-
65 of pSRII were positioned as the –3 and –2 residues of the N-extein. Only 2 out of the 
21 combinations of extein sequences investigated by Cheriyan et al. contain Ala and Glu at 
the –3 and –2 positions: Ala-Glu-Tyr/Cys-Phe-Asn (the native extein sequence; abbreviated 
as AEY/CFN) and Ala-Glu-Lys/Cys-Trp-Leu (AEK/CWL). The latter was chosen in this 
investigation because (1) the Lys at the –1 position is chemically more similar to Arg-66 of 
WT-pSRII, and (2) the AEK/CWL extein sequence yields slightly faster protein 
trans-splicing kinetics [396]. The construct encoding for the C-precursor was designed to 
preserve Arg-66, considering its potential importance in anchoring the BC loop in place via 
H-bonds. In short, in the final ligated product, the residues KCWL would be inserted between 
the original Glu-65 and Arg-66, thus lengthening the linker region of the hairpin by four 
residues (Figure 5.3a). 
 
Next, the appropriate affinity tags must be incorporated for the purposes of detecting 
expression yield, identifying ligation products and protein purification. The C-precursor and 
ligated pSRII-KCWL are both His6-tagged and have similar molecular weights (25.7 kDa and 
27.0 kDa, respectively). This indicates potential problems with resolving the two species on 
SDS-PAGE and Western blots probing only for the His6 tag. A Strep-tag II was therefore 
added to the N-terminus of the C-precursor. Expression of the C-precursor yields a 25.7-kDa 
band which is detectable by probing for His6 and Strep tags. With successful ligation, the 
C-intein is cleaved from the C-precursor along with the Strep tag. In principle, this would 
lead to decreased intensity of the 25.7-kDa band (detectable by both His6 and Strep probes) 






and the appearance of bands at 5.5 kDa and 13.1 kDa corresponding to the excised C-intein 
and N-intein, respectively, both of which are detectable only by Strep probe (Figure 5.3c). 
 
To summarise, constructs were designed to encode for pSRIIN(KCWL)-DnaEN-Strep (the 
N-precursor) under the control of the T7 promoter in a pET28b(+) vector, and 
Strep-DnaEC-pSRIIC(KCWL)-His6 (the C-precursor) under the control of the 
arabinose-inducible PBAD promoter in a pBad vector. These constructs were produced by 
PCR and Gibson assembly using the dual-expression system made available by the Iwai lab 




Figure 5.3: Constructs for in vivo trans-splicing of pSRII 
(a) 2D representation of the secondary structure of pSRII. Lys-205, the site of retinal Schiff base 
attachment, is circled in red. To ensure efficient trans-splicing reaction by Npu DnaE split intein, the 
four residues Lys-Cys-Trp-Leu (KCWL) were inserted in the middle of the BC loop and constitute the 
splice junction. Helices which are part of the N-precursor are coloured blue, and those in the 
C-precursor are coloured red. (b) The BC loop of pSRII forms a β-hairpin structure. The side-chains 
of residues 64–66, which join the two β-strands of the hairpin, are shown using stick representation. 
The side-chain of Arg-66 forms H-bonds with the backbone carbonyls of Ala-116 and Val-118 at the 
end of helix D (PDB 1H68; [336]). This Arg residue was therefore preserved in the C-precursor to 
minimise structural changes. The splice site is indicated with an arrow. (c) Schematic diagram 
illustrating in vivo protein trans-splicing of two fragments of pSRII using Npu DnaE split intein. The 
N-precursor consists of helices A–B, the first β-strand of the hairpin constituting the BC loop, DnaEN 
and a Strep tag. The C-precursor consists of a Strep tag, DnaEC, the second β-strand in the BC loop, 
helices C–G and the C-terminal tail of pSRII followed by a His6 tag. Upon successful trans-splicing, 
both Strep tags and the intein should be excised, yielding full-length pSRII(KCWL)-His6. 
 








5.2.2 Expression and purification of full-length pSRII-KCWL 
To confirm the stability and retinal-binding function of the ligated protein with insertion of 
four non-native residues (Lys-Cys-Trp-Leu, or KCWL) in the BC loop as the intein scar, a 
full-length pSRII-KCWL mutant with the same BC loop was prepared. pSRII-KCWL in 
pET28b(+) vector was obtained by site-directed mutagenesis of WT-pSRII. The protein was 
expressed and purified in a similar manner as WT-pSRII, up to and including the 60-h 






incubation at 55 °C to precipitate contaminating proteins (see Materials & Methods). The 
retinal chromophore of pSRII-KCWL had a similar absorption profile as WT-pSRII, with 
λmax = 498 nm and visible shoulder peaks at 460 and 420 nm indicative of a tight retinal 
binding pocket. 
 
Assuming the same extinction coefficient at 498 nm, pSRII-KCWL in DDM had an 
estimated purity of 69%, whereas WT-pSRII in DDM typically has 75–85% purity (78% in 
Figure 5.4b). Misfolded pSRII-KCWL absorbing at 390 nm was clearly observable. In an 
attempt to separate well-folded pSRII-KCWL (λmax = 498 nm) from the misfolded species, 
the sample was subjected to size exclusion chromatography (Figure 5.4c). Absorption at 498, 
390 and 280 nm were monitored in order to determine the proportion of well-folded 
pSRII-KCWL with respect to the total protein concentration of each eluted fraction. Each 
eluted fraction was analysed by UV/vis spectroscopy and SDS-PAGE (Figure 5.4d–e). 
Fractions 9–11 showed predominantly well-folded pSRII-KCWL, with minimal amounts of 
misfolded protein. The proportion of misfolded protein was higher in later fractions, as 
evidenced by the increasing intensity of the 390-nm peak. The two species could not be 
completely separated. The later elution of misfolded species suggests that, on average, fewer 
DDM monomers surround these species compared to well-folded protein. This could perhaps 
be attributed to the low DDM concentration (0.05%) being used in the gel filtration buffer.  
 
To determine the stability of pSRII-KCWL, the protein was incubated at 25, 35 and 45 °C for 
16 h, showing nearly identical UV/vis spectra before and after incubation. This indicates that 
pSRII-KCWL was stable under the examined conditions, thus providing a benchmark for 
assessing the stability of trans-spliced pSRII-KCWL. 
 







Figure 5.4: Purification of full-length pSRII-KCWL 
(a) SDS-PAGE showing the expression and purification of full-length pSRII-KCWL. Lane 1, 50 µM 
WT-pSRII in c7-DHPC; lane 2, molecular weight marker (M); lane 3, whole cell lysate (WCL) of 
uninduced Tuner(DE3)LacI cells; lane 4, WCL after pSRII-KCWL was expressed for 8 h at 30 °C; 
lane 5, cytoplasmic fraction of lysed culture; lane 6, DDM-insoluble fraction solubilised using 
3% SDS + 9 M urea; lane 7, fraction which could not be bound to Ni-NTA beads; lanes 8–9, 
flow-through from washing pSRII-KCWL bound to Ni-NTA beads with Buffer S (lane 8) and Buffer 
W1 (lane 9); elution with Buffer W2 (lanes 10–11), Buffer E300 (lanes 12–13) and Buffer E (lanes 
14–15) before and after heat incubation. (b) UV/vis spectra of WT-pSRII (black) and pSRII-KCWL 
before (lime) and after (teal) size exclusion chromatography, scaled according to absorbance at 280 
nm. (c) Size exclusion chromatography trace for pSRII-KCWL purification using a Superdex 200 
Increase 10/300 GL column running at 0.5 ml/min at 4 °C. Each eluted fraction was 1 ml. 
 







Figure 5.4: Purification of full-length pSRII-KCWL (cont.) 
(d) UV/vis spectra of fractions 8–15 eluted from size exclusion chromatography of pSRII-KCWL. 
Fractions 9–11 had the greatest proportions of well-folded pSRII-KCWL (λmax = 498 nm) and little 
misfolded species (λmax = 390 nm). The proportion of misfolded species increased in later fractions. (e) 
SDS-PAGE gel for fractions 8−15. M: molecular weight marker; L: pre-gel filtration sample. (f) 
UV/vis spectra of pSRII-KCWL in DDM incubated at different temperatures for 16 h, demonstrating 










5.2.3 Test expression 
To maximise the yield of the ligated product, individual test expression of 
pSRIIN(KCWL)-DnaEN-Strep and Strep-DnaEC-pSRIIC(KCWL)-His6 were conducted to 
identify the optimal temperature and inducer concentration for expressing the two precursors. 
 
For Strep-DnaEC-pSRIIC(KCWL)-His6, expression at 18, 25 and 37 °C, both in the absence 
and presence of retinal, were first attempted (Figure 5.5). Whole cell lysates were analysed 
by SDS-PAGE and Western blotting using HisProbe-HRP conjugate. The whole cell lysate of 
an uninduced sample showed no expression. Fast onset of expression was observed within 
1 h after addition of 0.1% L-arabinose. Test expression was monitored for up to 20 h to 
determine the stability of the C-precursor, should prolonged expression times be required for 
maximal yield of ligated product in dual-expression of both precursors. Overnight expression 
at 37 °C led to significant degradation of the expressed C-precursor, while similar yields 
were obtained at 18 and 25 °C. Most of the C-precursor localised to the crude membrane 
fraction (Figure 5.6). Some of the protein expressed at 18 °C could be observed in the soluble 
fraction, although it is unclear whether this is due to bona fide partial localisation to the 
cytosol or due to the protein being solubilised by detergents in the RIPA buffer. Similar 
results were obtained regardless of the absence or presence of all-trans retinal during 
expression. The expression levels of the C-precursor upon induction by adding 0.05, 0.1 and 
0.2% L-arabinose at 18 °C were also assessed (Figure 5.7). A gradual accumulation of the 
C-precursor was observed for all conditions, with induction by 0.05% L-arabinose yielding 
the fastest accumulation of the C-precursor. Although an N-terminal Strep-tag II was cloned 
into the construct, the StrepTactin-HRP probe did not yield very visible bands despite the 
probe being reported as suitable for detecting N-terminal, C-terminal and internal Strep-tag II. 
This suggests that either the expression levels of the C-precursor were not ideal despite 
extensive attempts at optimisation, or the binding of StrepTactin-HRP probe to the 
N-terminal Strep-tag II was weak. It would therefore be impractical to attempt detecting 
protein trans-splicing by monitoring the depletion of the C-precursor. 
 
Expression of pSRIIN(KCWL)-DnaEN-Strep was first monitored at 18, 25 and 30 °C for up to 
20 h (Figure 5.8a–b). Higher temperatures were not tested given the low yield of the 
C-precursor after overnight expression at 37 °C. All-trans retinal was not added in expression 






trials of the N-precursor, since the absence of Lys-205 would preclude formation of the 
retinal Schiff base. Western blot analysis shows very small amount of leaky expression in the 
uninduced whole cell lysate, and fast onset of N-precursor expression within 1 h after adding 
1 mM IPTG. Out of the three temperatures, overnight expression at 18 °C gave the greatest 
yield. The N-precursor appeared to oligomerise, regardless of lysing the E. coli culture by 
sonication in Buffer A with 5 mM TCEP-HCl (Figure 5.8a) or using RIPA buffer 
(Figure 5.8b) (see Materials & Methods). This indicates that oligomerisation was not due to 
the presence of SDS in RIPA buffer (cf. oligomerisation of SDS-denatured pSRII in 
Chapter 2) or formation of disulphide bonds between protomers. Despite the presence of 
oligomeric species, there was a higher proportion of monomeric N-precursor which should 
remain accessible for trans-splicing. The effects of using different concentrations of IPTG 
(0.1, 0.3 and 1 mM) for inducing N-precursor expression at 18 °C were also studied. There 
was little difference in expression yield across the three conditions, although 0.1 mM IPTG 
gave arguably slightly greater yield. Almost all of the expressed N-precursor localised to the 
crude membrane fraction (Figure 5.8c). 
 
In summary, out of the conditions examined, expression of Strep-DnaEC-pSRIIC(KCWL)-
His6 was optimal at 18 °C in the presence of 0.05% L-arabinose, and expression of 
pSRIIN(KCWL)-DnaEN-Strep was optimal at 18 °C in the presence of 0.1 mM IPTG. Both 
precursors localised to the membrane fraction. 
 







Figure 5.5: Optimising expression temperature for Strep-DnaEC-pSRIIC(KCWL)-His6 
The C-precursor was expressed in Tuner(DE3)LacI cells at different temperatures (18, 25 and 37 °C), 
both with (a) and without (b) supplementation of all-trans retinal at 2-h intervals. Expression was 
induced by the addition of 0.1% L-arabinose at OD600 = 0.8–1.0, and monitored for up to 20 h. The 
C-precursor was detected from whole cell lysates by Western blotting using HisProbe-HRP. 
M: molecular weight marker; U: uninduced whole cell lysate; positive control: 0.1 µM WT-pSRII in 
c7-DHPC. The arrows indicate the expected migration of the C-precursor and WT-pSRII. 
 







Figure 5.6: Localisation of Strep-DnaEC-pSRIIC(KCWL)-His6 
The C-precursor was expressed in Tuner(DE3)LacI cells at different temperatures (18, 25 and 37 °C), 
both with (a) and without (b) supplementation of all-trans retinal at 2-h intervals. The C-precursor 
was detected from whole cell lysates (W), soluble fraction (S) and crude membranes (P) by Western 
blotting using HisProbe-HRP. M: molecular weight marker; U: uninduced whole cell lysate; positive 
control: 0.1 µM WT-pSRII in c7-DHPC. The arrows indicate the expected migration of the 
C-precursor and WT-pSRII. 
 
 







Figure 5.7: Optimising inducer concentration for Strep-DnaEC-pSRIIC(KCWL)-His6 
The C-precursor was expressed in Tuner(DE3)LacI cells at 18 °C, with supplementation of all-trans 
retinal at 2-h intervals. Expression was induced by adding 0.05, 0.1 or 0.2% L-arabinose, and 
monitored for up to 20 h. The C-precursor was detected from whole cell lysates by Western blotting 
using HisProbe-HRP (a) and StrepTactin-HRP (b). M: molecular weight marker; U: uninduced whole 
cell lysate. 0.1 µM WT-pSRII in c7-DHPC was used as the positive control in panel a, and as the 











Figure 5.8: Optimising expression conditions of pSRIIN(KCWL)-DnaEN-Strep 
(a–b) Expression of the N-precursor in Tuner(DE3)LacI cells was induced by adding 1 mM IPTG. 
Expression at different temperatures (18, 25 and 30 °C) was monitored for up to 20 h. Cells were 
lysed by sonication in Buffer A (a) or by incubation in RIPA buffer (b), and expression levels were 
assessed using whole cell lysates. (c) Expression at 18 °C was induced by adding different 
concentrations of IPTG (0.1, 0.3 and 1 mM). Expression yield and localisation of the N-precursor 
were assessed using whole cell lysates (W), soluble fraction (S) and crude membranes (P). For all 
panels, the N-precursor was detected by Western blotting using StrepTactin-HRP. M: molecular 
weight marker; U: uninduced whole cell lysate; negative control: 0.1 µM WT-pSRII in c7-DHPC. 
The arrows indicate the expected migration of the N-precursor, WT-pSRII and dimeric N-precursor. 
 







Dual-expression of the N- and C-precursors was attempted using the optimal expression 
conditions identified from individual test expressions of the two precursors. Four conditions 
were tested to further optimise dual-expression (Table 5.1). Several factors which might 
affect the yield of ligated pSRII-KCWL were examined, including the presence (condition 1) 
vs. absence (condition 2) of all-trans retinal, the order in which expression of the two 
precursors were induced (condition 3), and expression temperature (condition 4). Given the 
stable membrane localisation of both precursors, the order of expression could be important 
for determining the final yield of the ligated product. Ideally, the precursor which localises 
slower to the membrane should be expressed first, such that this precursor is available within 





Temperature (°C) All-trans retinal 
1 C-precursor 18 P 
2 C-precursor 18 - 
3 N-precursor 18 
P 
only upon expression 
of C-precursor 
4 C-precursor 
25 °C for 8 h 
18 °C overnight 
P 
 
Table 5.1: Conditions tested for dual-expression of pSRIIN(KCWL)-DnaEN-Strep and 
Strep-DnaEC-pSRIIC(KCWL)-His6 
 







Figure 5.9: Schematic illustration of different patterns in SDS-PAGE upon dual-expression. 
(a) N-precursor only. (b) C-precursor only. (c) Dual-expression without successful trans-splicing. (d) 
Dual-expression with successful trans-splicing. (e) Dual-expression with trans-splicing and 
trans-cleavage. Figure was produced using ChemDraw (PerkinElmer). 
 
Aliquots were taken from cell cultures at specific time-points, and expression yield was 
analysed by probing for His6-tagged and Strep-tagged proteins on Western blots. In principle, 
successful protein trans-splicing can be assessed from the appearance of additional bands 
which are different from the two precursor proteins (Figure 5.9d). If splicing occurs with 100% 
efficiency and equal amounts of both precursors, only one new dominant band corresponding 
to the ligated product would be observed and all precursors would be depleted. In practice, it 
is not trivial to obtain equal expression of both precursors, so at least one of the precursors 
would still be observable on SDS-PAGE. Detection of ligated pSRII-KCWL was difficult. 
The C-precursor (25.7 kDa) and ligated pSRII-KCWL (27.0 kDa) have very similar 
molecular weights (Figure 5.9d), thus hampering straightforward detection of the ligated 
product by probing for His6-tagged protein on Western blot. The Strep-tagged C-intein 
(excised upon successful trans-splicing) has molecular weight of 5.5 kDa, which would have 
been too small to be detected by 12% SDS-PAGE. In principle, the difference in molecular 
weight between the excised Strep-tagged N-intein (13.1 kDa) and the N-precursor (19.9 kDa) 






could provide sufficient resolution of the two species by SDS-PAGE. However, no bands 
were observed below 15 kDa, possibly indicating that trans-splicing was not successful. On 
the other hand, the high expression levels of the N-precursor yielded very thick bands on the 
Western blots, and it is possible for membrane proteins to migrate anomalously on 
SDS-PAGE compared to their expected molecular weights. 
 
Greater amounts of leaky expression were observed in the uninduced whole cell lysates 
across all four different expression conditions. There was little difference in expression yield 
in the presence (condition 1) vs. absence (condition 2) of all-trans retinal (Figure 5.10a–b). 
This is somewhat surprising, considering the important roles of all-trans retinal in backbone 
amide dynamics and the tertiary structure of pSRII (see Chapters 2–3). Similar expression 
yields were obtained across the three conditions in which expression of the C-precursor was 
induced first, while induction of N-precursor expression prior to C-precursor expression 
(condition 3) gave slightly lower yield (Figure 5.10c–d). 
 
To summarise, dual-expression of Strep-DnaEC-pSRIIC(KCWL)-His6 and 
pSRIIN(KCWL)-DnaEN-Strep showed expression of each precursor. The inability to observe 
any excised N-intein possibly indicates that trans-splicing might not have occurred, although 
this conclusion could not be made with great certainty given the similar molecular weights of 
the precursors, ligated product and side-products. Expression yield appeared to be slightly 
higher if the C-precursor was expressed prior to the N-precursor, although all four conditions 
examined resulted in fairly comparable expression yields. 
 







Figure 5.10: Dual-expression of pSRIIN(KCWL)-DnaEN-Strep and Strep-DnaEC-
pSRIIC(KCWL)-His6 
(a–b) Expression of the C-precursor in Tuner(DE3)LacI cells was induced by adding 0.05% 
L-arabinose before expression of the N-precursor was induced by adding 0.1 mM IPTG. Expression 
was conducted at 18 °C in the presence (Condition 1) vs. absence (Condition 2) of all-trans retinal, 
and was monitored for up to 21 h. M: molecular weight marker; U: uninduced whole cell lysate. 
0.1 µM WT-pSRII in c7-DHPC was used as the positive control in panel a and as the negative control 
in panel b. In panel a, the arrows indicate the expected migration of the C-precursor, WT-pSRII and 
ligated pSRII-KCWL. In panel b, the arrows indicate the expected migration of the cleaved N-intein 
(IntN), the N-precursor, WT-pSRII and dimeric N-precursor. 
 







Figure 5.10: Dual-expression of pSRIIN(KCWL)-DnaEN-Strep and Strep-DnaEC-
pSRIIC(KCWL)-His6 (cont.) 
(c–d) Condition 3: Expression of the N-precursor in Tuner(DE3)LacI cells was induced by adding 
0.1 mM IPTG before expression of the C-precursor was induced by adding 0.05% L-arabinose. 
Expression was conducted at 18 °C in the presence of all-trans retinal for 21 h. Condition 4: 
Expression of the C-precursor in Tuner(DE3)LacI cells was induced by adding 0.05% L-arabinose 
before expression of the N-precursor was induced by adding 0.1 mM IPTG. Expression was 
conducted at 25 °C for the first 9 h and at 18 °C for the next 12 h. M: molecular weight marker; U: 
uninduced whole cell lysate. 0.1 µM WT-pSRII in c7-DHPC was used as the positive control in panel 
c and as the negative control in panel d. In panel c, the arrows indicate the expected migration of the 
C-precursor, WT-pSRII and ligated pSRII-KCWL. In panel d, the arrows indicate the expected 
migration of the cleaved N-intein (IntN), the N-precursor, WT-pSRII and dimeric N-precursor. 







Considering the aforementioned complications with detecting the ligated pSRII-KCWL, 
dual-expression of pSRIIN(KCWL)-DnaEN-Strep and Strep-DnaEC-pSRIIC(KCWL)-His6 was 
performed with 3 L of E. coli Tuner(DE3)LacI culture (Figure 5.11). Expression was 
conducted at 25 °C for the first 8 h and at 18 °C overnight. Expression of the C-precursor was 
induced first with 0.05% L-arabinose followed by induction of N-precursor expression with 
0.1 mM IPTG. All-trans retinal was supplemented at 2-h intervals for the first 8 h. 
 
 
Figure 5.11: Large-scale dual-expression in E. coli Tuner(DE3)LacI cells 
Whole cell lysates from specific time-points of overnight dual-expression were analysed by Western 
blotting using HisProbe-HRP (a) and StrepTactin-HRP (b), and by SDS-PAGE (c). M: molecular 
weight marker. 0.1 µM WT-pSRII in c7-DHPC was used as the positive control in panel a and as the 
negative control in panel b. In panel a, the arrows indicate the expected migration of the C-precursor, 
WT-pSRII and ligated pSRII-KCWL. In panel b, the arrows indicate the expected migration of the 
cleaved N-intein (IntN), the N-precursor, WT-pSRII and dimeric N-precursor. In panel c, the arrows 
indicate the expected migration of all six species which are marked in panels a and b (from low to 
high molecular weight: IntN, N-precursor, C-precursor, WT-pSRII, ligated pSRII-KCWL and dimeric 
N-precursor). 
 
Purification of putative ligated pSRII-KCWL was performed using the same method as for 
the full-length pSRII-KCWL mutant (see section 5.2.2), and aliquots taken from each stage 
of the purification protocol were analysed by SDS-PAGE and Western blotting 
(Figure 5.12a–c). The yield was alarmingly low; bands corresponding to the expected species 
were unobservable on SDS-PAGE even after concentrating the eluted fractions (W2, E and 






E300) using a 3 kDa MWCO concentrator, and must be detected by Western blotting. One 
dominant band running at ~25 kDa was observed in fractions W2, E and E300 on the 
Western blot detected with HisProbe-HRP, likely to be corresponding to the C-precursor. A 
faint band could be observed just below the dominant band, which could suggest a small 
amount of C-terminal cleavage leading to liberation of the C-extein (Figure 5.12a). 
 
A UV/vis absorption spectrum was recorded for fraction E, in which most of the protein was 
eluted. The spectrum showed clear absence of the 498-nm peak corresponding to all-trans 
retinal in a properly-folded and ligated pSRII-KCWL, providing conclusive evidence that 
protein trans-splicing was not successful in generating functional protein. The peaks detected 
in the 300- to 650-nm spectral region likely corresponded to different isomers or chemical 
modifications of retinal. It is noted that the 559-nm peak is significantly red-shifted compared 
to the reported absorption wavelengths for isomers and chemical derivatives of retinal in 
ethanol [240], and is instead closer to the range of different wavelengths reported for visual 
pigments [418]. Although it might be possible for protein trans-splicing and retinal Schiff 
base formation to have occurred without formation of a functional retinal binding pocket, this 
would be very difficult to assess by biophysical techniques or mass spectrometry due to the 
extremely low yield. 
 
The split intein method can, in principle, be applied both in vitro and in vivo. However, 
Western blot analysis shows that the C-precursor is DDM-soluble but the N-precursor is not 
(Figure 5.12b). This indicates that for future studies involving in vitro assembly of pSRII, 
different detergents and membrane mimetics must be screened to identify conditions which 
are suitable for (1) solubilising both precursors, (2) maintaining both precursors in 
conformations that are amenable for trans-splicing, and (3) maintaining the functionality of 
ligated pSRII-KCWL. 
 







Figure 5.12: Purification from E. coli Tuner(DE3)LacI cells 
Aliquots were taken from each stage of purification and analysed by Western blotting using 
HisProbe-HRP (a) and StrepTactin-HRP (b), and by SDS-PAGE (c). Lane 1, molecular weight 
marker (M); lane 2, cytoplasmic fraction of lysed culture; lane 3, DDM-insoluble fraction solubilised 
using 3% SDS + 9 M urea; lane 4, fraction which could not be bound to Ni-NTA beads; lanes 5–6, 
flow-through from washing pSRII-KCWL bound to Ni-NTA beads with Buffer S (lane 5) and Buffer 
W1 (lane 6); lanes 7–9, elution with Buffer W2, Buffer E and Buffer E300, respectively; lane 10, 
WT-pSRII in c7-DHPC. In panel a, the arrows indicate the expected migration of the cleaved 
C-extein (ExtC), the C-precursor, WT-pSRII and ligated pSRII-KCWL. In panel b, the arrows indicate 
the expected migration of the cleaved N-intein (IntN), the N-precursor, WT-pSRII and dimeric 
N-precursor. In panel c, the arrows indicate the expected migration of all seven species which are 
marked in panels a and b (from low to high molecular weight: IntN, ExtC, N-precursor, C-precursor, 
WT-pSRII, ligated pSRII-KCWL and dimeric N-precursor). (d) UV/vis spectrum of Fraction E, 
showing clear absence of the 498-nm peak expected for well-folded pSRII-KCWL. 







The C41(DE3) E. coli strain is typically used for producing proteins which express poorly or 
are toxic for BL21(DE3). C41(DE3) is suitable for the overexpression of many membrane 
proteins, although the reason for its improved characteristics is not well-understood [419,420]. 
 
Dual-expression of the N- and C-precursors in C41(DE3) cells and purification were 
performed as described previously. The onset of N-precursor expression was noted to be 
slower in C41(DE3) compared to that in Tuner(DE3)LacI cells, as the N-precursor was 
barely detectable by Western blotting even at 2 h after induction (Figure 5.13b). The 
N-precursor was predominantly DDM-insoluble, but a small fraction appeared to have 
co-purified with the C-precursor. There was extra complication with degradation of the 
C-precursor beginning from between 3 and 7 h after its expression was induced. This 
suggests that the limiting factor of this experiment could have been the low amounts of the 
C-precursor available after overnight expression. 
 
Similar to dual-expression in Tuner(DE3)LacI cells, the final yield in fraction E was also 
very low, as the expected bands were difficult to detect on SDS-PAGE. The 498-nm peak 
indicative of well-folded ligated pSRII-KCWL could not be observed either (Figure 5.13d). 
The species eluted in W2, E and E300 fractions would therefore be predominantly the 
C-precursor, with a faint band at ~20 kDa which likely corresponds to the cleaved C-extein 
(Figure 5.13a). Interestingly, an extra band running between 30 and 40 kDa was observed in 
Fraction E detected by HisProbe-HRP. The molecular weight of this band does not match any 
of the expected products (Figure 5.9). There are two possible candidates for this species: the 
branched intermediate (expected molecular weight = 32.5 kDa) or dimeric C-extein (expected 
molecular weight = 39.6 kDa). Observation of the branched intermediate is more likely, and 
would suggest that protein trans-splicing was limited by excision of the split intein, which 
should have occurred by cyclisation of Asn, the last residue of the C-intein. The stability of 
the pSRII branched intermediate in the cellular context and during purification are unknown, 
but its observation has been reported for trans-splicing mediated by the Psp pol intein-1 [391]. 
The less plausible explanation for the extra band is the observation of dimeric C-extein, 
which could suggest that significantly more C-terminal cleavage has occurred during 
expression in C41(DE3) cells, and the liberated C-extein has a tendency to dimerise. 






However, the reason behind different amounts of C-terminal cleavage in Tuner(DE3)LacI 
and C41(DE3) cells is unknown.  
 
 
Figure 5.13: Large-scale dual-expression in and purification from in E. coli C41(DE3) cells 
Aliquots were taken from specific time-points during expression and at each stage of purification, and 
analysed by Western blotting using HisProbe-HRP (a) and StrepTactin-HRP (b), and by SDS-PAGE 
(c). In panel a, the arrows indicate the expected migration of the cleaved C-extein (ExtC), the 
C-precursor, WT-pSRII, ligated pSRII-KCWL, branched intermediate and dimeric ExtC. In panel b, 
the arrows indicate the expected migration of the cleaved N-intein (IntN), the N-precursor, WT-pSRII 
and dimeric N-precursor. In panel c, the arrows indicate the expected migration of all nine species 
which are marked in panels a and b (from low to high molecular weight: IntN, ExtC, N-precursor, 
C-precursor, WT-pSRII, ligated pSRII-KCWL, branched intermediate, dimeric ExtC and dimeric 
N-precursor). (d) UV/vis spectrum of fraction E, showing clear absence of the 498-nm peak expected 
for well-folded pSRII-KCWL. 
 






5.3 Discussion and conclusions 
In this chapter, attempts were made to assemble pSRII using the Npu DnaE split intein, with 
the vision of applying this method towards studying the roles of different loops and helices in 
the folding pathway of pSRII. Protein trans-splicing in vivo was chosen because it permits 
protein assembly from complementary fragments without the need for optimising reaction 
conditions for the splicing reaction or separate purification protocols for each precursor, as 
would have been required for in vitro approaches. The splice site was introduced between the 
two β-strands in the BC loop of pSRII. The relevant constructs were cloned to encode for 
helices A–B fused with the N-terminal half of the DnaE split intein (the N-precursor) and for 
helices C–G fused with the C-terminal half of the split intein (the C-precursor). Numerous 
attempts were made to optimise the conditions for individual expression of each precursor 
and for dual-expression of both precursors using E. coli Tuner(DE3)LacI cells. However, 
large-scale dual-expression in Tuner(DE3)LacI and C41(DE3) cells did not yield well-folded 
pSRII-KCWL, as evidenced by the lack of absorption peak at 498 nm. 
 
The most important factors contributing towards successful utilisation of split intein tools are:  
(1) the yield of the ligated product, (2) the rate constant of the trans-splicing reaction, (3) the 
solubility of the precursor fragments, and (4) tolerance for non-native extein sequences [401]. 
The observations reported in this chapter can be reconciled with potential problems in the 
above factors occurring at various steps of the trans-splicing mechanism. Firstly, association 
of the two precursors was likely to have been a major limiting factor, as evidenced by the 
observation of both the N- and C-precursors but not the excised N-intein indicative of 
successful trans-splicing during small-scale and large-scale dual-expression. The fast rate of 
the trans-splicing reaction [396] suggests that trans-splicing of pSRII was unlikely to be 
limited by reaction kinetics. Instead, it is hypothesised here that very minimal amounts of the 
two precursors were in close proximity and aligned with the required orientations for stable 
association. Existing studies in literature have assumed that trans-splicing is more efficient in 
the cytosol due to greater mobility of the precursors for achieving the required orientations to 
associate with each other [228,388]. It is unknown whether trans-splicing could also occur 
once the precursors have localised to the membranes. The efficiency of trans-splicing in 
membranes is likely to be much lower as there are more stringent requirements: both 






precursors must insert into the membrane with the same orientation and their association 
would depend on lateral diffusion within the membrane bilayer, which is influenced by the 
composition of the membrane. For the case of pSRII, the low trans-splicing efficiency could 
potentially suggest fast membrane localisation of the precursors, despite the lack of signal 
peptide in both precursors. Solubility enhancement tags can be added to both precursors in 
future studies to improve the expression yield and ligation efficiency, as has been previously 
reported for proteorhodopsin [228]. Careful assessment will be required to ensure that 
addition of such tags does not interfere with the structure of each precursor. Considering that 
most α-helical membrane proteins are co-translationally inserted into the membrane 
[142,144], delaying membrane localisation of the precursors could result in protein 
misfolding and/or partitioning to inclusion bodies. Co-expression of chaperones, such as 
GroEL-GroES, might help to avoid misfolding and improve proper folding of the precursors 
[400,421]. In addition, the effects of the Npu DnaE intein fusion on the rate and orientation of 
membrane insertion of the pSRII fragments are unknown. Future studies should include 
control experiments where the reconstitution of the native chromophore is attempted by 
co-expressing and co-purifying the N-terminal and the C-terminal fragment of pSRII in the 
absence of the intein fusion. Different expression vectors could also be tested to explore 
whether the expression level of each pSRII fragment has any effects on the rate of membrane 
insertion, protein folding, and reconstitution of the native chromophore. 
 
The trans-splicing reaction might also have been hampered by unsuccessful liberation of the 
C-intein from the branched thioester intermediate, as evidenced by the extra band running 
between 30 and 40 kDa observed in fraction E purified from dual-expression in C41(DE3) 
cells. The C-intein is cleaved from the branched intermediate upon cyclisation of Asn, the 
last residue of the C-intein. The reason behind unsuccessful Asn cyclisation is unclear. Given 
the importance of the +2 residue in the C-extein in positioning His-125, the general acid/base 
of the internal cyclisation reaction, future studies would involve exploring alternative 
sequences at the splice junction. In addition, the native Npu DnaE extein sequence, 
AEY/CFN, must also be investigated as a control to ascertain whether the AEK/CWL splice 
junction sequence is suitable for trans-splicing. Further optimisation of the splice junction 
sequence could also decrease the amount of C-terminal cleavage or other side reactions. 
 






The location of the split site may also require careful evaluation in future studies. Although 
the insertion of four residues appeared to be inert in the full-length pSRII-KCWL mutant, 
introducing a split site between the two β-strands of the hairpin may interfere with the 
formation of the hairpin structure. Since the H-bonds between Arg-66 and residues in helix D 
might be important in anchoring the β-hairpin, it is proposed that an alternative split site in 
the BC loop could be introduced before the hairpin. 
 
One approach for determining the rate limiting factors of in vivo trans-splicing is attempting 
trans-splicing in vitro in the presence of defined reaction conditions and molar ratios of the 
two precursors [400,422]. However, this approach will not be trivial since the N-precursor 
was DDM-insoluble. In vitro studies would therefore require the screening of different 
detergents and buffer conditions in order to identify conditions which are suitable for 
solubilising both precursors and for functional folding of the ligated pSRII-KCWL. 
 
In summary, the studies presented in this chapter lay considerable foundation for in vivo 
assembly of pSRII using split inteins. Further optimisation likely requires exploring 
alternative extein sequences at the splice site, or selecting another location in the BC loop as 
the split site. The overarching goal of establishing these proof-of-concept studies is to 
examine how different loops and helices affect the folding pathway of pSRII. It is envisioned 
that systematic comparison of experimental results will be difficult for in vivo trans-splicing 
across different loops of pSRII, because of the high likelihood of resorting to different –3 to 
+3 extein sequences at the splice sites in different loops, and the large number of factors 
which contribute towards the stability of precursors, the yield of the ligated product, and the 
rate of protein trans-splicing. Future studies on assembling pSRII from complementary 







6 Concluding remarks and future 
directions 
 
Considerable progress has been made towards understanding the folding process of 
membrane proteins by experimental and computational methods over the past few decades. 
The challenging nature of membrane protein folding studies remains evident from the small 
number of such studies available in literature compared to soluble protein folding studies.  
 
The blueprints for proteins to obtain their native folds are, in principle, embedded in their 
sequences. Existing studies on bacteriorhodopsin and bovine rhodopsin have led to the 
proposal of the two-stage model and the long-range interactions model for α-helical 
membrane protein folding. These studies raise intriguing questions which serve as the driving 
questions of this thesis – Do structurally homologous membrane proteins have the same 
folding mechanism? What factors underpin different folding mechanisms being adopted by 
membrane proteins? 
 
Chapters 2 and 3 have provided detailed insights on the unfolding and refolding mechanisms 
of pSRII, an archaeal member of the rhodopsin family. The SDS-denatured, acid-denatured 
and apo-sensory opsin states were characterised using biophysical techniques and 
solution-state NMR. pSRII remained largely helical when unfolded, and tertiary structure was 
disrupted. The loss of native retinal-protein contacts led to changes in backbone amide 
dynamics, with increased amount of intermediate timescale exchange observed across 
different parts of the protein depending on the unfolding condition employed. There are very 
few solution-state NMR studies on the denatured states of full-length membrane proteins. 
Future studies will also require experimental techniques which provide sufficient structural 
and time resolution particularly for characterising motions in the µs–ms timescale, which are 
important in helix-helix interactions. Kinetic studies on the unfolding and refolding of pSRII 
in SDS/diheptanoylphosphatidylcholine (c7-DHPC) mixed detergent micelles demonstrated 
pSRII as one of the very few membrane proteins which refolds from SDS-denatured states 
via a non-two-state mechanism, thus distinguishing pSRII from the two-state folder, 
bacteriorhodopsin, and bovine rhodopsin, for which the SDS-denatured state has evaded 






in vitro refolding in existing literature. This is the first demonstration of a heptahelical 
transmembrane protein folding via a complex non-two-state mechanism. 
 
The detailed molecular insights on pSRII illustrate the diversity of folding mechanisms 
across the rhodopsin family and α-helical membrane proteins. Existing studies in literature 
and the results presented in this thesis have demonstrated that studying the native fold alone 
is insufficient to account for the diverse folding mechanisms across the rhodopsin family. In 
the soluble protein folding field, many experimental studies have been performed to compare 
the folding pathways of proteins with similar tertiary structures but divergent sequences 
[423,424]. Quantitative comparisons of folding transition state structures, determined by 
ϕ-value analysis of folding kinetics, show that certain proteins, such as the SH3 domains and 
Ig-like domains, share common transition state structures within the families, whereas other 
proteins, such as Suc1 and Cks1, possess rather different transition state structures despite 
high sequence and structural similarities. Specific native tertiary structures impose different 
constraints on the choice of folding pathways, yielding a continuum of different extents of 
transition state structure conservation. It has been theorised that the transition states of 
proteins with diverse folding pathways are influenced more by variations in protein sequence 
and local structural propensity, thus leading to differences in how the native tertiary structure 
is formed [423,424]. 
 
Detailed studies on transition states have thus far been sparse for membrane proteins due to 
challenges in identifying conditions which permit reversible unfolding in vitro. Having 
demonstrated reversible unfolding of pSRII in Chapter 2, future experiments should include 
ϕ-value analysis to compare the transition state structures of pSRII against those of other 
rhodopsin family members. Extending the summarised findings from the soluble protein field 
to membrane protein folding studies, the caveat with direct comparison of folding pathways 
across the rhodopsin family is that although all rhodopsin family members are composed of 
seven transmembrane helices with a covalently-bound retinal chromophore (i.e. similar 
topologies), there are notable differences in interhelical packing and loop structures 
(i.e. differences in tertiary structure) between microbial and metazoan rhodopsins. These 
structural differences may already partially account for different unfolding and refolding 
mechanisms elucidated by in vitro studies. In addition, there is no detectable sequence 






homology between microbial and metazoan rhodopsins, although there is clear sequence 
identity within the respectable groups [425]. Future studies on the folding mechanisms of 
G protein-coupled receptors (GPCRs), which have the same topology and highly similar 
tertiary structure to metazoan rhodopsins, might yield better insights on how sequence 
variation and native tertiary structure contribute towards the folding pathway respectively. In 
fact, a recent study on the refolding of the β1-adrenergic receptor (β1AR) on a solid support 
shows that the protein cannot be refolded from the SDS-denatured state whereas urea 
denaturation is reversible, indicating different responses to urea but similar irreversibility of 
SDS-denaturation compared to bovine rhodopsin [109]. It is hoped that exploring the folding 
mechanisms of more heptahelical membrane proteins will ultimately shed insights as to 
which aspects of the folding mechanism (e.g. folding nucleation sites, transition states or 
roles of particular residues) are conserved between structurally homologous proteins and 
between evolutionarily related proteins. 
 
As discussed in Chapters 2 and 3, comparable membrane mimetics and experimental 
conditions should ideally be used in comparative studies of folding mechanisms across 
different membrane proteins. A set of experimental conditions has been recommended to 
standardise and facilitate comparison of soluble protein folding studies [426]. Although 
similar guidelines will likewise be highly valuable for comparative studies of membrane 
protein folding, identifying conditions which permit reversible unfolding/refolding studies for 
any particular membrane protein is already a laborious trial-and-error process of finding the 
suitable membrane mimetics and buffer conditions, let alone proposing standardised 
conditions which are applicable across multiple membrane proteins [18]. It is therefore 
paramount to further study the molecular properties of different mimetics and the 
determinants of solubility and functionality of membrane proteins [427]. For example, a 
recent study has explored the effects of different membrane mimetics on urea-mediated 
unfolding of LeuT, including different detergent micelles, liposomes and lipid bilayers [110]. 
 
H-bonding is one of the major stabilising forces for protein structure. Accurate descriptions 
of transient H-bonds in denatured states and the processes of H-bond formation during 
protein folding will provide valuable information about the folding pathway. In Chapter 4, 
1JNH measurements were performed to assess H-bonding in folded and denatured membrane 






proteins, albeit with somewhat limited success due to challenges with data precision and/or 
accuracy attributable to cross-correlated relaxation. Utilisation of perdeuterated samples and 
further optimisation of pulse sequences will provide more conclusive assessment of the 
applicability of 1JNH measurements towards studying H-bonding and obtaining detailed 
molecular insights on the structures of transition states and folding intermediates. 
 
One of the key differentiators of the two-stage model vs. the long-range interactions model is 
the contribution of loop regions towards membrane protein folding. Analysis of the crystal 
structures of 41 α-helical membrane proteins shows significant variations in the 
extramembranous regions [428]. 53% of the loops are found to be stretched, and impose 
geometrical constraints on the distances between the two connected helices. Non-stretched 
loops tend to prefer conformations which keep hydrophobic residues buried. Such 
conformational preferences may be extended into the transmembrane regions, thus affecting 
the assembly of surrounding helices and not just the consecutive ones. Such hydrophobic 
interactions therefore constitute as long-range interactions. For 70% of the membrane 
proteins investigated, at least one side is significantly affected by such long-range 
interactions driven by the compacting of longer loops [428].  
 
Experimental assessment of the roles of loops in protein folding has traditionally been 
performed by assembling different complementary fragments with the protein being split at 
different loop regions. In Chapter 5, attempts were made, albeit unsuccessfully, to assemble 
pSRII using split intein. Improving the yield of the ligated product would require careful 
choice of protein sequences constituting the splice junction and possible utilisation of 
solubilisation enhancement tags. In future studies, it would be valuable to study how protein 
sequence and local structure propensities influence the contribution of different loops towards 
short- and long-range interactions in the contexts of protein folding and stability. 
 
It must be emphasised that the biological context of protein folding is much more complex 
than the in vitro experimental systems which are currently employed in soluble and 
membrane protein folding studies. Additional factors include in vivo folding rates, 
co-translational folding and insertion into the membrane, interactions with chaperones and 
other protein quality control mechanisms, and subcellular localisation. In recent years, novel 






approaches have been developed for studying the folding and membrane insertion of 
ribosome nascent chains during in vitro cell-free expression [429] and from structural studies 
on purified ribosome-SecY protein complexes with nascent membrane protein chains [430]. 
These approaches hold great promise for obtaining structural and mechanistic insights on 
membrane protein folding and the roles of different biological factors. 
 
In summary, the current opinion is that “the devil is in the details” when it comes to 
understanding how membrane proteins fold. It is anticipated that combined in vitro, in silico 
and in vivo approaches will continue to play instrumental roles in elucidating the complex 













A Materials and methods 
A.1 Media and Buffers 
A.1.1 Molecular biology 
Medium Composition 
TF1 10 mM MOPS (pH 6.8), 10 mM CaCl2 
TF2 10 mM MOPS (pH 6.8), 75 mM CaCl2 
TF3 50 mM MOPS (pH 7.5), 75 mM CaCl2, 5% glycerol, 1 mM EDTA, 100 mM KCl 
LB 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl 
LB Agar 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 17.5 g/L bacto-agar 
2TY 16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl 
M9 (pSRII) 
[216] 
47.7 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM NaCl, 4 µM ZnSO4, 1 µM MnCl2, 
0.7 µM H3BO3, 0.7 µM CuSO4, 2 µM FeCl3, 5 µM MgSO4, 100 µM CaCl2, 
0.5% glucose, 0.1% 15NH4Cl, 50 mg/L kanamycin, 34 mg/L chloramphenicol 
M9 (OmpX) 47.7 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM NaCl, 1 µM FeCl3, 2 mM MgSO4, 
100 µM CaCl2, 50 µM ZnSO4, 1 mg/L biotin, 1 mg/L choline chloride, 1 mg/L folic 
acid, 1 mg/L niacinamide, 1 mg/L D-pantothenate, 1 mg/L pyridoxal-HCl, 0.1 mg/L 
(-)riboflavin, 5 mg/L thiamine, 0.6% glucose, 0.1% 15NH4Cl, 30 mg/L kanamycin 
 




Native loading dye (2×) 62.5 mM Tris-HCl (pH 6.8), 25% glycerol, 0.01% bromophenol blue 
RIPA 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% SDS, 1% Triton 
X-100, 0.5% sodium deoxycholate, 1 mM TCEP-HCl 
NuPAGE® transfer buffer 25 mM Bicine, 25 mM bis-tris, 1 mM EDTA, 0.05 mM chlorobutanol, 
10% (one blot) or 20% (two blots) methanol 
Tris-buffered saline (TBS) 25 mM Tris-HCl (pH 7.2), 150 mM NaCl 
Tris-buffered saline with 
Tween-20 (TBST) 
25 mM Tris-HCl (pH 7.2), 150 mM NaCl, 0.05% Tween-20 
 
Table A.2: Composition of buffers for biochemistry techniques 
 






A.1.3 Protein purification 
Protein Buffer Composition 
pSRII 
Buffer A 50 mM Tris-HCl (pH 8.0), 5 mM MgCl2 
Buffer S 50 mM MES-NaOH (pH 6.5), 300 mM NaCl, 5 mM imidazole 
Buffer W1 50 mM MES-NaOH (pH 6.5), 300 mM NaCl, 25 mM imidazole 
Buffer W2 50 mM MES-NaOH (pH 6.5), 300 mM NaCl, 50 mM imidazole 
Buffer E 50 mM Tris-HCl (pH 7.0), 300 mM NaCl, 150 mM imidazole 
Buffer E300 50 mM Tris-HCl (pH 7.0), 300 mM NaCl, 300 mM imidazole 
Buffer N7 20 mM NaH2PO4/Na2HPO4 (pH 7.0), 50 mM NaCl, 0.05% NaN3 
Buffer N6 50 mM NaH2PO4/Na2HPO4 (pH 6.0), 50 mM NaCl, 0.05% NaN3 
OmpX 
Buffer TE 20 mM Tris-HCl (pH 8.0), 5 mM EDTA 
Buffer G 50 mM Tris-HCl (pH 8.5), 100 mM NaCl, 5 mM EDTA, 6 M GdnHCl 
Buffer U 20 mM Tris-HCl (pH 8.5), 5 mM EDTA, 8 M Urea 
Buffer R 50 mM Tris-HCl (pH 8.5), 5 mM EDTA, 0.5 M L-arginine-HCl, 0.5% DPC  
Buffer D 20 mM Tris-HCl pH (8.5), 5 mM EDTA, 100 mM NaCl 
Buffer N 20 mM NaH2PO4/Na2HPO4 (pH 6.8), 100 mM NaCl, 5 mM EDTA 
Buffer X 20 mM NaH2PO4/Na2HPO4 (pH 6.5), 8 M urea, 0.1 mM NaN3 
 
Table A.3: Compositions of buffers used for protein purification 
MES = 2-(N-morpholino)ethanesulphonic acid 
Tris = Tris(hydroxymethyl)aminomethane 
 
 
A.2 Molecular Biology 
A.2.1 Sensory rhodopsin II (pSRII) 
The wild type full-length sensory rhodopsin II psopII gene (EMBL-EBI accession number 
CAI50508) from Natronomonas pharaonis was previously cloned between the NcoI and 
XhoI sites of the pET-28b(+) vector (Novagen), which adds the amino acid sequence 
LEHHHHHH to the C-terminus and also carries a kanamycin resistance gene. The clone was 
obtained from Prof. Javier Navarro (University of Texas Medical Branch, Galveston, USA). 
pSRII expression is under the control of a T7 promoter. The final construct encodes residues 
1–241 of Natronomonas pharaonis pSRII plus the C-terminal hexahistidine (His6) tag: 
MVGLTTLFWL GAIGMLVGTL AFAWAGRDAG SGERRYYVTL VGISGIAAVA 5 0  
YAVMALGVGW VPVAERTVFV PRYIDWILTT PLIVYFLGLL AGLDSREFGI 1 0 0 
VITLNTVVML AGFAGAMVPG IERYALFGMG AVAFIGLVYY LVGPMTESAS 1 5 0 
QRSSGIKSLY VRLRNLTVVL WAIYPFIWLL GPPGVALLTP TVDVALIVYL 2 0 0 
DLVTKVGFGF IALDAAATLR AEHGESLAGV DTDTPAVADL EHHHHHH 2 4 7 







A.2.2 Outer membrane protein X (OmpX) 
The plasmid used for expressing OmpX was a gift from Prof. Sebastian Hiller (Biozentrum, 
University of Basel). The plasmid was constructed by inserting the N-terminally truncated 
OmpX gene from E. coli strain K-12 (Uniprot P0A917), encoding for amino acids 24-171 of 
OmpX, into a pET-28b(+) vector (Novagen) containing a kanamycin resistance gene. OmpX 
expression is under the control of a T7 promoter. 
The encoded sequence for Met-OmpX(24–171) is: 
MATSTVTGGY AQSDAQGQMN KMGGFNLKYR YEEDNSPLGV IGSFTYTEKS 5 0  
RTASSGDYNK NQYYGITAGP AYRINDWASI YGVVGVGYGK FQTTEYPTYK 1 0 0 
HDTSDYGFSY GAGLQFNPME NVALDFSYEQ SRIRSVDVGT WIAGVGYRF 1 4 9 
 
A.2.3 Cloning pSRIIN(KCWL)-DnaEN and DnaEC-pSRIIC(KCWL) 
The pSKDuet01 (Addgene plasmid #12172) and pSKBAD2 (Addgene plasmid #15335) 
plasmids [387] were gifts from Dr. Hideo Iwai (University of Helsinki, Finland). 
Amplification of whole vectors and insert sequences by polymerase chain reaction (PCR) 
were performed with Phusion DNA polymerase (New England BioLabs). The reaction mix 
(prepared on ice) (Table A.4) and thermocycle parameters (Table A.5) were defined 
according to manufacturer’s instructions. Sequences of the DNA primers, annealing 
temperature and extention time are defined in Table A.7. 
 
Component Volume (µl) Final Concentration 
Nuclease-free water 30–34   
5× Phusion HF buffer 10.0 1× 
10 mM dNTPs 1.0 200 µM 
10 µM Forward primer 2.5 0.5 µM 
10 µM Reverse primer 0 or 2.5 0.5 µM 
Template DNA 0.5–2.0 10 ng plasmid DNA 
DMSO 1.5 3% 
Phusion DNA polymerase 0.5 1 unit 
Total Volume 50  
 
Table A.4: Composition of PCR reaction mix 
 
 






Step Temperature (°C) Time 







30 s per kb 
Final extension 72 10 min 
Hold 4-10 ∞ 
 
Table A.5: Thermocycle parameters 
 
pSRIIN and pSRIIC were first inserted into pSKDuet01 and pSKBAD2 by ligation 
independent cloning. The insert sequences were PCR-amplified from pET28b(+)-pSRII-His6. 
The vectors were linearised by PCR. The appropriate pairs of PCR-amplified inserts and 
vectors (boxed pairs in Table A.7) were then assembled by Gibson assembly (New England 
BioLabs) according to the manufacturer’s instructions. The reaction mix (Table A.6) was 
prepared on ice, and the mixture was incubated for 1 h at 50 ºC. 
 
Component Volume 
Insert 3–5 µl unpurified PCR product 
Vector 1 µl unpurified PCR product 
Gibson assembly master mix (2×) 10 µl 
Deionised H2O 4–6 µl 
Total volume 20 µl 
 
Table A.6: Gibson assembly reaction mix 
 
2–4 µl of the Gibson assembly reaction mix was then transformed into competent E. coli 
DH5α cells. DNA sequence was confirmed by Sanger DNA sequencing (DNA Sequencing 
Facility, Department of Biochemistry, University of Cambridge). 
 
Strep-tag II insertion before pSRIIC, insertion of the appropriate sequences for the splice site, 
and insertion of a flexible linker sequence (Ser-Ala) between the start codon and Strep-tag II 
before pSRIIC, were all achieved by single primer PCR. Strep-tag II insertion after pSRIIN 
was achieved by encoding the Strep-tag II as the 5’ overhangs of the forward and reverse 






primers. 2 µl of each of these PCR products were transformed directly into E. coli DH5α 
cells as un-ligated plasmids, and the sequence confirmed by Sanger DNA sequencing. 
 
The final constructs encoded the following sequences: 
 
pET28b(+)-pSRIIN(KCWL)-IntN-Strep: 
MVGLTTLFWL GAIGMLVGTL AFAWAGRDAG SGERRYYVTL VGISGIAAVA 50 
YAVMALGVGW VPVAEKCLSY ETEILTVEYG LLPIGKIVEK RIECTVYSVD 100 
NNGNIYTQPV AQWHDRGEQE VFEYCLEDGS LIRATKDHKF MTVDGQMLPI 150 
DEIFERELDL MRVDNLPNSA WSHPQFEK   178 
 
pBad-Strep-IntC-pSRIIC(KCWL)-His6: 
MSAWSHPQFE KSAMIKIATR KYLGKQNVYD IGVERDHNFA LKNGFIASNC 50 
WLRTVFVPRY IDWILTTPLI VYFLGLLAGL DSREFGIVIT LNTVVMLAGF 100 
AGAMVPGIER YALFGMGAVA FIGLVYYLVG PMTESASQRS SGIKSLYVRL 150 
RNLTVVLWAI YPFIWLLGPP GVALLTPTVD VALIVYLDLV TKVGFGFIAL 200 
DAAATLRAEH GESLAGVDTD TPAVADLEHH HHHH  232 
 
A.2.4 Insertional mutagenesis 
Insertion of the residues Lys-Cys-Trp-Leu (KCWL) into pET28b(+)-pSRII-His6 was 
achieved by single primer PCR. 2 µl PCR products were transformed directly into E. coli 
DH5α cells as un-ligated plasmids, and the sequence confirmed by Sanger DNA sequencing. 
The final construct encodes: 
MVGLTTLFWL GAIGMLVGTL AFAWAGRDAG SGERRYYVTL VGISGIAAVA 5 0  
YAVMALGVGW VPVAEKCWLR TVFVPRYIDW ILTTPLIVYF LGLLAGLDSR 1 0 0 
EFGIVITLNT VVMLAGFAGA MVPGIERYAL FGMGAVAFIG LVYYLVGPMT 1 5 0 
ESASQRSSGI KSLYVRLRNL TVVLWAIYPF IWLLGPPGVA LLTPTVDVAL 2 0 0 




Table A.7: Primers 
Pairs of insert and vector used in Gibson Assembly reactions are boxed. Other PCR products were 
transformed into E. coli DH5α cells as un-ligated plasmids. Regions of primer sequences which 
anneal to their respective templates are shown in red font. 











































































site insertion - 
ATAGCTTCTAATTGTTGGCTCCG







CCATCCGC 70 141 
pET28b(+)-pSRII-KCWL-His6 
pET28b(+)-pSRII-
His6 Insert KCWL - 
GTTCCCGTGGCCGAAAAGTGTTG
GCTCCGGACTGTTTTCGTC 52 179 
 
 







Glycerol stocks of E. coli Tuner(DE3)LacI cells (Novagen) and BL21(DE3) cells (Novagen) 
were made competent using the CaCl2 method [431]: 0.2 ml of an overnight culture was 
added to 10 ml 2TY and grown at 37 ºC until OD600 = 0.4–0.6. Cells were pelleted (4000 × g, 
10 min, 4 ºC), resuspended in 7 ml ice-cold 0.1 M CaCl2, kept on ice for 1 h, pelleted again, 
resuspended in 0.5 ml ice-cold 0.1 M CaCl2, and incubated with ~100 ng DNA on ice for 30 
min. The cells were heat-shocked (42 °C for 90 s, then on ice for 3 min). 0.7 ml LB was 
added and the cells were incubated at 37 °C for 45 min. Transformed cells were grown 
overnight at 37 °C on LB agar with the appropriate antibiotics. 
 
E. coli C41(DE3) cells were a gift from George Sophocleous. 0.2 ml of an overnight culture 
of C41(DE3) cells was added to 10 ml 2TY and grown at 37 ºC until OD600 = 0.4–0.6. Cells 
were pelleted (4000 × g, 10 min, 4 ºC), resuspended in 10 ml TF1, pelleted again, 
resuspended in 1 ml TF2, and kept on ice for 16 h. 1 µl (~100 ng) DNA was added to 100 µl 
of super-competent cells and 99 µl TF3. The mixture was incubated on ice for 45 min. The 
cells were heat-shocked (42 °C for 10 min, then on ice for 3 min). 0.7 ml LB was added and 
the cells were incubated at 37 °C for 45 min. Transformed cells were grown overnight at 




A.3.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was carried out according to Laemmli [432]. Gels were poured in 1.0 mm 
mini-gel casettes (NC2010, Thermo Fisher Scientific) with the components of the stacking 
gel and the resolving gel detailed in Table A.8. 
 
Protein samples were mixed with the appropriate volume of 4× NuPAGE® LDS sample 
buffer (Thermo Fisher Scientific) for denaturing SDS-PAGE. Alternatively, 2× native 
loading dye [270] was used for the analysis of aggregation states in unfolded protein samples. 
SDS-PAGE analysis was performed on a 12% polyacrylamide gel (Table A.8) at 90 V for 15 
min followed by 180 V for 40 min in NuPAGE® MES SDS running buffer (Thermo Fisher 






Scientific). PageRuler prestained protein ladder (10–180 kDa) (Thermo Fisher Scientific) was 
used as molecular weight markers. Protein bands were visualised using InstantBlue 
(Expedeon) or the Pierce™ Silver Stain Kit (Thermo Fisher Scientific) according to 
manufacturers’ instructions. 
 
Ingredient 12% Resolving gel 6% Stacking gel 
milliQ-H2O 1.69 ml 1 ml 
40% acrylamide 1.75 ml 0.3 ml 
2% bis-acrylamide 0.93 ml 0.15 ml 
0.5 M Tris-HCl (pH 6.8) - 0.5 ml 
1.5 M Tris-HCl (pH 8.8) 1.5 ml - 
10% SDS 60 µl 20 µl 
10% APS 60 µl 20 µl 
TEMED 6 µl 2 µl 
 
Table A.8: Compositions of stacking gel and resolving gel for SDS-PAGE 
SDS: electrophoresis grade sodium dodecyl sulphate (Sigma-Aldrich); APS: ammonium persulphate; 
TEMED: tetramethylethylenediamine 
 
A.3.2 Western blot 
Proteins separated by SDS-PAGE were transferred onto Immobilon®-P (PVDF) membranes 
with 0.45 µm pore size (Merck Millipore) according to protocol from Invitrogen, using 
NuPAGE® transfer buffer, at a constant voltage of 30 V for 1 h at room temperature. 
Membranes were blocked with 2.5% bovine serum albumin (BSA) in TBST buffer with 
gentle agitation for 1 h at room temperature or overnight at 4 °C. 50 µg/ml avidin was also 
added to the blocking solution to minimise detection of endogenous biotin carrier proteins 
during Strep-tag II detection. For His6-tag detection, membranes were washed for 2 × 10 min 
with TBST, incubated in 1:5000 dilution of HisProbeTM-HRP (horseradish peroxidase) 
conjugate (Thermo Fisher Scientific) for 1 h at room temperature, and washed for 4 × 10 min 
with TBST. For Strep-tag II detection, membranes were washed for 3 × 5 min with TBST, 
incubated in 1:10000 dilution of Precision Protein™ StrepTactin-HRP Conjugate (Bio-Rad 
Laboratories) for 1 h at room temperature, and washed for 2 × 5 min with TBST and once for 
5 min in TBS. Signals were developed using PierceTM ECL Western Blotting substrate 










A.4 Protein expression and purification 
A.4.1 pSRII 
Expression of pSRII in E. coli Tuner(DE3)LacI cells (Novagen) was performed as described 
by Gautier et al [216]. Single transformed colonies from an LB agar plate were inoculated 
into 50 ml LB media with 34 µg/ml chloramphenicol and 50 µg/ml kanamycin, and incubated 
overnight (37 °C, 200 rpm). Each overnight culture was then transferred to 500 ml LB media 
to give starting OD600 = 0.1. Cells were grown at 37 °C with shaking at 200 rpm until 
OD600 = 0.8–1.0. Expression of pSRII was induced by adding 1 mM IPTG. The cells were 
further incubated for 10 h at 25 °C, 200 rpm, with 10 µM all-trans retinal (Sigma-Aldrich; 
dissolved in absolute ethanol and kept at -20 °C in the dark) supplemented at 2 h-intervals. 
Cells were centrifuged (5000 × g, 20 min, 4 °C) and the cell pellets were frozen (–20 °C). 
 
For the expression of uniformly 15N-labelled pSRII, M9 media was used for overnight starter 
cultures and for protein expression (Table A.1). For the expression of 19F-5-Trp-labelled 
pSRII, 60 mg L-1 5-fluoroindole (Sigma-Aldrich; dissolved in sterile DMSO) [334] was 
added to un-induced cultures at OD600 ≈ 0.8. The cultures were further incubated at 37 °C, 
200 rpm for 10 min before pSRII expression was induced by adding 1 mM IPTG and 10 µM 
all-trans retinal was supplemented at 2 h-intervals for 10 h, as described for the expression of 
unlabelled pSRII. 
 
The cells were resuspended in 1/40th of the original culture volume in ice-cold lysis Buffer A 
with protease inhibitor cocktail (Sigma-Aldrich, P2714). The lysate was passed thrice 
through an Emulsiflex-C5 High Pressure Homogeniser (Avestin, Inc.) operating at 50 Psi. 
Crude membranes were pelleted by ultracentrifugation (100,000 × g, 90 min, 4 °C) and 
resuspended in 1/75th of the original culture volume in Buffer S with protease inhibitor 
cocktail (Sigma-Aldrich). The suspension was homogenised on ice (T18 basic 
ULTRA-TURRAX®, IKA®). 1.5% n-dodecyl-β-D-maltoside (DDM) (Melford) was added 






and the solution solubilised by rotation (in the dark, 16 h, 4 °C). Insoluble material was 
removed by ultracentrifugation (100,000 × g, 60 min, 4 °C). 
 
Ni-NTA agarose beads (Qiagen) (4 ml beads per litre of culture) were equilibrated with 
5 column volumes (CV) milliQ water, followed by 5 CV Buffer S. The beads were mixed 
with the supernatant containing solubilised membrane proteins and lipids by rotation (in the 
dark, 2.5 h, 4 °C). Beads were filtered out using gravity-flow columns (BioRad Econo-Pac 
columns) and washed with 25 CV Buffer S, 25 CV Buffer W1 and 7.5 CV Buffer W2. All 
wash buffers were ice-cold and contained 0.06% DDM. 
 
The protein was eluted in 2.5 CV Buffer E, followed by 2 CV Buffer E300, both containing 
with 0.1% DDM. The sample was concentrated to 0.5–1 ml using 50 kDa cut-off centrifugal 
concentrators (Sartorius) and heated to precipitate impurities (55 °C, 60 h). The sample was 
then resuspended in Buffer N7 + 0.03% DDM, and centrifuged to pellet precipitated 
impurities. 
 
The protein was mixed by rotation (in the dark, 2.5 h, 4 °C) with Ni-NTA beads that were 
pre-equilibrated in Buffer N7. The beads were filtered out using gravity-flow columns, and 
washed with 50 CV Buffer N7 to remove DDM. 2 CV Buffer N7 was retained in each 
column and 0.6% 1,2-diheptanoyl-sn-glycero-3-phosphocholine (c7-DHPC) (Avanti Polar 
Lipids or Anatrace) was added before the sample was mixed by rotation (in the dark, 16 h, 
4 °C). The flow-through was discarded and the column was washed with 50 CV Buffer N7 
with 0.1% c7-DHPC. The protein was eluted with 2.5 CV Buffer N6 + 0.1% c7-DHPC + 300 
mM Imidazole. Imidazole was removed from the eluted protein by at least 3 rounds of 
concentration/dilution in a centrifugal concentrator (50 kDa cut-off) using 60 ml Buffer N6 + 
0.1% c7-DHPC. The final sample was concentrated to ~500 µl. Additional c7-DHPC (from a 
20% c7-DHPC stock solution) was added to the sample to achieve a final c7-DHPC 
concentration of ~2%. 
 
Expression and purification of pSRII-KCWL were performed as described for WT-pSRII. 
Size exclusion chromatography was done using a Superdex 200 Increase 10/300 GL column 






(GE Healthcare) equilibrated in Buffer N6 + 0.05% DDM and running at 0.5 ml/min at 4 °C. 
Each eluted fraction was 1 ml. 
 
A.4.2 pSRIIN(KCWL)-IntN-Strep and Strep-IntC-pSRIIC(KCWL)-His6 
Different expression temperatures, order of induction, and inducer concentrations were 
screened, as detailed in Chapter 5. For test expressions, single transformed colonies from an 
LB agar plate were inoculated into 10 ml LB media with the appropriate antibiotics, and 
incubated overnight (37 °C, 200 rpm). Each overnight culture was then transferred to 80 ml 
LB media to give starting OD600 = 0.1. Cells were grown at 37 °C with shaking at 200 rpm 
until OD600 = 0.8–1.0. Expression of pSRIIN(KCWL)-IntN-Strep or Strep-IntC-
pSRIIC(KCWL)-His6 were induced by addition of IPTG or L-arabinose, respectively. 5 ml 
aliquots of cell culture which were taken at specific time-points, and the final ~40 ml cultures 
were centrifuged (4000 × g, 10 min, 4 °C). All cell pellets were kept frozen (–20 °C) before 
being used for Western blotting. 
 
To obtain whole cell lysates for Western blotting, the cell pellets were resuspended in 
ice-cold RIPA buffer and kept on ice for 1 h. The amount of RIPA buffer used for each 
sample was based on the OD600 measured by UV/vis spectroscopy and cell density was 
adjusted to the equivalent of a final OD600 = 5.0. The lysed cells were mixed with 
4× NuPAGE® LDS sample buffer (Thermo Fisher Scientific) and analysed by SDS-PAGE 
and Western blotting. 
 
The pellets from the final ~40 ml E. coli cultures were used for determining the cellular 
localisation of the expressed proteins. Each pellet was resuspended in 5–10 ml RIPA buffer, 
with the volume adjusted to yield comparable cell density across samples. The suspension 
was left on ice for 1 h. Unlysed cells were pelleted by centrifugation at low speed (1000 × g, 
4 °C, 10 min). The supernatant was ultracentrifuged (100,000 × g, 4 °C, 90 min) to pellet the 
crude membranes. The resulting pellet was resuspended and incubated with rotation in the 
original volume of RIPA buffer + 1.5% DDM for 30 min at room temperature. The samples 
were mixed with 4× NuPAGE® LDS sample buffer (Thermo Fisher Scientific) and analysed 
by SDS-PAGE and Western blotting. 
 






For large-scale (3 L) co-expression in E. coli Tuner(DE3)LacI or C41(DE3) cells, single 
transformed colonies from an LB agar plate were inoculated into 50 ml LB media with 
100 µg/ml ampicillin and 50 µg/ml kanamycin (plus 34 µg/ml chloramphenicol for 
Tuner(DE3)LacI cells), and incubated overnight (37 °C, 200 rpm). Each 50 ml culture was 
then transferred to 500 ml LB media to give starting OD600 = 0.1. Cells were grown at 37 °C 
with shaking at 200 rpm until OD600 = 0.8–1.0. Expression of Strep-IntC-pSRIIC(KCWL)-
His6 was first induced by adding 0.05% L-arabinose, and 10 µM all-trans retinal was added. 
The cells were incubated for 1 h at 25 °C, 200 rpm, before the expression of 
pSRIIN(KCWL)-IntN-Strep was induced by adding 0.1 mM IPTG. The cells were incubated 
for 7 h at 25 °C, 200 rpm, with 10 µM all-trans retinal supplemented at 2 h-intervals. The 
cells were further incubated overnight (total ~20 h expression) at 18 °C, 200 rpm without 
supplementation of all-trans retinal, and harvested by centrifugation (5000 × g, 20 min, 4 °C). 
 
Purification from the co-expression of pSRIIN(KCWL)-IntN-Strep and 
Strep-IntC-pSRIIC(KCWL)-His6 was performed with the same method as for pSRII, except 
5 mM TCEP-HCl was added to Buffer A, 2 mM TCEP-HCl to Buffer S, and 1 mM 
TCEP-HCl to all other buffers. 
 
A.4.3 OmpX 
Single transformed colonies from an LB agar plate were inoculated into 50 ml LB media with 
50 µg/ml kanamycin and incubated overnight (37 °C, 180 rpm). Each overnight culture was 
then transferred to 500 ml M9 media [433] to give a starting OD600 = 0.1. Expression of 
OmpX as inclusion bodies was induced by adding 1 mM IPTG at an OD600 of 0.4–0.5. The 
cells were further incubated for 5 h at 37 °C, harvested by centrifugation (4000 × g, 4 °C, 20 
min), and the cell pellets were frozen (–20 °C). 
 
Inclusion body purification was done as previously described [377]. The harvested cell pellet 
was resuspended in Buffer TE and lysed by three passes through an Emulsiflex-C5 High 
Pressure Homogeniser (Avestin, Inc.) operating at 50 Psi. The solution was centrifuged 
(4300 × g, 4 °C, 1 h). Then, the pellet was homogenized (T18 basic ULTRA-TURRAX®, 
IKA®) in Buffer TE + 2% (v/v) Triton X-100 and shaken for 20 min at 37 °C. The solution 






was centrifuged (4300 × g, 4 °C, 1 h), and the pellet was resuspended in Buffer TE, shaken 
for 1 h at 37 °C, and centrifuged again. The new pellet was dissolved in Buffer G and shaken 
for 2 h at 37 °C. Finally, the solution was centrifuged (14300 × g, 4 °C, 20 min), and the 
supernatant was retained. 
 
The protein solution was concentrated using a 10 kDa MWCO centrifugal concentrator 
(Vivaspin) and loaded onto a size exclusion column equilibrated in Buffer U. Size exclusion 
chromatography was performed using either the Äkta Start (GE Healthcare) or the Äkta Pure 
(GE Healthcare) chromatography system. Either a Sephadex 200 10/300 GL column (GE 
Healthcare) running at 0.12 ml/min or a HiPrep 16/60 Sephacryl S-200 HR column (GE 
Healthcare) running at 0.5 ml/min was used. Typically, 1 ml and 4 ml fractions were 
collected from the respective columns. No significant differences were observed between the 
chromatography traces from the two columns. The relevant fractions were identified by 
SDS-PAGE, pooled, exchanged back into Buffer G using a PD-10 desalting column (GE 
Healthcare), and concentrated to about 300 µM. 
 
Refolding was performed at room temperature by dropwise dilution of 5 ml 300 µM OmpX 
into 45 ml Buffer R with gentle stirring. The solution was stirred at room temperature 
overnight. The refolded protein was dialysed in a 3.5 kDa MWCO dialysis tubing (Spectrum 
Laboratories, Inc.) twice overnight against 5 L of Buffer D, followed by twice overnight 
against 5 L of Buffer N. 0.1% dodecylphosphocholine (DPC) was added to the protein 
solution between each change of buffer. Finally, the dialysed protein was concentrated using 
a 10 kDa MWCO centrifugal concentrator (Vivaspin). 
 
A.4.4 OmpX in urea 
15N-OmpX in Buffer N with 10% D2O and 5% DPC was first exchanged into Buffer U using 
a PD-10 desalting column. The eluted sample (4.5 ml) was loaded onto a HiPrep 16/60 
Sephacryl S-200 HR column (GE Healthcare) running at 0.5 ml/min, and 3 ml fractions were 
collected. The fractions containing unfolded OmpX (assessed by SDS-PAGE) were pooled 
and dialysed twice for > 8 h each against 1 L of Buffer X. The dialysed sample was 
diluted/concentrated thrice in a 3 kDa MWCO centrifugal concentrator (Vivaspin) using 
45 ml of Buffer X. The final DPC concentration, determined by 1D 1H NMR, was < 0.02%. 







A.5.1 UV/vis spectroscopy 
UV/vis spectra were recorded at room temperature in a 10-mm path length quartz cuvette 
using a UV-1800 spectrophotometer (Shimadzu). Spectra were recorded between 250 and 
600 nm with a fast scan rate (accumulation time = 0.05 s) and a sampling interval of 1 nm. 
Each steady-state spectrum was reported as an average of three measurements. Time-course 
measurements were done by recording spectra in 1-min or 5-min intervals using the 
aforementioned settings, with a typical dead-time of 25 s before the first spectrum was 
recorded. 
 
Protein concentrations were confirmed by UV-vis spectroscopy using the method outlined 
above for steady-state spectra. Extinction coefficients (Table A.9) were obtained using 
ExPASy ProtParam tool (Swiss Institute of Bioinformatics) unless indicated otherwise. 
Concentrations of pSRII and OmpX were also confirmed by standard 
ion-exchange-ninhydrin analysis (performed by Peter Sharratt, Department of Biochemistry 









pSRII [434] 26420 
498 48000 
280 49390 
pSRII-KCWL 26967 280 54890 
pSRIIN(KCWL)-IntN-Strep 19870 280 39420 
Strep-IntC-pSRIIC(KCWL)-His6 25747 280 42400 
OmpX 16514 280 34840 
 
Table A.9: Extinction coefficients of pSRII and OmpX 
 
The purity of pSRII samples was calculated as follows: 




× 100 (A.1) 
 
 






A.5.2 Far-UV CD 
To avoid strong UV absorbance by NaN3, NaN3 was first removed from small aliquots 
(100 µl) of pSRII stock solutions by concentrating and diluting thrice in a 0.5-ml centrifugal 
filter unit (10-kDa cutoff) (Merck Millipore) using a total of ~1.5 ml of 50 mM sodium 
phosphate (pH 6.0), 50 mM NaCl and 0.1% c7-DHPC. CD spectra were recorded at 25 °C by 
scanning between 194 and 250 nm on an Aviv 410 spectrometer (Aviv Biomedical Inc.) 
using a 1×1-mm cuvette. Each sample contained 0.17 mg/ml protein in a volume of 400 µl, 
measured 2 h after exposure to unfolding buffer. CD spectra of the buffer solutions were 
subtracted from the sample spectra and smoothed using a window width of 11 and a degree 
of 2. Spectra were reported as the average of three scans. Data for each experimental 
condition are reported as the average of three independent samples. 
 
All CD spectra were analysed using CDPro [298]. The helicity was estimated by taking basis 
set 10 containing both soluble and membrane proteins [298]. The built-in secondary 
structure-determination algorithms CONTIN/LL [298,435], SELCON3 [436] and CDSSTR 
[437] were executed, using delta epsilon as the input. 
 
 ∆P = (
64×é×è×Q×äEÔR
 (A.2) 
Here, θ is the observed ellipticity (millidegrees), l the path length (cm), c the protein 
concentration (M) and n the number of peptide bonds, taken as 246 for pSRII. 
 
Molar residue ellipticity (MRE) is calculated as: 
 [à] = ∆P × 3298 (A.3) 
 
To monitor time-dependent changes in α-helical content during SDS-mediated unfolding of 
pSRII, ellipticity was recorded at fixed wavelengths of 222 and 208 nm at 30-s intervals for 
2 h. The typical experimental dead-time is 1 min. 
 
A.5.3 Tryptophan Fluorescence 
Fluorescence spectra were measured at 25 °C using a LS55 fluorescence spectrometer 
(Perkin Elmer) (excitation slit: 5.0 nm, emission slit: 17.5 nm). Emission scans were recorded 






from 310 to 500 nm using an excitation wavelength of 295 nm, at a scan rate of 100 nm/min 
and with a sampling interval of 0.5 nm. For time-course measurements, fluorescence 
emission at 335 nm was recorded with an integration time of 3 s. The typical experimental 
dead-time was 25 s. 
 
A.5.4 Unfolding pSRII in different denaturants 
pSRII at ~450 µM was unfolded by a 67-fold dilution into unfolding buffer containing 50 
mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.1% c7-DHPC and different concentrations 
of denaturants. NaN3 was excluded from unfolding buffers for fair data comparison across 
different biophysical techniques, as the strong UV absorbance by NaN3 interferes with 
far-UV CD spectroscopy. 
 
A.5.5 Hydroxylamine treatment of pSRII 
Hydroxylamine hydrochloride was added to unfolding buffers to a final concentration of 
10 mM. The relative concentrations of the monobasic and dibasic sodium phosphate salts 
were adjusted accordingly to ensure that the final pH values of all unfolding buffers 
containing hydroxylamine were consistent (within 0.1 pH unit) with pH values of matching 
conditions without hydroxylamine. 
 
A.5.6 Refolding from SR440 
pSRII at ~450 µM was unfolded at room temperature for 4 min by 33-fold dilution into 
unfolding buffer containing 50 mM sodium phosphate (pH 6.0), 50 mM NaCl and 0.943 ΧSDS 
(5% SDS + 0.5% c7-DHPC). The protein was refolded from the SR440 state by 12-fold 
dilution into refolding buffer containing 50 mM sodium phosphate (pH 6.0), 50 mM NaCl 
and different ΧSDS in 0.5% c7-DHPC. The quoted ΧSDS is the final ΧSDS remaining in the 
reaction after 12-fold dilution of the unfolding reaction into refolding buffer. The refolding 
reaction was monitored by UV/vis spectroscopy for up to 2 h. 
 
A.5.7 Refolding from SO390 
SO390 was obtained by a 2-h incubation of pSRII diluted 33-fold into unfolding buffer 
containing 50 mM sodium phosphate (pH 6.0), 50 mM NaCl and 0.893 ΧSDS (2.5% SDS + 






0.5% c7-DHPC). Refolding from SO390 was initiated in a similar manner as for refolding 
from SR440, and the refolding reaction was monitored by UV/vis spectroscopy for up to 2 h. 




A.5.8.1 Mole fraction of SDS 






A.5.8.2 Equilibrium unfolding 
Absorbance at 498 nm was plotted against ΧSDS. Assuming that only the folded and unfolded 
conformations are present at any given time point of the unfolding reaction, the fraction of 
protein present in the folded (XL) and unfolded (XY) conformations, respectively, can then be 
represented as: 
 XL + XY = 1 (A.5) 
XY was calculated as: 
 XY = (AL − A!) (AL − AY)⁄  (A.6) 
where AL is the A498 of completely folded or native protein, A! is the observed A498 at any 
point of denaturant concentration, AY is A498 of the completely denatured protein. 
 
A.5.9 Kinetics fitting 
UV/vis spectroscopy, CD spectroscopy and tryptophan fluorescence time-course data were 
subjected to Levenberg-Marquardt nonlinear least squares fitting using R codes written by 
James Mitchell (University of Warwick) [438]. 
 
A.5.9.1 UV/Vis spectra 
Time courses of absorbance spectra were modelled as the combinations of absorbance peaks 
varying over time according to a kinetic model. Each peak was treated as a Gaussian peak of 
the form :;
([)ú)F
F\F , where c is the wavelength corresponding to the fitted peak centre and w is 
the half width at half maximum of the fitted Gaussian. 







All absorbances in the region 350–650 nm were assumed to be due to retinal species varying 
according to the kinetic model. The kinetic model was described with two consecutive 
first-order reactions, converting pSRII (absorbing at 498 nm) to SR440, which subsequently 





Time courses were unfolded to a three-column matrix with a column for wavelength (nm), 
time (min) and absorbance for that wavelength at that time. These were then fitted to 
Equation A.8 using the Levenberg-Marquardt least-squares fitting algorithm [250] as 

















where [Total] is the total protein concentration (see Equation A.9), ku and kh are the fitted rate 
constants, and f is an error term that is added to allow for the dead-time and the small amount 
of absorbance at 380 nm present in native spectra. Rate constants were reported as the mean 
of three independent measurements, with error bars representing the standard deviation. 
 
As no retinal was added during the experiment, at every point, the Beer-Lambert law was 
used with a known total concentration to approximate extinction coefficient-like values 
(Equation A.9) to convert the amplitudes of the fitted peaks to concentrations while 
accounting for peak overlap. This allowed peak amplitudes to be replaced in fitting with the 
concentration terms of the rate equations. 








A.5.9.2 Tryptophan fluorescence and CD 
Rate equations were used to fit tryptophan fluorescence (intensity at 335 nm vs. time) and 
CD (MRE at 222 nm vs. time) time-courses. Fluorescence increases over time were fit to the 
sum of the rate equations for SR440 and SO390. The initial fluorescence was subtracted to 






remove contribution from pSRII and simplify fitting. This yields Equation A.10 when k1 is 
sufficiently large. 
 ∆Intensity = 	 SK˙˚ˇ[Total] [
+,
+/;+,
\ (:;+,= − :;+/=) + S¯Ù˚[Total] ∫1 + [
6
+,;+/
\ ('0:;+,= − '(:;+/=)ª (A.10) 
Under conditions where ku < kh, time-courses approximate a single exponential curve. Single 
and double exponential fits to the data were compared using the Akaike Information Criterion 
[268] and checked with cross-validation wherever ambiguous.  
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The 350- to 650-nm region of the absorption spectra of pSRII was fitted to Equation A.11. 
Each time point of the refolding time-courses was fitted to a combination of three Gaussian 
peaks at around 390, 440 and 500 nm, and terms for both linear and scattering baseline 
variation. Changes in the fitted absorbance intensities at ~500 nm over time were fitted to a 
double exponential model: 
 2344~26(1 − :;BC=) + 2E(:;BF=) + @ (A.12) 
where R1 and R2 are the macroscopic rate constants, and A1 and A2 are the amplitudes of the 
fast phase and the slow phase, respectively. 
 
R1 and R2 are the solutions to the following quadratic equation: 
 GE − 7'H + 'I + 'J>G + 'I'J = 0 (A.13) 
Derivation of Equation A.13 was done as outlined by Schlebach et al. [118]. 
 
Based on the quadratic equation, the microscopic rate constants kf and ku were extracted using 
the following relationships and experimentally determined values of R1, R2 and kh: 
 G6GE = 'I'J (A.14) 
 G6 + GE = 'H + 'I + 'J (A.15) 
 
Under conditions where the rate of retinal hydrolysis is very slow compared to the rate of 
folding, changes in the fitted absorbance intensities at ~500 nm over time were approximated 
to a single exponential model: 






 2344~2671 − :;+<=> + @ (A.16) 
where the observed rate constant was approximated as the de novo refolding rate kf. 
 
A.5.9.4 Refolding from SO390 
The absorption spectrum of native pSRII contains one main retinal absorption peak at 498 nm, 
three shoulder peaks at 460, 420 and 370 nm, and protein absorption peak at 280 nm [224]. 
Five native spectra were fitted to these peaks, four of which were symmetrical Gaussian 
functions, and the 420-nm peak, the width of which was allowed to vary sigmoidally with 
wavelength to allow for previously reported skewedness [224]. Retinal peak amplitudes were 
normalised to have a sum of 1, and parameters were averaged for the retinal peaks to find a 
peak profile for native pSRII. 
 
Each time point of the refolding time-courses was fitted as a combination of some multiple of 
the native profile, a peak around 390 nm for free retinal and terms for both linear and 
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The concentrations of free retinal and native pSRII were extracted from these time-points. 
Since the total concentration is constant, and the parameters B and A390 were assumed to be 
proportional to the concentrations of native pSRII and free retinal respectively, the 
concentrations of these species were estimated by fitting these parameters for each time-point 
to Equation A.18. 
 [Total] = A390 × SO390 + B× pSRII (A.18) 
where [Total] is the total protein concentration determined from the A280 peak, A390 and B 
were fitted values from Equation A.18, and SO390 and pSRII were fitted coefficients, later 
used to calculate concentrations. 
 
The estimated values for SO390 concentration were fitted to an exponential decay model of 
the form 2 × :;+kll= + H, from which an apparent rate constant, kapp, and an asymptote, C, 






were obtained. The asymptote of the curve estimates the fraction of the total concentration 
that cannot be refolded on the timescale of the experiment (2 h). 
 
 
A.6 NMR spectroscopy 
All pulse sequences were written by Dr. Daniel Nietlispach. A final concentration of 
10% D2O (v/v) was typically (unless stated otherwise) added to the protein sample before 
NMR experiment to provide lock stabilisation. All 1H chemical shifts were referenced to TSP 
(trimethylsilylpropanoic acid) as internal standard. Detergent concentrations of all protein 
samples were confirmed by comparing the detergent peaks in the 1D 1H NMR spectra of the 
protein sample vs. a solution of known detergent concentration. 
 
A.6.1 1D 1H NMR 
1D 1H NMR spectra were measured using a Bruker AvanceIII AV800 equipped with 5 mm 
TXI CryoProbe (HCN/z). Pulse sequences were 1D spin echos. Water suppression was 
achieved using a 3-9-19 180° WATERGATE sequence. All spectra of pSRII were recorded at 
308 K, for 512 complex data points, 512 scans and acquisition time of 51.2 ms, with a 
spectral width of 10000 Hz. Selective suppression of detergent signals was achieved using a 
Gaussian Q5 cascade with duration of 5 ms followed by purging by gradient pulses. Spectra 
of 0.2% DPC with 5% D2O and OmpX in Buffer X with 5% D2O were recorded at 293 K and 
288 K, respectively. Both spectra were recorded for 9999 complex data points, 4 scans and 
acquisition time of 1 s, and with spectral width of 10000 Hz.  
 
A.6.2 1D 19F NMR 
1D 19F NMR spectra were measured using a Bruker AvanceIII AV600 spectrometer equipped 
with a 5 mm QCI CryoProbe (HCNF/z). All 19F NMR chemical shifts were referenced to 
CFCl3 (trichloro-fluoro-methane) as external standard. The pulse sequence was a spin-echo. 
All spectra were recorded with 1H broadband decoupling with 4997 complex data points, 
1024 scans and acquisition time of 100 ms. 
 
 






A.6.3 Multidimensional (2D and 3D) NMR 
A.6.3.1 pSRII 
All 2D [1H,15N] SOFAST-TROSY-HSQC experiments were recorded with samples of 
15N-labelled pSRII in 50 mM NaH2PO4/Na2HPO4, 50 mM NaCl, 0.5% c7-DHPC with varied 
pH and SDS concentrations, at 308 K. Except for the two experiments on 15N,19F-5-Trp-apo-
pSRII, all spectra were recorded on a Bruker AvanceIII AV800 spectrometer equipped with a 
5 mm TXI CryoProbe (HCN/z), with 512 × 128 complex points, spectral width of 
2777.78 Hz in the indirect dimension (t1max = 46.08 ms) and acquisition time of 51.2 ms. 
For 15N,19F-5-Trp-apo-pSRII, experiments were using a Bruker AvanceIII AV600 
spectrometer equipped with a 5 mm QCI CryoProbe (HCNF/z), with 512 × 100 complex 
points, spectral width of 2500 Hz in the indirect dimension (t1max = 52.70 ms) and acquisition 
time of 51.2 ms. Frequency discrimination in the 15N dimension was achieved using P/N-type 
coherence order selection combined with axial peak shifting by one-half the spectral width. 
Solvent suppression was not required due to utilisation of amide-selective 1H pulses for 
magnetisation transfer. 
 
Details of the sample concentration and number of scans for each reported spectrum are 
shown in Table A.10. 
 
15N R1 and R1ρ experiments were recorded at 308 K on a Bruker AvanceIII AV600 
spectrometer equipped with a 5 mm QCI CryoProbe (HCNF/z) using samples of ~525 µM 
15N-pSRII in 0 ΧSDS (2% c7-DHPC) and in 0.728 ΧSDS (0.8% SDS + 0.5% c7-DHPC). 
Sample preparation and NMR experiments on 15N-pSRII in 0 ΧSDS (2% c7-DHPC) were 
performed by Dr. Mark Bostock. TROSY-modified pulse sequences were used. All spectra 
were recorded with 1024 × 64 complex points. Both 15N R1ρ experiments were recorded using 
an adiabatically ramped spin lock field with a B1 field strength of 1164 Hz. On- and 






























0 1.8 162 96 





0.400 (0.2%) 94 
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Table A.10: Data acquisition parameters for NMR experiments on 15N-pSRII in different ΧSDS 













15N R1 9 3040 32 - 
15N R1ρ 10 200 128 1500 
0.728 ΧSDS 
(0.8% SDS + 0.5% c7-DHPC) 
15N R1 6 2000 120 - 
15N R1ρ 8 100 128 0 
 
Table A.11: Data acquisition parameters for 15N relaxation experiments. 
tmax represents the maximum relaxation delay. 
 







The sample of 700 µM 15N-labelled RalAΔC-GDP in 20 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 1 mM MgCl2, 0.05% NaN3 and 10% D2O was made by Dr. Arooj Shafiq. Descriptions 
of the pulse sequences for IPAP-HSQC and 1JNH-modulated HSQC (and variations thereof) 
can be found in Chapter 4. All experiments were recorded at 298 K on a Bruker Avance 












IPAP-HSQC 512 × 300 136.2 51.2 
32 - 
112 - 
SOFAST-IPAP-HSQC 512 × 300 136.2 51.2 64 - 












Table A.12: Data acquisition parameters for NMR experiments on 15N-RalAΔC-GDP 
 







All experiments were recorded on a Bruker AvanceIII AV800 spectrometer equipped with 
5 mm TXI CryoProbe (HCN/z). 
 
995 µM 15N-labelled OmpX 
20 mM NaPi (pH 6.8), 100 mM NaCl, 5 mM EDTA, 3.8% DPC and 10% D2O 
Temperature: 318 K 
Experiment 
Complex points 










512 × 36 × 110 
t1max: 12.00 ms 
t2max: 11.95 ms 
51.2 24 - 
2D [1H,15N] 
SOFAST-TROSY-HSQC 
512 × 150 45.00 51.2 32 - 
1JNH-modulated HSQC 
512 × 100 40.84 51.2 40 11.60–37.20 
512 × 100 40.84 51.2 96 11.60–37.20 
1JNH-modulated 
TROSY-HSQC 
512 × 100 40.84 51.2 40 11.60–37.20 
SOFAST-IPAP-HSQC 512 × 150 61.26 51.2 64 - 
221 µM 15N-labelled OmpX 
20 mM NaPi (pH 6.5), 8 M urea, 0.1 mM NaN3, 5% D2O 
Temperature: 288 K 
2D [1H,15N] 
SOFAST-TROSY-HSQC 
512 × 128 46.08 51.2 80 - 
SOFAST-IPAP-HSQC 1024 × 300 150.0 102.4 64 - 
1JNH-modulated HSQC 1024 × 200 100.0 102.4 40 22.24–47.84 
166 µM 15N-labelled OmpX 
20 mM NaPi (pH 6.5), 6 M urea, 0.1 mM NaN3, 5% D2O 
Temperature: 288 K 
2D [1H,15N] 
SOFAST-TROSY-HSQC 
512 × 128 46.08 51.2 80 - 
SOFAST-IPAP-HSQC 1024 × 300 150.0 102.4 64 - 
 
Table A.13: Data acquisition parameters for NMR experiments on 15N-OmpX 
 
A.6.4 Data Analysis 
Raw NMR data were processed in Azara v2.8 (Dr. Wayne Boucher, Department of 
Biochemistry, University of Cambridge). Assignment and measurement of peak intensities 
were performed in CCPN Analysis [375]. 







A.6.4.1 Chemical shift differences 
Chemical shift differences were calculated using Equation A.19: 
 






A.6.4.2 1JNH coupling constants 
Using custom-written R code (from Dr. Mark Bostock), 1JNH scalar coupling constants 
(denoted as J) were obtained from 1JNH-modulated HSQC experiments using a fit to 
Equation A.20: 
 S(í) = 2 sin(göí) :
;‘õ
  (A.20) 
where S(í) denotes the peak intensity, τ the variable delay time in seconds, C the decay rate 
of the 15N magnetisation as a result of transverse relaxation, and A is an arbitrary signal 
intensity scaling factor. 
 
Signal-to-noise ratios (SNR) were calculated as: 
 SNR = Í
mn
 (A.21) 
where I denotes the peak intensity, and σn the standard deviation of the noise. 
 






+ 0.067GEI (A.22) 
where SNR denotes the signal-to-noise ratio of a peak calculated using Equation A.21, t1max 
the maximum increment of the t1 evolution period in seconds, and R2 the transverse 
relaxation rate constant. R2 for individual residues was taken as C in Equation A.20, obtained 
by fitting peak intensities from 1JNH-modulated HSQC experiments. Note that these R2 values 
are free-evolution R2* values. 
 
For IPAP-HSQC experiments, the RMSD in 1JNH of each residue was calculated as the sum 







B Chemical shifts and intensity ratios for pSRII 
B.1 Backbone chemical shifts and intensity ratios for pSRII in SDS 
Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
2 Val 7.948 120.186 7.877 119.583 0.910 7.824 119.029 0.696 7.776 118.686 0.654 
3 Gly 8.507 112.366 8.461 112.335 0.927 8.379 112.269 0.934 8.321 112.221 0.923 
5 Thr 8.339 108.141 8.266 107.931 0.835 8.218 107.754 0.634 8.189 107.670 0.672 
6 Thr 7.479 117.585 7.408 117.463 0.817 7.365 117.354 0.944 7.347 117.250 0.650 
7 Leu 7.350 120.064 7.316 119.825 0.933 7.289 119.685 0.777 7.263 119.577 0.868 
9 Trp 8.641 119.955 8.616 119.874 0.749 8.597 119.845 0.687 8.588 119.812 0.663 
10 Leu 8.209 120.260          
11 Gly 7.970 105.314 7.965 105.249 1.088 7.944 105.178 0.970 7.936 105.111 0.988 
12 Ala 8.378 123.335 8.351 123.302 1.196 8.346 123.271 0.722 8.347 123.282 0.406 
13 Ile 8.876 116.576 8.859 116.558 0.686 8.848 116.545 0.700 8.843 116.554 0.534 
14 Gly 8.702 107.748 8.699 107.692 0.777 8.699 107.616 0.750 8.696 107.573 0.617 
15 Met 8.352 117.820 8.335 117.751 0.673 8.319 117.671 0.745 8.308 117.607 0.582 
16 Leu 8.843 125.236 8.828 125.291 0.752 8.815 125.305 0.748 8.812 125.330 0.638 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
17 Val 8.506 119.005 8.520 119.056 0.713 8.526 119.035 0.681 8.529 119.015 0.591 
17b Val         8.567 119.138 0.157 
18 Gly 7.813 104.255 7.800 104.133 0.732 7.792 104.097 0.714 7.785 104.053 0.590 
20 Leu 8.089 118.821 8.108 118.747 0.379 8.104 118.675 0.589    
21 Ala 8.015 121.350 8.027 121.356 0.851 8.045 121.360 0.639 8.048 121.340 0.583 
22 Phe 8.591 118.274 8.627 118.324 0.800 8.642 118.217 0.835 8.645 118.187 0.665 
23 Ala 8.420 121.316 8.454 121.394 0.868 8.464 121.506 0.654 8.471 121.565 0.584 
24 Trp 8.651 118.459 8.685 118.455 0.828 8.707 118.461 0.712 8.726 118.495 0.645 
25 Ala 8.628 120.971 8.656 120.996 0.788 8.719 121.087 0.715 8.750 121.160 0.605 
26 Gly 7.642 103.903 7.714 104.182 0.841 7.749 104.336 0.718 7.761 104.405 0.657 
27 Arg 7.176 120.777 7.182 120.796 0.794 7.180 120.813 0.763 7.184 120.845 0.698 
28 Asp 7.804 118.024 7.733 117.784 0.734 7.712 117.779 0.705 7.709 117.810 0.641 
29 Ala 7.157 123.269 7.160 123.139 0.809 7.161 123.058 0.850 7.168 123.059 0.795 
30 Gly 8.765 109.747 8.759 109.757 0.831 8.745 109.804 0.861 8.728 109.830 0.793 
31 Ser 8.664 115.546 8.645 115.770 1.300 8.624 115.887 1.520 8.603 115.912 1.471 
32 Gly 8.998 111.170 8.912 111.657 1.369 8.843 112.324 1.623 8.811 112.771 1.527 
35 Arg 8.419 115.863 8.477 115.986 1.129 8.489 116.146 1.101 8.497 116.340 0.514 
37 Tyr 7.193 116.858 7.224 116.696 0.742 7.233 116.665 0.568 7.223 116.593 0.473 
38 Val 8.643 117.903 8.601 117.727 0.719 8.515 117.459 0.697 8.497 117.339 0.495 
40 Leu 7.310 118.971 7.206 119.004 1.079 7.149 119.034 1.031 7.122 119.022 0.946 
41 Val 8.153 118.234 8.152 118.345 0.383       
42 Gly 8.417 106.641 8.406 106.528 0.709 8.368 106.408 0.714 8.355 106.341 0.545 
43 Ile 8.116 120.539 8.102 120.497 0.578       
44 Ser 7.844 109.747 7.867 109.800 0.701 7.888 109.844 0.687 7.890 109.819 0.630 
45 Gly 8.898 114.911 8.880 114.897 0.808 8.858 114.849 0.743 8.853 114.868 0.668 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
46 Ile 8.062 120.636 8.072 120.649 0.811 8.072 120.631 0.931 8.072 120.625 1.012 
47 Ala 6.689 120.852 6.693 120.748 0.805 6.701 120.710 0.811 6.692 120.696 0.629 
48 Ala 8.484 120.132 8.474 120.249 0.762 8.467 120.298 0.702 8.462 120.345 0.619 
49 Val 7.503 115.657 7.512 115.726 0.905 7.522 115.776 0.768 7.522 115.815 0.578 
50 Ala 8.397 122.457 8.404 122.458 0.812 8.411 122.481 0.792 8.413 122.482 0.632 
51 Tyr 8.801 115.439 8.798 115.511 0.741 8.792 115.545 0.656 8.792 115.571 0.537 
52 Ala 8.132 121.707 8.155 121.887 0.735 8.175 122.007 0.688 8.188 122.085 0.606 
53 Val 8.268 113.936 8.300 114.146 0.753 8.325 114.255 0.735 8.339 114.341 0.574 
54 Met 7.498 118.559 7.509 118.382 1.043 7.517 118.357 0.896 7.534 118.381 1.261 
55 Ala 8.330 124.951 8.329 124.930 2.178 8.358 125.083 1.448 8.376 125.199 1.127 
56 Leu 7.262 115.991 7.286 116.041 0.695 7.324 116.104 0.842 7.335 116.144 1.036 
57 Gly 8.035 107.243 8.040 107.241 0.786 8.050 107.372 0.795 8.052 107.466 0.656 
58 Val 7.620 122.869 7.629 122.903 0.776 7.646 123.027 0.734 7.661 123.149 0.616 
59 Gly 8.834 112.230 8.574 111.893 0.672 8.429 111.664 0.713 8.362 111.529 0.639 
60 Trp 8.464 122.785 8.461 122.829 0.768 8.440 122.802 0.675 8.420 122.756 0.598 
61 Val 9.028 127.097 9.005 127.312 0.896 8.993 127.415 0.894 8.989 127.460 0.779 
63 Val 8.435 126.326 8.402 126.389 0.899 8.374 126.411 0.954 8.357 126.424 0.751 
64 Ala 8.835 128.446 8.848 128.364 0.847 8.845 128.295 0.722 8.836 128.247 0.610 
65 Glu 8.446 120.820          
66 Arg 8.605 121.424 8.635 121.294 0.893 8.653 121.201 0.912 8.668 121.174 0.748 
67 Thr 8.010 118.069 8.019 118.086 0.704 8.021 118.132 0.851 8.022 118.199 0.950 
68 Val 9.210 128.868 9.234 129.054 0.855 9.254 129.193 0.865 9.264 129.280 0.725 
69 Phe 8.018 127.209 8.021 127.302 0.907 8.024 127.366 1.571 8.024 127.410 1.234 
70 Val 8.575 123.674 8.554 123.461 0.959 8.537 123.350 0.917 8.520 123.298 0.807 
74 Ile 7.025 117.767 6.992 117.714 0.839 6.976 117.682 0.881 6.965 117.668 0.688 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
75 Asp 7.607 117.374 7.593 117.485 0.773 7.584 117.507 0.760 7.570 117.509 0.677 
76 Trp 7.940 115.164 7.887 115.024 1.237 7.843 114.885 2.332 7.822 114.777 4.547 
77 Ile 8.280 120.176 8.279 120.149 0.806       
78 Leu 7.504 115.756 7.500 115.767 0.840 7.483 115.739 0.538 7.474 115.705 0.425 
79 Thr 9.791 107.411 9.788 107.280 0.741 9.782 107.188 0.816 9.781 107.133 0.638 
80 Thr 8.186 117.719 8.192 117.736 0.845 8.191 117.744 0.661 8.197 117.760 0.377 
82 Leu 6.788 117.856 6.762 117.814 0.731 6.753 117.742 0.747 6.756 117.727 0.651 
83 Ile 7.778 122.669 7.811 122.815 0.934 7.831 122.867 0.777 7.843 122.919 0.604 
85 Tyr 8.990 122.438 9.011 122.559 0.670 9.029 122.689 0.745 9.038 122.762 0.573 
86 Phe 8.550 121.521 8.590 121.628 0.587 8.616 121.605 0.393 8.630 121.640 0.448 
87 Leu 8.466 116.583 8.511 116.762 0.761 8.537 116.887 0.586 8.547 116.945 0.535 
88 Gly 9.360 108.206 9.387 108.287 0.737 9.413 108.357 0.744 9.424 108.397 0.532 
89 Leu 8.892 126.017 8.971 126.434 0.911 9.024 126.709 0.837 9.048 126.826 0.702 
90 Leu 7.666 119.836 7.714 119.955 0.703 7.743 120.123 0.768 7.750 120.123 0.756 
91 Ala 8.100 116.884 8.140 117.078 0.523 8.167 117.162 0.633 8.176 117.216 0.516 
92 Gly 7.562 105.638 7.588 105.941 0.810 7.606 106.156 0.861 7.612 106.235 0.749 
93 Leu 7.253 118.078 7.262 118.099 0.418 7.271 118.040 0.398 7.265 118.014 0.388 
94 Asp 8.404 120.824 8.359 120.754 0.852 8.311 120.743 0.717 8.289 120.721 0.631 
95 Ser 8.572 114.953 8.483 114.501 0.738 8.423 114.286 0.728 8.395 114.187 0.677 
96 Arg 8.231 123.224 8.092 122.869 0.852 8.000 122.716 0.829 7.957 122.585 0.648 
97 Glu 8.244 119.403 8.264 119.400 0.537       
98 Phe 8.531 118.132 8.552 117.891 0.887 8.559 117.731 0.729 8.560 117.651 0.638 
99 Gly 8.187 105.159 8.251 105.376 0.794 8.302 105.436 0.768 8.321 105.435 0.596 
100 Ile 7.779 123.485 7.884 123.436 0.724 7.961 123.398 0.700 7.989 123.375 0.549 
101 Val 7.675 115.946 7.717 115.956 0.825 7.738 116.147 0.718 7.736 116.225 0.587 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
102 Ile 8.538 120.582 8.592 120.880 0.708 8.626 121.124 0.885 8.633 121.220 0.711 
103 Thr 7.961 122.658 7.957 122.690 0.767 7.941 122.687 0.734 7.937 122.668 1.000 
105 Asn 8.047 115.250 8.036 115.201 0.770 8.018 115.137 0.802 8.006 115.086 0.641 
106 Thr 8.072 114.555 8.086 114.651 0.803 8.102 114.743 0.643 8.109 114.794 0.515 
108 Val 7.581 118.040 7.552 117.948 0.692 7.527 117.879 0.756 7.514 117.842 0.599 
109 Met 7.395 112.681 7.430 112.726 0.696 7.437 112.840 0.659 7.433 112.927 0.585 
110 Leu 8.839 118.819 8.866 119.043 0.897 8.887 119.202 0.889 8.895 119.286 0.705 
111 Ala 8.529 121.369 8.514 121.378 0.734 8.505 121.387 0.759 8.501 121.393 0.647 
112 Gly 8.121 102.804 8.154 102.848 0.854 8.171 102.850 0.899 8.176 102.855 0.613 
113 Phe 7.982 122.037 7.986 122.083 0.678 8.006 122.101 2.051 7.974 122.088 2.179 
114 Ala 8.724 119.281 8.732 119.393 0.776 8.742 119.490 0.772 8.746 119.564 0.613 
115 Gly 8.542 101.318 8.562 101.284 0.807 8.576 101.261 0.801 8.584 101.278 0.639 
116 Ala 7.808 121.466 7.806 121.478 0.800 7.805 121.462 0.856 7.804 121.469 0.819 
117 Met 7.120 112.781 7.134 112.946 0.725 7.150 113.130 0.699 7.164 113.270 0.540 
118 Val 7.208 121.328 7.216 121.448 0.727 7.216 121.427 0.643 7.216 121.379 0.547 
121 Ile 8.590 120.363 8.577 120.665 0.863 8.568 120.810 0.885 8.556 120.882 0.739 
122 Glu 10.303 122.575 10.184 122.105 0.817 9.951 121.534 0.886 9.792 121.137 0.571 
123 Arg 8.102 120.558 8.097 120.512 0.834       
124 Tyr 8.025 118.968 7.997 118.783 0.928 8.055 118.811 1.079 8.081 118.784 1.006 
125 Ala 7.836 122.290 7.844 122.127 0.952 7.834 122.051 0.963 7.817 122.008 0.748 
126 Leu 6.989 118.440 6.941 118.350 0.592 6.905 118.279 0.561 6.898 118.263 0.491 
127 Phe 7.899 118.978          
128 Gly 8.410 105.675 8.395 105.587 0.809 8.379 105.557 0.908 8.369 105.559 0.825 
129 Met 7.867 120.523 7.873 120.771 0.599 7.872 120.939 0.615 7.867 121.019 0.456 
131 Ala 8.557 124.210 8.546 124.237 0.855 8.535 124.262 0.807 8.527 124.271 0.634 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
132 Val 7.911 116.923 7.915 116.866 0.731 7.924 116.872 0.517 7.927 116.863 0.501 
133 Ala 7.784 121.009 7.779 121.045 0.962 7.795 121.058 0.861 7.799 121.095 0.674 
134 Phe 8.364 119.309 8.360 119.352 0.716 8.378 119.401 0.681    
135 Ile 8.033 120.291 8.044 120.367 0.921 8.047 120.506 0.743 8.056 120.582 0.825 
136 Gly 7.822 105.793          
137 Leu 8.379 124.623 8.430 124.738 1.367 8.452 124.793 1.504 8.470 124.811 1.274 
138 Val 8.588 119.093 8.605 119.160 0.799 8.614 119.231 0.798 8.618 119.285 0.678 
139 Tyr 8.421 119.459 8.436 119.413 0.778 8.457 119.398 0.809 8.476 119.406 0.617 
140 Tyr 8.156 120.630          
141 Leu 8.320 117.187 8.349 117.259 0.603 8.373 117.273 0.605 8.392 117.255 0.585 
142 Val 8.497 115.607 8.488 115.966 1.139 8.475 116.057 1.272 8.457 116.083 0.918 
143 Gly 8.114 111.690 8.159 111.519 0.881 8.200 111.393 0.762 8.226 111.323 0.756 
145 Met 8.642 114.430 8.629 114.678 0.787 8.616 114.876 0.725 8.605 114.971 0.599 
146 Thr 6.915 115.071 6.900 115.214 0.654 6.887 115.325 0.657 6.876 115.377 0.589 
147 Glu 8.034 124.505 8.027 124.577 0.853 8.026 124.623 0.893 8.023 124.666 0.780 
148 Ser 7.931 115.490 7.871 115.411 0.805 7.825 115.356 0.839 7.802 115.335 0.760 
149 Ala 7.837 123.568 7.851 123.428 0.783 7.850 123.327 0.825 7.853 123.303 0.732 
150 Ser 7.724 110.134 7.738 110.279 0.781 7.744 110.401 0.793 7.748 110.455 0.775 
151 Gln 7.373 118.193 7.392 118.222 0.922 7.405 118.258 0.926 7.409 118.270 0.855 
153 Ser 7.897 113.548 7.847 113.589 1.117 7.812 113.585 0.796 7.803 113.604 0.658 
154 Ser 8.850 117.125 8.825 117.079 1.490 8.806 117.060 1.692 8.798 117.049 1.567 
155 Gly 8.971 110.777 8.990 110.936 1.047 8.983 111.009 1.119 8.966 110.994 1.022 
156 Ile 7.426 124.014 7.430 124.126 0.774 7.419 124.174 0.868 7.410 124.120 0.824 
157 Lys 8.485 121.239 8.466 121.246 1.007 8.458 121.183 0.849 8.448 121.171 0.885 
158 Ser 8.175 112.184 8.188 112.270 0.776 8.192 112.360 0.791 8.192 112.409 0.699 






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
159 Leu 7.539 123.172 7.509 123.334 0.783 7.500 123.382 0.787 7.487 123.425 0.630 
160 Tyr 8.933 118.651 8.880 118.584 0.767 8.835 118.513 0.904 8.817 118.470 0.746 
161 Val 8.465 118.036 8.475 117.975 0.740 8.478 117.907 0.703 8.473 117.868 0.525 
163 Leu 8.059 117.674 8.072 117.591 0.604 8.057 117.338 1.033 8.045 117.226 0.884 
164 Arg 9.424 124.793 9.400 124.714 0.777 9.364 124.602 0.876 9.343 124.513 0.657 
165 Asn 8.533 119.461 8.520 119.551 0.778 8.508 119.639 0.760 8.500 119.667 0.612 
167 Thr 7.686 114.269 7.671 114.241 0.768 7.670 114.180 0.767 7.656 114.164 0.687 
168 Val 8.701 117.065 8.692 116.999 0.700 8.677 116.972 0.662 8.664 116.925 0.579 
169 Val 7.325 112.502 7.342 112.556 0.797 7.347 112.634 0.768 7.345 112.658 0.662 
171 Trp 9.736 119.386 9.758 119.394 0.864 9.763 119.371 0.746 9.767 119.340 0.686 
173 Ile 7.672 113.796 7.665 113.723 0.737 7.659 113.672 0.868 7.642 113.653 0.625 
176 Phe 7.363 115.864 7.353 116.013 0.814 7.333 116.086 1.010 7.336 116.143 1.278 
177 Ile 7.705 120.178 7.724 120.271 0.745 7.736 120.213 1.087 7.735 120.218 0.926 
178 Trp 7.999 123.281 8.013 123.549 0.685 8.003 123.714 0.760 8.000 123.783 0.579 
179 Leu 7.988 113.817 7.972 113.731 0.741 7.953 113.733 0.551 7.947 113.737 0.918 
180 Leu 8.257 113.389 8.323 113.368 0.684 8.364 113.382 0.775 8.381 113.377 0.567 
181 Gly 7.895 110.691 7.898 110.665 0.802 7.896 110.609 0.733 7.891 110.581 0.606 
184 Gly 6.995 105.808 6.976 105.637 0.792 6.960 105.528 0.723 6.950 105.475 0.578 
185 Val 8.939 120.076 8.977 120.269 0.770 9.006 120.410 0.785 9.022 120.483 0.738 
186 Ala 7.862 120.423 7.833 120.328 0.752 7.822 120.347 0.706 7.820 120.364 0.558 
188 Leu 7.865 115.776 7.871 115.936 0.741 7.871 116.085 0.821 7.870 116.148 0.609 
191 Thr 7.650 109.049 7.583 108.975 1.010 7.549 109.088 1.165 7.531 109.181 1.046 
192 Val 7.093 121.746 7.105 121.939 0.761 7.109 122.050 0.729 7.107 122.081 0.632 
193 Asp 8.076 119.864 8.073 119.847 0.588 8.069 119.822 0.517 8.065 119.848 0.511 
194 Val 7.968 115.054 7.919 114.957 0.572       






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
195 Ala 8.229 121.277 8.240 121.279 0.747 8.281 121.297 0.741 8.273 121.294 0.575 
196 Leu 8.376 114.649 8.395 114.559 0.750 8.414 114.553 0.775 8.423 114.624 0.668 
197 Ile 7.866 118.132 7.796 117.969 0.813 7.767 117.938 0.759 7.751 117.929 0.693 
198 Val 8.545 122.256 8.496 122.210 0.778 8.483 122.162 0.766 8.479 122.123 0.699 
199 Tyr 7.349 118.465 7.348 118.075 0.727 7.344 117.807 0.833 7.345 117.739 0.768 
200 Leu 8.425 118.013 8.413 118.242 0.544 8.426 118.508 0.639 8.431 118.617 0.679 
201 Asp 9.540 121.095 9.509 121.114 0.785 9.478 121.133 0.755 9.460 121.124 0.691 
202 Leu 8.327 119.216 8.323 119.192 0.877       
203 Val 8.229 119.910 8.234 119.932 0.790 8.227 119.771 1.289 8.210 119.788 0.725 
204 Thr 9.215 110.627 9.178 110.622 0.719 9.154 110.644 0.706 9.137 110.640 0.641 
205 Lys 7.500 114.021 7.484 113.974 0.872 7.469 113.971 0.802 7.461 113.986 0.740 
206 Val 7.678 121.105 7.671 121.037 0.670 7.660 121.022 0.688 7.668 121.058 0.679 
207 Gly 8.949 110.058 8.984 110.111 0.534 8.999 110.130 0.643 8.993 110.135 0.567 
208 Phe 7.314 121.292 7.360 121.386 0.728 7.375 121.455 0.731 7.374 121.503 0.580 
209 Gly 7.912 103.927 7.931 104.039 0.813 7.947 104.094 0.907 7.960 104.143 0.823 
210 Phe 9.021 121.627 9.031 121.633 0.611 9.025 121.616 0.606 9.021 121.611 0.489 
211 Ile 8.337 121.320 8.340 121.532 1.035 8.356 121.561 0.983 8.357 121.532 1.865 
212 Ala 7.633 122.212          
213 Leu 8.498 117.133 8.568 117.767 0.823 8.694 118.102 0.640 8.719 118.206 0.479 
215 Ala 7.730 121.020 7.762 121.073 1.074 7.777 121.157 1.014 7.790 121.270 0.793 
216 Ala 8.065 121.099 8.144 121.199 2.131 8.178 121.233 2.534 8.194 121.241 2.096 
218 Thr 7.827 114.688 7.828 114.757 0.848 7.822 114.730 0.973 7.819 114.710 0.843 
219 Leu 7.907 122.088 7.950 122.264 1.024 7.960 122.310 1.185 7.958 122.410 1.224 
220 Arg 7.908 118.609 7.870 118.193 0.839 7.818 117.692 0.766 7.816 117.518 0.781 
221 Ala 7.695 122.253          






Table B.1: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS + 0.5% c7-DHPC) 
# Resi 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
222 Glu 7.963 118.618 7.939 118.504 0.827 7.936 118.446 0.879 7.935 118.420 0.866 
223 His 8.134 118.137 8.118 118.156 0.893 8.108 118.150 1.152 8.107 118.163 1.123 
224 Gly 8.218 109.591 8.219 109.430 0.994 8.218 109.288 1.016 8.216 109.252 0.945 
225 Glu 8.304 121.075 8.269 121.021 0.970 8.251 120.963 1.055 8.245 120.947 1.055 
226 Ser 8.286 116.876 8.262 116.813 0.923 8.244 116.730 0.896 8.239 116.716 0.829 
227 Leu 8.252 124.505 8.214 124.466 0.881 8.192 124.446 0.928 8.185 124.451 0.881 
228 Ala 8.106 124.210 8.087 124.230 0.882 8.082 124.282 1.000 8.081 124.317 0.981 
229 Gly 8.226 108.530 8.221 108.500 0.934 8.222 108.489 0.975 8.222 108.489 0.898 
230 Val 7.839 118.836 7.823 118.829 0.915 7.811 118.832 0.881 7.804 118.835 0.815 
231 Asp 8.402 123.994 8.398 123.988 0.901 8.393 123.955 0.876 8.390 123.961 0.792 
232 Thr 8.006 114.002 8.002 114.026 0.872 7.989 114.024 0.843 7.982 114.042 0.776 
233 Asp 8.316 123.032 8.316 123.002 0.879 8.315 122.969 0.834 8.314 122.982 0.758 
234 Thr 8.001 117.048 7.994 117.004 0.898 7.988 116.982 0.872 7.988 116.999 0.798 
236 Ala 8.296 124.685 8.292 124.646 0.859 8.296 124.757 0.805 8.298 124.857 0.708 
237 Val 7.930 119.238 7.924 119.177 0.929 7.943 119.228 0.865 7.955 119.273 0.772 
238 Ala 8.216 127.141 8.207 127.053 0.887 8.196 127.023 0.761 8.183 126.980 0.642 
239 Asp 8.113 119.558 8.108 119.525 0.933 8.105 119.562 0.858 8.099 119.582 0.721 
240 Leu 8.057 122.523 8.055 122.501 0.883 8.042 122.479 0.784 8.027 122.480 0.655 
241 Glu 8.155 119.722 8.149 119.699 0.872 8.134 120.014 0.761 8.126 120.284 0.643 
 






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
2 Val 7.760 118.586 0.842 7.729 118.340 0.531 7.722 118.302 0.330 7.722 118.307 0.096 
3 Gly 8.290 112.201 0.818 8.236 112.167 0.607 8.222 112.155 0.396    
5 Thr 8.177 107.633 0.710          
6 Thr 7.332 117.198 0.548          
7 Leu 7.241 119.553 0.466          
9 Trp 8.576 119.836 0.609 8.557 119.876 0.374       
11 Gly 7.921 105.088 0.742 7.913 105.063 0.453       
12 Ala 8.346 123.301 0.301 8.343 123.354 0.256       
13 Ile 8.841 116.557 0.477 8.831 116.575 0.210       
14 Gly 8.695 107.557 0.537 8.707 107.542 0.323 8.719 107.551 0.234    
15 Met 8.310 117.613 0.472          
16 Leu 8.811 125.361 0.516 8.814 125.411 0.262 8.811 125.399 0.200    
17 Val 8.531 119.009 0.518 8.538 119.004 0.266 8.537 119.015 0.206    
17b Val 8.571 119.107 0.194 8.581 119.058 0.336 8.581 119.023 0.195 8.559 119.295 0.168 
18 Gly 7.784 104.036 0.510 7.776 104.003 0.239       
21 Ala 8.045 121.345 0.608 8.049 121.339 0.374 8.073 121.456 0.317 8.087 121.466 0.532 
22 Phe 8.645 118.191 0.563 8.648 118.162 0.292       
23 Ala 8.478 121.572 0.536 8.485 121.707 0.275 8.497 121.702 0.154 8.482 121.647 0.149 
24 Trp 8.734 118.550 0.511 8.758 118.615 0.396       
25 Ala 8.766 121.220 0.612 8.783 121.274 0.380 8.782 121.291 0.214    






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
26 Gly 7.766 104.442 0.556 7.785 104.495 0.294       
27 Arg 7.185 120.861 0.595 7.194 120.913 0.357 7.181 120.917 0.260    
28 Asp 7.710 117.832 0.634 7.714 117.889 0.444 7.706 117.877 0.208    
29 Ala 7.170 123.063 0.744 7.177 123.089 0.528 7.176 123.091 0.328 7.179 123.099 0.106 
30 Gly 8.719 109.837 0.780 8.707 109.854 0.565 8.695 109.835 0.318 8.688 109.805 0.091 
31 Ser 8.593 115.919 1.452 8.576 115.918 1.061 8.570 115.910 0.646 8.566 115.917 0.186 
32 Gly 8.797 112.969 1.430 8.779 113.257 1.031 8.772 113.269 0.648    
35 Arg 8.499 116.400 0.373 8.504 116.543 0.260 8.482 116.576 0.164 8.488 116.404 0.181 
37 Tyr 7.221 116.596 0.400          
38 Val 8.490 117.325 0.485 8.471 117.320 0.276 8.446 117.298 0.166    
40 Leu 7.110 119.018 0.885 7.091 119.000 0.603 7.087 118.985 0.410 7.084 118.980 0.183 
42 Gly 8.351 106.332 0.447 8.332 106.315 0.273       
44 Ser 7.885 109.806 0.532 7.885 109.770 0.338 7.890 109.883 0.259 7.883 109.910 0.337 
45 Gly 8.856 114.893 0.669 8.856 114.969 0.370       
46 Ile 8.076 120.657 0.955 8.071 120.746 0.521       
47 Ala 6.684 120.695 0.554          
48 Ala 8.459 120.361 0.538 8.459 120.404 0.276       
49 Val 7.521 115.824 0.539 7.525 115.861 0.354 7.521 115.905 0.157    
50 Ala 8.412 122.496 0.574 8.410 122.481 0.361 8.407 122.464 0.191    
51 Tyr 8.793 115.565 0.489          
52 Ala 8.194 122.121 0.534 8.210 122.199 0.312 8.202 122.191 0.154 8.140 122.325 0.189 
53 Val 8.345 114.373 0.539 8.364 114.386 0.304 8.362 114.432 0.183    
55 Ala 8.377 125.240 0.959 8.403 125.331 0.469 8.394 125.356 0.418    
56 Leu 7.344 116.184 0.815 7.369 116.290 0.294       
57 Gly 8.058 107.493 0.522 8.068 107.572 0.286       
58 Val 7.668 123.223 0.505 7.688 123.342 0.268 7.683 123.367 0.158    






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
59 Gly 8.330 111.473 0.544 8.289 111.390 0.427       
60 Trp 8.411 122.721 0.613 8.387 122.647 0.288    8.380 122.501 0.128 
61 Val 8.992 127.490 0.721 8.992 127.561 0.379       
63 Val 8.352 126.417 0.699 8.338 126.445 0.393 8.334 126.489 0.220    
64 Ala 8.828 128.215 0.556 8.815 128.173 0.332 8.809 128.193 0.148    
66 Arg 8.673 121.163 0.668 8.685 121.132 0.285 8.681 121.154 0.190 8.684 121.089 0.122 
67 Thr 8.013 118.172 0.771 8.057 118.197 0.440 8.069 118.196 0.543 8.058 117.971 0.176 
68 Val 9.268 129.338 0.659 9.269 129.384 0.414       
69 Phe 8.024 127.407 1.163 8.017 127.446 0.725       
70 Val 8.519 123.347 0.563          
74 Ile 6.963 117.690 0.673 6.958 117.682 0.408       
75 Asp 7.568 117.541 0.638 7.561 117.550 0.304       
76 Trp 7.819 114.785 4.584 7.820 114.767 3.033 7.815 114.734 1.718 7.809 114.728 0.697 
78 Leu 7.470 115.711 0.412 7.454 115.711 0.178 7.451 115.657 0.157    
79 Thr 9.781 107.135 0.498          
82 Leu 6.751 117.682 0.573          
83 Ile 7.832 122.951 0.485          
85 Tyr 9.045 122.793 0.664 9.061 122.858 0.308       
86 Phe 8.631 121.678 0.379          
87 Leu 8.557 116.989 0.356          
88 Gly 9.426 108.400 0.573 9.431 108.443 0.355       
89 Leu 9.056 126.842 0.529 9.079 126.916 0.367       
90 Leu 7.755 120.139 0.599 7.760 120.180 0.403 7.768 120.173 0.229    
91 Ala 8.185 117.249 0.510 8.199 117.299 0.295       
92 Gly 7.612 106.261 0.702 7.614 106.295 0.459 7.604 106.332 0.257    
93 Leu 7.260 117.993 0.222 7.261 117.972 0.252 7.263 117.998 0.131    






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
94 Asp 8.275 120.733 0.546          
95 Ser 8.383 114.161 0.664 8.367 114.128 0.431 8.364 114.109 0.271    
96 Arg 7.947 122.391 0.836 7.929 122.270 0.429 7.919 122.270 0.258 7.908 122.227 0.217 
98 Phe 8.554 117.614 0.541 8.539 117.493 0.332 8.556 117.583 0.225    
98b Phe 8.589 117.638 0.370 8.585 117.635 0.526 8.581 117.590 0.413 8.583 117.564 0.218 
99 Gly 8.330 105.418 0.519 8.331 105.422 0.393       
100 Ile 7.996 123.351 0.411 8.017 123.269 0.321       
101 Val 7.732 116.253 0.652 7.719 116.299 0.319 7.715 116.209 0.202    
102 Ile 8.636 121.272 0.567 8.640 121.334 0.289       
103 Thr 7.934 122.662 0.995 7.958 122.699 0.499 7.964 122.694 0.647    
105 Asn 7.999 115.073 0.578 7.968 115.495 0.658 7.970 115.631 1.008 7.972 115.733 1.775 
106 Thr 8.111 114.833 0.400 8.068 115.578 0.480 8.066 115.579 0.922 8.059 115.572 1.862 
106b Thr    8.109 115.710 0.361 8.102 115.732 0.747 8.095 115.733 1.941 
108 Val 7.507 117.835 0.581 7.497 117.740 0.340 7.483 117.755 0.200    
109 Met 7.437 112.908 0.524 7.416 113.052 0.991 7.412 113.039 1.313 7.406 113.036 1.951 
110 Leu 8.900 119.346 0.600 8.902 119.413 0.315       
111 Ala 8.499 121.411 0.574 8.502 121.383 0.313 8.497 121.406 0.134    
112 Gly 8.181 102.842 0.664 8.191 102.864 0.384       
113 Phe 7.951 122.013 1.876 7.905 122.046 2.350 7.889 122.015 3.364 7.873 121.989 5.126 
114 Ala 8.748 119.604 0.515 8.758 119.670 0.286       
115 Gly 8.585 101.285 0.485 8.601 101.282 0.262       
116 Ala 7.807 121.479 1.036 7.816 121.418 0.686 7.830 121.435 0.333    
117 Met 7.167 113.336 0.499 7.180 113.477 0.291       
118 Val 7.214 121.360 0.497 7.219 121.327 0.217 7.216 121.286 0.155    
121 Ile 8.547 120.916 0.607 8.532 120.973 0.279 8.528 120.922 0.207    
122 Glu 9.711 120.958 0.446          






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
124 Tyr 8.089 118.768 0.836 8.101 118.719 0.514 8.093 118.693 0.329 8.093 118.665 0.154 
125 Ala 7.810 121.985 0.660 7.797 122.288 1.120 7.797 122.233 1.578 7.796 122.179 2.262 
126 Leu 6.888 118.270 0.424          
128 Gly 8.364 105.564 0.628          
129 Met 7.862 121.070 0.447 7.871 121.141 0.258 7.865 121.193 0.166    
131 Ala 8.524 124.277 0.596 8.518 124.302 0.308 8.510 124.287 0.161    
132 Val 7.928 116.891 0.359 7.950 116.776 0.493 7.948 116.779 0.499 7.952 116.817 0.586 
133 Ala 7.807 121.029 0.489 7.818 121.017 0.348 7.816 120.981 0.218 7.836 120.871 0.143 
135 Ile 8.051 120.617 0.703 8.056 120.722 0.465 8.063 120.732 0.261    
137 Leu 8.478 124.826 1.093          
138 Val 8.621 119.334 0.631 8.629 119.354 0.282       
139 Tyr 8.487 119.488 0.590 8.502 119.482 0.413 8.499 119.546 0.218    
141 Leu 8.404 117.258 0.475          
142 Val 8.444 116.080 0.756 8.422 116.071 0.443 8.419 116.101 0.269    
143 Gly 8.235 111.295 0.693 8.270 111.247 0.655 8.263 111.258 0.548 8.259 111.290 0.681 
145 Met 8.608 115.026 0.590          
146 Thr 6.872 115.420 0.531 6.862 115.433 0.461 6.857 115.464 0.326    
147 Glu 8.024 124.681 0.850 8.016 124.738 0.571       
148 Ser 7.792 115.325 0.730 7.782 115.314 0.495 7.772 115.280 0.295    
149 Ala 7.853 123.308 0.659 7.853 123.302 0.443 7.850 123.253 0.307    
150 Ser 7.750 110.485 0.738 7.755 110.521 0.503 7.751 110.541 0.291    
151 Gln 7.410 118.279 0.805 7.413 118.295 0.496 7.413 118.250 0.263    
153 Ser 7.800 113.603 0.641 7.794 113.601 0.410 7.789 113.605 0.212 7.777 113.589 0.110 
154 Ser 8.794 117.055 1.484 8.790 117.079 0.915 8.786 117.089 0.557    
155 Gly 8.954 110.968 0.864 8.934 110.951 0.413 8.921 110.875 0.226    
156 Ile 7.404 124.089 0.784 7.394 124.023 0.602 7.388 124.010 0.255    






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
157 Lys 8.443 121.165 0.937 8.436 121.167 0.610 8.431 121.184 0.445 8.423 121.224 0.228 
158 Ser 8.192 112.433 0.694 8.192 112.488 0.478 8.188 112.488 0.274    
159 Leu 7.481 123.450 0.561 7.469 123.513 0.310 7.469 123.597 0.165    
160 Tyr 8.810 118.457 0.724 8.795 118.418 0.544 8.791 118.441 0.312    
161 Val 8.471 117.841 0.491    8.473 117.814 0.185    
163 Leu 8.045 117.198 0.564 8.052 117.400 1.939 8.045 117.284 2.681 8.044 117.192 4.210 
164 Arg 9.338 124.481 0.527          
165 Asn 8.496 119.618 0.606 8.484 119.582 0.334 8.484 119.574 0.262    
167 Thr 7.660 114.130 0.612          
168 Val 8.656 116.885 0.502 8.646 116.790 0.278 8.636 116.782 0.191    
169 Val 7.339 112.696 0.552 7.334 112.700 0.402       
171 Trp 9.761 119.343 0.576    9.756 119.320 0.310    
173 Ile 7.640 113.617 0.687          
176 Phe 7.338 116.152 1.106 7.322 116.152 0.469 7.316 116.210 0.236    
177 Ile 7.738 120.233 0.992 7.738 120.222 0.502       
178 Trp 8.002 123.818 1.260 7.960 123.466 3.488 7.944 123.377 5.374 7.928 123.269 8.118 
179 Leu 7.950 113.627 0.419          
180 Leu 8.389 113.397 0.533 8.409 113.426 0.364       
181 Gly 7.885 110.566 0.494 7.877 110.543 0.276       
184 Gly 6.943 105.437 0.504 6.933 105.410 0.305       
185 Val 9.035 120.557 0.674 9.051 120.612 0.383       
186 Ala 7.819 120.378 0.520 7.819 120.374 0.270 7.812 120.361 0.178 7.784 120.134 0.167 
188 Leu 7.876 116.190 0.563 7.882 116.219 0.437 7.886 116.317 0.292 7.881 116.285 0.287 
191 Thr 7.520 109.217 1.014 7.508 109.346 0.498 7.506 109.383 0.307    
192 Val 7.103 122.084 0.593 7.096 122.040 0.270       
193 Asp 8.060 119.842 0.611 8.050 119.790 0.428       






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
195 Ala 8.273 121.273 0.519 8.272 121.262 0.277 8.262 121.290 0.171    
196 Leu 8.426 114.650 0.587 8.427 114.665 0.350       
197 Ile 7.750 117.943 0.542          
198 Val 8.477 122.099 0.531 8.462 122.090 0.321       
199 Tyr 7.338 117.742 0.705 7.331 117.694 0.415 7.331 117.734 0.270    
200 Leu 8.433 118.666 0.491          
201 Asp 9.456 121.129 0.571 9.444 121.120 0.283       
203 Val 8.209 119.764 0.585 8.200 119.722 0.375    8.175 119.758 0.265 
204 Thr 9.129 110.644 0.615 9.126 110.656 0.373       
205 Lys 7.461 114.004 0.538 7.450 113.976 0.313       
206 Val 7.672 121.041 0.753 7.697 121.348 0.636       
207 Gly 8.986 110.152 0.622          
208 Phe 7.375 121.518 0.564          
209 Gly 7.968 104.163 0.547 7.979 104.208 0.457       
210 Phe 9.022 121.622 0.458 9.028 121.640 0.251       
211 Ile 8.368 121.585 2.126 8.379 121.667 1.016 8.383 121.689 0.828 8.421 121.721 0.386 
213 Leu 8.722 118.215 0.475 8.731 118.211 0.272       
215 Ala 7.789 121.307 0.615          
216 Ala 8.203 121.231 1.847 8.216 121.203 1.093 8.219 121.180 0.729 8.232 121.219 0.458 
218 Thr 7.813 114.689 0.684 7.807 114.597 0.330 7.801 114.548 0.202 7.807 114.589 0.258 
219 Leu 7.961 122.286 1.224 7.960 122.201 0.555 7.942 122.220 0.410 7.931 122.188 0.412 
220 Arg 7.817 117.467 0.789 7.825 117.400 0.577 7.819 117.377 0.363 7.822 117.400 0.115 
222 Glu 7.935 118.413 0.842 7.937 118.406 0.602 7.935 118.387 0.331    
222b Glu       7.910 118.685 0.103 7.913 118.666 0.204 
223 His 8.107 118.176 1.079 8.110 118.206 0.788 8.108 118.196 0.503 8.099 118.212 0.359 
224 Gly 8.214 109.248 0.913 8.211 109.258 0.696 8.204 109.256 0.445 8.186 109.230 0.489 






Table B.2: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS + 0.5% c7-DHPC) 
# Resi 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
225 Glu 8.242 120.943 1.023 8.240 120.944 0.733 8.236 120.939 0.465 8.235 120.945 0.126 
225b Glu    8.218 120.635 0.205 8.213 120.585 0.325 8.211 120.545 0.492 
226 Ser 8.238 116.716 0.780 8.237 116.726 0.547 8.234 116.730 0.335 8.231 116.743 0.098 
227 Leu 8.182 124.456 0.869 8.179 124.461 0.633 8.177 124.463 0.391 8.174 124.458 0.117 
227b Leu          8.186 123.998 0.017 
228 Ala 8.080 124.330 0.966 8.078 124.349 0.706 8.074 124.351 0.445 8.070 124.353 0.129 
229 Gly 8.220 108.488 0.863 8.218 108.477 0.608 8.213 108.471 0.373 8.208 108.460 0.111 
230 Val 7.802 118.841 0.776 7.799 118.857 0.550 7.795 118.860 0.336 7.790 118.870 0.106 
231 Asp 8.388 123.970 0.765 8.382 124.000 0.591 8.372 123.993 0.431 8.357 123.997 0.489 
232 Thr 7.980 114.058 0.735 7.978 114.096 0.521 7.976 114.115 0.319 7.971 114.150 0.101 
233 Asp 8.313 123.001 0.714 8.312 123.050 0.494 8.308 123.066 0.292 8.306 123.095 0.070 
233b Asp    8.306 122.683 0.145 8.302 122.688 0.261 8.298 122.702 0.411 
234 Thr 7.988 117.008 0.753 7.991 117.024 0.534 7.990 117.027 0.322 7.990 117.019 0.089 
236 Ala 8.297 124.892 0.665 8.296 124.934 0.459 8.293 124.934 0.275 8.288 124.911 0.075 
237 Val 7.956 119.269 0.732 7.957 119.216 0.493 7.952 119.182 0.303 7.948 119.154 0.098 
238 Ala 8.173 126.914 0.589 8.150 126.712 0.388 8.137 126.613 0.228 8.126 126.503 0.061 
239 Asp 8.093 119.574 0.641 8.076 119.519 0.393 8.067 119.475 0.229 8.057 119.434 0.065 
240 Leu 8.017 122.476 0.615 7.997 122.455 0.417 7.987 122.442 0.256 7.977 122.597 0.078 
241 Glu 8.122 120.386 0.604 8.119 120.516 0.414 8.112 120.497 0.245 8.109 120.486 0.062 
 






Table B.3: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.909–0.990 ΧSDS (3–30% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
Table B.3: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.909–0.990 ΧSDS (3–30% SDS + 0.5% c7-DHPC) 
# Resi 
0.909 ΧSDS (3% SDS) 0.971 ΧSDS (10% SDS) 0.985 ΧSDS (20% SDS) 0.990 ΧSDS (30% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
2 Val 7.713 118.371 0.109 7.710 118.409 0.134       
17b Val 8.539 119.348 0.276 8.529 119.582 0.207       
21 Ala 8.083 121.468 0.921 8.060 121.556 0.737       
23 Ala 8.448 121.678 0.193          
35 Arg 8.493 116.432 0.361 8.488 116.669 0.189       
38 Val 8.404 117.068 0.232 8.352 117.102 0.195       
40 Leu 7.085 118.848 0.355 7.039 118.802 0.286       
44 Ser 7.884 109.941 0.592          
52 Ala 8.134 122.317 0.586 8.085 122.384 0.326       
60 Trp 8.373 122.617 0.236 8.333 122.715 0.234       
67 Thr 8.062 117.958 0.512 8.026 118.001 0.350       
75 Asp 7.554 117.665 0.375 7.540 117.666 0.354       
98b Phe 8.595 117.508 0.269 8.596 117.624 0.235       
101 Val 7.752 116.624 0.281 7.724 116.678 0.194       
105 Asn 7.972 115.851 2.490 7.959 115.992 1.412       
106 Thr 8.050 115.580 2.851 8.026 115.694 0.817       
106b Thr 8.085 115.733 3.900 8.060 115.735 6.348 8.053 115.814 4.132 8.051 115.887 0.292 
109 Met 7.401 113.041 2.366 7.376 113.079 2.066 7.363 113.127 0.832    






Table B.3: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.909–0.990 ΧSDS (3–30% SDS + 0.5% c7-DHPC) 
# Resi 
0.909 ΧSDS (3% SDS) 0.971 ΧSDS (10% SDS) 0.985 ΧSDS (20% SDS) 0.990 ΧSDS (30% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
113 Phe 7.848 121.966 6.483 7.818 122.025 7.004 7.812 122.049 4.747 7.802 122.049 1.540 
121 Ile 8.556 120.885 0.384 8.568 121.044 0.335       
124 Tyr 8.126 118.714 0.209          
125 Ala 7.795 122.110 2.733 7.773 122.112 1.374       
132 Val 7.947 116.793 0.497          
133 Ala 7.825 120.814 0.228 7.802 120.737 0.176       
143 Gly 8.247 111.319 1.067 8.216 111.462 0.382       
163 Leu 8.042 117.095 5.467 8.018 117.068 3.684 8.005 117.249 0.588    
178 Trp 7.905 123.131 10.408 7.883 123.187 11.888 7.898 123.366 10.343 7.898 123.313 5.686 
186 Ala 7.780 120.112 0.330 7.749 120.080 0.146       
188 Leu    7.880 116.403 0.398       
203 Val 8.159 119.763 0.740 8.144 119.731 0.785       
211 Ile 8.427 121.642 0.571 8.426 121.653 0.482       
213 Leu 8.739 118.141 0.227 8.724 118.133 0.219       
216 Ala 8.237 121.315 0.357          
218 Thr 7.801 114.604 0.228 7.763 114.619 0.217 7.741 114.637 0.194 7.732 114.675 0.163 
219 Leu 7.911 122.160 0.478 7.879 122.223 0.274 7.874 122.215 0.314    
220 Arg 7.746 117.447 0.126 7.721 117.440 0.157       
222b Glu 7.915 118.683 0.301 7.892 118.688 0.129       
223 His 8.108 118.212 0.388 8.093 118.139 0.140       
224 Gly 8.183 109.235 0.595 8.161 109.269 0.505 8.147 109.323 0.208    
225b Glu 8.211 120.496 0.639 8.172 120.544 0.668 8.132 120.683 0.401 8.114 120.716 0.080 
226 Ser 8.230 116.792 0.017          






Table B.3: Backbone chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.909–0.990 ΧSDS (3–30% SDS + 0.5% c7-DHPC) 
# Resi 
0.909 ΧSDS (3% SDS) 0.971 ΧSDS (10% SDS) 0.985 ΧSDS (20% SDS) 0.990 ΧSDS (30% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
227 Leu 8.163 124.451 0.017 8.177 124.415 0.017       
227b Leu 8.181 124.040 0.049 8.165 124.029 0.035       
228 Ala 8.065 124.321 0.023 7.996 124.578 0.150 7.999 124.864 0.074 7.991 124.840 0.020 
229 Gly 8.203 108.431 0.017          
230 Val 7.744 118.935 0.054 7.741 119.128 0.041       
231 Asp 8.349 124.057 0.559 8.323 124.256 0.523 8.311 124.344 0.399 8.304 124.398 0.254 
232 Thr 7.952 114.155 0.040 7.938 114.317 0.022       
233b Asp 8.292 122.724 0.510 8.267 122.959 0.550 8.258 123.181 0.422 8.254 123.288 0.284 
234 Thr 8.030 116.914 0.100 7.951 116.949 0.020       
236 Ala 8.262 124.654 0.023 8.247 124.519 0.015       
237 Val 7.948 119.188 0.072 7.925 119.301 0.051       
239 Asp 7.896 119.123 0.037 7.828 118.656 0.080 7.818 118.596 0.059    
240 Leu 7.979 122.730 0.095 7.969 122.804 0.047       
241 Glu 8.028 120.440 0.033 8.001 120.586 0.044       
 






B.2 Tryptophan side-chain chemical shifts and intensity ratios for pSRII in SDS 
Table B.4: Tryptophan side-chain chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0–0.728 ΧSDS (0–0.8% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
 
# 
0 ΧSDS 0.400 ΧSDS (0.2% SDS) 0.625 ΧSDS (0.5% SDS) 0.728 ΧSDS (0.8% SDS) 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
9 10.223 128.543 10.159 128.354 0.845 10.086 128.103 0.864 10.034 127.922 0.752 
24 10.249 129.921 10.143 129.610 1.039 10.032 129.289 1.125 9.966 129.089 0.988 
60 10.097 127.529 10.154 127.730 0.779 10.183 127.867 0.800 10.199 127.946 0.715 
76 9.560 127.531 9.560 127.610 0.820 9.553 127.627 0.815 9.546 127.630 0.668 
171 10.077 128.464 10.063 128.461 0.849 10.051 128.418 0.701 10.043 128.409 0.625 
178 9.357 125.573 9.334 125.341 0.792 9.327 125.218 0.873 9.326 125.153 0.674 
 
 






Table B.5: Tryptophan side-chain chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.769–0.893 ΧSDS (1.0–2.5% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
# 
0.769 ΧSDS (1.0% SDS) 0.834 ΧSDS (1.5% SDS) 0.870 ΧSDS (2.0% SDS) 0.893 ΧSDS (2.5% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
9 10.005 127.819 0.627 9.951 127.619 0.346 9.935 127.555 0.188    
9b       9.976 127.961 0.097 9.961 127.960 0.241 
24 9.934 128.990 0.910 9.876 128.810 0.726 9.859 128.771 0.646 9.840 128.738 0.643 
24b    9.903 129.394 0.102 9.882 129.405 0.238 9.867 129.388 0.499 
60 10.206 127.989 0.517          
76 9.541 127.620 0.517 9.537 127.623 0.280 9.534 127.666 0.180    
171 10.038 128.388 0.588 10.025 128.449 0.312       
178 9.326 125.120 0.623 9.329 125.082 0.364 9.326 125.067 0.179    
 
Table B.6: Tryptophan side-chain chemical shifts and intensity ratios (relative to 0 ΧSDS) of pSRII in 0.909–0.990 ΧSDS (3–30% SDS) 
Conditions: ~90 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
# 
0.909 ΧSDS (3% SDS) 0.971 ΧSDS (10% SDS) 0.985 ΧSDS (20% SDS) 0.990 ΧSDS (30% SDS) 
1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 1H (ppm) 15N (ppm) !/!# 
9b 9.940 127.951 0.491 9.880 127.945 0.691 9.867 128.071 0.187    
9c 9.747 127.779 0.110 9.706 127.751 1.123 9.682 127.724 0.329    
24 9.815 128.696 0.796 9.766 128.671 0.868 9.750 128.767 0.422    
24b 9.845 129.360 0.712 9.796 129.302 1.055 9.776 129.297 0.210    
24c 9.557 128.773 0.118 9.514 128.682 0.281       






B.3 H/D exchange intensity ratios for pSRII 
Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
Conditions: ~245 µM 15N-pSRII, 50 mM sodium phosphate (pH 6.0), 50 mM NaCl, 0.5% c7-DHPC, 
90% D2O vs. 9% D2O, 308 K. 
 
Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
# Resi 0 ΧSDS 0.769 ΧSDS (1.0% SDS) 
2 Val 0.093 0.146 
3 Gly 0.107 0.128 
5 Thr 0.151  
7 Leu 0.622 0.759 
9 Trp 0.553 0.661 
10 Leu 0.538  
11 Gly 0.533 0.636 
12 Ala 0.490 0.831 
13 Ile 0.552 0.630 
14 Gly 0.566 0.611 
15 Met 0.481 0.569 
16 Leu 0.570 0.636 
17 Val 0.565 0.640 
18 Gly 0.570 0.595 
20 Leu 0.723  
21 Ala 0.604 0.719 
22 Phe 0.612 0.700 
23 Ala 0.603 0.649 
24 Trp 0.601 0.733 
25 Ala 0.693 0.820 
26 Gly 0.262 0.163 
27 Arg 0.150 0.123 
28 Asp 0.126 0.137 
29 Ala 0.129 0.155 
30 Gly 0.068 0.109 
31 Ser 0.095 0.100 
32 Gly 0.090 0.112 
34 Arg 0.134  
35 Arg 0.088 0.776 
37 Tyr 0.589 0.408 
38 Val 0.672 0.839 
40 Leu  0.139 
41 Val 0.632  
42 Gly 0.519 0.599 
44 Ser 0.626 0.731 
45 Gly 0.559 0.656 






Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
# Resi 0 ΧSDS 0.769 ΧSDS (1.0% SDS) 
46 Ile 0.604 0.553 
47 Ala 0.561 0.693 
48 Ala 0.555 0.623 
49 Val 0.545 0.648 
50 Ala 0.606 0.707 
51 Tyr 0.496 0.630 
52 Ala 0.567 0.617 
53 Val 0.592 0.638 
54 Met 0.580  
55 Ala 0.420 0.680 
56 Leu 0.508  
57 Gly 0.631 0.698 
58 Val 0.569 0.653 
60 Trp 0.115 0.313 
61 Val 0.175  
63 Val 0.188 0.132 
64 Ala 0.087 0.110 
65 Glu 0.109  
66 Arg 0.133  
67 Thr  0.121 
68 Val 0.239  
70 Val 0.477 0.508 
74 Ile 0.525 0.601 
75 Asp 0.507 0.471 
76 Trp 0.549  
77 Ile 0.585  
78 Leu 0.743 0.559 
79 Thr 0.610 0.607 
80 Thr 0.537 0.807 
82 Leu 0.523  
83 Ile 0.411 0.559 
85 Tyr 0.523 0.614 
86 Phe 0.560 0.575 
87 Leu 0.471 0.662 
88 Gly 0.516 0.637 
89 Leu 0.541 0.638 
90 Leu 0.513 0.610 
91 Ala 0.750 0.856 
92 Gly 0.461 0.271 
93 Leu 0.135 0.188 
94 Asp  0.155 
95 Ser 0.095 0.099 
96 Arg 0.107 0.177 






Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
# Resi 0 ΧSDS 0.769 ΧSDS (1.0% SDS) 
97 Glu 0.119  
98 Phe 0.186 0.262 
99 Gly 0.138 0.166 
101 Val 0.641 0.599 
102 Ile 0.606  
103 Thr 0.760 0.519 
105 Asn 0.528 0.638 
106 Thr 0.774 1.050 
108 Val 0.524 0.543 
109 Met 0.529 0.600 
110 Leu 0.569 0.577 
111 Ala 0.589 0.663 
112 Gly 0.566 0.635 
113 Phe 0.503 0.080 
114 Ala 0.551 0.583 
115 Gly 0.567 0.679 
116 Ala 0.580  
117 Met 0.620 0.660 
118 Val 0.666 0.741 
120 Gly 0.099  
124 Tyr 0.284 0.255 
125 Ala 0.268 0.139 
126 Leu 0.875 1.199 
127 Phe 0.882  
128 Gly 0.577 0.636 
129 Met  0.149 
130 Gly 0.561  
131 Ala 0.612 0.709 
132 Val 0.821  
133 Ala 0.599 0.639 
134 Phe 0.508  
135 Ile 0.501 0.600 
136 Gly 0.591  
137 Leu 1.399 0.735 
138 Val 0.546 0.613 
139 Tyr 0.642 0.632 
140 Tyr 0.637  
141 Leu 0.483 0.594 
142 Val 0.638 0.119 
143 Gly 0.468 0.503 
145 Met 0.523 0.544 
146 Thr 0.939 0.920 
147 Glu 0.216 0.180 






Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
# Resi 0 ΧSDS 0.769 ΧSDS (1.0% SDS) 
148 Ser 0.232 0.162 
149 Ala 0.153 0.146 
150 Ser 0.147 0.153 
151 Gln 0.132 0.168 
153 Ser 0.087 0.095 
154 Ser  0.071 
155 Gly 0.136  
156 Ile 0.136 0.170 
157 Lys 0.162 0.164 
158 Ser 0.109 0.141 
159 Leu 0.107 0.115 
160 Tyr 0.579 0.471 
161 Val 0.597 0.727 
163 Leu 0.768 0.734 
164 Arg 0.606 0.755 
165 Asn 0.537 0.609 
167 Thr 0.893 0.999 
168 Val 0.545 0.618 
169 Val 0.563 0.684 
171 Trp 0.508 0.572 
173 Ile 0.499 0.460 
174 Tyr 0.615  
176 Phe 0.514  
177 Ile 0.416 0.567 
178 Trp 0.440 0.358 
179 Leu  0.094 
180 Leu 0.502 0.705 
181 Gly 0.558 0.626 
184 Gly 0.270 0.138 
185 Val 0.566 0.639 
186 Ala  0.709 
188 Leu 0.532 0.641 
191 Thr  0.115 
192 Val 0.126  
194 Val 0.677  
195 Ala 0.642 0.682 
196 Leu 0.476 0.517 
197 Ile 0.437 0.409 
198 Val 0.541 0.659 
199 Tyr 0.484 0.650 
200 Leu 0.489 0.633 
201 Asp 0.531 0.675 
202 Leu 0.608  






Table B.7: Intensity ratios for pSRII in deuterated vs. protonated solvent 
# Resi 0 ΧSDS 0.769 ΧSDS (1.0% SDS) 
203 Val 0.506 0.520 
204 Thr 0.536 0.765 
205 Lys 0.470 0.503 
206 Val 0.576 0.628 
207 Gly 0.503 0.582 
208 Phe 0.494 0.564 
209 Gly 0.489 0.574 
210 Phe 0.564 0.567 
211 Ile 0.854 0.682 
212 Ala 0.598  
213 Leu 0.714 0.847 
214 Asp 0.334  
215 Ala 0.187  
216 Ala 0.108 0.245 
218 Thr 0.131  
219 Leu 0.142  
220 Arg 0.116 0.219 
221 Ala 0.121  
222 Glu 0.109 0.130 
223 His 0.090 0.108 
224 Gly 0.093 0.107 
225 Glu 0.091 0.109 
226 Ser 0.094 0.104 
227 Leu 0.084 0.108 
228 Ala 0.096 0.109 
229 Gly 0.091 0.100 
230 Val 0.105 0.114 
231 Asp 0.098 0.107 
232 Thr 0.095 0.106 
233 Asp 0.093 0.102 
234 Thr 0.096 0.126 
236 Ala 0.100 0.113 
237 Val 0.110 0.120 
238 Ala 0.093 0.116 
239 Asp 0.092 0.106 
240 Leu 0.099 0.125 
241 Glu 0.099 0.117 
9 Trp-NεHε 0.098 0.081 
24 Trp-NεHε 0.102 0.112 
76 Trp-NεHε 0.255  
171 Trp-NεHε 0.589 0.788 
178 Trp-NεHε 0.081 0.100 






B.4 Chemical shifts for pSRII at acidic pHs 
Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
Conditions: 112 µM 15N-pSRII, 50 mM sodium phosphate (pH 2.0, 2.6, 3.7, 4.7), 50 mM NaCl, 0.5% c7-DHPC, 10% D2O, 308 K. 
Alternative conformations are labelled with letters. 
 
Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
2 Val 7.963 120.278 7.962 120.288     
3 Gly 8.497 112.330 8.487 112.291     
5 Thr 8.352 108.276 8.358 108.331     
6 Thr 7.501 117.587 7.501 117.613     
7 Leu 7.370 120.109 7.389 120.155     
7b Leu 7.379 120.162       
9 Trp 8.638 120.099 8.627 120.024     
10 Leu 8.230 120.203 8.298 120.051     
11 Gly 7.981 105.342       
12 Ala 8.392 123.382 8.414 123.563     
13 Ile 8.876 116.596 8.879 116.618     
14 Gly 8.686 107.740 8.682 107.718     
15 Met 8.375 117.952 8.390 118.148     
16 Leu 8.843 125.193 8.840 125.188     
17 Val 8.498 118.980 8.494 119.007     
18 Gly 7.795 104.247 7.780 104.175     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
21 Ala 8.002 121.296 7.988 121.254     
22 Phe 8.592 118.059 8.594 117.905     
23 Ala 8.431 121.345 8.457 121.385     
24 Trp 8.643 118.525 8.639 118.659     
25 Ala 8.647 120.923 8.658 120.873     
26 Gly 7.681 103.926 7.736 104.034     
27 Arg 7.207 120.845 7.257 120.956     
28 Asp 7.779 117.605 7.766 117.130     
29 Ala 7.160 123.196 7.173 123.122   7.226 122.931 
30 Gly 8.668 109.370 8.530 108.944     
31 Ser 8.679 115.772 8.689 116.000 8.709 116.347 8.708 116.325 
32 Gly 8.978 111.072 8.962 111.069     
35 Arg 8.505 115.923 8.590 116.039     
37 Tyr 7.226 116.970 7.261 117.012     
38 Val 8.639 117.950 8.655 118.015     
40 Leu 7.296 118.943 7.249 118.895 7.240 118.991 7.252 118.969 
41 Val 8.158 118.276 8.199 118.405     
42 Gly 8.403 106.648 8.393 106.599     
44 Ser 7.858 109.758 7.868 109.743     
45 Gly 8.896 114.874 8.898 114.856     
47 Ala 6.695 120.876       
48 Ala 8.489 120.116 8.486 120.146     
49 Val 7.503 115.639 7.500 115.637     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
50 Ala 8.397 122.501 8.385 122.531     
51 Tyr 8.798 115.414       
52 Ala 8.133 121.698 8.130 121.696     
53 Val 8.261 113.775 8.263 113.736     
55 Ala 8.302 124.772 8.291 124.766     
56 Leu 7.258 115.996 7.254 115.996     
57 Gly 8.031 107.235       
58 Val 7.617 122.869 7.605 122.841     
59 Gly 8.806 112.232 8.817 112.349     
60 Trp 8.408 122.612 8.361 122.561     
61 Val 9.045 127.157 9.055 127.166     
63 Val 8.423 126.313 8.407 126.198     
64 Ala 8.843 128.397 8.864 128.330     
66 Arg 8.602 121.152 8.611 120.815     
68 Val 9.213 129.047 9.235 129.299     
77 Ile 8.257 120.302       
78 Leu 7.505 115.833       
80 Thr 8.184 117.457 8.182 117.253     
83 Ile 7.799 122.756       
85 Tyr 9.001 122.489       
86 Phe 8.561 121.585       
87 Leu 8.459 116.552       
88 Gly 9.362 108.174 9.360 108.197     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
89 Leu 8.906 126.058 8.920 126.107     
90 Leu 7.687 119.880 7.681 119.938     
91 Ala 8.102 116.704       
92 Gly 7.578 106.137 7.584 106.300     
93 Leu 7.252 117.952 7.258 117.903     
95 Ser 8.601 114.867 8.623 114.911     
96 Arg 8.146 123.351 8.133 123.281     
97 Glu 8.269 118.834 8.287 118.216     
98 Phe 8.575 118.461 8.578 118.526     
99 Gly 8.212 105.136 8.245 105.141     
100 Ile 7.745 123.497 7.750 123.498     
101 Val 7.713 116.305 7.723 116.433     
102 Ile 8.520 120.711 8.515 120.759 8.554 120.976 8.591 121.089 
103 Thr 7.951 122.583 7.947 122.626     
105 Asn 8.056 115.282 8.058 115.276     
106 Thr 8.061 114.560 8.063 114.543     
108 Val 7.582 118.063 7.572 118.068     
110 Leu 8.811 118.700 8.792 118.598     
111 Ala 8.524 121.356 8.528 121.367     
112 Gly 8.105 102.888       
113 Phe 7.975 121.908 7.976 121.812     
114 Ala 8.706 119.178 8.682 119.063     
115 Gly 8.527 101.597 8.523 101.851     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
116 Ala 7.857 121.712 7.961 122.214     
117 Met 7.138 112.831 7.161 112.909     
118 Val 7.236 121.157 7.257 120.956     
120 Gly 7.848 105.650 7.817 105.575     
121 Ile 8.588 120.266 8.597 120.328 8.618 120.546 8.617 120.536 
122 Glu 9.867 121.949 9.346 121.166     
125 Ala 7.813 122.356       
126 Leu 7.033 118.599 7.077 118.677     
128 Gly 8.424 105.738 8.442 105.769     
129 Met 7.862 120.599 7.859 120.601     
130 Gly 7.921 106.039 7.945 106.135     
131 Ala 8.566 124.240 8.576 124.262     
132 Val 7.931 117.117 7.945 117.186 7.950 117.128 7.941 117.115 
133 Ala 7.809 121.076 7.824 121.124     
134 Phe 8.378 119.243 8.386 119.281     
135 Ile 8.012 120.229 8.012 120.255     
136 Gly 7.822 105.794 7.829 105.784     
137 Leu 8.389 124.669 8.391 124.707     
138 Val 8.560 119.105 8.501 119.118     
139 Tyr 8.403 119.481 8.403 119.470     
140 Tyr 8.154 120.407 8.191 120.131     
141 Leu 8.317 117.460 8.323 117.532     
142 Val 8.482 115.732 8.485 115.815     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
143 Gly 8.121 111.589 8.129 111.444     
145 Met 8.683 114.520 8.694 114.545     
146 Thr 6.913 115.214 6.897 115.244     
147 Glu 8.069 124.383 8.072 123.880     
148 Ser 7.873 115.235 7.850 115.227     
149 Ala 7.823 123.434 7.816 123.399     
150 Ser 7.728 110.223 7.724 110.254     
151 Gln 7.368 118.187 7.359 118.140     
153 Ser 7.914 113.511 7.927 113.503     
154 Ser 8.850 117.208 8.841 117.254     
155 Gly 8.882 110.525 8.815 110.352     
156 Ile 7.377 123.697 7.343 123.460     
157 Lys 8.482 121.241 8.475 121.216     
158 Ser 8.178 112.217 8.179 112.257   8.184 112.427 
159 Leu 7.522 123.195 7.521 123.238     
160 Tyr 8.922 118.662 8.910 118.645     
161 Val 8.477 118.067 8.484 118.121     
163 Leu 8.046 117.609 8.045 117.606     
164 Arg 9.421 124.834 9.419 124.863     
165 Asn 8.533 119.440 8.542 119.424 8.565 119.874 8.555 119.886 
165b Asn     8.531 119.718 8.519 119.734 
167 Thr 7.690 114.295 7.691 114.373     
168 Val 8.685 117.152 8.678 117.208     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
169 Val 7.344 112.549 7.352 112.586     
171 Trp 9.721 119.386 9.708 119.327     
176 Phe 7.320 115.729 7.274 115.517     
177 Ile 7.699 119.815 7.714 119.560     
180 Leu 8.197 113.492 8.148 113.585     
181 Gly 7.868 110.429       
184 Gly 6.977 105.754 6.959 105.693     
185 Val 8.932 119.957 8.923 119.818     
186 Ala 7.878 120.508 7.904 120.539     
188 Leu 7.879 115.889       
191 Thr 7.681 108.971 7.705 108.924     
192 Val 7.095 121.508 7.090 121.306     
198 Val 8.586 122.189 8.617 122.127     
201 Asp 9.526 121.112 9.506 121.147     
202 Leu 8.331 119.211 8.342 119.190     
203 Val 8.238 119.967 8.264 120.132     
204 Thr 9.225 110.680       
205 Lys 7.472 114.074       
208 Phe 7.345 121.306       
209 Gly 7.925 103.904 7.932 103.829     
210 Phe 9.036 121.666       
212 Ala 7.630 122.106 7.625 122.027     
213 Leu 8.556 117.312 8.587 117.387     






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
218 Thr 7.847 114.219 7.860 113.871 7.902 113.434 7.891 113.432 
219 Leu 7.871 122.194 7.833 122.286   7.785 122.447 
221 Ala 7.744 122.446 7.793 122.599 7.861 122.893 7.855 122.840 
221b Ala     7.864 122.130 7.846 122.031 
222 Glu 7.957 118.448 7.954 118.263 7.962 118.719 7.950 118.783 
222b Glu     7.931 118.168 7.919 118.165 
224 Gly 8.289 109.597 8.302 109.567 8.326 109.662 8.327 109.660 
224b Gly     8.230 109.087 8.231 109.087 
225 Glu 8.282 120.745 8.222 120.394 8.147 120.038 8.141 120.009 
225b Glu     8.087 119.619 8.081 119.612 
226 Ser 8.283 116.840 8.277 116.848 8.284 116.982 8.283 117.013 
226b Ser     8.222 116.417 8.221 116.429 
227 Leu 8.262 124.448 8.257 124.465 8.253 124.498 8.253 124.540 
227b Leu     8.285 124.102 8.288 124.107 
228 Ala 8.110 124.135 8.107 124.139 8.111 124.256 8.110 124.280 
228b Ala     8.057 123.444 8.058 123.440 
229 Gly 8.221 108.460 8.214 108.384 8.214 108.256 8.215 108.244 
229b Gly     8.189 107.726 8.189 107.711 
230 Val 7.819 118.812 7.805 118.849 7.810 119.002 7.812 119.010 
230b Val     7.766 118.753 7.767 118.770 
231 Asp 8.424 123.678 8.451 123.301 8.516 122.473 8.523 122.387 
231b Asp     8.473 121.924 8.477 121.819 
232 Thr 8.018 114.083 8.030 114.236 8.027 114.388 8.022 114.391 






Table B.8: Backbone and tryptophan side-chain chemical shifts for pSRII at acidic pHs 
# Resi 
pH 4.7 pH 3.7 pH 2.6 pH 2.0 
1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 
232b Thr     7.979 113.882 7.974 113.846 
233 Asp 8.318 122.696 8.319 122.269 8.325 121.272 8.325 121.174 
233b Asp     8.294 121.000 8.291 120.896 
234 Thr 7.989 116.834 7.980 116.778 7.970 116.774 7.966 116.767 
234b Thr     7.914 116.427 7.908 116.396 
236 Ala 8.272 124.289 8.257 124.068 8.213 123.769 8.204 123.661 
236b Ala     8.190 122.886 8.180 122.770 
237 Val 7.891 118.925 7.885 118.946 7.878 118.873 7.872 118.825 
237b Val     7.818 118.279 7.809 118.213 
238 Ala 8.194 126.664 8.190 126.504 8.192 126.213 8.191 126.159 
238b Ala     8.154 125.401 8.150 125.297 
239 Asp 8.107 119.257 8.117 118.885     
240 Leu 8.062 122.528 8.034 122.453 7.946 122.095 7.927 121.972 
240b Leu     7.893 121.594 7.877 121.487 
241 Glu 8.113 118.876 8.067 118.628     
9 Trp-NεHε 10.210 128.515 10.209 128.550     
24 Trp-NεHε 10.243 129.902 10.242 129.889 10.237 129.916 10.248 129.935 
24b Trp-NεHε       10.199 129.542 
60 Trp-NεHε 10.129 127.505       
76 Trp-NεHε 9.558 127.435       
171 Trp-NεHε 10.067 128.394       







C Scalar coupling 
C.1 RalAΔC-GDP 
Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
Conditions: 700 µM 15N-RalAΔC-GDP, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl2, 0.05% NaN3, 10% D2O, 298 K. 
SNR (Add) and SNR (Sub) are the signal-to-noise ratios of peaks in the sub-spectrum obtained by taking the sum or the difference, respectively, of the 
in-phase (IP) and antiphase (AP) spectra. 
 
Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
13 Ala -92.860 100.769 56.503 -92.442 76.444 46.289 -92.829 163.708 94.431 -92.276 120.864 66.308 -92.787 102.445 60.079 
14 Leu -91.768 91.152 35.941 -92.119 73.048 27.348 -91.875 152.417 58.954 -92.146 103.593 44.664 -93.270 93.373 40.111 
15 His -94.301 78.324 43.301 -94.050 64.031 37.606 -94.174 132.660 73.413 -94.010 99.206 62.848 -94.112 86.684 56.813 
17 Val -93.830 73.441 40.398 -93.606 69.639 38.958 -93.748 137.364 80.106 -93.791 115.042 62.126 -93.527 104.436 56.860 
18 Ile -93.339 88.857 43.126 -93.741 87.612 45.698 -93.692 167.471 87.324 -93.552 135.947 68.839 -93.833 123.165 63.900 
19 Met -93.440 70.241 35.530 -93.362 63.644 32.779 -93.524 128.896 67.222 -93.555 102.996 51.688 -93.534 94.336 47.586 
20 Val -95.875 117.603 74.342 -96.093 105.973 71.612 -96.213 212.632 142.053 -97.819 170.656 110.737 -96.686 162.766 104.276 
21 Gly -93.988 100.561 52.512 -94.086 101.682 50.404 -94.033 189.111 95.812 -94.230 89.231 45.537 -94.114 88.893 47.099 
23 Gly -94.710 137.271 72.859 -94.838 132.074 71.057 -94.874 250.266 139.623 -94.812 187.380 100.618 -94.606 180.599 99.565 
24 Gly -93.302 56.613 30.985 -93.146 56.001 31.198 -93.496 101.612 52.325    -92.969 28.548 15.126 
26 Gly -93.716 92.354 45.915 -93.421 88.668 44.207 -93.474 168.412 84.941 -93.425 132.134 67.448 -93.738 125.972 61.673 






Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
27 Lys -90.250 46.519 23.128 -91.400 44.013 23.114 -90.919 83.171 46.717       
28 Ser -94.150 102.436 50.287 -94.461 92.980 49.715 -94.220 186.288 98.891 -94.485 144.013 72.725 -94.355 140.431 70.510 
29 Ala -93.640 82.544 45.013 -93.887 77.106 44.496 -94.095 158.063 88.969 -93.978 119.986 66.215 -94.238 111.528 60.880 
30 Leu -94.821 120.911 62.603 -94.397 116.149 58.770 -94.634 225.804 119.696 -94.735 181.152 92.007 -94.779 169.977 86.791 
32 Leu -93.115 87.815 43.581 -92.978 83.012 43.388 -93.107 161.826 88.744 -93.222 120.630 63.203 -93.367 117.493 61.229 
35 Met -92.849 98.074 51.788 -93.031 93.535 48.481 -92.998 182.525 93.493 -93.576 146.122 69.759 -93.411 139.799 66.871 
36 Tyr -90.351 106.705 59.405 -90.474 105.763 59.473 -90.438 203.223 112.198 -90.538 166.533 88.157 -89.988 156.907 82.314 
39 Phe -92.553 135.152 69.495 -92.589 125.627 67.839 -92.573 251.207 134.083 -92.409 189.437 99.407 -92.558 178.045 91.215 
40 Val -92.933 33.823 17.866 -91.721 31.570 16.556          
41 Glu -92.780 111.985 55.159 -92.749 108.899 55.070 -92.925 210.750 106.325 -92.666 156.895 83.784 -92.812 148.847 75.949 
43 Tyr -94.312 50.212 26.051 -94.239 43.011 24.745 -94.089 87.405 49.542 -94.836 60.796 33.398 -94.409 60.726 32.412 
44 Glu -93.225 96.469 53.309 -93.121 89.465 52.536 -93.301 175.939 104.464 -93.044 132.775 75.853 -93.269 123.190 69.700 
47 Lys -93.068 60.479 33.152 -93.313 59.965 32.801 -92.710 116.665 61.532 -92.783 67.564 33.832 -91.815 70.320 33.264 
48 Ala -92.485 42.777 25.113 -93.038 36.127 23.682 -92.791 77.432 48.755 -92.250 56.106 34.898 -92.290 51.742 29.967 
50 Ser -91.696 133.270 69.541 -91.857 125.625 70.218 -91.894 246.502 134.444 -91.768 175.672 102.288 -91.736 166.670 94.197 
51 Tyr -92.969 82.761 47.865 -92.901 78.893 44.944 -92.726 157.122 88.487 -93.059 128.947 70.114 -92.877 122.159 67.381 
52 Arg -93.134 157.658 80.744 -93.427 152.050 80.674 -93.221 295.426 156.459 -93.436 230.260 120.931 -93.365 218.233 112.412 
54 Lys -93.037 161.435 86.489 -92.741 154.284 87.197 -92.849 306.717 169.406 -92.922 228.927 127.435 -93.052 216.748 118.735 
56 Val -92.498 205.923 106.258 -92.890 204.389 107.277 -92.765 393.275 210.755 -92.713 291.514 153.064 -92.988 281.839 149.114 
57 Leu -92.941 130.150 62.560 -93.188 125.107 61.684 -93.160 248.384 118.986 -93.070 195.807 94.593 -93.223 183.786 90.195 
58 Asp -93.115 41.898 21.363 -93.833 36.195 20.439 -94.294 71.881 39.806 -93.325 56.450 28.967 -94.042 49.620 26.029 
59 Gly -92.565 111.058 63.279 -92.509 106.946 63.309 -92.569 200.401 115.059 -92.449 149.681 85.479 -92.459 146.992 81.444 
60 Glu -95.202 176.639 98.393             
61 Glu -93.310 151.975 81.111 -93.552 126.034 69.629 -93.498 262.497 149.543 -93.471 186.507 105.869 -93.442 164.568 90.606 






Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
62 Val -93.667 95.790 51.250 -94.182 76.068 43.003 -93.769 159.003 91.181 -93.679 123.092 66.063 -93.371 108.070 60.315 
63 Gln -92.367 90.300 54.181 -91.987 70.971 44.647 -92.751 152.417 93.527 -92.085 109.725 64.695 -92.034 99.341 61.393 
64 Ile -92.835 82.584 43.918 -93.110 68.004 41.282 -93.202 143.009 79.720 -93.236 107.548 59.693 -93.408 102.771 57.766 
65 Asp -92.747 90.721 43.552 -92.898 80.026 40.984 -93.364 162.767 81.148 -92.884 130.631 65.839 -92.729 118.889 59.744 
66 Ile -93.547 87.141 43.568 -93.238 80.436 43.364 -93.451 159.944 87.867 -93.486 133.931 71.656 -93.360 127.881 70.221 
67 Leu -93.993 90.177 40.658 -93.593 86.083 42.464 -93.604 169.353 82.837 -93.674 135.707 66.175 -93.667 128.611 60.431 
68 Asp -93.936 67.698 33.144 -94.614 63.676 32.028 -93.892 126.074 65.369 -93.700 99.723 48.962 -93.433 92.009 47.139 
71 Gly -94.004 76.273 53.786 -94.151 63.960 47.780 -93.970 127.015 93.744 -94.035 90.745 63.725 -94.191 83.754 57.995 
72 Gln -92.870 59.244 43.240 -92.650 49.500 38.149 -92.349 103.493 77.728 -92.378 71.058 50.607 -92.223 64.724 44.162 
73 Glu -92.548 60.682 41.943 -93.300 49.188 36.203 -92.319 105.375 75.099 -92.563 67.545 49.223 -92.166 61.915 45.801 
74 Asp -93.388 144.312 97.566 -93.313 135.489 96.404 -93.253 270.964 192.807 -93.387 196.043 134.865 -93.169 179.112 122.935 
78 Ile -92.002 81.400 44.064 -91.952 77.284 40.825 -92.080 148.654 82.585 -92.059 104.340 60.476 -92.384 96.892 55.850 
79 Arg -92.191 50.671 27.927 -92.610 48.148 25.019 -93.107 93.332 50.055 -92.423 69.388 38.321 -92.924 62.795 32.720 
80 Asp -93.524 115.503 67.358 -93.722 103.513 61.432 -93.806 207.928 120.010 -93.743 151.438 85.698 -93.766 140.741 76.368 
83 Phe -94.553 77.277 46.289 -94.843 70.978 44.185 -93.992 143.009 84.470 -94.052 110.385 64.490 -94.239 102.231 59.361 
86 Gly -96.199 118.028 60.043 -96.289 106.189 60.920 -96.241 204.164 110.936 -96.239 167.288 95.450 -96.157 155.437 90.454 
87 Glu    -91.466 35.327 26.779    -90.477 63.813 46.163    
88 Gly -94.277 105.296 61.732 -94.168 97.730 57.316 -94.232 183.465 111.233 -93.889 150.371 89.573 -93.945 148.134 86.651 
89 Phe    -93.123 136.535 89.379 -93.998 247.443 162.380 -93.467 184.412 118.553    
91 Cys -94.051 128.763 62.055 -94.151 123.496 62.666 -94.200 242.739 121.377 -94.227 187.146 96.701 -94.192 175.807 87.761 
92 Val -94.444 115.078 53.692 -94.351 109.052 54.535 -94.301 217.336 105.832 -94.336 177.798 85.882 -94.246 167.312 79.382 
93 Phe -94.869 124.369 61.065 -95.007 118.137 60.198 -94.468 234.271 118.021 -94.714 188.781 92.896 -94.581 183.954 90.836 
94 Ser -91.982 81.484 44.394 -92.500 77.405 42.175 -92.152 145.832 80.685 -92.096 111.528 60.412 -92.298 105.976 56.499 
95 Ile -95.220 97.451 49.070 -95.090 94.143 48.623 -95.214 180.643 96.104 -95.375 141.159 75.799 -95.646 136.304 69.364 






Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
96 Thr -92.978 121.049 56.957 -93.254 119.127 56.604 -93.230 232.390 110.817 -93.184 180.029 82.679 -93.199 170.060 80.310 
97 Glu -92.642 167.551 67.547 -93.046 161.733 72.081 -92.816 311.421 138.194 -92.992 237.769 106.336 -92.542 228.547 99.326 
98 Met -93.846 72.814 34.641 -93.035 66.140 37.086 -93.520 133.601 72.647 -93.863 105.498 54.161 -93.353 96.763 50.790 
99 Glu -92.624 85.880 45.262 -92.464 75.878 42.896 -92.933 152.417 84.813 -92.423 103.956 57.160 -93.100 99.950 54.088 
100 Ser -91.283 110.415 59.310 -91.904 109.752 60.878 -91.477 209.809 114.226 -91.591 163.461 88.196 -91.590 155.769 78.128 
101 Phe -92.767 93.423 41.111 -92.235 91.939 41.077 -92.945 176.880 79.915 -92.324 136.952 60.451 -92.484 127.587 54.888 
102 Ala -93.719 158.462 71.446 -93.676 154.890 73.201 -93.715 304.835 143.230 -93.918 227.059 103.328 -93.821 212.810 94.908 
103 Ala -92.877 169.041 79.923 -92.938 169.818 83.302 -92.929 319.889 158.654 -92.987 255.311 120.971 -93.054 238.956 112.373 
104 Thr -93.319 112.923 57.716 -93.100 106.694 56.065 -93.024 206.046 106.132 -93.196 161.288 80.213 -93.149 157.983 77.856 
105 Ala -93.385 180.790 81.492 -93.525 180.624 82.440 -93.447 344.351 158.737 -93.131 209.322 92.137 -93.432 204.837 92.435 
106 Asp -92.226 169.676 81.182 -92.456 169.689 84.734 -92.550 323.652 161.004 -92.585 249.891 120.200 -92.455 238.004 113.876 
107 Phe -93.200 116.048 61.156 -93.356 105.181 57.398 -93.135 207.928 114.812 -93.355 169.848 92.331 -93.004 158.087 83.413 
110 Gln -93.434 120.376 59.579 -93.599 111.230 57.194 -93.522 219.218 114.696 -93.595 178.158 89.972 -93.516 163.928 81.641 
111 Ile -93.890 95.079 56.075 -93.733 90.193 56.227 -93.651 178.761 108.831 -94.325 145.816 93.605 -94.267 133.606 83.807 
112 Leu -93.842 115.211 57.785 -93.729 108.171 58.697 -93.824 219.218 109.756 -94.058 174.066 84.987 -93.843 163.153 77.515 
113 Arg -93.650 150.673 74.997 -93.671 143.646 73.824 -93.654 279.432 142.324 -93.711 226.059 112.817 -93.399 211.781 102.650 
115 Lys -92.511 102.634 56.087 -93.175 96.706 53.469 -92.650 190.992 102.661 -92.694 146.045 79.107 -92.825 137.291 75.494 
119 Asn -92.378 214.798 112.812 -92.370 204.062 111.381 -92.392 396.097 218.425 -92.324 290.760 155.560 -92.375 276.071 146.675 
120 Val -93.600 191.991 102.780 -93.771 182.430 102.322 -93.685 352.818 194.361 -93.792 211.697 116.359 -93.744 204.496 109.274 
122 Phe -91.967 115.138 57.306 -92.123 108.950 58.338 -92.091 216.395 114.187 -91.967 175.560 102.255 -92.289 162.745 93.801 
123 Leu -93.733 130.424 67.544 -93.465 125.535 67.565 -93.704 248.384 134.624 -93.807 204.934 108.638 -93.701 192.099 99.760 
124 Leu -93.554 129.025 62.066 -93.374 124.859 65.313 -93.487 247.443 124.346 -92.985 198.587 90.689 -93.464 183.504 84.807 
125 Val -93.009 112.257 51.581 -93.002 105.498 54.410 -93.095 214.513 106.062 -93.048 175.009 85.656 -93.024 166.183 80.403 
126 Gly -93.878 93.332 49.978 -93.613 92.200 49.612 -93.673 177.820 95.925 -93.880 142.578 72.742 -93.211 140.192 71.223 






Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
127 Asn -94.211 129.246 60.929 -93.548 123.758 61.731 -94.037 241.798 117.366 -94.166 200.587 95.356 -93.967 187.904 86.505 
128 Lys    -92.329 72.568 35.973    -92.343 103.343 55.347 -91.796 100.821 51.854 
129 Ser -93.041 102.500 52.514 -93.155 99.910 53.826 -93.280 190.992 100.828 -93.014 155.910 80.902 -93.442 152.952 77.633 
130 Asp -92.851 119.753 54.369 -92.985 113.824 54.150 -93.191 224.863 104.683 -93.414 178.311 83.341 -93.614 170.224 78.115 
131 Leu -91.962 129.703 63.951 -92.366 126.748 65.185 -91.948 246.502 128.714 -91.839 205.514 104.399 -92.021 190.320 96.567 
132 Glu -92.339 169.064 86.250 -92.202 171.389 91.998 -92.403 321.770 170.792 -92.662 163.538 83.366 -92.147 164.357 83.089 
133 Asp -93.572 163.291 88.415 -93.822 155.573 85.491 -93.648 303.894 167.448 -93.548 229.262 123.174 -93.667 221.982 118.465 
134 Lys -91.987 146.275 79.769 -91.664 152.948 84.205 -91.749 289.781 159.248 -91.706 234.449 121.115 -91.706 224.100 115.926 
135 Arg -94.400 141.978 69.850 -94.167 139.461 69.576 -94.474 269.083 135.657 -94.259 211.664 103.132 -94.270 202.236 97.550 
136 Gln -91.373 30.738 19.657 -90.258 28.417 16.011       -90.761 46.976 27.646 
137 Val -92.523 89.723 43.992 -92.356 89.888 44.997 -92.659 169.353 84.902 -92.716 133.219 67.091 -92.415 125.552 62.130 
138 Ser -94.596 113.376 58.034 -94.751 108.960 57.194 -94.485 215.454 110.977 -94.449 169.439 87.400 -94.602 165.751 85.027 
140 Glu -92.450 207.014 101.775 -92.465 204.158 102.020 -92.457 394.216 199.251 -92.538 298.063 146.957 -92.449 285.720 138.012 
142 Ala -94.286 160.270 68.918 -94.095 160.082 71.757 -94.173 305.776 138.274 -94.174 228.600 100.814 -94.177 219.816 98.230 
143 Lys -93.804 200.288 93.268 -93.609 188.979 91.650 -93.860 368.813 178.558 -93.749 281.071 130.311 -93.727 265.046 121.980 
145 Arg -93.463 157.105 70.308 -93.265 159.455 75.390 -93.494 301.072 141.152 -93.593 213.400 100.852 -93.326 207.256 93.107 
146 Ala -94.437 158.254 74.407 -94.371 158.526 75.572 -94.092 302.012 144.576 -94.573 240.479 119.584 -94.376 228.349 113.735 
147 Asp -93.693 197.166 93.524 -93.562 195.827 93.973 -93.619 377.280 184.044 -93.624 292.060 136.729 -93.664 282.637 132.834 
148 Gln -93.802 178.375 89.769 -93.551 178.215 92.483 -93.520 341.528 179.110 -93.527 269.035 140.816 -93.463 254.094 128.001 
149 Trp -92.854 124.555 65.180 -92.726 122.507 65.912 -93.057 238.035 123.581 -92.803 193.105 102.036 -93.046 185.353 94.939 
151 Val -92.775 193.797 97.561 -92.736 186.954 95.015 -92.801 358.463 180.107 -92.638 287.733 141.027 -92.835 277.319 134.695 
152 Asn -93.121 146.390 75.672 -93.191 141.904 77.087 -93.330 278.491 146.647 -93.329 218.081 111.476 -93.210 212.515 104.492 
154 Val -95.115 161.035 81.577 -95.138 158.715 81.701 -95.051 308.598 160.041 -95.180 249.200 129.915 -95.137 236.671 118.422 
156 Thr -94.169 110.756 56.786 -94.367 106.025 58.101 -94.257 206.046 108.248 -94.221 171.649 90.218 -94.358 163.472 85.075 






Table C.1: 1JNH of RalAΔC-GDP from IPAP-HSQC and SOFAST-IPAP-HSQC 
# Resi 
IPAP-HSQC SOFAST-IPAP-HSQC 
ns = 32 [A] ns = 32 [B] ns = 112 ns = 64 [A] ns = 64 [B] 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
157 Ser -93.079 116.664 58.220 -93.248 113.156 57.817 -93.085 218.277 112.305 -92.687 174.651 88.988 -93.059 167.200 83.786 
158 Ala -95.170 112.713 52.478 -95.290 107.227 54.565 -95.431 216.395 106.133 -95.654 178.162 84.093 -95.205 170.086 78.905 
159 Lys -91.849 98.435 56.194 -92.041 95.855 50.358 -92.392 183.465 97.972 -92.592 106.753 51.289 -91.796 105.844 50.968 
160 Thr -92.780 88.592 47.570 -92.421 88.346 47.394 -92.816 163.708 89.421 -92.798 137.401 70.337 -92.272 131.213 68.240 
161 Arg -92.490 97.531 46.587 -92.745 94.535 46.745 -92.677 185.347 91.387 -92.842 148.755 71.496 -92.660 139.616 66.897 
162 Ala -94.438 184.728 88.614 -94.370 184.731 91.018 -94.256 356.582 175.995 -94.192 273.320 131.639 -94.127 257.051 121.623 
163 Asn -93.726 117.923 63.186 -93.583 113.058 63.676 -93.909 222.040 122.893 -93.580 173.204 95.978 -93.662 168.786 90.931 
164 Val -93.295 146.514 67.682 -93.119 144.645 68.289 -93.097 279.432 133.443 -93.354 215.530 105.890 -93.159 205.453 98.178 
167 Val -94.149 121.180 59.895 -94.207 118.791 60.012 -93.814 221.099 112.069 -93.761 177.702 86.874 -93.740 172.493 85.117 
168 Phe -93.776 85.468 43.559 -93.556 81.631 42.004 -93.399 155.240 79.643 -93.165 73.788 38.825 -92.564 72.195 37.706 
170 Asp -94.082 145.323 70.800 -93.986 140.246 68.263 -93.961 273.787 137.900 -93.995 234.193 115.457 -94.203 223.468 104.854 
171 Leu -94.409 121.964 58.484 -94.841 116.021 55.068 -94.633 222.981 108.116 -94.279 188.998 92.693 -94.695 177.340 83.529 
174 Glu -91.060 162.413 97.289    -91.911 327.415 190.212       
176 Arg -93.252 120.359 59.423 -93.122 115.492 58.637 -93.481 230.508 117.079 -93.357 176.854 88.120 -93.642 170.128 83.588 
180 Met -93.556 139.835 71.988 -93.822 107.591 60.059 -93.515 228.626 126.765 -94.499 184.832 101.041 -95.426 157.856 86.462 
183 Ser -93.023 260.341 204.672 -93.051 213.522 173.088 -92.992 438.435 352.916 -93.039 321.144 253.435 -93.026 286.328 224.283 
184 Lys -92.601 745.686 616.414 -92.626 686.103 583.143 -92.610 1373.639 1167.415 -92.629 1012.839 831.987 -92.627 928.013 748.345 
 
 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
Conditions: 700 µM 15N-RalAΔC-GDP, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl2, 0.05% NaN3, 10% D2O, 298 K. 
C is the decay rate of the 15N magnetisation as a result of transverse relaxation. J2.5% and J97.5% denote the 2.5% and 97.5% confidence intervals for the fitted J 
value, respectively. All units are in Hz. 
 
Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
12 Leu -92.894 -92.326 -93.496 29.247 -92.399 -92.060 -92.752 25.145 -92.715 -92.576 -92.858 26.603 -93.039 -92.861 -93.224 27.282 -92.942 -92.725 -93.170 26.039 
13 Ala -92.471 -92.155 -92.800 22.018 -92.750 -92.428 -93.086 21.986 -92.672 -92.475 -92.874 21.841 -92.882 -92.686 -93.088 21.548 -92.740 -92.569 -92.919 20.997 
14 Leu -92.120 -91.712 -92.552 17.231 -92.125 -91.749 -92.520 18.898 -92.178 -91.953 -92.409 17.910 -92.295 -92.065 -92.538 18.083 -92.045 -91.710 -92.411 14.002 
15 His -93.849 -93.218 -94.524 21.012 -94.047 -93.624 -94.490 21.782 -94.191 -94.017 -94.367 23.421 -93.982 -93.774 -94.199 22.383 -93.881 -93.681 -94.089 24.146 
16 Lys -91.562 -91.231 -91.907 21.646 -91.756 -91.377 -92.156 25.232 -91.672 -91.318 -92.043 21.702 -91.895 -91.741 -92.056 23.187 -91.805 -91.565 -92.060 24.477 
17 Val -93.334 -92.600 -94.131 25.868 -93.387 -92.973 -93.820 24.276 -93.474 -93.137 -93.823 25.489 -93.469 -93.292 -93.654 25.115 -93.339 -93.146 -93.540 26.480 
18 Ile -93.305 -92.868 -93.765 20.124 -93.392 -93.067 -93.730 22.764 -93.209 -92.926 -93.500 22.347 -93.436 -93.264 -93.615 21.104 -93.292 -93.142 -93.446 21.819 
19 Met -93.348 -92.527 -94.251 24.130 -93.049 -92.571 -93.555 25.361 -93.348 -93.142 -93.558 23.918 -93.272 -93.040 -93.516 24.353 -93.428 -92.937 -93.972 25.685 
21 Gly -93.194 -92.850 -93.552 19.831 -92.836 -92.434 -93.259 18.364 -93.035 -92.780 -93.298 19.480 -93.172 -93.062 -93.285 19.144 -93.098 -92.843 -93.367 19.705 
22 Ser -93.679 -93.271 -94.105 21.178 -93.712 -93.490 -93.939 20.684 -93.639 -93.438 -93.846 22.200 -93.923 -93.764 -94.088 21.625 -93.953 -93.765 -94.148 22.330 
23 Gly -94.288 -94.049 -94.533 19.306 -94.496 -94.304 -94.692 19.467 -94.372 -94.202 -94.545 19.469 -94.343 -94.193 -94.497 19.476 -94.642 -94.481 -94.807 19.368 
24 Gly -92.774 -92.164 -93.432 20.646 -92.686 -92.319 -93.070 20.419 -92.743 -92.425 -93.073 19.061 -92.901 -92.682 -93.130 19.579 -93.053 -92.889 -93.223 20.596 
25 Val         -92.078 -90.354 -94.126 18.218         
26 Gly -93.032 -92.593 -93.495 20.667 -93.078 -92.780 -93.386 21.327 -93.145 -92.949 -93.346 19.890 -93.200 -93.016 -93.392 20.805 -93.219 -93.012 -93.436 20.537 
27 Lys -90.941 -90.290 -91.649 21.939 -90.405 -89.957 -90.883 24.535 -90.140 -89.743 -90.560 22.372 -90.441 -90.192 -90.709 23.696 -90.604 -90.336 -90.893 24.845 
28 Ser -94.265 -93.994 -94.544 21.840 -93.848 -93.544 -94.162 22.583 -94.040 -93.795 -94.291 21.589 -94.160 -94.004 -94.320 23.069 -94.206 -94.039 -94.379 21.920 
29 Ala -93.808 -93.444 -94.186 20.647 -93.690 -93.420 -93.968 20.117 -93.501 -93.248 -93.760 20.349 -93.705 -93.562 -93.852 22.057 -93.806 -93.587 -94.035 21.357 
30 Leu -94.200 -93.955 -94.451 20.999 -94.065 -93.815 -94.321 21.242 -94.184 -93.992 -94.379 20.327 -94.250 -94.096 -94.409 23.254 -94.222 -94.085 -94.361 23.493 
31 Thr -92.793 -92.503 -93.094 25.735 -92.884 -92.700 -93.072 23.205 -92.804 -92.695 -92.915 24.083 -92.949 -92.825 -93.078 24.863 -92.742 -92.612 -92.877 23.420 
32 Leu -93.079 -92.508 -93.690 23.410 -92.900 -92.557 -93.258 21.277 -92.874 -92.601 -93.155 23.257 -93.092 -92.915 -93.276 25.463 -92.980 -92.726 -93.250 25.622 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
33 Gln -93.000 -92.574 -93.447 20.434 -93.022 -92.796 -93.253 19.448 -93.115 -92.910 -93.325 20.745 -93.195 -93.083 -93.311 20.902 -93.273 -93.067 -93.489 21.984 
34 Phe -93.495 -93.256 -93.741 19.025 -93.517 -93.408 -93.627 20.332 -93.496 -93.348 -93.646 19.605 -93.567 -93.454 -93.683 20.269 -93.577 -93.454 -93.703 21.419 
35 Met -92.730 -92.357 -93.121 21.257 -92.993 -92.755 -93.236 22.190 -92.839 -92.633 -93.051 22.156 -93.031 -92.848 -93.223 22.278 -92.997 -92.740 -93.271 21.223 
36 Tyr     -90.682 -90.014 -91.387 18.650     -90.412 -90.247 -90.581 23.098     
38 Glu -91.776 -91.496 -92.066 17.153 -91.435 -91.209 -91.669 17.476 -91.499 -91.289 -91.715 17.089 -91.811 -91.686 -91.939 19.302 -91.779 -91.705 -91.854 18.566 
39 Phe -92.212 -92.037 -92.392 20.281 -92.227 -92.041 -92.419 19.488 -92.186 -92.022 -92.354 18.595 -92.365 -92.208 -92.529 18.451 -92.215 -92.082 -92.352 18.600 
40 Val -94.577 -92.867 -96.547 24.954 -92.781 -91.724 -93.971 29.605 -93.071 -92.177 -94.048 35.799 -92.692 -92.047 -93.429 25.585 -92.746 -91.744 -93.995 23.367 
41 Glu -92.576 -92.237 -92.930 18.877 -92.662 -92.556 -92.769 19.300 -92.462 -92.262 -92.668 19.496 -92.682 -92.571 -92.797 19.288 -92.698 -92.549 -92.854 18.985 
43 Tyr -94.564 -93.825 -95.349 19.821 -94.094 -93.609 -94.605 22.951 -94.270 -93.928 -94.623 22.449 -94.095 -93.792 -94.416 22.528 -93.846 -93.520 -94.193 25.352 
44 Glu -93.547 -93.177 -93.933 22.535 -93.446 -93.243 -93.655 24.110 -93.232 -93.043 -93.425 23.621 -93.221 -93.075 -93.372 23.855 -93.298 -93.081 -93.525 23.888 
46 Thr         -91.305 -90.214 -92.516 44.519         
47 Lys -93.028 -92.305 -93.807 27.481 -92.073 -91.709 -92.454 19.776 -92.329 -91.946 -92.731 21.361 -92.590 -92.311 -92.889 22.738 -92.540 -92.238 -92.863 22.744 
48 Ala -91.838 -89.704 -94.542 42.682 -92.782 -92.249 -93.346 39.763 -92.831 -92.283 -93.415 39.683 -92.714 -91.717 -93.956 40.343 -93.069 -92.393 -93.831 42.944 
49 Asp -93.037 -92.989 -93.085 10.283 -93.011 -92.912 -93.112 10.186     -93.042 -92.956 -93.129 8.820 -93.036 -92.982 -93.090 9.176 
50 Ser -91.440 -91.106 -91.790 16.427 -91.597 -91.413 -91.786 18.572 -91.627 -91.456 -91.802 16.560 -91.632 -91.520 -91.748 17.182 -91.788 -91.678 -91.901 18.511 
51 Tyr -92.029 -91.565 -92.520 18.960 -92.368 -92.044 -92.706 20.690 -92.402 -92.160 -92.651 23.026 -92.400 -92.206 -92.603 23.268 -92.499 -92.226 -92.790 24.369 
52 Arg -92.682 -92.472 -92.898 17.428 -92.795 -92.555 -93.043 16.499 -92.791 -92.627 -92.959 18.233 -92.960 -92.893 -93.028 17.622 -92.959 -92.876 -93.044 18.258 
53 Lys -93.603 -93.292 -93.926 19.864 -93.529 -93.345 -93.716 20.189 -93.677 -93.520 -93.837 19.832 -93.801 -93.645 -93.962 20.055 -93.989 -93.853 -94.129 22.274 
54 Lys -92.460 -92.314 -92.609 17.595 -92.543 -92.360 -92.731 18.137 -92.404 -92.244 -92.568 18.567 -92.642 -92.560 -92.726 18.600 -92.605 -92.483 -92.732 18.647 
56 Val -92.018 -91.855 -92.183 16.783 -92.001 -91.856 -92.148 17.465 -92.009 -91.914 -92.106 17.940 -92.144 -92.075 -92.215 16.891 -92.127 -92.059 -92.195 16.902 
57 Leu -92.827 -92.512 -93.155 20.107 -92.771 -92.510 -93.040 21.893 -92.913 -92.733 -93.097 21.053 -92.949 -92.849 -93.051 21.929 -92.990 -92.736 -93.258 21.345 
58 Asp -94.822 -93.359 -96.444 29.153 -93.894 -92.765 -95.151 32.249 -94.336 -93.824 -94.873 35.449 -94.407 -93.683 -95.229 33.809 -93.502 -92.707 -94.416 36.200 
59 Gly -92.094 -91.900 -92.293 22.651 -91.925 -91.759 -92.095 23.147 -92.182 -91.985 -92.384 22.019 -92.147 -92.039 -92.258 20.886 -92.142 -91.990 -92.300 22.453 
61 Glu -92.816 -92.625 -93.011 18.490 -92.964 -92.764 -93.169 19.241 -92.977 -92.841 -93.115 19.465 -92.940 -92.854 -93.028 21.110 -92.968 -92.881 -93.057 19.861 
62 Val -93.327 -93.084 -93.576 19.040 -93.357 -92.952 -93.781 20.614 -93.446 -93.310 -93.585 21.183 -93.506 -93.276 -93.747 21.672 -93.351 -93.190 -93.519 19.580 
63 Gln                 -92.665 -92.467 -92.873 19.928 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
64 Ile -93.094 -92.364 -93.882 22.642 -92.510 -92.163 -92.874 22.727 -92.677 -92.446 -92.914 24.089 -92.480 -92.355 -92.609 22.968 -92.548 -92.310 -92.800 23.232 
65 Asp -92.550 -92.032 -93.099 20.840 -92.806 -92.532 -93.090 19.627 -92.865 -92.623 -93.114 21.905 -92.839 -92.676 -93.008 21.711 -92.727 -92.400 -93.080 21.732 
66 Ile -92.654 -92.194 -93.141 21.763 -92.947 -92.628 -93.278 22.332 -93.019 -92.797 -93.247 21.840 -93.295 -93.132 -93.464 20.694 -93.391 -93.127 -93.671 22.018 
67 Leu -93.090 -92.697 -93.502 23.039 -93.409 -93.127 -93.700 21.665 -93.335 -93.147 -93.528 21.593 -93.455 -93.264 -93.653 20.436 -93.460 -93.311 -93.615 22.890 
68 Asp -93.355 -92.616 -94.160 21.983 -93.392 -93.119 -93.674 25.188 -93.397 -93.077 -93.728 24.545 -93.334 -93.163 -93.512 26.679 -93.588 -93.261 -93.938 27.220 
69 Thr -91.776 -90.368 -93.428 24.698 -92.218 -91.588 -92.903 25.855 -91.890 -91.219 -92.619 25.972 -92.372 -91.663 -93.212 28.322 -91.860 -91.026 -92.909 26.711 
71 Gly -93.695 -93.205 -94.211 23.609 -93.392 -93.135 -93.657 22.832 -93.431 -93.227 -93.639 23.490 -93.635 -93.459 -93.818 22.792 -93.584 -93.312 -93.871 24.294 
72 Gln -92.310 -91.487 -93.218 26.866 -92.188 -91.909 -92.477 24.702 -92.068 -91.766 -92.381 23.617 -92.051 -91.689 -92.448 27.218 -92.364 -92.012 -92.746 23.855 
73 Glu -92.543 -91.668 -93.508 24.847 -92.312 -92.075 -92.556 27.542 -92.344 -92.029 -92.671 27.294 -92.529 -92.321 -92.748 30.688 -92.275 -91.864 -92.730 26.940 
74 Asp -92.722 -92.502 -92.949 14.945 -92.600 -92.447 -92.756 15.814 -92.669 -92.527 -92.813 16.610 -92.654 -92.592 -92.718 14.547 -92.722 -92.631 -92.815 15.268 
78 Ile -91.468 -91.004 -91.961 20.334 -91.706 -91.428 -91.996 18.521 -91.821 -91.628 -92.019 20.498 -91.787 -91.493 -92.105 19.825 -91.846 -91.703 -91.995 22.460 
79 Arg -92.629 -91.798 -93.537 29.748 -92.749 -92.307 -93.215 27.258 -92.687 -92.326 -93.064 28.713 -92.649 -92.454 -92.853 30.426 -92.401 -91.985 -92.860 31.450 
80 Asp -93.368 -92.999 -93.752 22.767 -93.385 -93.195 -93.580 20.661 -93.267 -93.077 -93.461 21.467 -93.207 -93.069 -93.349 21.826 -93.321 -93.118 -93.533 22.076 
83 Phe -93.863 -93.418 -94.329 29.866 -93.900 -93.504 -94.314 27.065 -93.740 -93.517 -93.967 28.252 -93.947 -93.686 -94.221 30.037 -93.980 -93.712 -94.262 28.877 
84 Arg -93.104 -92.830 -93.387 21.865 -93.159 -92.922 -93.402 21.913 -93.289 -93.077 -93.505 22.178 -93.325 -93.203 -93.450 22.233 -93.267 -93.152 -93.386 23.365 
85 Ser -92.276 -91.677 -92.919 26.023 -92.008 -91.327 -92.754 29.119 -92.282 -91.944 -92.636 26.659 -92.343 -91.935 -92.795 28.234 -92.207 -91.525 -93.009 32.395 
86 Gly -95.325 -94.949 -95.714 21.866 -95.367 -95.091 -95.650 19.141 -95.321 -95.174 -95.470 19.545 -95.440 -95.294 -95.589 19.618 -95.454 -95.271 -95.642 20.628 
88 Gly -93.996 -93.704 -94.297 20.154 -93.889 -93.624 -94.161 19.573 -93.806 -93.604 -94.011 19.931 -93.796 -93.672 -93.923 20.219 -93.772 -93.595 -93.955 19.688 
91 Cys -93.861 -93.554 -94.177 21.132 -93.777 -93.444 -94.123 21.360 -93.860 -93.729 -93.992 20.917 -93.785 -93.706 -93.866 20.756 -93.759 -93.605 -93.918 21.424 
92 Val -94.114 -93.684 -94.562 19.172 -93.818 -93.491 -94.158 20.545 -93.745 -93.560 -93.933 20.015 -93.855 -93.702 -94.014 20.435 -93.933 -93.762 -94.111 21.101 
93 Phe -93.994 -93.730 -94.264 21.392 -94.295 -94.075 -94.519 20.550 -94.255 -94.037 -94.478 21.838 -94.429 -94.322 -94.538 22.581 -94.295 -94.134 -94.461 21.396 
94 Ser -91.982 -91.379 -92.632 23.244 -91.489 -91.280 -91.703 22.802 -91.505 -91.214 -91.810 22.759 -92.024 -91.814 -92.245 24.461 -92.009 -91.666 -92.384 21.048 
95 Ile -94.802 -94.379 -95.242 23.741 -94.982 -94.735 -95.235 24.496 -94.669 -94.495 -94.845 23.009 -94.821 -94.614 -95.036 24.636 -95.092 -94.871 -95.321 26.088 
96 Thr -92.830 -92.493 -93.180 21.314 -92.754 -92.515 -93.000 20.801 -92.767 -92.619 -92.919 21.365 -92.907 -92.803 -93.013 22.714 -92.812 -92.662 -92.968 22.811 
98 Met -93.406 -92.970 -93.863 26.433 -93.171 -92.704 -93.663 28.107 -93.238 -92.888 -93.603 26.463 -93.272 -93.016 -93.542 27.155 -93.527 -93.080 -94.016 29.790 
99 Glu -92.141 -91.640 -92.673 28.824 -92.210 -91.856 -92.579 29.143 -92.165 -91.838 -92.507 28.420 -92.416 -92.183 -92.663 26.371 -92.537 -92.200 -92.902 32.354 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
100 Ser -91.487 -91.054 -91.946 22.678 -91.269 -91.017 -91.531 21.532 -91.227 -91.103 -91.353 20.903 -91.417 -91.286 -91.553 23.003 -91.320 -91.179 -91.466 22.748 
101 Phe -92.365 -92.009 -92.739 19.814 -92.391 -92.117 -92.675 22.572 -92.329 -92.172 -92.490 21.586 -92.536 -92.391 -92.686 23.276 -92.550 -92.411 -92.693 22.132 
102 Ala -93.763 -93.429 -94.110 20.766 -93.659 -93.518 -93.802 19.884 -93.670 -93.483 -93.861 20.638 -93.692 -93.584 -93.802 20.784 -93.649 -93.486 -93.818 21.820 
103 Ala -92.801 -92.558 -93.051 18.159 -92.635 -92.495 -92.777 18.725 -92.608 -92.517 -92.700 18.534 -92.736 -92.663 -92.809 19.458 -92.696 -92.609 -92.784 20.028 
104 Thr -92.704 -92.351 -93.073 19.043 -92.726 -92.459 -93.003 20.086 -92.730 -92.559 -92.904 20.375 -93.016 -92.892 -93.142 21.027 -92.917 -92.790 -93.047 20.907 
105 Ala -92.819 -92.499 -93.153 20.356 -92.955 -92.764 -93.151 18.667 -92.887 -92.681 -93.099 18.596 -93.093 -92.999 -93.190 20.431 -93.019 -92.919 -93.122 17.851 
106 Asp -92.312 -92.110 -92.520 17.648 -92.153 -91.949 -92.362 17.677 -92.151 -92.006 -92.298 18.086 -92.246 -92.144 -92.352 18.610 -92.290 -92.136 -92.451 18.191 
109 Glu     -92.998 -92.809 -93.191 19.892             
110 Gln -93.067 -92.742 -93.404 19.625 -93.287 -93.104 -93.475 21.714 -93.209 -93.064 -93.356 21.380 -93.257 -93.138 -93.379 20.338 -93.268 -93.135 -93.406 21.583 
112 Leu -93.686 -93.265 -94.126 21.253 -93.584 -93.258 -93.921 21.874 -93.831 -93.582 -94.086 22.906 -93.659 -93.532 -93.790 17.533 -93.551 -93.417 -93.689 22.268 
113 Arg -93.235 -92.974 -93.504 20.101 -93.375 -93.226 -93.528 19.956 -93.382 -93.166 -93.603 20.994 -93.406 -93.316 -93.498 21.996 -93.469 -93.360 -93.579 21.932 
114 Val -92.614 -92.362 -92.875 21.137 -92.578 -92.399 -92.762 20.501 -92.750 -92.660 -92.841 20.069 -92.838 -92.702 -92.978 21.702 -92.903 -92.776 -93.032 20.330 
115 Lys -92.387 -91.913 -92.890 22.724 -92.417 -92.209 -92.631 21.693 -92.521 -92.326 -92.721 24.195 -92.717 -92.609 -92.828 26.479 -92.659 -92.461 -92.866 25.387 
116 Glu     -92.792 -92.608 -92.979 23.218     -92.832 -92.684 -92.983 23.133 -92.882 -92.720 -93.051 24.734 
117 Asp -90.725 -90.391 -91.076 13.451 -90.857 -90.433 -91.310 14.632 -90.955 -90.678 -91.242 14.972 -91.112 -90.975 -91.255 15.970 -91.088 -90.929 -91.254 14.856 
119 Asn -92.059 -91.864 -92.258 19.153 -91.998 -91.884 -92.115 19.577 -92.053 -91.929 -92.179 19.007 -92.092 -92.016 -92.169 18.900 -92.108 -92.015 -92.204 18.892 
120 Val -93.208 -92.909 -93.517 14.541 -93.227 -93.073 -93.385 14.488 -93.189 -93.028 -93.353 14.532 -93.386 -93.311 -93.462 15.807 -93.450 -93.360 -93.541 15.714 
122 Phe -91.607 -91.135 -92.108 21.024 -91.467 -91.192 -91.753 19.643 -91.358 -91.198 -91.521 20.855 -91.479 -91.368 -91.593 20.816 -91.618 -91.423 -91.825 20.082 
124 Leu -92.586 -92.217 -92.973 18.747 -92.775 -92.519 -93.040 21.551 -92.581 -92.397 -92.769 21.212 -92.812 -92.638 -92.993 22.390 -92.770 -92.634 -92.910 21.418 
125 Val -92.548 -92.200 -92.911 20.525 -92.412 -92.267 -92.560 20.839 -92.545 -92.343 -92.752 21.243 -92.544 -92.468 -92.622 21.118 -92.683 -92.523 -92.849 21.736 
126 Gly -93.614 -93.031 -94.235 23.199 -93.464 -93.213 -93.722 21.841 -93.664 -93.359 -93.979 21.811 -93.552 -93.436 -93.671 21.604 -93.449 -93.203 -93.708 21.786 
127 Asn -93.632 -93.378 -93.893 22.311 -93.806 -93.585 -94.031 20.568 -93.864 -93.662 -94.069 22.615 -93.808 -93.653 -93.968 21.968 -93.762 -93.638 -93.890 19.451 
128 Lys -91.675 -90.793 -92.665 23.270 -91.811 -91.251 -92.417 22.922 -91.603 -91.154 -92.083 22.827 -91.611 -91.242 -92.020 22.394 -91.816 -91.305 -92.398 24.036 
129 Ser -92.775 -92.381 -93.188 22.514 -92.799 -92.572 -93.032 22.501 -92.883 -92.650 -93.122 23.018 -92.690 -92.543 -92.842 23.109 -92.619 -92.503 -92.738 23.699 
130 Asp -92.563 -92.255 -92.884 23.218 -92.606 -92.382 -92.836 21.312 -92.631 -92.480 -92.784 21.750 -92.760 -92.602 -92.924 21.451 -92.652 -92.484 -92.827 23.045 
131 Leu -92.111 -91.790 -92.445 21.206 -91.832 -91.711 -91.956 19.647 -91.853 -91.671 -92.040 21.833 -91.947 -91.841 -92.057 22.738 -91.858 -91.711 -92.011 22.623 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
132 Glu -91.521 -91.270 -91.782 15.759 -91.666 -91.513 -91.822 16.115 -91.634 -91.480 -91.792 16.088 -91.876 -91.805 -91.947 16.631 -91.880 -91.746 -92.020 16.717 
133 Asp -93.223 -93.034 -93.416 21.559 -93.395 -93.224 -93.570 23.038 -93.370 -93.228 -93.515 22.122 -93.364 -93.260 -93.470 23.609 -93.354 -93.215 -93.497 23.192 
134 Lys -91.468 -91.205 -91.742 18.361 -91.484 -91.332 -91.638 18.168 -91.502 -91.374 -91.632 19.144 -91.506 -91.403 -91.612 20.173 -91.567 -91.455 -91.683 19.680 
135 Arg -93.830 -93.548 -94.121 20.947 -93.837 -93.679 -93.998 19.486 -93.869 -93.687 -94.053 19.501 -94.135 -94.029 -94.244 19.896 -93.989 -93.829 -94.154 20.000 
136 Gln -89.540 -87.344 -92.267 20.559 -90.155 -89.611 -90.744 36.480 -90.042 -89.165 -91.034 32.341         
137 Val -92.261 -91.869 -92.672 21.475 -92.034 -91.795 -92.280 20.096 -92.077 -91.857 -92.304 19.956 -92.369 -92.178 -92.570 20.786 -92.198 -92.039 -92.363 19.244 
138 Ser -93.965 -93.607 -94.337 22.717 -93.957 -93.627 -94.298 24.204 -94.105 -93.859 -94.357 23.705 -94.361 -94.155 -94.575 23.598 -94.387 -94.169 -94.613 24.720 
140 Glu -92.048 -91.902 -92.196 18.330 -92.263 -92.153 -92.375 19.907 -92.142 -92.021 -92.264 18.957 -92.255 -92.163 -92.349 20.476 -92.229 -92.131 -92.328 20.115 
142 Ala -93.691 -93.504 -93.881 19.059 -93.720 -93.577 -93.866 19.928 -93.702 -93.618 -93.786 19.630 -93.927 -93.830 -94.026 20.582 -93.972 -93.852 -94.095 19.882 
143 Lys -93.404 -93.287 -93.523 19.758 -93.464 -93.366 -93.563 19.794 -93.427 -93.284 -93.572 19.570 -93.519 -93.420 -93.619 20.493 -93.495 -93.387 -93.606 21.523 
144 Asn -93.218 -93.005 -93.436 18.772 -93.322 -93.178 -93.468 18.649 -93.372 -93.262 -93.483 18.676 -93.497 -93.386 -93.610 19.709 -93.607 -93.510 -93.706 20.024 
145 Arg -92.978 -92.657 -93.312 19.729 -92.878 -92.635 -93.129 19.139 -92.918 -92.793 -93.044 19.477 -93.109 -93.038 -93.182 21.140 -93.074 -92.916 -93.238 19.558 
146 Ala -93.319 -93.049 -93.597 21.086 -93.449 -93.252 -93.650 20.381 -93.285 -93.099 -93.474 20.549 -93.573 -93.476 -93.672 20.866 -93.548 -93.379 -93.723 19.922 
147 Asp -93.293 -93.101 -93.490 18.958 -93.395 -93.202 -93.593 19.378 -93.339 -93.186 -93.494 19.168 -93.361 -93.272 -93.453 19.612 -93.371 -93.266 -93.479 19.876 
149 Trp -92.859 -92.623 -93.102 21.100 -92.750 -92.632 -92.869 18.867 -92.871 -92.623 -93.127 19.515 -92.776 -92.681 -92.873 20.338 -92.942 -92.811 -93.076 20.073 
151 Val -92.511 -92.285 -92.743 19.331 -92.345 -92.144 -92.553 18.984 -92.463 -92.316 -92.613 18.557 -92.514 -92.448 -92.581 19.182 -92.582 -92.497 -92.668 19.022 
152 Asn -93.058 -92.813 -93.310 20.511 -92.923 -92.753 -93.095 19.230 -92.994 -92.839 -93.153 18.594 -93.005 -92.911 -93.101 21.444 -92.939 -92.825 -93.056 21.252 
153 Tyr -91.529 -91.168 -91.908 20.038 -91.386 -91.207 -91.569 18.449 -91.503 -91.347 -91.663 19.462 -91.478 -91.369 -91.590 19.179 -91.496 -91.316 -91.685 17.818 
156 Thr -93.927 -93.628 -94.236 22.735 -94.272 -93.914 -94.643 22.930 -94.168 -94.026 -94.312 22.563 -93.953 -93.801 -94.110 22.142 -94.109 -93.991 -94.230 22.087 
157 Ser -92.367 -91.834 -92.938 20.239 -92.687 -92.466 -92.915 21.568 -92.628 -92.451 -92.810 20.260 -92.599 -92.450 -92.754 21.579 -92.548 -92.463 -92.634 20.108 
158 Ala -94.876 -94.519 -95.244 22.091 -94.725 -94.412 -95.048 21.859 -94.816 -94.627 -95.008 20.745 -94.877 -94.686 -95.074 21.827 -95.067 -94.911 -95.227 22.134 
159 Lys -92.041 -91.711 -92.385 19.627 -92.168 -91.829 -92.521 20.524 -92.285 -92.092 -92.484 19.208 -92.455 -92.293 -92.623 21.695 -92.612 -92.318 -92.928 21.667 
160 Thr -92.464 -92.173 -92.765 21.456 -92.254 -91.990 -92.526 21.218 -92.335 -92.159 -92.516 20.718 -92.460 -92.328 -92.597 22.282 -92.398 -92.245 -92.557 21.429 
161 Arg -92.558 -92.224 -92.907 21.114 -92.531 -92.300 -92.768 20.879 -92.572 -92.435 -92.712 20.791 -92.445 -92.312 -92.583 20.873 -92.537 -92.344 -92.740 20.445 
162 Ala -94.094 -93.932 -94.258 17.646 -93.962 -93.781 -94.147 17.829 -94.098 -93.964 -94.234 18.227 -93.994 -93.898 -94.092 18.260 -93.994 -93.907 -94.083 18.544 
163 Asn -93.365 -93.102 -93.636 20.732 -93.498 -93.339 -93.660 21.594 -93.481 -93.288 -93.677 20.997 -93.479 -93.361 -93.600 20.686 -93.532 -93.385 -93.684 21.838 






Table C.2: 1JNH of RalAΔC-GDP from 1JNH-modulated HSQC experiments 
# Resi 
ns = 8, Δ = 11.60–37.20 ms ns = 16*, Δ = 11.60–37.20 ms ns = 32, Δ = 11.60–37.20 ms ns = 32, Δ = 32.88–58.48 ms ns = 8*, Δ = 32.88–58.48 ms 
1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 1JNH J2.5% J97.5% C 
164 Val -92.645 -92.394 -92.903 18.476 -92.740 -92.554 -92.930 19.160 -92.714 -92.598 -92.831 19.653 -92.900 -92.789 -93.015 20.207 -92.873 -92.727 -93.024 20.322 
165 Asp -92.752 -92.505 -93.006 19.341 -92.692 -92.568 -92.818 17.625 -92.520 -92.406 -92.636 18.407 -92.746 -92.640 -92.855 18.910 -92.689 -92.570 -92.812 19.555 
167 Val -93.425 -93.077 -93.787 20.734 -93.562 -93.349 -93.779 20.310 -93.744 -93.639 -93.850 20.735 -93.752 -93.623 -93.883 22.404 -93.685 -93.514 -93.863 22.542 
168 Phe -93.031 -92.668 -93.411 22.159 -92.702 -92.403 -93.012 19.711 -92.788 -92.572 -93.010 21.266 -93.044 -92.875 -93.220 21.113 -93.019 -92.841 -93.204 21.871 
170 Asp -93.811 -93.529 -94.102 20.707 -93.733 -93.532 -93.939 20.610 -93.664 -93.513 -93.816 19.178 -93.858 -93.753 -93.965 21.581 -93.845 -93.768 -93.922 21.887 
171 Leu -94.136 -93.875 -94.405 20.379 -94.186 -93.941 -94.437 20.100 -94.245 -94.073 -94.421 20.594 -94.235 -94.118 -94.354 21.275 -94.288 -94.155 -94.425 21.903 
172 Met -93.947 -93.610 -94.297 22.207 -93.958 -93.717 -94.205 21.710 -93.925 -93.709 -94.147 21.797 -93.974 -93.904 -94.044 23.335 -93.947 -93.823 -94.075 23.806 
176 Arg -93.078 -92.803 -93.362 23.416 -93.069 -92.930 -93.210 23.169 -93.036 -92.769 -93.311 21.243 -93.185 -93.044 -93.331 23.035 -93.156 -93.053 -93.261 22.566 
177 Ala -93.123 -92.889 -93.364 20.161 -93.316 -93.161 -93.474 20.903 -93.175 -93.037 -93.315 20.135 -93.265 -93.197 -93.333 20.723 -93.244 -93.152 -93.337 21.844 
179 Lys -92.928 -92.602 -93.267 20.040 -93.010 -92.784 -93.243 21.786 -92.838 -92.640 -93.042 21.444 -92.973 -92.855 -93.094 22.252 -92.954 -92.792 -93.122 21.881 
180 Met -93.116 -92.854 -93.385 18.193 -93.045 -92.912 -93.179 18.710 -92.992 -92.842 -93.144 18.267 -93.176 -93.086 -93.267 18.686 -93.048 -92.941 -93.158 19.244 
181 Glu -92.788 -92.572 -93.010 15.136 -92.778 -92.634 -92.925 15.012 -92.831 -92.707 -92.956 14.874 -92.929 -92.888 -92.970 16.361 -92.940 -92.873 -93.008 16.138 
182 Asp -92.840 -92.746 -92.936 12.669                 
183 Ser -92.575 -92.452 -92.699 12.222 -92.640 -92.512 -92.771 12.139 -92.644 -92.535 -92.754 11.910 -92.724 -92.694 -92.754 12.549 -92.719 -92.660 -92.779 12.232 
184 Lys -92.306 -92.226 -92.388 3.158 -92.296 -92.223 -92.370 3.524 -92.306 -92.235 -92.377 3.465 -92.381 -92.357 -92.406 3.874 -92.373 -92.327 -92.420 3.960 
 
 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
Conditions: 700 µM 15N-RalAΔC-GDP, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl2, 0.05% NaN3, 10% D2O, 298 K. 
C is the decay rate of the 15N magnetisation as a result of transverse relaxation. 
J2.5% and J97.5% denote the 2.5% and 97.5% confidence intervals for the fitted J value, respectively. 
 
Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
12 Leu -93.283 -92.719 -93.924 28.879 -92.982 -92.594 -93.394 30.278 
13 Ala -92.718 -92.352 -93.116 21.992 -92.906 -92.559 -93.273 22.749 
14 Leu -92.130 -91.959 -92.309 19.485 -92.278 -92.098 -92.465 18.285 
15 His -94.030 -93.758 -94.317 25.352 -94.017 -93.672 -94.381 23.475 
16 Lys -91.871 -91.579 -92.187 26.446 -91.757 -91.126 -92.471 23.878 
17 Val -93.543 -93.198 -93.913 25.373 -93.487 -93.187 -93.800 26.011 
18 Ile -93.334 -93.156 -93.520 20.631 -93.415 -93.210 -93.627 22.971 
19 Met -93.425 -93.193 -93.669 26.549 -93.430 -93.223 -93.644 23.987 
21 Gly -93.138 -93.017 -93.263 19.404 -93.186 -93.025 -93.352 18.697 
22 Ser -94.071 -93.937 -94.208 23.763 -94.038 -93.698 -94.396 22.417 
23 Gly -94.513 -94.389 -94.640 20.217 -94.411 -94.213 -94.613 20.392 
24 Gly -92.828 -92.669 -92.994 19.417 -92.873 -92.596 -93.163 20.208 
26 Gly -93.164 -93.002 -93.332 21.428 -93.298 -93.131 -93.470 21.865 
27 Lys -90.522 -89.916 -91.222 28.264 -90.775 -90.368 -91.218 26.488 
28 Ser -94.182 -93.981 -94.391 25.300 -94.224 -93.968 -94.488 22.807 
29 Ala -93.982 -93.775 -94.199 21.963 -93.692 -93.505 -93.884 20.465 
30 Leu -94.362 -94.180 -94.549 23.266 -94.454 -94.217 -94.699 22.708 
31 Thr -93.050 -92.901 -93.204 22.969 -93.033 -92.901 -93.168 24.055 
32 Leu -93.094 -92.789 -93.421 24.326 -93.326 -93.018 -93.649 25.510 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
33 Gln -93.303 -93.137 -93.474 19.620 -93.337 -93.088 -93.596 19.939 
34 Phe -93.711 -93.554 -93.873 20.399 -93.683 -93.531 -93.839 19.816 
35 Met -93.013 -92.788 -93.250 25.806 -93.049 -92.773 -93.337 21.477 
38 Glu -91.856 -91.648 -92.075 17.002 -91.855 -91.668 -92.050 17.711 
39 Phe -92.366 -92.238 -92.499 20.246 -92.360 -92.222 -92.502 20.397 
40 Val     -93.599 -91.374 -96.462 33.908 
41 Glu -92.836 -92.688 -92.989 19.355 -92.811 -92.661 -92.966 19.610 
43 Tyr -94.202 -93.802 -94.631 20.210 -94.225 -93.591 -94.917 23.488 
44 Glu -93.176 -93.016 -93.342 22.802 -93.218 -92.935 -93.515 22.781 
47 Lys -92.662 -92.436 -92.899 23.426 -92.547 -92.105 -93.026 24.877 
48 Ala     -92.325 -91.414 -93.375 45.348 
49 Asp -93.206 -93.136 -93.278 9.873 -93.268 -93.149 -93.389 10.483 
50 Ser -91.714 -91.558 -91.876 18.154 -91.750 -91.631 -91.872 16.377 
51 Tyr -92.559 -92.320 -92.812 21.494 -92.455 -92.178 -92.745 22.104 
52 Arg -92.948 -92.815 -93.086 16.997 -92.937 -92.813 -93.064 18.954 
53 Lys -93.939 -93.806 -94.075 20.875 -93.901 -93.758 -94.048 21.467 
54 Lys -92.664 -92.554 -92.777 18.346 -92.573 -92.406 -92.744 19.455 
56 Val -92.149 -92.064 -92.236 16.200 -92.261 -92.137 -92.388 18.137 
57 Leu -92.997 -92.829 -93.172 20.890 -92.958 -92.781 -93.141 22.838 
58 Asp -94.268 -93.244 -95.416 29.519 -94.476 -93.509 -95.549 36.233 
59 Gly -92.171 -92.035 -92.312 23.535 -92.163 -92.061 -92.268 22.847 
61 Glu -93.011 -92.916 -93.109 18.953 -92.974 -92.842 -93.108 19.514 
62 Val -93.583 -93.370 -93.806 21.192 -93.672 -93.438 -93.914 20.714 
64 Ile -92.690 -92.410 -92.990 24.193 -92.561 -92.223 -92.921 24.637 
65 Asp -92.902 -92.696 -93.118 21.028 -93.263 -93.051 -93.483 23.627 
66 Ile -93.285 -93.050 -93.533 23.962 -93.285 -93.080 -93.497 22.611 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
67 Leu -93.482 -93.238 -93.739 20.941 -93.553 -93.340 -93.773 22.730 
68 Asp -93.906 -93.671 -94.152 26.719 -93.459 -93.098 -93.840 27.038 
69 Thr -92.278 -91.343 -93.432 29.615 -91.370 -90.452 -92.476 26.713 
71 Gly -93.822 -93.550 -94.108 25.155 -93.521 -93.203 -93.854 24.726 
72 Gln -91.935 -91.473 -92.451 27.194 -92.249 -91.660 -92.903 29.585 
73 Glu -92.875 -92.207 -93.641 31.344 -92.307 -91.857 -92.794 29.640 
74 Asp -92.892 -92.728 -93.062 16.096 -92.906 -92.792 -93.022 17.053 
78 Ile -91.910 -91.698 -92.135 20.043 -92.012 -91.745 -92.291 23.537 
79 Arg -92.223 -91.666 -92.863 31.039 -92.871 -92.445 -93.327 32.431 
80 Asp -93.422 -93.241 -93.611 23.519 -93.535 -93.215 -93.870 24.005 
83 Phe -94.012 -93.482 -94.597 27.873 -93.945 -93.603 -94.303 28.799 
84 Arg -93.346 -93.184 -93.515 21.046     
85 Ser -92.362 -91.705 -93.136 25.701 -92.654 -92.301 -93.028 31.184 
86 Gly -95.605 -95.421 -95.793 19.256 -95.554 -95.290 -95.826 20.142 
88 Gly -93.861 -93.632 -94.102 20.496 -93.994 -93.734 -94.263 20.324 
91 Cys -93.851 -93.720 -93.986 23.179 -93.786 -93.621 -93.954 21.043 
92 Val -93.930 -93.794 -94.070 22.539 -93.804 -93.604 -94.010 22.832 
93 Phe -94.420 -94.248 -94.596 21.293 -94.308 -94.120 -94.502 23.070 
94 Ser -91.823 -91.445 -92.242 22.012 -92.056 -91.612 -92.542 21.486 
95 Ile -94.825 -94.631 -95.026 22.483 -94.855 -94.595 -95.124 24.343 
96 Thr -92.859 -92.758 -92.962 24.720 -92.984 -92.819 -93.154 22.851 
98 Met -93.460 -93.187 -93.749 28.334 -93.188 -92.832 -93.565 27.566 
99 Glu -92.218 -91.838 -92.636 27.456 -92.394 -92.221 -92.573 29.600 
100 Ser -91.381 -91.272 -91.494 24.179 -91.291 -91.138 -91.449 22.495 
101 Phe -92.579 -92.288 -92.891 23.369 -92.435 -92.234 -92.644 23.514 
102 Ala -93.710 -93.492 -93.937 20.964 -93.789 -93.614 -93.968 20.819 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
103 Ala -92.708 -92.612 -92.807 19.656 -92.710 -92.586 -92.837 18.932 
104 Thr -92.944 -92.821 -93.069 21.780 -93.007 -92.797 -93.225 22.153 
105 Ala -92.998 -92.875 -93.125 19.808 -93.068 -92.956 -93.182 20.037 
106 Asp -92.351 -92.223 -92.484 19.283 -92.377 -92.263 -92.494 19.706 
110 Gln -93.295 -93.105 -93.494 22.253 -93.147 -92.992 -93.306 22.704 
112 Leu -93.517 -93.376 -93.662 16.621 -93.633 -93.438 -93.835 20.943 
113 Arg -93.477 -93.359 -93.598 21.393 -93.380 -93.185 -93.581 21.540 
114 Val -92.777 -92.688 -92.868 21.974 -92.815 -92.576 -93.063 20.835 
115 Lys -92.752 -92.484 -93.037 23.733 -92.690 -92.364 -93.036 24.630 
117 Asp -91.201 -91.069 -91.339 16.330 -90.865 -90.670 -91.069 14.657 
119 Asn -92.180 -92.051 -92.313 19.559 -92.193 -92.097 -92.291 19.085 
120 Val -93.388 -93.282 -93.495 15.560 -93.356 -93.217 -93.498 15.763 
122 Phe -91.525 -91.325 -91.736 19.123 -91.510 -91.227 -91.810 21.276 
124 Leu -92.773 -92.650 -92.899 20.427 -92.899 -92.759 -93.042 22.210 
125 Val -92.692 -92.524 -92.867 20.408 -92.671 -92.517 -92.830 21.537 
126 Gly -93.610 -93.402 -93.828 22.353 -93.655 -93.472 -93.844 24.285 
127 Asn -93.990 -93.765 -94.224 21.875 -93.942 -93.780 -94.109 22.198 
128 Lys -91.671 -91.384 -91.981 24.270 -91.855 -91.387 -92.367 25.319 
129 Ser -92.820 -92.615 -93.036 23.556 -92.887 -92.708 -93.072 23.445 
130 Asp -93.033 -92.900 -93.170 22.211 -92.881 -92.740 -93.025 22.237 
131 Leu -92.081 -91.855 -92.322 22.634 -91.857 -91.718 -92.000 23.011 
132 Glu -91.899 -91.766 -92.038 16.354 -91.924 -91.739 -92.116 17.142 
133 Asp -93.423 -93.268 -93.583 22.803 -93.444 -93.340 -93.549 23.619 
134 Lys -91.539 -91.427 -91.655 19.251 -91.522 -91.393 -91.655 19.589 
135 Arg -94.049 -93.870 -94.234 19.850 -94.027 -93.833 -94.227 20.881 
137 Val -92.300 -92.045 -92.572 19.278 -92.390 -92.110 -92.686 21.077 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
138 Ser -94.306 -94.153 -94.463 24.413 -94.359 -94.145 -94.580 23.943 
140 Glu -92.301 -92.172 -92.435 20.247 -92.328 -92.168 -92.492 19.988 
142 Ala -94.020 -93.858 -94.187 20.434 -94.011 -93.872 -94.153 20.911 
143 Lys -93.599 -93.490 -93.711 19.368 -93.536 -93.364 -93.713 21.216 
144 Asn -93.582 -93.481 -93.686 20.252 -93.565 -93.432 -93.702 19.616 
145 Arg -93.162 -93.050 -93.278 20.868 -93.198 -93.059 -93.341 21.089 
146 Ala -93.645 -93.457 -93.841 21.849 -93.513 -93.362 -93.667 19.974 
147 Asp -93.421 -93.308 -93.537 19.276 -93.420 -93.277 -93.567 20.769 
149 Trp -92.796 -92.654 -92.944 20.154 -92.958 -92.727 -93.198 21.139 
151 Val -92.542 -92.434 -92.653 19.956 -92.663 -92.524 -92.806 20.188 
152 Asn -93.103 -92.961 -93.249 20.827 -93.083 -92.958 -93.212 20.620 
153 Tyr -91.398 -91.194 -91.612 19.639 -91.527 -91.379 -91.679 18.575 
156 Thr -94.134 -94.024 -94.247 22.580 -94.273 -94.120 -94.428 21.912 
157 Ser -92.626 -92.509 -92.746 20.445 -92.635 -92.426 -92.851 20.442 
158 Ala -94.951 -94.730 -95.181 22.104 -95.078 -94.899 -95.261 21.748 
159 Lys -92.484 -92.269 -92.710 20.761 -92.462 -92.227 -92.708 20.743 
160 Thr -92.545 -92.345 -92.756 20.232 -92.601 -92.396 -92.815 21.834 
161 Arg -92.450 -92.306 -92.600 22.420 -92.623 -92.444 -92.808 20.988 
162 Ala -94.061 -93.958 -94.166 18.613 -94.089 -93.929 -94.252 17.969 
163 Asn -93.589 -93.427 -93.757 22.990 -93.623 -93.492 -93.756 22.101 
164 Val -92.909 -92.775 -93.047 19.059 -92.865 -92.705 -93.030 19.635 
165 Asp -92.807 -92.709 -92.907 19.546 -92.853 -92.701 -93.008 20.284 
167 Val -93.805 -93.656 -93.958 21.963 -93.753 -93.573 -93.937 22.237 
168 Phe -92.972 -92.764 -93.190 20.653 -92.896 -92.735 -93.062 21.343 
170 Asp -93.932 -93.768 -94.102 20.974 -93.941 -93.789 -94.098 20.713 
171 Leu -94.347 -94.170 -94.529 22.238 -94.334 -94.183 -94.488 21.185 






Table C.3: 1JNH of RalAΔC-GDP from 1JNH-modulated TROSY-HSQC experiments 
# Resi 
ns = 64*, Δ = 32.88–58.48 ms ns = 48*, Δ = 22.24–47.84 ms 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C (s-1) 
172 Met -93.916 -93.764 -94.073 23.342 -93.775 -93.638 -93.914 22.261 
176 Arg -93.116 -92.953 -93.284 22.250 -93.055 -92.824 -93.295 22.714 
177 Ala -93.288 -93.144 -93.437 20.339 -93.355 -93.213 -93.501 21.168 
179 Lys -93.219 -92.988 -93.463 22.720 -93.168 -92.867 -93.483 21.729 
180 Met -93.052 -92.901 -93.209 18.617 -93.105 -92.894 -93.323 19.503 
181 Glu -92.982 -92.849 -93.119 15.983 -93.015 -92.886 -93.147 16.706 
183 Ser -92.807 -92.751 -92.864 13.058 -92.786 -92.702 -92.870 13.077 
184 Lys -92.435 -92.367 -92.504 4.145 -92.448 -92.378 -92.520 4.143 
 
 






C.2 OmpX in DPC 
Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
Conditions: 995 µM 15N-OmpX, 20 mM sodium phosphate (pH 6.8), 100 mM NaCl, 5 mM EDTA, 3.8% DPC, 10% D2O, 318 K. 
SNR (Add) and SNR (Sub) are the signal-to-noise ratios of peaks in the sub-spectrum obtained by taking the sum or the difference, respectively, of the 
in-phase (IP) and antiphase (AP) spectra. C is the decay rate of the 15N magnetisation as a result of transverse relaxation. J2.5% and J97.5% denote the 2.5% and 
97.5% confidence intervals for the fitted J value, respectively. 
 
Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH-modulated HSQC 
ns = 40, Δ = 11.60–37.20 ms  
1JNH-modulated HSQC 
ns = 96, Δ = 11.60–37.20 ms 
1JNH-modulated TROSY-HSQC 
ns = 40, Δ = 11.60–37.20 ms 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 
2 Thr -94.453 26.144 11.115             
3 Ser -92.860 41.934 15.843 -93.012 -91.556 -94.674 50.485 -92.057 -91.408 -92.746 51.839 -93.082 -91.372 -95.089 50.978 
4 Thr -94.775 44.505 17.563             
6 Thr -98.166 83.921 36.839         -92.791 -91.898 -93.786 49.578 
7 Gly -93.451 57.930 20.330     -93.822 -92.798 -94.937 57.134 -93.741 -92.441 -95.208 52.460 
8 Gly -94.956 78.884 29.624 -94.482 -93.793 -95.212 49.033 -94.003 -93.402 -94.640 52.135 -93.823 -92.858 -94.886 49.588 
9 Tyr -90.422 103.507 40.599 -91.084 -90.494 -91.715 51.331 -91.406 -90.915 -91.926 51.865     
10 Ala -94.255 51.845 17.513 -93.565 -92.083 -95.244 46.617 -92.398 -91.619 -93.237 57.330 -93.894 -92.663 -95.276 56.382 
11 Gln -91.656 48.016 18.814 -93.613 -92.095 -95.368 48.652     -93.258 -92.225 -94.391 46.608 
12 Ser -92.581 39.633 15.903             
13 Asp -92.009 37.811 14.418             
14 Ala -91.669 86.342 31.441 -93.092 -92.558 -93.654 52.282 -92.733 -92.360 -93.122 45.394 -92.777 -92.187 -93.402 46.505 
15 Gln -94.739 106.997 59.268     -92.121 -91.885 -92.365 46.036 -92.237 -91.848 -92.642 47.901 
21 Met -93.110 56.251 21.795             
23 Gly -90.191 31.611 17.819             






Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH-modulated HSQC 
ns = 40, Δ = 11.60–37.20 ms  
1JNH-modulated HSQC 
ns = 96, Δ = 11.60–37.20 ms 
1JNH-modulated TROSY-HSQC 
ns = 40, Δ = 11.60–37.20 ms 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 
24 Phe -93.435 64.780 21.229 -94.473 -93.318 -95.736 58.534 -93.947 -92.970 -95.012 57.732 -94.115 -92.877 -95.499 56.209 
25 Asn -92.758 79.522 29.138 -91.987 -91.144 -92.903 57.700 -91.943 -91.364 -92.555 50.768 -92.206 -91.472 -93.000 52.730 
26 Leu -92.397 85.087 25.150 -92.855 -91.697 -94.172 52.494 -92.888 -92.244 -93.575 49.071 -92.901 -92.276 -93.566 50.759 
27 Lys -93.855 36.987 12.315             
28 Tyr -90.067 63.503 24.176 -91.614 -90.536 -92.822 55.118 -91.368 -90.104 -92.831 52.861 -91.443 -90.462 -92.547 49.047 
29 Arg -97.075 47.959 16.197     -93.476 -92.353 -94.715 55.446 -93.869 -92.761 -95.087 53.709 
30 Tyr -93.076 35.443 11.098             
31 Glu -92.581 50.038 16.309 -94.307 -93.269 -95.438 54.684 -94.652 -93.683 -95.704 49.636 -93.961 -92.611 -95.466 49.863 
32 Glu -93.510 79.221 28.680 -92.064 -91.354 -92.834 42.426 -92.156 -91.795 -92.532 45.678 -92.621 -91.635 -93.733 37.414 
33 Asp -93.380 51.846 24.938 -94.210 -92.922 -95.650 54.870 -93.519 -92.580 -94.544 49.201 -91.918 -90.377 -93.741 43.254 
35 Ser -92.252 144.003 58.155 -93.277 -92.907 -93.661 40.091 -93.167 -92.997 -93.339 39.969 -93.205 -92.862 -93.562 39.027 
37 Leu -95.901 104.511 33.276 -91.774 -91.288 -92.287 51.552 -92.117 -91.720 -92.530 53.291 -91.822 -91.235 -92.449 50.550 
38 Gly -94.605 64.083 27.587 -95.033 -94.187 -95.944 47.459 -94.307 -93.892 -94.738 51.454 -94.401 -93.457 -95.435 47.163 
39 Val -91.979 67.063 25.486 -93.189 -92.237 -94.230 57.166 -91.976 -91.347 -92.643 53.506 -92.100 -90.972 -93.363 52.339 
40 Ile -93.498 80.048 24.439 -93.383 -92.753 -94.052 51.015 -92.737 -92.133 -93.379 52.365 -94.102 -93.275 -94.997 53.279 
41 Gly -94.448 48.683 14.465             
42 Ser -91.700 78.474 25.738 -91.402 -90.524 -92.372 49.241 -92.490 -91.800 -93.227 57.575 -91.452 -90.063 -93.073 48.924 
43 Phe -93.197 65.261 16.571     -92.923 -92.064 -93.848 51.631 -92.149 -91.283 -93.095 51.052 
44 Thr -93.556 56.980 18.261     -93.699 -92.846 -94.613 55.365 -92.917 -91.600 -94.414 49.361 
45 Tyr -95.981 78.354 22.009 -93.278 -92.279 -94.368 59.695 -92.103 -91.187 -93.116 54.485 -93.077 -92.235 -93.991 60.040 
47 Glu -92.084 36.172 13.906             
50 Arg -95.608 28.173 17.097     -92.971 -91.769 -94.308 53.885     
53 Ser -92.157 15.397 11.727             
54 Ser -95.809 23.745 11.552             
57 Tyr -92.213 81.816 53.085 -92.493 -92.187 -92.810 39.027 -92.354 -92.202 -92.509 37.139 -92.502 -92.150 -92.869 36.362 






Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH-modulated HSQC 
ns = 40, Δ = 11.60–37.20 ms  
1JNH-modulated HSQC 
ns = 96, Δ = 11.60–37.20 ms 
1JNH-modulated TROSY-HSQC 
ns = 40, Δ = 11.60–37.20 ms 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 
60 Asn -94.556 47.494 30.220         -93.889 -92.675 -95.250 44.723 
61 Gln -94.360 52.213 19.862             
62 Tyr -89.880 43.288 19.995             
63 Tyr -92.829 66.659 20.432 -93.137 -91.896 -94.521 53.860 -92.829 -92.275 -93.414 51.646 -92.714 -91.089 -94.604 50.227 
64 Gly -94.118 36.875 18.066 -92.972 -91.438 -94.737 45.947 -94.669 -93.550 -95.884 51.905 -94.939 -92.977 -97.208 42.915 
65 Ile -94.553 85.470 24.649 -93.242 -92.251 -94.324 52.057 -93.147 -92.389 -93.962 55.006 -92.870 -92.091 -93.713 53.871 
66 Thr -94.320 79.242 29.744 -94.537 -93.805 -95.318 52.807 -94.283 -93.789 -94.799 54.807 -94.570 -93.749 -95.452 51.117 
67 Ala -93.166 92.068 31.511     -92.357 -91.764 -92.986 52.805     
68 Gly -94.827 80.181 31.580 -95.539 -95.023 -96.076 56.337 -94.374 -94.077 -94.679 54.111 -94.979 -94.198 -95.810 52.743 
70 Ala -94.074 92.695 37.702 -92.213 -91.784 -92.664 43.800 -92.252 -92.044 -92.466 41.115 -92.298 -91.787 -92.842 43.098 
71 Tyr -94.852 49.664 17.232 -92.546 -91.293 -93.951 57.818 -92.244 -91.276 -93.303 52.566     
72 Arg -92.613 40.372 12.276             
74 Asn -92.761 83.513 26.184 -92.390 -91.278 -93.629 55.215 -92.530 -91.915 -93.184 56.426 -91.737 -90.564 -93.062 56.764 
75 Asp -97.255 38.068 19.455 -92.981 -90.889 -95.521 44.087 -92.685 -91.235 -94.341 55.049     
76 Trp -93.785 107.258 37.245     -92.819 -91.035 -95.035 43.231 -93.006 -92.303 -93.765 46.393 
77 Ala -93.721 92.260 25.137 -93.087 -91.772 -94.572 58.797 -92.364 -91.893 -92.858 54.091 -92.534 -91.680 -93.465 57.737 
78 Ser -92.087 62.329 25.122     -91.533 -90.661 -92.490 50.928 -91.941 -90.649 -93.436 53.972 
79 Ile -92.876 81.948 25.489 -91.790 -90.826 -92.856 57.724 -92.108 -91.644 -92.594 58.162 -92.045 -91.162 -93.007 55.163 
81 Gly -92.727 72.427 24.094 -92.979 -91.689 -94.443 55.888 -92.471 -91.627 -93.391 54.768 -92.960 -91.879 -94.161 52.404 
82 Val        -93.042 -92.676 -93.423 51.672 -93.526 -93.016 -94.061 51.921 
83 Val -93.593 67.307 21.798 -92.788 -91.689 -94.001 57.341 -92.122 -90.979 -93.405 53.564 -92.505 -91.086 -94.144 49.978 
84 Gly -95.542 104.005 42.630 -94.193 -93.607 -94.814 51.659 -94.353 -94.039 -94.677 53.411 -94.313 -93.820 -94.830 50.999 
85 Val -91.611 87.123 25.896 -93.017 -92.395 -93.677 53.578 -92.747 -92.188 -93.334 57.643 -92.830 -92.328 -93.358 53.353 
86 Gly -93.815 72.596 25.986 -93.388 -92.002 -94.957 54.299 -93.319 -92.567 -94.126 54.700 -92.652 -91.201 -94.346 47.980 
87 Tyr -89.894 43.756 13.628         -94.234 -92.944 -95.670 46.553 






Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH-modulated HSQC 
ns = 40, Δ = 11.60–37.20 ms  
1JNH-modulated HSQC 
ns = 96, Δ = 11.60–37.20 ms 
1JNH-modulated TROSY-HSQC 
ns = 40, Δ = 11.60–37.20 ms 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 
88 Gly -94.353 33.655 14.798             
89 Lys -86.670 32.813 14.906         -93.556 -91.639 -95.954 50.092 
91 Gln -89.955 74.652 45.115         -91.982 -91.584 -92.396 46.691 
95 Tyr -92.458 150.336 89.634 -92.389 -92.220 -92.562 30.518 -92.582 -92.487 -92.678 30.711 -92.367 -92.152 -92.589 30.084 
98 Tyr -95.045 35.365 21.722 -91.868 -90.453 -93.540 41.166 -92.030 -91.385 -92.719 38.903 -93.315 -91.960 -94.848 48.312 
103 Ser -92.329 46.023 26.014 -92.018 -90.685 -93.536 50.555 -91.631 -91.093 -92.202 49.103 -92.440 -91.255 -93.775 43.345 
104 Asp -93.340 78.264 39.698 -93.327 -92.826 -93.855 47.342 -93.131 -92.848 -93.423 45.459 -93.241 -92.681 -93.836 44.963 
105 Tyr -92.429 55.403 18.879 -91.955 -90.700 -93.375 52.137         
106 Gly -95.997 46.981 24.491 -93.315 -92.308 -94.415 48.830 -93.349 -92.571 -94.186 50.319 -93.908 -92.623 -95.365 53.520 
107 Phe -92.296 136.741 44.547 -92.577 -92.187 -92.984 47.522 -92.444 -92.124 -92.776 47.653 -92.716 -92.238 -93.219 47.387 
108 Ser -91.791 81.591 34.344 -92.365 -91.669 -93.116 47.810 -92.772 -92.357 -93.205 45.991 -92.814 -92.110 -93.575 49.567 
109 Tyr -97.368 102.867 37.459 -93.903 -93.373 -94.460 54.714 -93.861 -93.644 -94.083 54.481 -93.631 -93.020 -94.281 53.346 
110 Gly -93.775 76.922 30.554 -94.002 -93.045 -95.049 53.335 -93.626 -92.762 -94.560 54.077 -94.183 -93.387 -95.037 54.617 
111 Ala -92.672 145.094 46.048 -92.022 -91.462 -92.616 51.690 -92.048 -91.770 -92.335 51.976 -92.190 -91.770 -92.631 50.174 
112 Gly -93.819 91.430 36.218 -93.957 -93.488 -94.447 51.847 -94.112 -93.606 -94.644 50.758 -94.155 -93.511 -94.842 49.118 
113 Leu -91.871 110.192 40.729             
114 Gln -92.067 71.718 27.008 -92.463 -91.771 -93.207 49.683 -92.248 -91.721 -92.801 50.117 -93.234 -92.200 -94.381 50.223 
115 Phe -92.474 53.006 14.742 -93.750 -91.525 -96.409 57.534 -92.292 -91.021 -93.728 55.620 -93.324 -91.253 -95.804 56.928 
116 Asn -90.681 64.849 23.883             
118 Met -87.178 102.258 36.855             
119 Glu -89.949 32.702 16.867             
120 Asn -91.865 90.390 35.814 -91.964 -91.344 -92.634 46.922 -91.652 -91.238 -92.086 47.675 -91.621 -90.790 -92.536 49.137 
121 Val -92.281 120.848 39.041 -92.369 -92.051 -92.700 47.721 -92.888 -92.581 -93.205 48.158 -92.793 -92.350 -93.258 47.474 
122 Ala -91.115 68.350 24.402 -93.073 -92.369 -93.825 50.138 -92.691 -92.136 -93.275 52.489 -93.150 -92.341 -94.024 54.550 
123 Leu -90.483 77.925 28.326 -90.634 -89.797 -91.552 52.422 -90.590 -89.946 -91.281 55.238 -90.963 -90.348 -91.622 55.269 






Table C.4: 1JNH of OmpX in DPC from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH-modulated HSQC 
ns = 40, Δ = 11.60–37.20 ms  
1JNH-modulated HSQC 
ns = 96, Δ = 11.60–37.20 ms 
1JNH-modulated TROSY-HSQC 
ns = 40, Δ = 11.60–37.20 ms 
1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 1JNH (Hz) J2.5% J97.5% C 
124 Asp -92.755 74.402 23.627 -93.218 -92.430 -94.068 49.643 -92.415 -91.722 -93.160 56.751 -92.421 -91.550 -93.375 54.867 
125 Phe -94.291 106.016 34.832 -93.380 -92.662 -94.150 49.275 -93.688 -93.290 -94.102 53.165 -93.488 -92.788 -94.235 51.929 
126 Ser -95.413 94.488 30.103 -94.852 -94.245 -95.492 55.294 -95.148 -94.731 -95.580 56.367 -94.597 -93.552 -95.744 54.077 
127 Tyr -91.807 66.322 23.685 -91.798 -91.049 -92.605 55.392         
128 Glu -93.821 49.667 15.876 -93.917 -92.303 -95.784 52.287 -93.300 -92.145 -94.579 52.868 -92.999 -91.989 -94.115 49.651 
129 Gln -92.800 51.795 17.289         -95.360 -93.506 -97.482 57.384 
130 Ser -89.725 49.125 21.703 -93.619 -92.798 -94.497 46.248 -92.749 -92.184 -93.344 48.084 -93.498 -91.929 -95.331 51.746 
131 Arg -92.697 94.538 36.631 -93.846 -93.366 -94.350 46.736 -93.633 -93.206 -94.079 45.023 -93.582 -93.123 -94.063 46.400 
133 Arg -94.124 59.092 21.274 -93.657 -92.250 -95.261 50.057 -94.282 -93.339 -95.308 55.913 -93.660 -92.676 -94.736 50.081 
135 Val -93.301 92.195 37.213 -93.952 -93.535 -94.386 44.416 -93.466 -93.073 -93.876 45.125 -93.534 -92.947 -94.159 44.873 
136 Asp -95.075 54.688 19.965 -92.889 -91.329 -94.684 50.918 -92.621 -91.810 -93.500 54.038 -93.492 -92.196 -94.958 47.136 
137 Val -92.417 58.270 25.068 -93.593 -92.701 -94.560 49.531 -92.630 -91.919 -93.394 49.790 -92.815 -92.115 -93.567 45.405 
138 Gly -92.359 59.091 22.375     -92.393 -91.579 -93.275 51.297 -93.365 -92.098 -94.783 55.164 
139 Thr -92.002 59.330 20.499 -92.664 -91.921 -93.467 49.786 -91.843 -91.118 -92.623 53.434 -93.139 -92.160 -94.208 45.989 
140 Trp -89.204 49.797 16.569     -91.729 -90.807 -92.737 53.643     
141 Ile -91.936 43.569 15.337             
142 Ala -92.791 83.013 23.355 -92.953 -91.841 -94.186 54.697 -93.054 -92.063 -94.137 55.579 -92.992 -92.092 -93.975 51.406 
143 Gly -95.135 82.099 34.743 -93.338 -92.742 -93.972 46.804 -94.034 -93.591 -94.496 49.867 -94.012 -93.290 -94.788 45.902 
144 Val -93.490 100.166 28.957 -92.700 -91.834 -93.646 49.663 -92.240 -91.833 -92.665 55.880 -92.571 -91.672 -93.557 52.413 
145 Gly -94.657 86.308 36.304 -94.720 -93.938 -95.552 54.112 -93.568 -93.241 -93.905 50.418 -94.235 -93.217 -95.343 53.119 
146 Tyr -93.319 67.736 27.492 -91.562 -90.471 -92.794 53.941 -91.904 -91.563 -92.257 48.250 -91.625 -90.356 -93.075 47.349 
147 Arg -91.711 34.368 14.508             
148 Phe -92.337 62.356 21.865 -93.957 -92.630 -95.448 56.202 -92.638 -91.855 -93.480 53.272 -92.932 -91.823 -94.169 55.232 
 






C.3 OmpX in urea 
Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
Conditions: 221 µM 15N-OmpX, 8 M urea or 166 µM 15N-OmpX, 6 M urea, both in 20 mM sodium phosphate (pH 6.5), 0.1 mM NaN3, 5% D2O, 288 K. 
SNR (Add) and SNR (Sub) are the signal-to-noise ratios of peaks in the sub-spectrum obtained by taking the sum or the difference, respectively, of the 
in-phase (IP) and antiphase (AP) spectra. C is the decay rate of the 15N magnetisation as a result of transverse relaxation. J2.5% and J97.5% denote the 2.5% and 
97.5% confidence intervals for the fitted J value, respectively. 
 
Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
2 Thr -92.920 -92.681 -93.169 11.378 -92.848 104.694 95.760 -92.986 117.767 106.509 
3 Ser -93.116 -93.024 -93.209 4.733 -93.060 190.995 166.866 -93.133 167.895 149.431 
4 Thr -92.866 -92.809 -92.924 9.190 -92.970 206.101 130.566 -93.128 161.186 137.356 
5 Val -92.731 -92.659 -92.803 4.679 -92.708 195.983 160.457 -92.832 224.286 187.729 
6 Thr -93.225 -93.012 -93.445 4.862 -93.069 91.840 76.278 -93.152 191.164 158.420 
6b Thr        -93.255 28.013 24.515 
7 Gly -93.888 -93.814 -93.962 4.748 -93.895 239.781 194.992 -94.069 187.395 157.344 
10 Ala -93.185 -93.130 -93.241 5.234 -93.150 289.989 227.081 -93.260 252.862 197.387 
11 Gln -92.712 -92.654 -92.771 5.995 -92.701 293.187 227.012 -92.786 236.940 186.343 
12 Ser -92.904 -92.819 -92.990 6.450 -92.923 256.481 193.816 -93.016 186.947 146.937 
12b Ser        -92.967 21.490 17.252 
13 Asp -93.033 -92.963 -93.104 6.155 -92.970 270.262 203.609 -93.092 220.417 170.848 
14 Ala -93.040 -92.960 -93.122 6.080 -93.086 260.526 198.434 -93.168 213.168 166.287 
14b Ala     -92.839 45.680 34.000 -92.640 30.665 24.073 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
15 Gln -92.779 -92.726 -92.831 5.212 -92.612 195.830 151.106 -92.745 167.196 129.626 
15b Gln     -92.613 31.723 34.676 -93.484 44.058 40.099 
16 Gly        -94.140 132.509 107.008 
17 Gln -92.672 -92.597 -92.747 6.727 -92.568 216.967 159.588 -92.695 165.951 125.694 
17b Gln     -91.256 16.588 18.250 -92.463 38.184 35.660 
17c Gln     -92.337 23.871 24.040 -92.225 11.973 13.427 
18 Met        -93.466 34.488 26.081 
18b Met        -92.726 32.717 27.309 
19 Asn -93.026 -92.885 -93.170 6.943 -92.987 148.148 111.506 -93.164 102.204 79.045 
19b Asn -93.576 -92.917 -94.299 7.373 -92.598 31.143 22.906 -93.416 29.187 22.628 
20 Lys -92.672 -92.518 -92.829 7.740 -92.722 106.615 80.255 -92.935 71.775 55.928 
20b Lys     -93.981 15.237 18.349    
21 Met -92.675 -92.608 -92.743 6.136 -92.602 135.081 105.342 -92.848 98.714 77.910 
21b Met     -92.613 28.840 22.162 -92.741 37.507 28.269 
22 Gly -93.874 -93.728 -94.024 6.434 -93.849 166.959 131.907 -94.031 118.549 92.882 
22b Gly -94.036 -93.200 -94.951 10.447 -93.803 26.168 19.389 -94.564 11.409 9.472 
22c Gly     -93.556 14.729 13.602    
24 Phe -92.623 -92.553 -92.694 7.063 -92.548 202.174 146.535 -92.739 151.716 112.405 
24b Phe     -92.320 26.780 19.050 -92.297 31.302 27.364 
25 Asn -92.953 -92.839 -93.070 8.053 -93.032 153.484 108.270 -93.146 106.335 77.761 
25b Asn     -92.965 25.495 18.861 -93.003 30.545 23.761 
26 Leu -92.784 -92.627 -92.946 8.943 -92.813 146.475 100.622 -92.941 119.374 85.227 
26b Leu -92.616 -92.042 -93.248 11.115 -92.652 46.638 33.425 -92.811 49.430 34.343 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
27 Lys        -92.208 79.808 58.362 
28 Tyr     -92.244 32.565 21.518 -92.859 105.717 73.400 
28b Tyr        -92.853 27.588 19.060 
29 Arg -92.565 -92.407 -92.728 12.113 -92.718 102.471 67.212 -92.758 93.587 61.416 
30 Tyr -92.559 -92.245 -92.891 9.335 -92.621 97.335 65.139 -92.713 85.928 60.995 
31 Glu -92.424 -92.281 -92.571 10.413 -92.620 108.648 73.925 -92.692 101.482 70.763 
31b Glu -92.557 -91.676 -93.592 6.016 -92.383 34.448 26.684 -92.669 38.956 27.021 
32 Glu -92.594 -92.439 -92.752 10.624 -92.507 126.916 87.606 -92.734 112.178 78.832 
32b Glu     -93.198 43.911 36.065 -93.231 46.185 36.894 
33 Asp -92.793 -92.675 -92.914 8.796 -92.859 156.113 103.632 -92.780 143.129 99.034 
34 Asn     -92.727 152.115 107.679 -92.966 138.510 100.722 
35 Ser -93.352 -93.297 -93.408 8.092 -93.259 257.748 172.462 -93.441 232.833 161.674 
37 Leu        -92.753 200.167 147.342 
38 Gly        -94.084 192.090 145.736 
39 Val -92.423 -92.313 -92.536 6.522 -92.393 241.023 165.384 -92.440 214.529 154.199 
40 Ile -92.897 -92.839 -92.956 7.111 -92.867 250.117 172.044 -93.001 228.280 162.328 
41 Gly -94.038 -93.962 -94.115 7.244 -93.973 224.318 163.347 -94.127 191.256 142.520 
42 Ser -92.690 -92.618 -92.763 7.766 -92.685 245.905 169.357 -92.876 192.777 136.218 
43 Phe -92.695 -92.579 -92.813 8.023 -92.716 224.755 160.106 -92.921 182.452 135.121 
43b Phe     -92.321 21.109 15.447 -92.862 28.769 22.275 
43c Phe        -92.961 24.290 23.529 
44 Thr -92.759 -92.622 -92.900 8.490 -92.707 159.755 108.663 -92.872 121.966 87.404 
45 Tyr -92.735 -92.656 -92.815 9.270 -92.777 180.853 117.498 -92.893 147.235 104.105 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
46 Thr -92.724 -92.601 -92.849 10.479 -92.620 143.231 93.325 -92.952 114.472 79.442 
46b Thr     -92.271 12.450 9.053 -92.397 19.835 12.180 
47 Glu -92.726 -92.618 -92.837 9.997 -92.698 199.886 127.660 -92.849 164.665 109.237 
47b Glu     -90.849 18.981 14.532 -92.571 30.238 18.703 
48 Lys -92.718 -92.554 -92.886 8.694 -92.582 115.568 76.964 -92.794 89.702 62.246 
48b Lys     -91.040 11.219 10.579    
49 Ser -93.040 -92.907 -93.175 9.955 -92.811 154.085 107.639 -93.208 103.023 74.317 
49b Ser     -92.564 16.391 12.600    
50 Arg -92.614 -92.534 -92.696 10.170 -92.516 167.144 111.789 -92.776 113.109 78.752 
51 Thr -92.903 -92.779 -93.030 8.737 -92.991 160.561 113.735 -93.019 113.693 84.178 
51b Thr     -91.993 13.371 14.336 -93.109 15.756 13.412 
52 Ala -92.971 -92.869 -93.074 8.455 -92.988 213.941 151.042 -93.137 148.857 109.065 
52b Ala     -92.838 12.943 10.053    
53 Ser -92.803 -92.715 -92.894 7.828 -92.839 194.022 145.060 -92.992 114.095 90.667 
53b Ser     -93.156 16.571 15.824 -92.893 21.305 18.574 
54 Ser -92.934 -92.855 -93.015 9.322 -92.942 194.791 123.357 -93.046 155.707 100.773 
55 Gly -94.136 -93.981 -94.294 6.915 -94.082 178.876 132.803 -94.051 121.282 93.677 
56 Asp -92.802 -92.718 -92.887 7.290 -92.819 228.885 157.231 -92.883 184.253 131.915 
56b Asp     -92.358 20.849 17.732    
57 Tyr -92.726 -92.624 -92.830 7.231 -92.773 181.775 124.714 -92.813 154.609 108.671 
57b Tyr     -91.702 17.918 8.137    
58 Asn -92.978 -92.883 -93.074 9.378 -93.049 138.803 94.488 -93.171 103.049 71.725 
59 Lys -92.941 -92.730 -93.159 10.939 -93.009 95.089 66.882 -92.951 74.049 53.085 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
59b Lys        -92.200 33.290 29.129 
60 Asn -93.020 -92.828 -93.218 10.239 -93.141 148.161 96.873 -93.351 110.456 75.014 
61 Gln -92.584 -92.444 -92.727 7.757 -92.617 168.455 109.434 -92.805 133.107 87.230 
62 Tyr -92.485 -92.292 -92.684 8.673 -92.613 140.119 93.892 -92.662 121.118 80.353 
63 Tyr     -90.725 21.351 17.756 -92.651 110.944 76.712 
64 Gly -93.957 -93.787 -94.132 7.568 -93.927 130.137 91.937 -94.145 108.092 79.711 
65 Ile -92.414 -92.303 -92.527 8.591 -92.306 194.637 130.395 -92.465 174.253 118.363 
66 Thr -92.854 -92.739 -92.970 9.208 -92.931 169.965 114.006 -93.107 128.002 90.302 
66b Thr     -92.510 16.764 13.796 -93.490 14.079 13.104 
66c Thr     -92.704 17.459 13.775    
67 Ala -92.716 -92.628 -92.805 7.740 -92.739 212.685 149.101 -92.993 161.657 115.587 
67b Ala     -93.333 21.042 15.819 -92.636 22.606 15.471 
68 Gly -93.992 -93.877 -94.109 6.533 -93.873 222.434 169.117 -94.042 181.916 139.766 
70 Ala -92.701 -92.633 -92.770 8.809 -92.790 217.129 142.593 -92.899 173.263 117.458 
71 Tyr -92.570 -92.427 -92.716 8.486 -92.532 162.313 106.511 -92.626 131.496 89.484 
72 Arg -92.586 -92.385 -92.794 11.467 -92.505 116.070 71.095 -92.840 104.979 64.026 
73 Ile -92.625 -92.366 -92.900 10.265 -92.450 134.701 82.478 -92.716 125.638 78.198 
74 Asn -92.760 -92.538 -92.990 11.992 -92.786 122.349 74.865 -92.787 94.818 65.605 
74b Asn        -93.601 90.150 66.327 
75 Asp -92.742 -92.621 -92.865 11.359 -92.785 146.684 91.404 -92.923 124.413 82.366 
76 Trp -92.644 -92.394 -92.907 12.674 -92.487 109.692 67.713 -92.766 121.749 78.305 
77 Ala -93.177 -93.021 -93.338 10.724 -93.216 146.297 84.790 -93.135 133.294 78.967 
78 Ser -92.941 -92.764 -93.123 9.867 -92.875 144.242 86.538 -92.879 127.375 78.021 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
79 Ile -92.315 -92.168 -92.466 10.414 -92.606 124.048 77.691 -92.619 118.602 75.462 
80 Tyr -92.498 -92.336 -92.664 11.656 -92.602 131.639 79.581 -92.583 98.459 65.226 
81 Gly -94.052 -93.738 -94.381 9.777 -94.080 121.511 81.228 -94.168 110.277 73.912 
82 Val -92.242 -92.095 -92.393 8.118 -92.225 196.659 128.390 -92.383 174.684 118.729 
83 Val -92.643 -92.577 -92.710 8.662 -92.765 210.798 143.968 -92.844 189.774 132.779 
84 Gly -94.084 -93.961 -94.209 7.711 -93.959 215.296 147.989 -94.075 180.831 126.479 
85 Val -92.443 -92.351 -92.537 7.380 -92.361 247.339 166.484 -92.497 212.671 146.048 
86 Gly -94.029 -93.946 -94.113 7.843 -94.009 216.556 150.675 -94.038 170.551 122.562 
88 Gly -94.080 -93.875 -94.290 7.221 -93.967 189.751 133.826 -94.170 147.934 108.990 
89 Lys -92.502 -92.347 -92.661 8.332 -92.576 128.772 85.038 -92.660 98.564 66.385 
90 Phe -92.786 -92.672 -92.903 8.335 -92.750 196.378 132.466 -92.926 154.626 104.538 
91 Gln -92.765 -92.660 -92.873 9.729 -92.581 185.759 123.827 -92.780 147.712 99.709 
91b Gln        -92.292 9.767 12.077 
92 Thr -92.857 -92.676 -93.045 9.538 -92.819 139.981 92.790 -93.141 101.765 73.236 
92b Thr -94.148 -93.265 -95.128 8.415 -93.331 24.455 16.065 -93.401 18.972 12.590 
93 Thr -92.591 -92.432 -92.754 10.271 -92.675 133.884 83.646 -92.837 101.555 68.678 
94 Glu -92.541 -92.428 -92.656 10.726 -92.576 150.439 102.776 -92.754 123.389 85.424 
94b Glu -92.912 -92.184 -93.733 9.614 -92.888 26.502 19.352 -92.302 21.748 14.287 
95 Tyr -92.990 -92.823 -93.161 11.178 -92.555 117.663 78.774 -92.823 123.592 81.018 
97 Thr -92.439 -92.319 -92.562 9.828 -92.483 133.007 81.106 -92.550 115.009 75.641 
98 Tyr -92.622 -92.407 -92.845 11.271 -92.543 132.077 83.386 -92.838 113.079 75.915 
99 Lys -92.899 -92.603 -93.210 13.320 -92.680 78.065 50.247 -92.907 63.722 42.259 
99b Lys     -93.262 14.337 8.555    






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
100 His     -92.872 58.968 40.493    
101 Asp -92.625 -92.386 -92.876 11.435 -92.684 125.152 82.203    
102 Thr -92.789 -92.673 -92.909 10.195 -92.709 147.974 99.574 -92.857 116.229 79.428 
102b Thr        -93.805 12.874 11.650 
103 Ser -92.840 -92.711 -92.973 9.437 -92.866 157.045 113.628 -93.171 77.908 61.285 
104 Asp -92.819 -92.720 -92.920 7.847 -92.924 197.059 128.258 -92.986 169.219 113.964 
105 Tyr -92.779 -92.659 -92.903 8.641 -92.769 201.816 137.505 -92.781 211.707 145.308 
106 Gly -94.075 -93.965 -94.187 8.097 -93.978 177.765 122.417 -94.102 153.367 111.024 
107 Phe -92.742 -92.651 -92.835 7.884 -92.765 226.065 146.800 -92.704 202.715 135.846 
108 Ser -93.059 -93.006 -93.112 6.824 -92.793 338.087 263.685 -93.013 160.476 112.702 
109 Tyr -92.856 -92.776 -92.938 8.465 -92.794 225.819 154.428 -92.927 196.898 137.943 
109b Tyr     -93.701 19.465 18.427    
110 Gly -94.151 -94.040 -94.263 7.252 -93.977 211.742 154.262 -94.034 174.244 129.090 
111 Ala -92.884 -92.811 -92.957 6.891 -92.854 298.065 206.272 -92.897 248.149 173.975 
112 Gly -94.003 -93.913 -94.095 5.873 -94.088 244.794 185.289 -94.201 206.469 156.081 
113 Leu -92.667 -92.620 -92.715 7.573 -92.657 274.196 190.820 -92.822 247.761 175.381 
113b Leu     -92.602 20.387 12.817    
113c Leu     -92.486 12.761 9.238    
114 Gln        -92.589 238.181 174.987 
114b Gln        -93.884 123.657 105.634 
115 Phe        -92.936 199.355 141.808 
116 Asn -92.931 -92.785 -93.080 8.952 -92.991 188.279 124.497 -93.136 171.913 115.932 
118 Met -92.621 -92.496 -92.750 9.684 -92.575 184.567 114.747 -92.547 171.531 110.999 






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
119 Glu -92.664 -92.528 -92.802 9.597 -92.666 212.117 137.134 -92.721 193.791 129.778 
119b Glu        -92.042 10.160 14.248 
120 Asn -92.747 -92.634 -92.862 9.225 -92.687 207.873 140.764 -92.937 181.064 124.450 
121 Val -92.502 -92.411 -92.594 7.975 -92.470 212.960 144.475 -92.677 197.430 136.434 
122 Ala -93.221 -93.110 -93.333 8.138 -93.165 238.549 154.755 -93.247 221.781 148.625 
123 Leu -92.643 -92.563 -92.723 8.015 -92.576 231.837 157.577 -92.711 218.505 153.282 
123b Leu     -91.508 15.355 20.099    
124 Asp -92.723 -92.630 -92.817 8.561 -92.664 236.352 158.660 -92.576 236.498 176.419 
125 Phe -92.578 -92.475 -92.682 9.316 -92.634 207.085 138.516 -92.778 200.559 134.802 
125b Phe        -91.779 11.729 17.911 
126 Ser -93.082 -92.958 -93.208 10.169 -93.026 199.897 121.787 -93.113 188.195 116.877 
127 Tyr -92.687 -92.581 -92.794 9.971 -92.822 261.775 162.902 -92.904 178.000 110.716 
128 Glu -92.803 -92.712 -92.896 9.477 -92.814 216.161 133.897 -92.949 210.744 133.105 
129 Gln -92.691 -92.602 -92.781 9.931 -92.838 204.150 130.846 -93.486 184.083 132.616 
130 Ser -92.992 -92.914 -93.071 5.189 -92.943 172.922 148.211 -92.995 173.911 113.731 
131 Arg -92.622 -92.519 -92.727 10.285 -92.721 195.753 125.473 -92.876 162.033 107.358 
132 Ile -92.752 -92.651 -92.855 9.455 -92.650 218.278 141.335 -92.814 200.000 131.812 
132b Ile        -92.955 14.100 8.699 
132c Ile        -91.176 10.396 12.513 
133 Arg -92.816 -92.689 -92.945 9.508 -92.851 202.650 132.383 -92.957 181.600 120.557 
133b Arg     -91.966 7.422 14.378    
134 Ser -92.811 -92.733 -92.889 8.675 -92.839 223.380 151.891 -92.953 171.025 117.140 
134b Ser -93.145 -92.781 -93.533 5.799 -93.074 68.609 61.163    






Table C.5: 1JNH of OmpX in 8 M and 6 M urea from SOFAST-IPAP-HSQC and 1JNH-modulated HSQC experiments 
# Resi 
8 M urea 6 M urea 
1JNH-modulated HSQC 
ns = 40, Δ = 22.24–47.84 ms 
SOFAST-IPAP-HSQC 
ns = 64 
SOFAST-IPAP-HSQC 
ns = 64 
1JNH (Hz) J2.5% (Hz) J97.5% (Hz) C 1JNH (Hz) SNR (Add) SNR (Sub) 1JNH (Hz) SNR (Add) SNR (Sub) 
135 Val -92.375 -92.248 -92.505 8.892 -92.289 225.898 151.070 -92.480 207.449 144.085 
136 Asp -92.962 -92.864 -93.061 8.729 -92.979 266.022 179.193 -93.047 243.071 169.583 
138 Gly -94.112 -94.025 -94.201 7.468 -94.096 231.963 160.876 -94.141 204.585 144.843 
139 Thr -92.777 -92.697 -92.858 7.116 -92.635 227.327 156.934 -92.767 196.214 136.831 
140 Trp -92.968 -92.850 -93.088 6.824 -92.795 250.070 177.648 -92.906 219.224 152.445 
140b Trp        -94.001 13.313 12.743 
141 Ile -92.791 -92.656 -92.929 8.945 -92.782 187.218 131.471 -92.879 167.240 119.087 
142 Ala -93.376 -93.300 -93.454 7.357 -93.387 282.246 196.252 -93.518 253.098 178.252 
143 Gly -93.752 -93.638 -93.869 5.421 -93.826 229.170 177.311 -93.927 187.338 143.750 
144 Val -92.479 -92.390 -92.569 5.694 -92.408 269.192 195.896 -92.461 235.834 172.912 
145 Gly -93.924 -93.840 -94.010 5.595 -93.973 252.670 193.749 -94.031 207.622 160.202 
146 Tyr -92.724 -92.669 -92.780 5.748 -92.683 291.632 218.242 -92.784 254.561 192.169 
147 Arg -92.728 -92.662 -92.794 5.765 -92.683 261.879 203.471 -92.750 223.892 175.991 
147b Arg     -93.351 28.288 18.901    
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